0000948830-16-000099.txt : 20160204 0000948830-16-000099.hdr.sgml : 20160204 20160204114623 ACCESSION NUMBER: 0000948830-16-000099 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 57 CONFORMED PERIOD OF REPORT: 20151231 FILED AS OF DATE: 20160204 DATE AS OF CHANGE: 20160204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BION ENVIRONMENTAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000875729 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 841176672 STATE OF INCORPORATION: CO FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-19333 FILM NUMBER: 161387433 BUSINESS ADDRESS: STREET 1: C/O BOX 566 STREET 2: 1774 SUMMITVIEW WAY CITY: CRESTONE STATE: CO ZIP: 81131 BUSINESS PHONE: (212) 758-6622 MAIL ADDRESS: STREET 1: C/O BOX 566 STREET 2: 1774 SUMMITVIEW WAY CITY: CRESTONE STATE: CO ZIP: 81131 FORMER COMPANY: FORMER CONFORMED NAME: RSTS CORP DATE OF NAME CHANGE: 19930328 10-Q 1 bion12311510q.htm BION ENVIRONMENTAL TECH 12-31-15 10-Q Converted by EDGARwiz

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended December 31, 2015


o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934


For the transition period from _______ to _________


Commission File No. 000-19333


Bion Environmental Technologies, Inc.

(Name of registrant in its charter)


Colorado

84-1176672

(State or other jurisdiction of incorporation or formation)

   

(I.R.S. employer identification number)


Box 566 / 1774 Summitview Way

Crestone, Colorado  81131

(Address of principal executive offices)

 

(212) 758-6622

(Registrants telephone number, including area code) 


Not Applicable

(Former name, former address and former fiscal year, if changed since last report)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

x  Yes   o  No


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).       x  Yes  o  No


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.




Large accelerated filer   o


Accelerated filer  o




Non-accelerated filer     o  

(Do not check if a smaller reporting company)


Smaller reporting company  x



SEC 1296 (03-10) Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    o Yes  x   No








APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS: Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.   Not applicable.

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date.  On February 1, 2016, there were 22,967,245 Common Shares issued and 22,262,936 Common Shares outstanding.









































2







BION ENVIRONMENTAL TECHNOLOGIES, INC.


FORM 10-Q


TABLE OF CONTENTS


PART I.  FINANCIAL INFORMATION


Page





Item 1.

Financial Statements



5


Consolidated financial statements (unaudited):




  Balance sheets


5


  Statements of operations


6


  Statement of changes in equity (deficit)


7


  Statements of cash flows


8


  Notes to unaudited consolidated financial statements


9-25





Item 2.

Management's Discussion and Analysis of Financial Condition

and Results of Operations


26





Item 3.

Quantitative and Qualitative Disclosures about Market Risk


43





Item 4.

Controls and Procedures


44





PART II.  OTHER INFORMATION







Item 1.

Legal Proceedings


45





Item 1A.

Risk Factors


45





Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds


45





Item 3.

Defaults Upon Senior Securities


45





Item 4.

Mine Safety Disclosures


45





Item 5.

Other Information


45





Item 6.

Exhibits


46






Signatures


47












3






FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements, within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), that involve substantial risks and uncertainties.  Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "will," "expect," "intend," "estimate," "anticipate," "project," "predict," "plan," "believe" or "continue" or the negative thereof or variations thereon or similar terminology.  The expectations reflected in forward-looking statements may prove to be incorrect.




















4








PART I FINANCIAL INFORMATION


BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS
















December 31,



June 30,






2015



2015



(Unaudited)




ASSETS






Current assets:







Cash

$

178,451 


$

339,286 


Promissory note receivable (Note 4)


35,000 




Prepaid expenses


12,350 



18,503 


Subscription receivable (Note 9)




13,125 


Deposits and other receivables


7,108 



7,108 



Total current assets



232,909 



378,022 










Property and equipment, net (Note 3)


1,829,508 



1,977,219 



Total assets


$

2,062,417 


$

2,355,241 










LIABILITIES AND EQUITY (DEFICIT)















Current liabilities:







Accounts payable and accrued expenses

$

1,479,267 


$

1,353,168 


Series B Redeemable Convertible Preferred stock, $0.01 par value,







   50,000 shares authorized; 200 shares issued and outstanding,







   liquidation preference of $29,000 and $28,000, respectively


26,400 



25,400 


Notes payable affiliates, net of discount (Note 5)




472,230 


Deferred compensation (Note 6)


1,170,731 



839,288 


Loan payable (Note 7)


7,754,000 



7,754,000 



Total current liabilities



10,430,398 



10,444,086 











Convertible notes payable affiliates, net of current portion (Note 8)



3,218,648 



2,654,708 



Total liabilities



13,649,046 



13,098,794 










Deficit:








 

Bion's stockholders' equity (deficit):







Series A Preferred stock, $0.01 par value, 10,000 shares authorized,







   no shares issued and outstanding





Series C Convertible Preferred stock, $0.01 par value,







   60,000 shares authorized; no shares issued and outstanding






Common stock, no par value, 100,000,000 shares authorized, 22,855,964






   and 22,089,650 shares issued, respectively; 22,151,655 and







   21,385,341 shares outstanding, respectively





Promissory note receivable for shares (Notes 4 and 9)


(71,878)




Additional paid-in capital


101,747,327 



100,889,127 


Accumulated deficit


(113,322,889)



(111,696,060)



Total Bions stockholders deficit



(11,647,440)



(10,806,933)


Noncontrolling interest


60,811 



63,380 



Total deficit



(11,586,629)



(10,743,553)



Total liabilities and deficit


$

2,062,417 


$

2,355,241 


See notes to consolidated financial statements.




5




BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

THREE AND SIX MONTHS ENDED DECEMBER 31, 2015 AND 2014

(UNAUDITED)




Three Months Ended

December 31,


Six Months Ended

December 31,



2015


2014


2015


2014














Revenue


$


$


$


$














Operating expenses:













  General and administrative (including stock-

    based compensation (Note 9))



550,095 



333,196 



1,058,000 



690,537 

  Depreciation



76,083 



127,159 



151,962 



312,043 

  Research and development (including stock-

    based compensation (Note 9))



84,286 



104,237 



218,775 



170,823 














Total operating expenses



710,464 



564,592 



1,428,737 



1,173,403 














Loss from operations



(710,464)



(564,592)



(1,428,737)



(1,173,403)














Other expense:













  Interest expense, net



86,405 



100,356 



200,661 



197,303 

















86,405 



100,356 



200,661 



197,303 














Net loss



(796,869)



(664,948)



(1,629,398)



(1,370,706)














Net loss attributable to the noncontrolling

  interest



1,274 



1,028 



2,569 



2,099 














Net loss attributable to Bion



(795,595)



(663,920)



(1,626,829)



(1,368,607)














Dividends on preferred stock



(500)



(500)



(1,000)



(1,000)














Net loss applicable to Bion's common

  stockholders


$

(796,095)


$

(664,420)


$

(1,627,829)


$

(1,369,607)














Net loss applicable to Bion's common

  stockholders per basic and  diluted common

  share


$

(0.03)


$

(0.03)


$

(0.07)


$

(0.07)

 













Weighted-average number of common shares

  outstanding:













  Basic and diluted



22,585,001 



19,965,459 



22,437,039 



19,891,267 



See notes to consolidated financial statements.












6






BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

SIX MONTHS ENDED DECEMBER 31, 2015

(UNAUDITED)

























Bions Shareholders






Series C Preferred Stock


Common Stock


 


 


 


 


 


Shares


Amount


Shares


Amount


Additional

Paid-in Capital


Promissory Note

Receivable for

Shares



Accumulated

Deficit


Non-

controlling

Interest


Total

Equity/

(Deficit)
























Balances, July 1, 2015


$


22,089,650


$


$

100,889,127 


$             - 


$

(111,696,060)


$  63,380 


$

(10,743,553)


























Issuance of common stock for services




36,296





100,904 







100,904 


Vesting of options for services

 - 








89,640 







89,640 


Modification of options








42,550 







42,550 


Sale of units




228,750





183,000 







183,000 


Commissions on sale of units








(18,300)







(18,300)


Warrants exercised for common stock




292,394





289,689 


(71,878)






217,811 


Dividend on Series B preferred stock




-





(1,000)







(1,000)


Conversion of debt




208,874





171,717 







171,717 


Net loss







(1,626,829)


(2,569)


(1,629,398)


Balances, December 31, 2015


$


22,855,964


$


$

101,747,327 


$  (71,878)


$

(113,322,889)


$  60,811 


$

(11,586,629)


See notes to consolidated financial statements.
















7





BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

SIX MONTHS ENDED DECEMBER 31, 2015 AND 2014 (UNAUDITED)













2015



2014










CASH FLOWS FROM OPERATING ACTIVITIES








  Net loss


$

(1,629,398)


$

(1,370,706)


  Adjustments to reconcile net loss to net cash used in operating

   activities:








    Depreciation expense



151,962 



312,043 


    Accrued interest on deferred compensation and other



200,940 



189,573 


    Stock-based compensation



233,094 



31,043 


    Decrease in prepaid expenses



6,153 



5,341 


    Increase in accounts payable and accrued expenses



27,351 



225,779 


    Increase in deferred compensation and convertible notes



490,800 



312,000 










      Net cash used in operating activities



(519,098)



(294,927)










CASH FLOWS FROM INVESTING ACTIVITIES








  Purchase of property and equipment



(4,251)




      Net cash used in investing activities



(4,251)












CASH FLOWS FROM FINANCING ACTIVITIES








  Decrease in subscription receivable



13,125 



30,000 


  Proceeds from sale of common stock





26,250 


  Proceeds from sale of units



183,000 



67,500 


  Commissions on sale of units



(18,300)




  Payment from exercise of warrants



184,689 












      Net cash provided by financing activities



362,514 



123,750 










Net decrease in cash



(160,835)



(171,177)










Cash at beginning of period



339,286 



186,148 










Cash at end of period


$

178,451 


$

14,971 










Supplemental disclosure of cash flow information:








  Cash paid for interest


$


$










Non-cash investing and financing transactions:








  Series B preferred  stock dividends accrued


$

1,000 


$

1,000 


  Issuance of common stock to satisfy deferred compensation


$

171,717 


$


  Exercise of warrants for promissory note receivable for shares


$

105,000 


$



See notes to consolidated financial statements.










8





BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015


1.

ORGANIZATION, NATURE OF BUSINESS, GOING CONCERN AND MANAGEMENTS PLANS:

Organization and nature of business:

Bion Environmental Technologies, Inc. (Bion or We or the "Company") was incorporated in 1987 in the State of Colorado and has developed and continues to develop patented and proprietary technology and business models that provide comprehensive environmental solutions to a significant source of pollution in United States agriculture, large scale livestock facilities known as Confined Animal Feeding Operations ("CAFO's"). Bion's technologies (and applications related thereto) produce substantial reductions of nutrient releases (primarily nitrogen and phosphorus) to both water and air (including ammonia, which is subsequently re-deposited to the ground) from livestock waste streams based upon our operations and research to date (and third party peer review thereof). We are continually involved in research and development to upgrade and improve our technology and technology applications, including integration with third party technology.  Bion provides comprehensive and cost-effective treatment of livestock waste onsite (and/or at nearby locations), while it is still concentrated and before it contaminates air, soil, groundwater aquifers and/or downstream waters, and, in certain configurations, recovers nutrients for potential use as fertilizer and feed additives.

During the 2014 and 2015 fiscal years, the Company increased its research and development activities with focus on augmenting the basic separate and aggregate approach of its technology platform to provide additional flexibility and to increase recovery of nutrient by-products (in organic and non-organic forms) and renewable energy production (either/both biogas and/or renewable electricity), thereby increasing potential related revenue streams and reducing dependence of its future projects on nutrient reduction credits (which still remain a very important part of project revenue streams).  This research and development effort also involves ongoing review of potential add-ons and applications to our technology platform for use in different regulatory and/or climate environments.  These research and development activities continued through the balance of the 2015 fiscal year, and we believe such activities will continue at least through the 2016 fiscal year, subject to availability of adequate financing for the Companys operations, of which there is no assurance.

Bion is  actively pursuing business opportunities in three broad areas 1) installation of Bion systems to retrofit and environmentally remediate existing CAFOs to reduce nutrient (primarily nitrogen and phosphorus) releases, gaseous emissions (ammonia, greenhouse gases, volatile organic compounds, etc.), and pathogens, hormones and other compounds in order to clean the air and water in the surrounding areas (as described below) to ensure compliance with existing (and future) regulations and to permit herd expansion; 2) development of Integrated Projects opportunities within the United States and internationally; and 3) licensing and/or joint venturing of Bions technology and applications outside North America. The opportunities described at 1) and 2) above (and below) each require substantial political and regulatory (federal, state and local) efforts on the part of the Company and a substantial part of Bions efforts are focused on such political and regulatory matters.  The most intense focus is currently on the requirements for the clean-up of the Chesapeake Bay faced by the Commonwealth of Pennsylvania and the potential use of Bions technology and technology platform on CAFOs as an alternative to what the Company believes is far more expensive nutrient removal downstream in storm water projects.


9


BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

Management believes that Bion's technology platform (including utilization of various third party technologies to supplement the Companys proprietary technologies), in addition to utilization for remediation of the waste streams of existing CAFOs, can enable the integration of large-scale  CAFO's and their end-product users, renewable energy production from the CAFO waste stream, on site utilization of the renewable energy generated and biofuel/ethanol production in an environmentally and economically sustainable manner while reducing the aggregate capital expense and operating costs for the entire integrated complex ("Integrated Projects" or "Projects"). In the context of Integrated Projects, Bion's waste treatment process, in addition to mitigating polluting releases, enables generation of renewable energy from cellulosic portions of the CAFO waste stream, which renewable energy can be utilized by integrated facilities including ethanol plants, CAFO end-product processors (including cheese, ice cream and/or bottling plants in the case of dairy CAFOs and/or slaughter and/or processing facilities in the context of beef CAFOs) and/or other users as a fossil fuel replacement. The nutrients (primarily nitrogen and phosphorus) can be harvested from the solids and liquid streams recovered from the livestock waste stream and can be utilized as either high value fertilizer and/or the basis for high protein animal feed and the nutrient rich effluent can potentially be utilized in integrated hydroponic agriculture and/or field applied as fertilizer.  Bion believes that its Integrated Projects will produce high quality, traceable animal protein which can address consumer food safety/security concerns at a lower cost than current industry practices while also maintaining  a far lower net environmental footprint per unit of protein produced due to water recycling (possible due to the removal of nutrients, etc. from the water by Bions technology applications), production of renewable energy from the waste stream (reducing the use of fossil fuels), and multiple levels of economies of scale, co-location and integration savings in transportation and other logistics. Some projects may involve only partial integration which will limit the benefits described herein.

On September 27, 2008, the Company executed an agreement with Kreider Farms (and its affiliated entities) (collectively "Kreider") to design, construct and operate (through its wholly-owned subsidiaries, Bion Services Group, Inc. (Bion Services) and Bion PA-1 LLC (PA-1) a Bion system to treat the waste of 1,200 milking dairy cows (milkers, dry cows and heifers) at the Kreider Dairy, located in Manheim, Pennsylvania. In addition, the agreement (as amended and supplemented) provides for a second phase which will treat the wastes from the rest of Kreiders herd and includes renewable energy production from the cellulosic solid wastes from the Phase 1 system (referred to as Kreider 1) together with the waste stream from Kreiders poultry facilities for use at the facilities and/or for market sales. The Kreider projects are owned and operated by Bion through subsidiaries, in which Kreider has the option to acquire a noncontrolling interest. Substantial capital (equity and/or debt) has been and will continue to be expended on these projects.  Additional funds will be required for continuing operations of Kreider 1 until sufficient revenues can be generated, of which there is no assurance. The Company anticipates that the Kreider 1 project will generate revenue primarily from the sale of nutrient reduction (and/or other) environmental credits while the Kreider Phase 2 poultry waste treatment system (Kreider 2)(not yet constructed) and other future projects will supplement its revenue from nutrient reductions with proceeds from multiple byproduct streams including i) feed additives and/or fertilizer (organic and non-organic) and ii) renewable energy (and related credits),  which sales are projected to generate, in aggregate,  revenue streams that, in certain circumstances, may approach 50% of total revenues.  To date the market for long-term nutrient reduction credits in Pennsylvania has been very slow to develop and the Companys activities have been negatively affected by the lack of such development.  A portion of Bions research and development activities is currently taking place at the Kreider 1 facility.

10


BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

The Companys subsidiary PA-1 financed Kreider 1 through a $7.8 million loan (Pennvest Loan) from Pennsylvania Infrastructure Investment Authority (Pennvest) secured by Kreider 1 (and its revenue streams, if any) plus advances from the Company. The economics (potential revenues and profitability) of Kreider 1 are based largely on the long-term sale of nutrient reduction credits (nitrogen and/or phosphorus) to meet the requirements of the Chesapeake Bay environmental clean-up.  The Pennsylvania Department of Environmental Protection (PADEP) issued final permits for Kreider 1 (including the credit verification plan) on August 1, 2012 on which date the Company deemed that Kreider 1 was placed in service.  However, liquidity in the Pennsylvania nutrient credit market has been slow to develop significant breadth and depth and has prevented Bion from monetizing the nutrient reduction credits created by PA-1s Kreider 1 project and Bions other proposed projects. These challenges and difficulties raise significant questions as to when PA-1 will be able to generate such revenues from Kreider 1.  PA-1 has elected not to make interest or principal payments on the Pennvest Loan since January 2013 and, therefore, the Company has classified the Pennvest Loan as a current liability as of December 31, 2015.  The Company recorded a $1,750,000 impairment of the Kreider 1 assets for the year ended June 30, 2015 (following a $2,000,000 impairment during the year ended June 30, 2014).

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA-1 did not make the payment and does not have the resources to make the payment demanded by Pennvest.  PA-1 has engaged in on/off discussions and negotiations with Pennvest concerning this matter but no such discussions/negotiations are currently active.  Neither party has any formal proposal on the table as of the date of this report. It is not possible at this date to predict the outcome of such negotiations, but the Company believes it is possible that an agreement may yet be reached that will result in a viable loan modification. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA-1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days.

During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the technology guaranty standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1.

Development work and technology evaluation, including amended credit certification and discussions with potential joint venture partners, continues related to the details of Kreider 2, which primarily relates to treatment of the wastes from Kreiders poultry operations. Assuming there are positive developments related to the market for nutrient reductions in Pennsylvania, the Company intends to pursue development, design and construction of the Kreider 2 poultry waste/renewable energy project with a goal of achieving operational status during calendar year 2017.  However, as discussed above, this project faces challenges related to the current limits of the existing nutrient reduction market and funding of technology-based, verifiable agricultural nutrient reductions which are anticipated to constitute the largest share of its revenues.

A significant portion of Bions activities concern efforts with private and public stakeholders (at local and state level) in Pennsylvania (and other Chesapeake Bay and Midwest and Great Lakes states) and  at the federal level (the Environmental Protection Agency (EPA) and the Department of Agriculture (USDA) (and other executive departments) and Congress) to establish appropriate public policies which will create regulations and funding mechanisms that foster installation of the low cost environmental solutions that Bion (and others) can provide through clean-up of agricultural waste streams.  The Company anticipates that such efforts will continue in Pennsylvania throughout the next 12 months and in various additional states thereafter.  

11



BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

Going concern and managements plans:

The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has not generated significant revenues and has incurred net losses (including significant non-cash expenses) of approximately $5,640,000 and $5,762,000 during the years ended June 30, 2015 and 2014, respectively, and a net loss of approximately $1,629,000 during the six months ended December 31, 2015.  At December 31, 2015, the Company has a working capital deficit and a stockholders deficit of approximately $10,197,000 and $11,647,000, respectively.  These factors raise substantial doubt about the Company's ability to continue as a going concern.  The accompanying consolidated financial statements do not include any adjustments relating to the recoverability or classification of assets or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.  The following paragraphs describe managements plans with regard to these conditions.  

The Company continues to explore sources of additional financing to satisfy its current operating requirements as it is not currently generating any significant revenues.

During the years ended June 30, 2015 and 2014, the Company received total proceeds of $1,000,940 and $944,400, respectively, from the sale of its equity securities. Proceeds during the 2015 and 2014 fiscal years have been lower than in earlier years which reduction has negatively impacted the Companys business development efforts.  

During the six months ended December 31, 2015, the Company entered into subscription agreements to exercise certain warrants with expiry dates on or before December 31, 2015, into restricted shares of the Companys common stock at a reduced exercise price of $1.05, for the period from June 30, 2015 through July 15, 2015.   Pursuant to the offering, 265,894 warrants were exercised and 265,894 shares of the Companys restricted common stock were issued during the six months ended December 31, 2015, resulting in cash proceeds of $174,189 and receipt of a $105,000 interest bearing, collateralized promissory note receivable for shares.  In January 2016, the Company received $35,000 of the promissory note receivable for shares.

During the six months ended December 31, 2015, the Company sold units of the Companys restricted securities for $0.80 per unit, with each unit consisting of one share of the Companys restricted common stock and one warrant to purchase one half of a share of the Companys restricted common stock for $1.10 per share until June 30, 2017.  During the six months ended December 31, 2015, the Company had sold a total of 228,750 units for gross proceeds of $183,000, and net proceeds of $164,700 after commissions of $18,300.  

During fiscal years 2015 and 2014 and through the six months ended December 31, 2015, the Company experienced greater difficulty in raising equity funding than in the prior years.  As a result, the Company faced, and continues to face, significant cash flow management challenges due to working capital constraints. To partially mitigate these working capital constraints, the Companys core senior management and several key employees and consultants have been deferring (and continue to defer) all or part of their cash compensation and/or are accepting compensation in the form of securities of the Company (Notes 6 and 8) and members of the Companys senior management have made loans to the Company.  Additionally, the Company made reductions in its personnel during the year ended June 30, 2014.  The constraint on available resources has had, and continues to have, negative effects on the pace and scope of the Companys efforts to develop its business.

12


BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

The Company has had to delay payment of trade obligations and has had to economize in many ways that have potentially negative consequences. If the Company does not have greater success in its efforts to raise needed funds during the balance of the 2016 fiscal year (and subsequent periods), management will need to consider deeper cuts (including additional personnel cuts) and curtailment of operations (including possibly Kreider 1 operations) and/or research and development activities.

The Company will need to obtain additional capital to fund its operations and technology development, to satisfy existing creditors, to develop Integrated Projects and CAFO waste remediation systems (including the Kreider 2 facility) and to continue to operate the Kreider 1 facility. The Company anticipates that it will seek to raise from $2,500,000 to $50,000,000 or more debt and/or equity through joint ventures and/or sale of its equity securities  (common, preferred and/or hybrid) and/or debt (including convertible) securities, and/or through use of rights and/or warrants (new and/or existing)  during the next twelve months.  However, as discussed above, there is no assurance, especially in light of the difficulties the Company has experienced in recent periods and the extremely unsettled capital markets that presently exist (especially for small companies), that the Company will be able to obtain the funds that it needs to stay in business, complete its technology development or to successfully develop its business and projects.

There is no realistic likelihood that funds required during the next twelve months or in the periods immediately thereafter for the Companys basic operations and/or proposed projects will be generated from operations.  Therefore, the Company will need to raise sufficient funds from external sources such as debt or equity financings or other potential sources. The lack of sufficient additional capital resulting from the inability to generate cash flow from operations and/or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Further, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significantly dilutive effect on the Company's existing shareholders.  All of these factors have been exacerbated by the extremely limited and unsettled credit and capital markets presently existing for small companies like Bion.

2.

SIGNIFICANT ACCOUNTING POLICIES

Principles of consolidation:

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Bion Integrated Projects Group, Inc. (Projects Group), Bion Technologies, Inc., BionSoil, Inc., Bion Services,  PA-1, and Bion PA 2 LLC; and its 58.9% owned subsidiary, Centerpoint Corporation (Centerpoint).  All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying consolidated financial statements have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (SEC).  The consolidated financial statements reflect all adjustments (consisting of only normal recurring entries) that, in the opinion of management, are necessary to present fairly the financial position at December 31, 2015, and the results of operations and cash flows of the Company for the three and six months ended December 31, 2015 and 2014.  Operating results for the three and six months ended December 31, 2015 are not necessarily indicative of the results that may be expected for the year ending June 30, 2016.


13


BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

Property and equipment:

Property and equipment are stated at cost and are depreciated, when placed into service, using the straight-line method over the estimated useful lives of the related assets, generally three to twenty years.  The Company capitalizes all direct costs and all indirect incrementally identifiable costs related to the design and construction of its Integrated Projects.  The Company reviews its property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  An impairment loss would be recognized based on the amount by which the carrying value of the assets or asset group exceeds its estimated fair value, and is recognized as a loss from operations.

Fair value measurements:

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market.  The Company uses a fair value hierarchy that has three levels of inputs, both observable and unobservable, with use of the lowest possible level of input to determine fair value.

Level 1 quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 2 observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and

Level 3 assets and liabilities whose significant value drivers are unobservable.

Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Companys market assumptions.  Unobservable inputs require significant management judgment or estimation.  In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy.  In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement.  Such determination requires significant management judgment.  

The fair value of cash, promissory note receivable and accounts payable approximates their carrying amounts due to their short-term maturities.  The fair value of the loan payable approximates its carrying amount as it bears interest at rates commensurate with market rates.  The fair value of the redeemable preferred stock approximates its carrying value due to the dividends accrued on the preferred stock which are reflected as part of the redemption value.  The fair value of deferred compensation and convertible notes payable - affiliates are not practicable to estimate due to the related party nature of the underlying transactions.

Revenue Recognition:

Revenues are generated from the sale of nutrient reduction credits.  The Company recognizes revenue from the sale of nutrient credits when there is persuasive evidence that an arrangement exists, when title has passed, the price is fixed or determinable, and collection is reasonably assured.

The Company expects that technology license fees will be generated from the licensing of Bions integrated system.  The Company anticipates that it will charge its customers a non-refundable up-front technology license fee, which will be recognized over the estimated life of the customer relationship.  In addition, any on-going technology license fees will be recognized as earned based upon the performance requirements of the agreement.  Annual waste treatment fees will be recognized upon receipt.  Revenues, if any, from the Companys interest in Integrated Projects will be recognized when the entity in which the Integrated Project has been developed recognizes such revenue.

14


BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

Loss per share:

Basic loss per share amounts are calculated using the weighted average number of shares of common stock outstanding during the period.  Diluted loss per share assumes the conversion, exercise or issuance of all potential common stock instruments, such as options or warrants, unless the effect is to reduce the loss per share.  During the six months ended December 31, 2015 and 2014, the basic and diluted loss per share was the same, as the impact of potential dilutive common shares was anti-dilutive.

The following table represents the warrants, options and convertible securities excluded from the calculation of diluted loss per share:



December 31,

2015


December 31,

2014

Warrants

8,396,364


7,757,653

Options

4,513,870


3,911,370

Convertible debt

7,562,213


5,583,740

Convertible preferred stock

14,500


13,500


The following is a reconciliation of the denominators of the basic loss per share computations for the three and six months ended December 31, 2015 and 2014:




Three months

ended

December 31,

2015

Three months

ended

December 31,

2014

Six months

ended

December 31,

2015

Six months

ended

December 31,

2014

Shares issued beginning of period

22,606,852   

19,787,068  

22,089,650   

19,576,619   

Shares held by subsidiaries (Note 9)

(704,309)  

(704,309)  

(704,309)  

(704,309)  

Shares outstanding beginning of period

21,902,543   

19,082,759   

21,385,341   

18,872,310   

Weighted average shares for fully

    vested  stock bonuses (Note 9)


652,989   


840,000   


626,495   


840,000   

Weighted average shares issued

    during the  period


29,469   


42,700   


425,203   


178,957   

Basic weighted average shares

    end of   period


22,585,001   

19,965,459   


22,437,039   


19,891,267   


Recent Accounting Pronouncements:

The Company continually assesses any new accounting pronouncements to determine their applicability.  When it is determined that a new accounting pronouncement affects the Companys financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Companys financial statements properly reflect the change.  

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09 Revenue from Contracts from Customers,  which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605), and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services.  ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017 and early adoption is not permitted.  The Company is currently evaluating the new standard and assessing the potential impact on its operations and financial statements.  


15



BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements Going Concern: Disclosures of Uncertainties about an Entitys Ability to Continue as a Going Concern.  The new standard requires management to perform interim and annual assessments of an entitys ability to continue as a going concern within one year of the date the financial statements are issued.  An entity must provide certain disclosures if conditions or events raise substantial doubt about the entitys ability to continue as a going concern.  The guidance is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early application is permitted.  The Company believes that the adoption of ASU No. 2014-15 will not have a material impact on its financial statements.

3.

PROPERTY AND EQUIPMENT:

Property and equipment consists of the following:



December 31,

2015


June 30,

2015

Machinery and equipment


$2,923,577  


$2,923,577  

Buildings and structures


1,385,125  


1,385,125  

Computers and office equipment


177,931  


175,248  



4,486,633  


4,483,950  

Less accumulated depreciation


(2,657,125) 


(2,506,731) 



$1,829,508  


$1,977,219  

Management reviewed property and equipment for impairment as of June 30, 2015 and determined that the carrying amount of property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits.  Kreider 1 was measured at estimated fair value on a non-recurring basis using level 3 inputs, which resulted in an impairment of $1,750,000 of the property and equipment for the year ended June 30, 2015.  As of December 31, 2015, management believes that no additional impairment exists.

Depreciation expense was $76,083 and $127,159 for the three months ended December 31, 2015 and 2014, respectively, and $151,962 and $312,043 for the six months ended December 31, 2015 and 2014, respectively.

4.

PROMISSORY NOTE RECEIVABLE:

During the six months ended December 31, 2015, the Company received an interest bearing, secured promissory note for $105,000.  The promissory note bears interest at 4% per annum, is collateralized, and was payable on January 31, 2016.  The promissory note receivable was issued as consideration for an unaffiliated investors subscription agreement to exercise warrants into 100,000 restricted common shares of the Companys common stock at $1.05 per share.  During January 2016, the Company received a $35,000 principal payment and entered into a new agreement with the borrowers which extended the maturity date of the remaining principal and interest until June 15, 2016.  All the other terms of the original agreement remain unchanged.  As of December 31, 2015, the Company has recorded the $35,000 as a promissory note receivable and the remaining unpaid principal and interest totaling $71,878, as a promissory note receivable for shares.  The Company recorded interest income of $1,878 for the six months ended December 31, 2015.


16



BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

5.

NOTES PAYABLE - AFFILIATES:

During the year ended June 30, 2015, the Company entered into promissory notes (FY2015 Promissory Notes), with effective dates of January 1, 2015, for initial principal amounts of $395,277, $15,956 and $80,764, with Dominic Bassani (Bassani), the Companys Chief Executive Officer (CEO), Edward Schafer (Schafer), the Companys Vice Chairman, and a major shareholder, (Shareholder), respectively.  The FY2015 Promissory Notes accrued interest at 4% per annum and were payable on December 31, 2015.  Effective September 8, 2015, the Company entered into new convertible promissory notes (September 2015 Convertible Notes) with Bassani, Schafer and Shareholder which replaced the FY2015 Promissory Notes. The initial principal balances of the September 2015 Convertible Notes were $405,831, $16,382 and $82,921, respectively. The new convertible promissory notes bear interest at 4% per annum, have maturity dates of December 31, 2017 and may be converted (at the sole election of the noteholders) into restricted common shares of the Company at a conversion price of $0.60 per share (Note 8).  

6.

DEFERRED COMPENSATION:

The Company owes deferred compensation to various employees, former employees and consultants totaling $1,170,731 as of December 31, 2015.  Included in the deferred compensation balances as of December 31, 2015, are $378,852, $54,632 and $183,316 owed Bassani, Smith and Schafer, respectively, pursuant to extension agreements effective January 1, 2015, whereby unpaid compensation earned after January 1, 2015, accrues interest at 4% per annum and can be converted into shares of the Companys common stock at the election of the employee during the first five calendar days of any month.  The conversion price shall be the average closing price of the Companys common stock for the last 10 trading days of the immediately preceding month.  During the six months ended December 31, 2015, Smith converted $82,861 of deferred compensation into 99,159 shares of the Companys common stock at conversion prices between $0.76 and $0.96 per share.  Also included are sums the Company owes various consultants, pursuant to various agreements, for deferred compensation of $312,447 as of December 31, 2015 with similar conversion terms as those described above for Bassani, Smith and Schafer, with the exception that the interest accrues at 3% per annum.  The Company also owes a former employee and a current employee deferred compensation of $168,000 and $984, respectively, which is convertible into 226,168 and 1,131 shares, respectively, of the Companys common stock as of December 31, 2015 and, the Company owes a former employee $72,500, which is not convertible and is non-interest bearing.

7.

LOAN PAYABLE:

As of December 31, 2015, PA-1, the Companys wholly-owned subsidiary, owes $7,754,000 under the terms of the Pennvest Loan related to the construction of the Kreider 1 System.  The terms of the Pennvest Loan provide for funding of up to $7,754,000 which is to be repaid by interest-only payments for three years, followed by an additional ten-year amortization of principal.  The Pennvest Loan accrues interest at 2.547% for years 1 through 5 and 3.184% for years 6 through maturity.  The Pennvest Loan requires minimum annual principal payments of approximately $574,000 in fiscal year 2013, $704,000 in fiscal year 2014, $723,000 in fiscal year 2015, $741,000 in fiscal year 2016, $760,000 in fiscal year 2017 and $4,252,000 thereafter.  The Pennvest Loan is collateralized by the Kreider 1 System and by a pledge of all revenues generated from Kreider 1 including, but not limited to, revenues generated from nutrient reduction credit sales and by-product sales. In addition, in consideration for the excess credit risk associated with the project, Pennvest is entitled to participate in the profits from Kreider 1 calculated on a net cash flow basis, as defined.  The Company has incurred interest expense related to the Pennvest Loan of $49,373 for both of the three months ended December 31, 2015 and 2014, respectively.

17



BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

The Company has incurred interest expense related to the Pennvest Loan of $98,747 for both of the six months ended December 31, 2015 and 2014, respectively.  As of December 31, 2015, the accrued interest and late charges related to the Pennvest Loan total $693,332.  Based on the limited development of the depth and breadth of the Pennsylvania nutrient reduction credit market to date, PA-1 has commenced negotiations with Pennvest related to forbearance and/or re-structuring the obligations under the Pennvest Loan. In the context of such negotiations, PA-1 has elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013.  Additionally, the Company has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of December 31, 2015.  

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA-1 did not make the payment and does not have the resources to make the payment demanded by Pennvest.  PA-1 has engaged in on/off discussions and negotiations with Pennvest concerning this matter but no such discussions/negotiations are currently active.  Neither party has any formal proposal on the table as of the date of this report. It is not possible at this date to predict the outcome of such negotiations, but the Company believes it is possible that an agreement may yet be reached that will result in a viable loan modification. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA-1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days.

In connection with the Pennvest Loan financing documents, the Company provided a technology guaranty regarding nutrient reduction performance of Kreider 1 which was structured to expire when Kreider 1s nutrient reduction performance had been demonstrated. During August 2012 the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 System had surpassed the requisite performance criteria and that the Companys technology guaranty was met.  As a result, the Pennvest Loan is solely an obligation of PA-1.

8.

CONVERTIBLE NOTES PAYABLE - AFFILIATES:

January 2015 Convertible Notes

The January 2015 Convertible Notes accrue interest at 4% per annum and are due and payable on December 31, 2017.  The January 2015 Convertible Notes (including accrued interest, plus all future deferred compensation), are convertible, at the sole election of the noteholder, into Units consisting of one share of the Companys common stock and one quarter warrant to purchase a share of the Companys common stock, at a price of $0.50 per Unit until December 31, 2020.  The warrant contained in the Unit shall be exercisable at $1.00 per share until December 31, 2020.  The original conversion price of $0.50 per Unit approximated the fair value of the Units at the date of the agreements; therefore no beneficial conversion feature exists.  Management evaluated the terms and conditions of the embedded conversion features based on the guidance of ASC 815-15 Embedded Derivatives to determine if there was an embedded derivative requiring bifurcation. An embedded derivative instrument (such as a conversion option embedded in the deferred compensation) must be bifurcated from its host instruments and accounted for separately as a derivative instrument only if the risks and rewards of the embedded derivative instrument are not clearly and closely related to the risks and rewards of the host instrument in which it is embedded.  Management concluded that the embedded conversion feature of the deferred compensation was not required to be bifurcated because the conversion feature is clearly and closely related to the host instrument, and because of the Companys limited trading volume that indicates the feature is not readily convertible to cash in accordance with ASC 815-10, Derivatives and Hedging.  

18



BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

As of December 31, 2015, the January 2015 Convertible Note balances, including accrued interest, owed Bassani, Smith and Schafer were $1,522,967, $790,856 and $393,380, respectively.   During the three and six months ended December 31, 2015, the Company recorded interest expense of $26,247 and $52,495, respectively, related to the January 2015 Convertible Notes.

September 2015 Convertible Notes

During the six months ended December 31, 2015, the Company entered into September 2015 Convertible Notes with Bassani, Schafer and Shareholder which replaced the previously issued FY2015 Promissory Notes. The initial principal balances of the September 2015 Convertible Notes were $405,831, $16,382 and $82,921, respectively. The September 2015 Convertible Notes bear interest at 4% per annum, have maturity dates of December 31, 2017 and may be converted at the sole election of the noteholders into restricted common shares of the Company at a conversion price of $0.60 per share.  As the conversion price of $0.60 approximated the fair value of the common shares at the date of the September 2015 Convertible Notes, no beneficial conversion feature exists.  The balances of the September 2015 Convertible Notes as of December 31, 2015 are $410,901, $16,587 and $83,957, respectively. The Company recorded interest expense related to the 2015 Convertible Notes of $5,093 and $6,311 for the three and six months ended December 31, 2015, respectively.

9.

STOCKHOLDERS' EQUITY:

Series B Preferred stock:

At July 1, 2014, the Company had 200 shares of Series B redeemable convertible Preferred stock outstanding with a par value of $0.01 per share, convertible at the option of the holder at $2.00 per share, with dividends accrued and payable at 2.5% per quarter.  The Series B Preferred stock is mandatorily redeemable at $2.00 per share by the Company three years after issuance and accordingly was classified outside of shareholders equity. The 200 shares have reached their maturity date, but due to the cash constraints of the Company have not been redeemed.

During the years ended June 30, 2015 and 2014, the Company declared dividends of $2,000 and $2,000 respectively.  During the six months ended December 31, 2015, the Company declared dividends of $1,000.  At December 31, 2015, accrued dividends payable are $9,000.

Common stock:

Holders of common stock are entitled to one vote per share on all matters to be voted on by common stockholders.  In the event of liquidation, dissolution or winding up of the Company, the holders of common stock are entitled to share in all assets remaining after liabilities have been paid in full or set aside and the rights of any outstanding preferred stock have been satisfied. Common stock has no preemptive, redemption or conversion rights.  The rights of holders of common stock are subject to, and may be adversely affected by, the rights of the holders of any outstanding series of preferred stock or any series of preferred stock the Company may designate in the future.  

Centerpoint holds 704,309 shares of the Companys common stock.  These shares of the Companys common stock held by Centerpoint are for the benefit of its shareholders without any beneficial interest.  The Company accounts for these shares similar to treasury stock.

During the six months ended December 31, 2015, the Company issued 36,296 shares of the Companys common stock at prices ranging from $0.69 to $1.15 per share for services valued at $100,904, in the aggregate, to consultants and employees, including $69,000 expensed for 75,000 fully vested bonus shares to Smith that were granted but not issued.  

During the six months ended December 31, 2015, the Company issued 12,500 shares of the Companys restricted common stock upon receipt of its subscription receivable of $13,125 for the exercise of 12,500 warrants.

19



BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

During the six months ended December 31, 2015, the Company entered into subscription agreements to exercise certain warrants with expiry dates on or before December 31, 2015, into restricted shares of the Companys common stock at a reduced exercise price of $1.05, for the period from June 30, 2015 through July 15, 2015.   Pursuant to the offering, 265,894 warrants were exercised and 265,894 shares of the Companys restricted common stock were issued resulting in cash proceeds of $174,189 and receipt of a $105,000 interest bearing, collateralized promissory note.  During January 2016, the Company received a $35,000 principal payment and entered into a new agreement with the borrowers which extended the maturity date of the remaining principal and interest until June 15, 2016.  All the other terms of the original agreement remain unchanged.  As of December 31, 2015, the Company has recorded the $35,000 as a promissory note receivable and the remaining unpaid principal and interest totaling $71,878, as a promissory note receivable for shares.

During the six months ended December 31, 2015, the Company entered into subscription agreements to sell units for $0.80 per unit, with each unit consisting of one share of the Companys restricted common stock and one warrant to purchase one half of a share of the Companys restricted common stock for $1.10 per share until June 30, 2017 and pursuant thereto, the Company issued 228,750 units for total proceeds of $183,000.  During the six months ended December 31, 2015, cash commissions of $18,300 were paid to brokers related to the unit offering.  The Company allocated the proceeds from the shares and the warrants based upon their relative fair values, using the share price on the day each of the subscription agreements were entered into and the fair value of the warrants, which was determined to be $0.05 per warrant.  As a result, $4,603 was allocated to the warrants and $178,397 was allocated to the shares, and both were recorded as additional paid in capital.

During the six months ended December 31, 2015, a warrant holder elected to exercise 14,000 warrants at an exercise price of $0.75 and 14,000 shares of the Companys common stock were issued resulting in cash proceeds of $10,500.  

During the six months ended December 31, 2015, Smith and various consultants elected to convert $82,861 and $88,856 of deferred compensation, respectively, into 99,159 and 109,715 shares, respectively, of the Companys common stock at conversion rates ranging from $0.76 to $1.15 per share.  

Warrants:

As of December 31, 2015, the Company had approximately 8.4 million warrants outstanding, with exercise prices from $0.75 to $3.00 and expiring on various dates through December 31, 2020.

The weighted-average exercise price for the outstanding warrants is $1.24, and the weighted-average remaining contractual life as of December 31, 2015 is 4.2 years.

During the six months ended December 31, 2015, warrants to purchase 957,806 shares of common stock of the Company at prices between $2.25 and $3.10 per share expired.

During the six months ended December 31, 2015, the Company entered into subscription agreements to exercise certain warrants with expiry dates on or before December 31, 2015, into restricted shares of the Companys common stock at a reduced exercise price of $1.05, for the period from July 1, 2015 through July 15, 2015.  As a result of the offering, 265,894 warrants were exercised and 265,894 shares of the Companys restricted common stock were issued resulting in cash proceeds of $174,189 and receipt of a collateralized promissory note receivable for $105,000, for the six months ended December 31, 2015.

During the six months ended December 31, 2015, a warrant holder elected to exercise 14,000 warrants at an exercise price of $0.75 and 14,000 shares of the Companys common stock were issued resulting in cash proceeds of $10,500.  

20



BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

Stock options:

The Companys 2006 Consolidated Incentive Plan, as amended (the 2006 Plan), provides for the issuance of options (and/or other securities) to purchase up to 22,000,000 shares of the Companys common stock. Terms of exercise and expiration of options/securities granted under the 2006 Plan may be established at the discretion of the Board of Directors, but no option may be exercisable for more than ten years.

During the six months ended December 31, 2015, the Company approved the modification of existing stock options held by a board member which extended certain expiration dates and resulted in incremental non-cash compensation expense of $42,550.

The Company recorded compensation expense related to employee stock options of $74,320 and $4,000 for the three months ended December 31, 2015 and 2014, respectively, and $89,640 and $4,000 for the six months ended December 31, 2015 and 2014, respectively.  The Company granted 100,000 and zero options during the six months ended December 31, 2015 and 2014, respectively.  During the six months ended December 31, 2014, 397,500 options expired.

The fair value of the options granted during the six months ended December 31, 2015 and 2014 were estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:



Weighted

Average,

December 31,

2015


Range,

December 31,

2015


Weighted

Average,

December 31,

2014


Range,

December 31,

2014

Volatility


74%

74%


80%

80%

Dividend yield


-

-


-

-

Risk-free interest rate


1.75%

1.75%


0.51%

0.51%

Expected term (years)


5

5


2

2

A summary of option activity under the 2006 Plan for the six months ended December 31, 2015 is as follows:











Options



Weighted-

Average

Exercise

Price

Weighted-

Average

Remaining

Contractual

Life




Aggregate

Intrinsic

Value

Outstanding at July 1, 2015

4,413,870 


 $1.88

4.1


-      

   Granted

100,000  


   0.92




   Exercised

-  


-




   Forfeited

-  


-




   Expired

-  


-




Outstanding at December 31, 2015

4,513,870 


$1.86

3.9


$36,050

Exercisable at December 31, 2015

4,413,870 


$1.89

3.7


$22,050


The following table presents information relating to nonvested stock options as of December 31, 2015:


21


 

BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015






Options


Weighted Average

Grant-Date Fair

Value

Nonvested at July 1, 2015

100,000 


$  0.76 

   Granted

       100,000


   0.59 

   Vested

      (100,000)


  (0.59)

Nonvested at December 31, 2015

100,000 


$ 0.76


The total fair value of stock options that vested during the six months ended December 31, 2015 and 2014 was $59,000 and nil, respectively.  As of December 31, 2015, the Company had $19,826 of unrecognized compensation cost related to stock options.


Stock-based employee compensation charges in operating expenses in the Companys financial statements for the three and six months ended December 31, 2015 and 2014 are as follows:  



Three

months

ended

December 31,

2015

Three

months

ended

December 31,

2014

Six months

ended

December 31,

2015

Six months

ended

December 31,

2014

General and administrative:





  Fair value of stock bonus expensed  

$   69,000 

$             -   

$     69,000

$           -   

  Change in fair value from modification of

    option terms

42,550 

11,783   

           42,550

11,783   

  Fair value of stock options expensed

62,371 

4,000   

64,209

4,000   

     Total

$   173,921 

$ 15,783  

$   175,759

$ 15,783   






Research and development:





  Fair value of stock options expensed

$    11,949

$             -   

$     25,431

$           -   

     Total

$     11,949

$             -   

$     25,431

$           -   


10.

COMMITMENTS AND CONTINGENCIES:

Employment and consulting agreements:

Smith has held the positions of Director, President and General Counsel of Company and its subsidiaries under various agreements and terms since March 2003.   During September 2014, Smith agreed to continue his employment agreement through April 15, 2015 and also agreed to continue to defer his temporarily reduced salary of $14,000 per month until such date.   On February 10, 2015, the Company executed an Extension Agreement with Smith pursuant to which Smith extended his employment with the Company to December 31, 2015 (with the Company having an option to extend his employment an additional six months).  As part of the Extension Agreement, the balance of Smiths existing convertible note payable as of December 31, 2014, adjusted for conversions subsequent to that date, was replaced with a new convertible note with an initial principal amount of $760,520 with terms that i) materially reduce the interest rate by 50% (from 8% to 4%), ii) increases the conversion price by 11% (from $0.45 to $0.50), iii) sets the conversion price at a fixed price so there can be no further reductions, iv) reduces the number of warrants received on conversion by 75% (from 1 warrant per unit to 1/4 per unit) and v) extends the maturity date to December 31, 2017.  


22



BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

Additionally, pursuant to the Extension Agreement, Smith: i) will continue to defer his cash compensation ($18,000 per month) until the Board of Directors re-instates cash payments to all employees and consultants who are deferring their compensation,  ii) cancelled  150,000 contingent stock bonuses previously granted to him by the Company, iii) has been granted 150,000 new options which vested immediately and iv) outstanding options and warrants owned by Smith (and his donees) have been extended and had the exercise prices reduced to $1.50 (if the exercise price exceeded $1.50).  In October 2015, the Company executed an Extension Agreement (FY2016 Extension Agreement) with Smith pursuant to which Smith extended his employment with the Company to June 30, 2016 (with Company having an option to extend his employment an additional six months).  As part of the FY2016 Extension Agreement, Smith: i) will continue to defer his cash compensation ($19,000 per month) until the Board of Directors re-instates cash payments, ii) has been granted 100,000 new options which vested immediately, and iii) has been granted 75,000 shares of common stock as an extension bonus which are immediately vested and were issued on January 5, 2016.  

Since March 31, 2005, the Company has had various agreements with Brightcap and/or Bassani, through which the services of Bassani are provided.  The Board appointed Bassani as the Company's CEO effective May 13, 2011.  During the fiscal years 2012 and 2013, Bassani entered into extension agreements whereby he was awarded fully vested stock grants totaling 600,000 shares, 500,000 shares of which are to be issued January 15, 2016 and 100,000 shares are to be issued January 15, 2017.  The stock grants were expensed in the years they were awarded as they are fully vested.  On February 10, 2015, the Company executed an Extension Agreement with Bassani pursuant to which Bassani extended the term of his service to the Company to December 31, 2017, (with the Company having an option to extend the term an additional six months.)  As part of the agreement, the Companys then existing loan payable, deferred compensation and convertible note payable to Bassani, were restructured into two promissory notes as follows: a) The sum of the cash loaned by Bassani to the Company of $279,000 together with $116,277 of unreimbursed expenses through December 31, 2014, were placed into a new promissory note with initial principal of $395,277 which was due and payable on December 31, 2015 and now has been replaced with a September 2015 Convertible Note (Note 8).  In connection with these sums and the new promissory note, Bassani was issued warrants to purchase 592,916 shares of the Companys common stock at a price of $1.00 until December 31, 2020; and b) the remaining balances of the Companys accrued obligations to Bassani ($1,464,545) were replaced with a new convertible promissory note with terms that compared with the largest prior convertible note obligation to Bassani:  i) materially reduce the interest rate by 50% (from 8% to 4%), ii) increase the conversion price by 11% (from $0.45 to $0.50), iii) sets the conversion price at a fixed price so there can be no further reductions, iv) reduces the number of warrants received on conversion by 75% (from 1 warrant per unit to 1/4 per unit) and v) extends the maturity date to December 31, 2017 (Note 8).  Additionally,  pursuant to the Extension Agreement, Bassani i) will continue to defer his cash compensation ($31,000 per month) until the Board of Directors re-instates cash payments to all employees and consultants who are deferring their compensation, ii) cancelled 250,000 contingent stock bonuses previously granted to him by the Company, iii) has been granted 450,000 new options which vested immediately and iv) outstanding options and warrants owned by Bassani (and his donees) have been extended and had the exercise prices reduced to $1.50 (if the exercise price exceeded $1.50).

On February 10, 2015, the Company entered into an agreement with Schafer pursuant to which Schafer will continue to provide services to the Company through December 31, 2015.  Additionally, pursuant to the  agreement, i) the exercise period of outstanding options and warrants owned by Schafer have been extended, and ii) 25,000 contingent stock bonuses previously granted to Schafer have been cancelled by the Company.  In January 2016, Schafer agreed to extend his agreement with the Company through December 31, 2016.

23


BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

Contingent stock bonuses:

The Company has declared contingent deferred stock bonuses to its key employees and consultants at various times throughout the years.  The stock bonuses are contingent upon the Companys stock price exceeding a certain target price per share, and the grantees still being employed by or providing services to the Company at the time the target prices are reached.  

The Companys outstanding contingent stock bonuses as of December 31, 2015 are as follows:

Target Price per share


$5.00

$10.00


$20.00

Number of shares


50,000

40,000


27,500

Execution/exercise bonuses:

As part of agreements the Company entered into with  Bassani and  Smith effective May 15, 2013, they were each granted the following: a) a 50% execution/exercise bonus which shall be applied upon the effective date of the notice of intent to exercise (for options and warrants) or issuance event, as applicable, of any currently outstanding and/or subsequently acquired  options, warrants and/or  contingent stock bonuses owned by each (and/or their donees) as follows: i) in the case of exercise by payment of cash, the bonus shall take the form of reduction of the exercise price; ii) in the case of cashless exercise, the bonus shall be applied to reduce the exercise price prior to the cashless exercise calculations; and iii) with regard to contingent stock bonuses, issuance shall be triggered upon the Companys common stock reaching a closing price equal to 50% of currently specified price; and b) the right to extend the exercise period of all or part of the applicable options and warrants for up to five years (one year at a time) by annual payments of $.05 per option or warrant to the Company on or before a date during the three months prior to expiration of the exercise period at least three business days before the end of the expiration period. Effective January 1, 2016 such annual payments to extend warrant exercise periods have been reduced to $.01 per option or warrant.

During the year ended June 30, 2014, the Company extended execution/exercise bonuses with the same terms as described above to Schafer and to Jon Northrop, the Companys other board member.

As of December 31, 2015, the execution/exercise bonus was applicable to 3,045,000 of the Companys outstanding options and 6,759,500 of the Companys outstanding warrants.  

Litigation:

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and has demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014.  PA-1 did not make the payment and does not have the resources to make the payment demanded by Pennvest.  During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the technology guaranty standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1.  No litigation has commenced related to this matter but such litigation is likely if negotiations do not produce a resolution (Note 1 and Note 7).

The Company currently is not involved in any other material litigation.




24


BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SIX MONTHS ENDED DECEMBER 31, 2015

11.

SUBSEQUENT EVENTS:

The Company has evaluated events that occurred subsequent to December 31, 2015 for recognition and disclosure in the financial statements and notes to the financial statements.

From January 1, 2016 through February 4, 2016, the Company has issued 5,031 shares of the Companys common shares to an employee and a consultant valued at approximately $4,500.

From January 1, 2016 through February 4, 2016, the Company has issued 75,000 shares of the Companys common shares to Smith per the terms of his extension agreement.

From January 1, 2016 through February 4, 2016, the Company has sold 31,250 units of the Companys restricted securities for $0.80 each, with each unit consisting of one share of the Companys restricted common stock and one warrant to purchase one half of a share of the Companys restricted common stock for $1.10 per share until June 30, 2017.  The proceeds from the sale of the units totaled $25,000.

































25





ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Statements made in this Form 10-Q that are not historical or current facts, which represent the Company's expectations or beliefs including, but not limited to, statements concerning the Company's operations, performance, financial condition, business strategies, and other information, involve substantial risks and uncertainties.  The Company's actual results of operations, most of which are beyond the Company's control, could differ materially.  These statements often can be identified by the use of terms such as "may," "will," "expect," "believe," anticipate," "estimate," or "continue" or the negative thereof.  We wish to caution readers not to place undue reliance on any such forward looking statements, which speak only as of the date made.  Any forward looking statements represent management's best judgment as to what may occur in the future.  However, forward looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected.

These factors include adverse economic conditions, entry of new and stronger competitors, inadequate capital, unexpected costs, failure (or delay)  to gain product or regulatory approvals in the United States (or particular states) or foreign countries and failure to capitalize upon access to new markets.  Additional risks and uncertainties that may affect forward looking statements about Bion's business and prospects include the possibility that markets for nutrient reduction credits (discussed below) and/or other ways to monetize nutrient reductions will be slow to develop (or not develop at all), the existing default by PA-1 on its loan secured by the Kreider #1 system, the possibility that a competitor will develop a more comprehensive or less expensive environmental solution, delays in market awareness of Bion and our Systems, uncertainties and costs related to research and development efforts to update and improve Bions technologies and applications thereof, and/or  delays in Bion's development of Projects and failure of marketing strategies, each of which could have both immediate and long term material adverse effects by placing us behind our competitors and requiring expenditures of our limited resources. Bion disclaims any obligation subsequently to revise any forward looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.  See our Form 10-K (period ended June 30, 2015) for more details regarding these risk factors.

The following discussion and analysis should be read in conjunction with the unaudited Consolidated Financial Statements and Notes to Consolidated Financial Statements filed herein with the Companys Form 10-K for the year ended June 30, 2015.

BUSINESS OVERVIEW

During the 2004-2008 calendar years, the Company focused on completion of the development of the second generation of its technology which provides comprehensive environmental solutions to a significant source of pollution in U.S. agriculture, large scale livestock facilities known as Confined Animal Feeding Operations ("CAFO"). That re-development process was substantially completed five years ago and the initial commercial system, based on that updated technology, was constructed and placed in full commercial operation. Bion continues to focus on refining, testing and/or developing technologies which can supplement and/or upgrade our technologies and or be utilized with our technology platform. During the 2014 and 2015 fiscal years, the Company increased its research and development activities with focus on augmenting the basic separate and aggregate approach of its technology platform to provide additional flexibility and to increase recovery of nutrient by-products (in organic and non-organic forms) and renewable energy production (either/both biogas and/or renewable electricity), thereby increasing potential related revenue streams and reducing dependence of its future projects on nutrient reduction credits (which still remain a very important part of project revenue streams).  

26


This research and development effort also involves ongoing review of potential add-ons and applications to our technology platform for use in different regulatory and /or climate environments.  These research and development activities continued through the balance of the 2015 fiscal year, and we believe such activities will continue at least through the 2016 calendar year and into 2017 (if the Company has sufficient funds to continue such activities).

Operational results from the initial commercial system confirmed the ability of Bions technologies to meet its nutrient reduction goals at commercial scale for an extended period of operation. Bions current generation technology platform (and the new variations under development) center on its patented and proprietary processes that separate and aggregate the various assets in the CAFO waste stream so they become benign, stable and/or transportable. Bion systems can: a) remove up to 95% of the nutrients (primarily nitrogen and phosphorus) in the effluent, b) reduce greenhouse gases by 90% (or more) including elimination of virtually all ammonia emissions, c) while materially reducing pathogens, antibiotics and hormones in the livestock waste stream. In addition to capturing valuable nutrients for reuse (in organic and/or non-organic forms), Bions technology platform also recovers cellulosic biomass which can be used to generate renewable energy from the waste stream in a process more efficient than other technologies that seek to exploit this CAFO waste stream. Our core technology and its primary CAFO applications are now proven in commercial operations. It has been accepted by the Environmental Protection Agency (EPA) and other regulatory agencies and it is protected by Bions portfolio of U.S. and international patents (both issued and applied for). Research and development activities are underway to improve, update and move toward the next generation of Bion systems to meet the needs of CAFOs in various geographic and climate areas with nutrient release constraints and to increase the recovery and generation of valuable by-products.

Currently, Bion is focused on using applications of its patented and proprietary waste management technologies and technology platform to pursue three main business opportunities: 1) installation of Bion systems to retrofit and environmentally remediate existing CAFOs in selected markets where: a) government policy supports such efforts (such as the Chesapeake Bay watershed,  Great Lakes Basin states,  and/or other states and watersheds facing EPA total maximum daily load (TMDL) issues, and/or b) where CAFOs need our technology to obtain permits to expand or develop without negative environmental consequences; 2) development of Integrated Projects which will include large CAFOs, such as large dairies, beef cattle feed lots and/or hog farms, with Bion waste treatment system modules processing the aggregate CAFO waste stream from the equivalent of 40,000 or more beef and/or dairy cows (or the waste stream equivalent of other species) while recovering cellulosic  (to be potentially utilized for renewable energy production) and nutrient rich solids (that can potentially to be marketed as feed and/or fertilizer), integrated with an ethanol plants capable of producing 40 million gallons (or more) of ethanol per year and/or with CAFO end product processors, and 3) licensing and/or joint venturing of Bions technology and applications (primarily) outside North America. The opportunities described at 1) and 2) above each require substantial political and regulatory (federal, state and local) efforts on the part of the Company and a substantial part of Bions efforts are focused on such political and regulatory matters. Bion is currently pursuing the international opportunities primarily through the use of consultants with existing relationships in target countries.

During 2008 the Company commenced actively pursuing the opportunity presented by environmental retrofit and remediation of the waste streams of existing CAFOs which effort has met with very limited success to date. The first commercial activity in this area is represented by our agreements with Kreider Farms ("KF") in Pennsylvania pursuant to which a Bion system to treat KF's dairy and poultry waste streams to reduce nutrient releases to the environment while generating marketable nutrient credits and renewable energy was designed, constructed and has been in full-scale operation since 2011. (No other Bion system has been contracted for and/or constructed to date.)

27



On January 26, 2009 the Board of the Pennsylvania Infrastructure Investment Authority (Pennvest) approved a $7.75 million loan to Bion PA 1, LLC (PA-1), a wholly-owned subsidiary of the Company, for the initial stage of Bion's Kreider Farms project (Phase 1 Kreider System or Kreider 1 System). After substantial unanticipated delays, on August 12, 2010 the PA-1 received a permit for construction of the Phase 1 Kreider system.  Construction activities commenced during November 2010.  The closing/settlement of the Pennvest Loan took place on November 3, 2010.  PA-1 finished the construction of the Phase 1 Kreider System and entered a period of system operational shakedown during May 2011.  The Phase 1 Kreider System reached full, stabilized operation by the end of the 2012 fiscal year.  During 2011 the Pennsylvania Department of Environmental Protection (PADEP) re-certified the nutrient credits for this project.  The economics (potential revenues and profitability) of the Phase 1 Kreider System are based largely on the long term sale of nutrient (nitrogen and/or phosphorus) reduction credits to meet the requirements of the Chesapeake Bay environmental clean-up, which sales have not yet materialized.  The PADEP issued final permits for the Kreider 1 System (including the credit verification plan) on August 1, 2012 on which date the Company deemed that the Kreider 1 System was placed in service.  As a result, PA-1 commenced generating and verifying nutrient reduction credits for potential sale while continuing to utilize the system to test improvements and add-ons. Operating results of the Phase 1 Kreider System have documented the efficacy of Bions nutrient reduction technology and vetted potential add-ons for future installations. During August 2012 the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 System met the technology guaranty standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1.  As a result of this extended period of operations, Bion is confident that future systems can be constructed with even higher operational efficiencies at lower capital expense and with lower operational costs. To date liquidity in the Pennsylvania nutrient credit market has been slow to develop significant breadth and depth  which limited liquidity has negatively impacted Bions business plans and has prevented Bion from monetizing the nutrient reductions created by PA-1s existing Kreider 1 project and Bions other proposed projects. These challenges and difficulties (which continue to this date) have prevented PA-1 from generating any material revenues from the Kreider 1 project to date (PA-1s Kreider 1 operating expenses have been funded by loans from Bion) and raise significant questions as to when, if ever, PA-1 will be able to generate such material revenues from the Kreider 1 system.  PA-1 has been engaged in on-and-off negotiations/discussions with Pennvest related to forbearance and/or re-structuring its obligations pursuant to the Pennvest Loan for over 36 months. In the context of such negotiations, PA-1 has elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013.  Additionally, PA-1 has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of December 31, 2015.  Due to the slow development of the nutrient reduction credit market, the Company determined that the carrying amount of the property and equipment related to the Kreider 1 System and project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits and, therefore, recorded a $2,000,000 impairment of the Kreider 1 during the year ended of June 30, 2014.  An additional impairment of $1,750,000 was recorded for the year ended June 30, 2015.  

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA-1 did not make the payment and does not have the resources to make the payment demanded by Pennvest. PA-1 has engaged in on/off discussions and negotiations with Pennvest concerning this matter but no such discussions/negotiations are currently active.  Neither party has any formal proposal on the table as of the date of this report.  

28


It is not possible at this date to predict the outcome of such negotiations, but the Company believes it is possible that an agreement may yet be reached that will result in a commercially viable loan modification.  Subject to the results of negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA-1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days.

During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the technology guaranty standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1.  

The Company is currently conducting a portion of its research and development activities at the Kreider 1 system while PA1 is maintaining the Kreider 1 System.

The Company continues its development work related to the second phase of the Kreider project (Phase 2 Kreider Project) which involves production of renewable energy from the waste of KFs poultry operations (and potentially other poultry operations and/or other waste streams) and the cellulosic solids recovered by the Kreider 1 system. During May 2011 the PADEP certified the Phase 2 Kreider Project for 559,457 nutrient credits under the old EPAs Chesapeake Bay model.  The Company anticipates that the Phase 2 Kreider Project will be re-certified for between 1.5-2 million nutrient reduction credits pursuant to the amended EPA Chesapeake Bay model which was published subsequent to the original certification. Various announcements related to negotiations/discussions between the EPA and PADEP regarding Pennsylvanias Chesapeake Bay nutrient reduction non-compliance suggest that a resolution of certain matters is likely during the balance of this calendar year which may allow the Phase 2 Kreider Project to move forward with re-certification and proceed toward design, permitting construction and eventual operation during the 2017 calendar year. Assuming there are also positive developments related to the market for nutrient reductions in Pennsylvania, of which there is no assurance, the Company intends to pursue development, design and construction of the Kreider poultry waste/renewable energy project with a goal of achieving operational status during the 2017 calendar year. While the Company believes that substantial revenues may be generated from the sale of by-products (organic and inorganic fertilizer, renewable energy and/or renewable energy credits) of its operation, the economics (potential revenues and profitability) of the Phase 2 Kreider Project are based, in large part, on the long term sale of nutrient (nitrogen and/or phosphorus) reduction credits to meet the requirements of the Chesapeake Bay environmental clean-up.  However, liquidity in the Pennsylvania nutrient reduction market has been slow to develop significant breadth and depth which lack of liquidity to date has negatively impacted Bions business plans and has resulted in challenges to monetizing the nutrient reduction credits created by PA-1s existing Kreider 1 project and will delay the Companys Phase 2 Kreider Project and other proposed projects in Pennsylvania.

A significant portion of Bions current activities concern efforts with private and public stakeholders (at local and state level) in Pennsylvania, (and other Chesapeake Bay, Midwest and Great Lakes states) and at the federal level (EPA and other executive departments and Congress) to establish appropriate public policies which will create regulations and funding mechanisms that foster installation of the low cost, technology-based  environmental solutions that Bion (and others) can provide through clean-up of agricultural waste streams. In January 2013, the Pennsylvania Legislative Budget and Finance Committee issued a report stating that targeting upstream livestock would save Pennsylvanias taxpayers up to 80% of previously estimated costs (potential savings for Pennsylvania in excess of a billion dollars per year over the next 20 years) which would be available for other needs (notably aging drinking water and sewer infrastructure) while creating large local benefits of an upstream treatment strategy including reduced freshwater compliance costs, future cost avoidance of treating drinking water from contaminated local aquifers and increased economic activity for agriculture, tourism and recreation.  The Coalition for an Affordable Bay Solution (Coalition) was formed to support the creation of a competitively-bid nitrogen trading program in Pennsylvania that will enable Pennsylvania to capture the economic benefits outlined in the legislative study.

29


The Coalition supports legislation to establish a competitively-bid RFP program for nitrogen reductions, where bids will also be scored to reflect the value of the benefits to Pennsylvanias interior waterways and communities.  Founding members of the Coalition represent both Chesapeake Bay and national industry participants, and include Bion, JBS, SA, Kreider Farms, and Fair Oaks Farms. The head of the Coalition is Ed Schafer, Bions Vice Chairman. The Company believes that: i)  the April 2015 release of a report from the Pennsylvania Auditor General titled Special Report on the Importance of Meeting Pennsylvanias Chesapeake Bay Nutrient Reduction Targets which highlighted the economic consequences of EPA-imposed sanctions if the state fails to meet the 2017 TMDL targets, as well as the need to support using low-cost solutions and technologies as alternatives to higher-cost public infrastructure projects, where possible, and ii)  the April 2015 introduction of Senate Bill 724 (successor to prior SB 924) The Watershed Improvement Act, which, if adopted, will establish a program that will allow the Pennsylvanias tax- and rate-payers to meet their EPA-mandated Chesapeake Bay pollution reductions at significantly lower cost by purchasing verified reductions (by competitive bidding) from all sources, including those that Bion can produce through livestock waste treatment, represent visible evidence of progress being made on these matters in Pennsylvania. This legislation, if passed and signed into law, will potentially enable Bion (and others) to compete for public funding on an equal basis with subsidized agricultural best management practices and public works and storm water authorities. Bions activity related to such legislation has intensified with increased stakeholder support (and increasing attacks on the Company by those opposed to the legislation) and Bion believes such primary provisions of such legislation may be passed (in some version) by the Pennsylvania Legislature during 2016, but cannot predict the exact final content of such legislation or guarantee such passage. Note, however, that there has been vocal opposition to SB 724 from threatened stakeholders committed to the existing status quo approaches--- a significant portion of which has been focused on attacking (in often inaccurate and/or vilifying ways) Bion in/through social media and internet articles, blogs, press releases, twitter posts and re-tweets, rather than engaging the substantive issues. The Company has responded in a press release and postings on its website. As a result, Bion is now exploring the use of social media including Facebook, twitter and other approaches to accurately communicate about the Companys business and positions and expending funds for that purpose. If SB 724 is passed and implemented (in something close to its current form), Bion expects that the policies and strategies being developed in Pennsylvania will not only benefit the Companys existing and proposed Pennsylvania projects, but will also subsequently provide the basis for a larger Chesapeake Bay watershed strategy and, thereafter, a national clean water strategy.  Legislation in Wisconsin, which became effective during April 2014, represents a significant step forward towards opening business opportunities in that state.

The Company believes that Pennsylvania (and the entire Chesapeake Bay watershed), to be followed by the Great Lakes Basin and Midwest/Mississippi Watershed/Gulf of Mexico states, represent ground zero in the long-standing clean water battle between agriculture and the further regulation of agriculture relative to nutrient impacts. The ability of Bion and other technology providers to achieve verified reductions from agricultural non-point sources can resolve the current stalemate and enable implementation of constructive solutions that benefit all stakeholders, providing a mechanism that ensures that taxpayer funds will be used to achieve the most beneficial result at the lowest cost, regardless of source. All sources, point and non-point, rural and urban, will be able to compete for tax payer-funded nutrient (primarily nitrogen and phosphorus) reductions in a fair and transparent process; and since payment from the tax and rate payers will now be performance-based, these providers will be held financially accountable.



30


We believe that the overwhelming environmental, economic, quality of life and public health benefits to all stakeholders in the watersheds, both within and outside of Pennsylvania/Chesapeake Bay watershed, make the case for adoption of the strategies outlined in the Pennsylvania legislative study less an issue of if, but of when and how. The adoption of a competitive procurement program will have significant positive impact on technology providers that can deliver verified nitrogen and phosphorus reductions such as Bion, by allocating existing tax- and rate-payer clean water funding to low cost solutions based upon a voluntary and transparent procurement process. The Company believes that implementation of a competitively-bid nutrient reduction program to achieve the goals for the Chesapeake Bay watershed  and/or the phosphorus reduction needs of Wisconsin can also provide a working policy models and platforms for other states to adopt that will enhance their efforts to comply with both current and future requirements for local and federal estuarine watersheds, including the Mississippi River/Gulf of Mexico, the Great Lakes Basin and other nutrient-impaired watersheds.

Additionally, we believe that Bion's technology platform (including utilization of various third party technologies to supplement the Companys proprietary technologies) will allow the integration of large-scale CAFOs and their end-product users, renewable energy production from the CAFO waste stream, and on site utilization of the renewable energy generated and biofuel/ethanol production in an environmentally and economically sustainable manner while reducing the aggregate capital expense and operating costs and increasing revenue and profitability for the entire integrated complex ("Integrated Projects" or "Projects"). In the context of Integrated Projects, Bion's waste treatment processes, in addition to mitigating polluting releases, will generate renewable energy from cellulosic portions of the CAFO waste stream which renewable energy can be utilized by integrated facilities including ethanol plants, CAFO end-product processors (including cheese, ice cream and/or bottling plants in the case of dairy CAFOs, and/or slaughter and/or processing facilities in the context of beef CAFOs) and/or other users as a  replacement for fossil fuel usage. In addition an integrated ethanol plant's main by-product, called distillers grain, can be added to the feed of the animals in wet form, thereby lowering the capital expenditures, operating, marketing and shipping costs and energy usage of the ethanol production process. In such cases, the ethanol plant would act as a feed mill for the integrated CAFO, thereby reducing the CAFO's feeding costs as well as generating revenue to the ethanol plant, and would also provide a market for the renewable energy that Bion's System produces from the CAFO waste stream. And, in some cases the nutrient rich liquid effluent from the Bion system modules may be directly utilized for greenhouse and/or hydroponic agriculture. Accordingly, such Bion Integrated Projects can be denominated "closed loop". Bion anticipates that many projects may initially include only partial integration.  Based on the degree of integration in a Project, greater or lesser amounts of benefits will be realized.  Bion, as developer of, and participant in, Integrated Projects, anticipates that it will share in the cost savings and the revenues generated from these activities.

Bion has worked with local, state and federal officials with regard to regulatory and legislative initiatives, and with such parties and potential industry participants to evaluate projects and/or sites in multiple states. The Company believes that its initial Integrated Project will most likely be located and developed (probably in stages) in Pennsylvania.  Note, however, that locations and/or projects in other states are also under review and the initial Integrated Project could be developed elsewhere. It is possible that the Company will develop one or more Integrated Projects as joint ventures specifically targeted to meet the growing animal protein demand outside of the United States (including without limitation Asia, Europe and/or the Middle East).  Bion intends to choose sites for additional Projects during the calendar years 2017-2019 to create a pipeline of Projects. Management has a 5-year development target (through calendar year 2023) of approximately 10-24 Integrated Projects.  At the end of that period, Bion projects that 5 or more of these Integrated Projects will be in full operation in 3-5 states (or other locations), and the balance would be in various stages ranging from partial operation to early permitting stage. No Integrated Project has been developed to date.

31


The Companys audited financial statements for the years ended June 30, 2015 and 2014 have been prepared assuming the Company will continue as a going concern.  The Company has incurred net losses of approximately $5,640,000 and $5,762,000 during the years ended June 30, 2015 and 2014, respectively. The Report of the Independent Registered Public Accounting Firm on the Company's consolidated financial statements as of and for the year ended June 30, 2015 includes a "going concern" explanatory paragraph which means that the accounting firm has expressed substantial doubt about the Company's ability to continue as a going concern.  The Company has incurred net losses of approximately $1,629,000 and $1,371,000 for the six months ended December 31, 2015 and 2014, respectively.   At December 31, 2015, the Company had a working capital deficit and a stockholders deficit of approximately $10,197,000 and $11,647,000, respectively. Management's plans with respect to these matters are described in this section and in our consolidated financial statements (and notes thereto), and this material does not include any adjustments that might result from the outcome of this uncertainty.  However, there is no guarantee that we will be able to raise sufficient funds or further capital for the operations planned in the near future.  

CRITICAL ACCOUNTING POLICIES

Management has identified the following policies below as critical to our business and results of operations.  Our reported results are impacted by the application of the following accounting policies, certain of which require management to make subjective or complex judgments.  These judgments involve making estimates about the effect of matters that are inherently uncertain and may significantly impact quarterly or annual results of operations.  For all of these policies, management cautions that future events rarely develop exactly as expected, and the best estimates routinely require adjustment.  Specific risks associated with these critical accounting policies are described in the paragraphs below.

Revenue Recognition

While the Company has not recognized any significant operating revenues for the past two fiscal years, the Company has commenced generation of revenues during the year ended June 30, 2013.  Revenues are generated from the sale of nutrient reduction credits, product sales, technology license fees, annual waste treatment fees and/or direct ownership interests in Integrated Projects.  The Company recognizes revenue from the sale of nutrient credits and products when there is persuasive evidence that an arrangement exists, when title has passed, the price is fixed or determinable, and collection is reasonably assured.  The Company expects that technology license fees will be generated from the licensing of Bion's systems.  The Company anticipates that it will charge its customers a non-refundable up-front technology license fee, which will be recognized over the estimated life of the customer relationship.  In addition, any on-going technology license fees will be recognized as earned based upon the performance requirements of the agreement. Annual waste treatment fees will be recognized upon receipt. Revenues, if any, from the Company's interest in Projects will be recognized when the entity in which the Project has been developed recognizes such revenue.

Stock-based compensation

The Company follows the provisions of Accounting Standards Codification (ASC) 718, which generally requires that share-based compensation transactions be accounted and recognized in the statement of income based upon their grant date fair values.  

Derivative Financial Instruments:

Pursuant to ASC Topic 815 Derivatives and Hedging (Topic 815), the Company reviews all financial instruments for the existence of features which may require  fair value accounting and a related mark-to-market adjustment at each reporting period end. Once determined, the Company assesses these instruments as derivative liabilities.  The fair value of these instruments is adjusted to reflect the fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives.  

32


Warrants:

The Company has issued warrants to purchase common shares of the Company.  Warrants are valued using a fair value based method, whereby the fair value of the warrant is determined at the warrant issue date using a market-based option valuation model based on factors including an evaluation of the Companys value as of the date of the issuance, consideration of the Companys limited liquid resources and business prospects, the market price of the Companys stock in its mostly inactive public market and the historical valuations and purchases of the Companys warrants.  When warrants are issued in combination with debt or equity securities, the warrants are valued and accounted for based on the relative fair value of the warrants in relation to the total value assigned to the debt or equity securities and warrants combined.

Property and equipment:

Property and equipment are stated at cost and are depreciated, when placed into service, using the straight-line method over the estimated useful lives of the related assets, generally three to twenty years.  The Company capitalizes all direct costs and all indirect incrementally identifiable costs related to the design and construction of its Integrated Projects.  The Company reviews its property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  An impairment loss would be recognized based on the amount by which the carrying value of the assets or asset group exceeds its estimated fair value, and is recognized as a loss from operations.

Recent Accounting Pronouncements:

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09 Revenue from Contracts from Customers,  which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605), and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services.  ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017 and early adoption is not permitted.  The Company is currently evaluating the new standard and assessing the potential impact on its operations and financial statements.  

In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements Going Concern: Disclosures of Uncertainties about an Entitys Ability to Continue as a Going Concern.  The new standard requires management to perform interim and annual assessments of an entitys ability to continue as a going concern within one year of the date the financial statements are issued.  An entity must provide certain disclosures if conditions or events raise substantial doubt about the entitys ability to continue as a going concern.  The guidance is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early application is permitted.  The Company believes the adoption of ASU No. 2014-15 will not have a material impact on its financial statements.

THREE MONTHS ENDED DECEMBER 31, 2015 COMPARED TO THE THREE MONTHS ENDED DECEMBER 31, 2014

Revenue

Total revenues were nil for both the three months ended December 31, 2015 and 2014, respectively.

General and Administrative

Total general and administrative expenses were $550,000 and $333,000 for the three months ended December 31, 2015 and 2014, respectively.


33


General and administrative expenses, excluding stock-based compensation charges of $174,000 and $16,000, were $376,000 and $317,000 for the three months ended December 31, 2015 and 2014, respectively, representing a $59,000 increase.  Salaries and related payroll tax expenses decreased to $74,000 for the three months ended December 31, 2015 from $102,000 for the three months ended December 31, 2014, primarily due to the fact that during the three months ended December 31, 2015 one employee became a consultant on an as-needed consulting basis receiving compensation in the Companys securities and/or deferring their compensation which reduced recurring salary and payroll tax costs.  Consulting costs were $198,000 and $107,000 for the three months ended December 31, 2015 and 2014, respectively, representing a $91,000 increase primarily due to increases in the costs of services provided by Schafer and Bassani effective January 1, 2015 and other consultants providing services for Kreider Farms related projects.

General and administrative stock-based employee compensation for the three months ended December 31, 2015 and 2014 consists of the following:



Three months

ended

December 31,

2015


Three months

ended

December 31,

2014

General and administrative:




  Fair value of stock bonus expensed

$   69,000       


$           -     

  Change in fair value from modification of option terms

43,000       


12,000    

  Fair value of stock options expensed under ASC 718

62,000       


4,000    

      Total

$  174,000       


$   16,000    


Stock-based compensation charges were $174,000 and $16,000 for the three months ended December 31, 2015 and 2014, respectively.  Compensation expense relating to stock bonus expensed for the three months ended December 31, 2015 related to Mark Smiths employment agreement extension for which he was granted 75,000 shares of fully vested stock which was issued in January 2016. Compensation expense relating to the change in fair value from the modification of option terms was $43,000 and $12,000 for the three months ended December 31, 2015 and 2014, respectively, as the Company granted an extension of option expiration dates for a director during both of the three months ended December 31, 2015 and 2014.  Compensation expense relating to stock options were $62,000 and $4,000 for the three months ended December 31, 2015 and 2014, respectively.  During the three months ended December 31, 2015 and 2014, respectively, the Company issued 100,000 and nil stock options to an employee, respectively.

Depreciation

Total depreciation expense was $76,000 and $127,000 for the three months ended December 31, 2015 and 2014, respectively.  Depreciation expense is lower for the three months ended December 31, 2015 due to the fiscal year 2015 $1,750,000 impairment of the Kreider 1 assets which reduced the depreciation base.

Research and Development

Total research and development expenses were $84,000 and $104,000 for the three months ended December 31, 2015 and 2014, respectively.

34


Research and development expenses, excluding stock-based compensation charges of $12,000 and nil were $72,000 and $104,000 for the three months ended December 31, 2015 and 2014, respectively.  The primary reason for the decrease is due to a reduction in expenses related to the pilot program testing to enhance the Companys technology for the three months ended December 31, 2015.  

Research and development stock-based employee compensation for the three months ended December 31, 2015 and 2014 consists of the following:



Three months

ended

December 31,

2015


Three months

ended

December 31,

2014

Research and development:




  Fair value of stock options expensed under ASC 718

$    12,000


$       -

      Total

$    12,000


$       -


Stock-based compensation expenses increased to $12,000 for the three months ended December 31, 2015 from nil for the three months ended December 31, 2014 due to the allocation of stock compensation expense for previously issued options for an employee working on research and development.

Loss from Operations

As a result of the factors described above, the loss from operations was $710,000 and $565,000 for the three months ended December 31, 2015 and 2014, respectively.

Other Expense

Other expense consisting of interest expense was $86,000 and $100,000 for the three months ended December 31, 2015 and 2014, respectively.  The interest related convertible notes payable affiliates decreased during the three months ended December 31, 2015 as various convertible notes were restructured effective January 1, 2015 which resulted in a reduction of interest rates from 8% to 4%.  Interest expense related to warrants was nil and $4,000 for the three months ended December 31, 2015 and 2014, respectively.  

Net Loss Attributable to the Noncontrolling Interest

The net loss attributable to the noncontrolling interest was $1,000 for both of the three months ended December 31, 2015 and 2014, respectively.  

Net Loss Attributable to Bions Common Stockholders

As a result of the factors described above, the net loss attributable to Bions stockholders was $796,000 and $664,000 for the three months ended December 31, 2015 and 2014, respectively, and the net loss per basic and diluted common share was $0.03 for both periods.  

SIX MONTHS ENDED DECEMBER 31, 2015 COMPARED TO THE SIX MONTHS ENDED DECEMBER 31, 2014

Revenue

Total revenues were nil for both the six months ended December 31, 2015 and 2014, respectively.

General and Administrative

Total general and administrative expenses were $1,058,000 and $691,000 for the six months ended December 31, 2015 and 2014, respectively.

35



General and administrative expenses, excluding stock-based compensation charges of $176,000 and $16,000, were $882,000 and $675,000 for the six months ended December 31, 2015 and 2014, respectively, representing a $207,000 increase.  Salaries and related payroll tax expenses decreased to $151,000 for the six months ended December 31, 2015 from $195,000 for the six months ended December 31, 2014, primarily due to the fact that during the six months ended December 31, 2015 one employee became a consultant on an as-needed consulting basis receiving compensation in the Companys securities and/or deferring their compensation which reduced recurring salary and payroll tax costs.  Consulting costs were $446,000 and $221,000 for the six months ended December 31, 2015 and 2014, respectively, representing a $225,000 increase primarily due to increases in the costs of services provided by Schafer and Bassani effective January 1, 2015 and other consultants providing services for Kreider Farms related projects.    Investor relation costs increased from $16,000 for the six months ended December 31, 2014 to $57,000 for the six months ended December 31, 2015 due to the Companys presence at multiple investor conferences and the hiring of an investor relations development firm during the six months ended December 31, 2015.

General and administrative stock-based employee compensation for the six months ended December 31, 2015 and 2014 consists of the following:



Six months

ended

December 31,

2015


Six months

ended

December 31,

2014

General and administrative:




  Fair value of stock bonus expensed

$       69,000       


$             -   

  Change in fair value from modification of option terms

43,000       


12,000   

  Fair value of stock options expensed under ASC 718

64,000       


4,000   

      Total

$     176,000       


$    16,000   

Stock-based compensation charges were $176,000 and $16,000 for the six months ended December 31, 2015 and 2014, respectively.  Compensation expense relating to stock bonus expensed for the six months ended December 31, 2015 related to Mark Smiths employment agreement extension for which he was granted 75,000 shares of fully vested stock which was issued in January 2016. Compensation expense relating to the change in fair value from the modification of option terms was $43,000 and $12,000 for the six months ended December 31, 2015 and 2014, respectively, as the Company granted an extension of option expiration dates for a director during both of the six months ended December 31, 2015 and 2014.  Compensation expense relating to stock options were $64,000 and $4,000 for the six months ended December 31, 2015 and 2014, respectively.  During the six months ended December 31, 2015 and 2014, respectively, the Company issued 100,000 and nil stock options to an employee, respectively.

Depreciation

Total depreciation expense was $152,000 and $312,000 for the six months ended December 31, 2015 and 2014, respectively.  Depreciation expense is lower for the six months ended December 31, 2015 due to the fiscal year 2015 $1,750,000 impairment of the Kreider 1 assets which reduced the depreciation base.

Research and Development

Total research and development expenses were $219,000 and $171,000 for the six months ended December 31, 2015 and 2014, respectively.

36


Research and development expenses, excluding stock-based compensation expenses of $25,000 and nil were $194,000 and $171,000 for the six months ended December 31, 2015 and 2014, respectively.  The primary reason for the increase is due to consulting costs and expenses related to the pilot program testing to enhance the Companys technology.  

Research and development stock-based employee compensation for the six months ended December 31, 2015 and 2014 consists of the following:



Six Months

ended

December 31,

2015


Six Months

ended

December 31,

2014

Research and development:




  Fair value of stock options expensed under ASC 718

$ 25,000


$   -

      Total

$ 25,000


$   -


Stock-based compensation expenses were $25,000 and nil for the six months ended December 31, 2015 and 2014, respectively.  The increase resulted from the vesting of options to an employee performing research and development during the six months ended December 31, 2015.

Loss from Operations

As a result of the factors described above, the loss from operations was $1,429,000 and $1,173,000 for the six months ended December 31, 2015 and 2014, respectively.

Other Expense

Other expense was $201,000 and $197,000 for the six months ended December 31, 2015 and 2014, respectively.  Interest expense increased slightly due to higher interest bearing deferred compensation as of December 31, 2015 compared to December 31, 2014.  Interest expense related to the Pennvest loan was $99,000 for both periods.  

Net Loss Attributable to the Noncontrolling Interest

The net loss attributable to the noncontrolling interest was $3,000 and $2,000 for the six months ended December 31, 2015 and 2014, respectively.  

Net Loss Attributable to Bions Common Stockholders

As a result of the factors described above, the net loss attributable to Bions stockholders was $1,628,000 and $1,370,000 for the six months ended December 31, 2015 and 2014, respectively, and the net loss per basic and diluted common share was $0.07 for both periods.    

LIQUIDITY AND CAPITAL RESOURCES

The Company's consolidated financial statements for the six months ended December 31, 2015 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business.  The Report of our Independent Registered Public Accounting Firm on the Company's consolidated financial statements as of and for the year ended June 30, 2015 includes a "going concern" explanatory paragraph which means that the auditors stated that conditions exist that raise substantial doubt about the Company's ability to continue as a going concern.

37


Operating Activities

As of December 31, 2015, the Company had cash of approximately $178,000. During the six months ended December 31, 2015, net cash used in operating activities was $519,000, primarily consisting of cash operating expenses related to salaries and benefits, and other general and administrative costs such as insurance and legal and accounting expenses. As previously noted, the Company is currently not generating significant revenue and accordingly has not generated cash flows from operations.  The Company does not anticipate generating sufficient revenues to offset operating and capital costs for a minimum of two to five years.  While there are no assurances that the Company will be successful in its efforts to develop and construct its Projects and market its Systems, it is certain that the Company will require substantial funding from external sources. Given the unsettled state of the current credit and capital markets for companies such as Bion, there is no assurance the Company will be able to raise the funds it needs on reasonable terms.

Investing Activities

During the six months ended December 31, 2015, the Company invested $4,000 for the purchase of new property and equipment.

Financing Activities

During the six months ended December 31, 2015, the Company received cash proceeds of $13,000 due to the receipt of a subscription receivable for the exercise of 12,500 warrants.  The Company also received cash proceeds of $174,000 due to the exercise of 165,894 warrants pursuant to subscription agreements which reduced the exercise price to $1.05 per warrant for certain warrants with expiry dates before December 31, 2015.  An additional $11,000 was received upon the election of a warrant holder to exercise 14,000 warrants into common stock of the Company.  The Company also received gross proceeds of $183,000 from the sale of units during the six months ended December 31, 2015, less commissions of $18,000.  

As of December 31, 2015 the Company has debt obligations consisting of: a) deferred compensation of $1,171,000, b) convertible notes payable affiliates of $3,219,000, and, c) a loan payable of $7,754,000 (owed by PA-1) (plus accrued interest of $693,000).  

Plan of Operations and Outlook

As of December 31, 2015, the Company had cash of approximately $178,000.

The Company continues to explore sources of additional financing to satisfy its current operating requirements as it is not currently generating any significant revenues. During fiscal years 2014 and 2015 the Company experienced greater difficulty in raising equity and debt funding than in the prior years. During the years ended June 30, 2014 and 2015, the Company had the greatest difficulty raising funds to date. As a result, the Company faced, and continues to face, significant cash flow management challenges due to material working capital constraints. These difficulties, challenges and constraints have continued during fiscal year 2016 to date and the Company anticipates that they may continue for the next twelve (12) months or longer. To partially mitigate these working capital constraints, the Companys core senior management and some key employees and consultants have been deferring all or part of their cash compensation and/or are accepting compensation in the form of securities of the Company (Notes 6 and 8 to Financial Statements) and members of the Companys senior management have made loans to the Company which have been converted into convertible promissory notes.  As of December 31, 2015, such deferrals totaled approximately $4,389,000 (including accrued interest and deferred compensation converted into promissory notes). The extended constraints on available resources have had, and continue to have, negative effects on the pace and scope of the Companys effort to develop its business.

38


The Company made reductions in its personnel during the year ended June 30, 2014.  The Company has had to delay payments of trade obligations and economize in many ways that have potentially negative consequences. If the Company does not have greater success in its efforts to raise needed funds during the current year (and subsequent periods), we will need to consider deeper cuts (including additional personnel cuts) and curtailments of operations (including possibly Kreider 1 operations). The Company will need to obtain additional capital to fund its operations and technology development, to satisfy existing creditors, to develop Integrated Projects and CAFO waste remediation systems (including the Kreider 2 facility) and to continue to operate the Kreider 1 facility (subject to agreements being reached with Pennvest as discussed above). The Company anticipates that it will seek to raise from $2,500,000 to $50,000,000 or more (debt and equity) during the next twelve months.  However, as discussed above, there is no guarantee that we will be able to raise sufficient funds or further capital for the operations planned in the near future.

The Company is not currently generating any significant revenues. Further, the Companys anticipated revenues, if any, from existing projects and proposed projects will not be sufficient to meet the Companys anticipated operational and capital expenditure needs for many years.  During the six months ended December 31, 2015 the Company raised proceeds of approximately $183,000 through the sale of its securities and an additional $185,000 through the exercise of warrants (Note 9 to Financial Statements) and anticipates raising additional funds from such sales and transactions.  However, there is no guarantee that we will be able to raise sufficient funds or further capital for the operations planned in the near future.  

Because the Company is not currently generating significant revenues, the Company will need to obtain additional capital to fund its operations and technology development, to satisfy existing creditors, to develop Projects and to sustain operations at the KF 1 facility.

On January 26, 2009, the Board of the Pennsylvania Infrastructure Investment Authority (Pennvest) approved a $7.75 million loan to Bion PA 1, LLC (PA-1), a wholly-owned subsidiary of the Company, for the initial stage of Bion's Kreider Farms project (Phase 1 Kreider System). After substantial unanticipated delays, on August 12, 2010 the PA-1 received a permit for construction of the Phase 1 Kreider system.  Construction activities commenced during November 2010.  The closing/settlement of the Pennvest Loan took place on November 3, 2010.  PA-1 finished the construction of the Phase 1 Kreider System and entered a period of system operational shakedown during May 2011.  The Phase 1 Kreider System reached full, stabilized operation by the end of the 2012 fiscal year.  During 2011 the Pennsylvania Department of Environmental Protection (PADEP) re-certified the nutrient credits for this project.  The economics (potential revenues and profitability) of the Kreider 1 System are based largely on the long term sale of nutrient (nitrogen and/or phosphorus) reduction credits to meet the requirements of the Chesapeake Bay environmental clean-up.  The PADEP issued final permits for the Kreider System (including the credit verification plan) on August 1, 2012 on which date the Company deemed that the Kreider System was placed in service. As a result, PA-1 commenced generating nutrient reduction credits for potential sale while continuing to utilize the system to test improvements and add-ons. Operating results of the Phase 1 Kreider system have documented the efficacy of Bions nutrient reduction technology and vetted potential add-ons for future installations. During August 2012 the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the technology guaranty standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1.  As a result of this extended period of operations, Bion is confident that future systems can be constructed with even higher operational efficiencies at lower capital expense and with lower operational costs.


39


To date liquidity in the Pennsylvania nutrient credit market has been slow to develop significant breadth and depth  which limited liquidity has negatively impacted Bions business plans and has prevented Bion from monetizing the nutrient reductions created by PA-1s existing Kreider 1 project and Bions other proposed projects. These challenges and difficulties (which continue to this date) have prevented PA-1 from generating any material revenues from the Kreider 1 project to date (PA-1s Kreider 1 operating expenses have been funded by loans from Bion) and raise significant questions as to when, if ever, PA-1 will be able to generate material revenues from the Kreider 1 system.  Additionally, PA-1 has not made any interest or principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of December 31, 2015.  Due to the slow development of the nutrient reduction credit market, the Company determined that the carrying amount of the property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits and, therefore, recorded a $2,000,000 impairment of the Kreider 1 assets during the year ended June 30, 2014.  An additional impairment of $1,750,000 was recorded for the year ended June 30, 2015.  

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA-1 did not make the payment and does not have the resources to make the payment demanded by Pennvest.  PA-1 has engaged in on/off discussions and negotiations with Pennvest concerning this matter, but no such discussions/negotiations are currently active.  Neither party has any formal proposal on the table as of the date of this report. It is not possible at this date to predict the outcome of such negotiations, but the Company believes it is possible that an agreement may yet be reached that will result in a commercially viable loan modification. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA-1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days.

During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the technology guaranty standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1.  

The Company is currently conducting a portion of its research and development activities at Kreider 1 while continuing commercial operations.

As indicated above, the Company anticipates that it will seek to raise from $2,500,000 to $50,000,000 or more (debt and equity) during the next twelve months, some of which may be in the context of joint ventures for the development of one or more Integrated Projects.  We reiterate that there is no assurance, especially in the extremely unsettled capital markets that presently exist for companies such as Bion, that the Company will be able to obtain the funds that it needs to stay in business, finance its Projects and other activities, continue its technology development and/or to successfully develop its business.

There is extremely limited likelihood that funds required during the next twelve months or in the periods immediately thereafter will be generated from operations and there is no assurance that those funds will be available from external sources such as debt or equity financings or other potential sources. The lack of additional capital resulting from the inability to generate cash flow from operations and/or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Further, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significantly dilutive effect on the Company's existing shareholders.  All of these factors have been exacerbated by the extremely limited and unsettled credit and capital markets presently existing for companies such as Bion.  

40



Currently, Bion is focused on using applications of its patented waste management technology and its technology platform to pursue three main business opportunities: 1) development of Integrated Projects which will include large CAFOs, such as large dairies, beef cattle feed lots and hog farms, with Bion waste treatment System modules processing the aggregate CAFO waste stream from the equivalent of 40,000 or more beef and/or dairy cows (or the waste stream equivalent of other species) while producing solids to be utilized for renewable energy production (and potentially to be marketed as feed and/or fertilizer), integrated with an ethanol plant capable of producing 40 million gallons (or more) of ethanol per year, and/or integrated with CAFO end product processors,  2) installation of Bion systems to retrofit and environmentally remediate existing CAFOs in selected markets where: a) government policy supports such efforts (such as the Chesapeake Bay watershed and Wisconsin or, potentially, other areas seeking to meet EPA TMDL requirements) and/or b) where CAFOs need our technology to obtain permits to expand or develop without negative environmental consequences, and 3) licensing and/or joint venturing its technology for use outside of North America.

While the Company has commenced activities related to marketing and potential use of its technology in relation to expansion and/or development of CAFOs in the Northeast and Midwest (and elsewhere), we have met with extremely limited success to date.  Bion considers these to be a large potential markets for the Companys growth over the next 36 months (and thereafter). Assuming that the Company can be successful in raising necessary funding and the development of a more robust market for nutrient reductions in Pennsylvania (and elsewhere), neither of which are assured at this date, the Company believes it will be able to succeed  at such activities based on the operating results of its technologies and systems.

The Company continues its development work related to the second phase of the Kreider project (Phase 2 Kreider Project) which involves production of renewable energy from the waste of KFs poultry operations and the cellulosic solids recovered by the Kreider 1 system. During May 2011 the PADEP certified the Phase 2 Kreider Project for 559,457 nutrient credits under the old EPAs Chesapeake Bay model.  The Company anticipates that the Phase 2 Kreider Project will be re-certified for between 1.5-2 million (or more) nutrient reduction credits pursuant to the amended EPA Chesapeake Bay model which was published subsequent to the original certification. Announcements related to negotiations between the EPA and PADEP regarding Pennsylvanias Chesapeake Bay nutrient reduction non-compliance suggest that a resolution of certain matters is likely during the balance of this calendar year which may allow the Phase 2 Kreider Project  to move forward with re-certification and proceed toward design, permitting, construction and eventual operation during the 2017 calendar year. Assuming there are also positive developments related to the market for nutrient reductions in Pennsylvania, the Company intends to pursue development, design and construction of the Kreider poultry waste/renewable energy project with a goal of achieving operational status during the 2017 calendar year. While the Company believes that substantial revenues may be generated from the sale of by-products (organic and inorganic fertilizer, renewable energy and/or renewable energy credits) of its operation, the economics (potential revenues and profitability) of the Phase 2 Kreider Project are based, in large part, on the long term sale of nutrient (nitrogen and/or phosphorus) reduction credits to meet the requirements of the Chesapeake Bay environmental clean-up.  However, liquidity in the Pennsylvania nutrient reduction market has been slow to develop significant breadth and depth, which lack of liquidity to date has negatively impacted Bions business plans and has resulted in challenges to monetizing the nutrient reductions created by PA-1s existing Kreider 1 project and will delay the Companys Phase 2 Kreider Project and other proposed projects in Pennsylvania.


41


Bion is currently working with local, state and federal officials with regard to regulatory and legislative initiatives, and with such parties and potential industry participants to evaluate sites in multiple states. The Company believes that its initial Integrated Project will most likely be located and developed (possibly in stages) in Pennsylvania.  Note that locations in other states are also under review and the initial Integrated Project could be developed elsewhere. It is possible that the Company will develop one or more Integrated Projects as joint ventures specifically targeted to meet the growing animal protein demand outside of the United States (including without limitation Asia, Europe and/or the Middle East).  Bion intends to choose sites for additional Projects during the calendar years 2017-2019 to create a pipeline of Projects. Management has a 5-year development target (through calendar year 2023) of approximately 10-24 Integrated Projects.  At the end of that period, Bion projects that 5 or more of these Integrated Projects will be in full operation in 3-5 states (or other locations), and the balance would be in various stages ranging from partial operation to early permitting stage. No Integrated Project has been developed to date.

CONTRACTUAL OBLIGATIONS

We have the following material contractual obligations (in addition to employment and consulting agreements with management and employees):

On September 27, 2008, the Company executed an agreement with Kreider Farms (and its affiliated entities) (collectively "Kreider") to design, construct and operate, through its wholly-owned subsidiary PA-1, a Bion system to treat the waste of the dairy cows (milkers, dry cows and heifers) at the Kreider Dairy, located in Mannheim, Pennsylvania. In addition, this agreement (as amended and extended) provides for a second phase which will include treatment of the cellulosic solid wastes from the Kreider 1 together with the waste stream from Kreider's poultry facilities to produce renewable energy for Bion's waste treatment facility and/or for market sales. The Kreider 1 system is owned and operated by PA-1, in which Kreider has the option to purchase a minority interest. Funds were expended over the last year to complete the construction of the Kreider 1 System and substantial capital and operating funds (equity and/or debt) has been and will continue to be expended.  The Company anticipates that PA-1 will receive revenue from the sale of nutrient (and other) environmental credits related to the Kreider 1 system, and through sales of renewable energy generated in connection with the second phase (largely poultry manure) of the Kreider project. The $7.75 million loan from the Pennsylvania Infrastructure Investment Authority to PA-1 (Pennvest Loan), together with funds provided by the Company, has provided the funds for construction of the Kreider 1 system. The Pennvest loan is to be repaid by interest only payments for the first three years, followed by an additional ten-year amortization of principal, and matures in November 2023.  The Kreider 1 system reached full, stabilized operation by the end of the 2012 fiscal year and received final permits during August 2012.  The Pennsylvania Department of Environmental Protection re-certified the nutrient credits for this project. As a result, PA-1 can now commence generating and verifying nutrient reduction credits for sale while continuing to utilize the system to test improvements and add-ons. Operating results of the Phase 1 Kreider system have documented the efficacy of Bions nutrient reduction technology and vetted potential add-ons for future installations. As a result of this extended period of operations, Bion is confident that future systems can be constructed with even higher operational efficiencies at lower capital expense and with lower operational costs. To date liquidity in the Pennsylvania nutrient credit market has been slow to develop significant breadth and depth  which limited liquidity has negatively impacted Bions business plans and has prevented Bion from monetizing the nutrient reductions created by PA-1s existing Kreider 1 project and Bions other proposed projects. These challenges and difficulties (which continue to this date) have prevented PA-1 from generating any material revenues from the Kreider 1 project to date (PA-1s Kreider 1 operating expenses have been funded by loans from Bion) and raise significant questions as to when, if ever, PA-1 will be able to generate material revenues from the Kreider 1 system.  

42


PA-1 has been engaged in on-and-off negotiations with Pennvest related to forbearance and/or re-structuring its obligations pursuant to the Pennvest Loan for over 36 months. In the context of such negotiations, PA-1 has elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013.  Additionally, PA-1 has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of December 31, 2015.  Due to the slow development of the nutrient reduction credit market, the Company determined that the carrying amount of the property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits and, therefore, recorded a $2,000,000 impairment of the Kreider 1 assets which reduced the value of the Kreider 1 System during the year ended June 30, 2014.  An additional impairment of $1,750,000 was recorded for the year ended June 30, 2015  

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA-1 did not make the payment and does not have the resources to make the payment demanded by Pennvest.  PA-1 has engaged in on/off discussions and negotiations with Pennvest concerning this matter but no such discussions/negotiations are currently active.  Neither party has any formal proposal on the table as of the date of this report. It is not possible at this date to predict the outcome of such negotiations, but the Company believes it is possible that an agreement may yet be reached that will result in a commercially viable loan modification. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA-1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days.

During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the technology guaranty standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1.  

The Company is currently conducting a portion of its research and development activities at Kreider 1 while PA1 maintains the Kreider 1 System.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any off-balance sheet arrangements (as that term is defined in Item 303 of Regulation SK) that are reasonably likely to have a current or future material effect on our financial condition, revenue or expenses, results of operations, liquidity, capital expenditures or capital resources.

Item 3.  Quantitative and Qualitative Disclosures About Market Risk.

Not applicable.






43



Item 4.  Controls and Procedures.

(a)  Evaluation of Disclosure Controls and Procedures.

The term "disclosure controls and procedures" is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). This term refers to the controls and procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files under the Exchange Act is recorded, processed, summarized, and reported within the required time periods. Our Chief Executive Officer and Principal Financial Officer has evaluated the effectiveness of the design and operations of our disclosure controls and procedures as of the end of the period covered by this quarterly report, and has concluded that, as of that date, our disclosure controls and procedures were not effective at ensuring that required information will be disclosed on a timely basis in our reports filed under the Exchange Act, as a result of the material weakness in internal control over financial reporting discussed in Item 9(A) of our Form 10-K for the year ended June 30, 2015.

(b)  Changes in Internal Control over Financial Reporting.

No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.































44







PART II OTHER INFORMATION

Item 1.  Legal Proceedings.

On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and has demanded that our wholly-owned subsidiary Bion PA-1 LLC (PA-1) pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. The Company anticipates that discussions and negotiations will take place between PA-1 and Pennvest concerning this matter over the next 90 days.  No proposals are currently under consideration to resolve this matter.  It is not possible at this date to predict the outcome of such negotiations, but the Company believes that it remains possible that negotiations will lead to a commercially reasonable loan modification agreement  be reached between PA-1 and Pennvest. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA-1 and Bion anticipate that it will be necessary for the Company to evaluate various options with regard to Kreider 1 over the coming months.  Litigation has not commenced in this matter but has been threatened by Pennvest.

The Company currently is not involved in any other material litigation.

Item 1A.  Risk Factors.

Not applicable.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

During the quarter ended December 31, 2015, the Company sold the following restricted securities: a) 6,362  shares issued pursuant to our 2006 Consolidated Incentive Plan (Plan), valued at $5,952, in aggregate, to an employee and consultants for services, and b) 228,750  units at $0.80 per unit, and received proceeds of $183,000 ($164,700 net of commissions)  (each unit consisted of one share of the Companys restricted common stock and one warrant to purchase half of a share of the Companys restricted common stock at $1.10 per share until June 30, 2017.  Additionally, warrant holders exercised warrants at $.75 per warrant and received 14,000 shares of the Companys common stock and the Company received cash proceeds of $10,500. In all of these transactions the Company relied on the exemptions in Section 4(2) of the Securities Act of 1933, as amended, and/or under Rule 506 of Regulation D under the Securities Act of 1933, as amended. See Notes to Financial Statements (included herein) for additional details.

The proceeds were utilized for general corporate purposes.

Item 3.  Defaults Upon Senior Securities.

Not applicable.

Item 4.  Mine Safety Disclosures.

Not applicable.

Item 5.  Other Information.

Not applicable.



45


Item 6.  Exhibits.

(a)  Exhibits required by Item 601 of Regulation S-K.

Exhibit

 

Description

 

31.1

 

Certification of CEO pursuant to Rule 13a-14(a) or Rule 15d-14(a) - Filed herewith electronically

 

 

 

31.2

 

Certification of Executive Chairman, President and CFO pursuant to Rule 13a-14(a) or Rule 15d-14(a) - Filed herewith electronically

 

 

 

32.1

 

Certification of CEO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 - Filed herewith electronically

 

 

 

32.2

 

Certification of Executive Chairman, President and CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 - Filed herewith electronically

 

 

 

101

 

XBRL Exhibits



















46


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.




BION ENVIRONMENTAL TECHNOLOGIES, INC.







Date:  February 4, 2016

By:

/s/ Mark A. Smith



Mark A. Smith, President and Chief Financial Officer (Principal Financial and Accounting Officer)










Date:  February 4, 2016

By:

/s/ Dominic Bassani



Dominic Bassani, Chief Executive Officer










47





EX-31 2 f2ex311.htm EXHIBIT 31.1 Exhibit 31

Exhibit 31.1


SECTION 302 CERTIFICATION


I, Dominic Bassani, certify that:


1.   I have reviewed this quarterly report on Form 10-Q of Bion Environmental Technologies, Inc.;


2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.   Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the of the registrant as of, and for, the periods presented in this report;


4.   The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


(a)  Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


(c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


(d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and


5.   The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:  February 4, 2016



/s/ Dominic Bassani

Dominic Bassani

Chief Executive Officer




EX-31 3 f3ex312.htm EXHIBIT 31.2 Exhibit 31

Exhibit 31.2


SECTION 302 CERTIFICATION


I, Mark A. Smith, certify that:


1.   I have reviewed this quarterly report on Form 10-Q of Bion Environmental Technologies, Inc.;


2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.   Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the of the registrant as of, and for, the periods presented in this report;


4.   The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


(a)  Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


(c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


(d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and


5.   The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:  February 4, 2016




/s/ Mark A. Smith

Mark A. Smith

Executive Chairman, President and

Interim Chief Financial Officer




EX-32 4 f4ex321.htm EXHIBIT 32.1 Exhibit 32

Exhibit 32.1


CERTIFICATION OF CEO PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Form 10-Q of Bion Environmental Technologies, Inc., a company duly formed under the laws of Colorado (the "Company"), for the period ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Dominic Bassani, Chief Executive Officer of the Company, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of his knowledge, that:


(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




February 4, 2016

/s/ Dominic Bassani

Dominic Bassani

Chief Executive Officer

   


This certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.


A signed original of this written statement required by Section 906 has been provided to Bion Environmental Technologies, Inc. and will be retained by Bion Environmental Technologies, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.



EX-32 5 f5ex322.htm EXHIBIT 32.2 Exhibit 32

Exhibit 32.2


CERTIFICATION OF CFO PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Form 10-Q of Bion Environmental Technologies, Inc., a company duly formed under the laws of Colorado (the "Company"), for the period ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Mark A. Smith, President (Executive Chairman) and Interim Chief Financial Officer (Principal Financial and  Accounting Officer) of the Company, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of his knowledge, that:


(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




February 4, 2016

/s/ Mark A. Smith

Mark A. Smith

President, Executive Chairman and

Interim Chief Financial Officer

(Principal Financial Officer)

   


This certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.


A signed original of this written statement required by Section 906 has been provided to Bion Environmental Technologies, Inc. and will be retained by Bion Environmental Technologies, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.



EX-101.INS 6 bnet-20151231.xml 75 265894 12500 265894 14000 265894 292394 1 177931 175248 0.5 0.50 0.60 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"><div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">8.</div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">CONVERTIBLE NOTES PAYABLE - AFFILIATES:</div></div></div></td> </tr> </table> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 2015 Convertible Notes</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The January 2015 Convertible Notes accrue interest at 4% per annum and are due and payable on December 31, 2017. The January 2015 Convertible Notes (including accrued interest, plus all future deferred compensation), are convertible, at the sole election of the noteholder, into Units consisting of one share of the Company&#x2019;s common stock and one quarter warrant to purchase a share of the Company&#x2019;s common stock, at a price of $0.50 per Unit until December 31, 2020. The warrant contained in the Unit shall be exercisable at $1.00 per share until December 31, 2020. The original conversion price of $0.50 per Unit approximated the fair value of the Units at the date of the agreements; therefore no beneficial conversion feature exists. Management evaluated the terms and conditions of the embedded conversion features based on the guidance of ASC 815-15 &#x201c;Embedded Derivatives&#x201d; to determine if there was an embedded derivative requiring bifurcation. An embedded derivative instrument (such as a conversion option embedded in the deferred compensation) must be bifurcated from its host instruments and accounted for separately as a derivative instrument only if the &#x201c;risks and rewards&#x201d; of the embedded derivative instrument are not &#x201c;clearly and closely related&#x201d; to the risks and rewards of the host instrument in which it is embedded. Management concluded that the embedded conversion feature of the deferred compensation was not required to be bifurcated because the conversion feature is clearly and closely related to the host instrument, and because of the Company&#x2019;s limited trading volume that indicates the feature is not readily convertible to cash in accordance with ASC 815-10, &#x201c;Derivatives and Hedging&#x201d;. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of December 31, 2015, the January 2015 Convertible Note balances, including accrued interest, owed Bassani, Smith and Schafer were $1,522,967, $790,856 and $393,380, respectively. During the three and six months ended December 31, 2015, the Company recorded interest expense of $26,247 and $52,495, respectively, related to the January 2015 Convertible Notes.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">September 2015 Convertible Notes</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, the Company entered into September 2015 Convertible Notes with Bassani, Schafer and Shareholder which replaced the previously issued FY2015 Promissory Notes. The initial principal balances of the September 2015 Convertible Notes were $405,831, $16,382 and $82,921, respectively. The September 2015 Convertible Notes bear interest at 4% per annum, have maturity dates of December 31, 2017 and may be converted at the sole election of the noteholders into restricted common shares of the Company at a conversion price of $0.60 per share. As the conversion price of $0.60 approximated the fair value of the common shares at the date of the September 2015 Convertible Notes, no beneficial conversion feature exists. The balances of the September 2015 Convertible Notes as of December 31, 2015 are $410,901, $16,587 and $83,957, respectively. The Company recorded interest expense related to the 2015 Convertible Notes of $5,093 and $6,311 for the three and six months ended December 31, 2015, respectively.</div></div></div> P3Y 693332 0.11 0.11 0.5 0.5 P10D P5D 0.76 0.96 82861 82861 88856 0.76 1.15 99159 109715 99159 226168 1131 0.5 0.05 0.01 P5Y 0.04 183000 25000 0.04 0.03 42550 42550 18000 19000 31000 14000 1 1 1 1 1 1 0.25 1 0.25 1 0.75 183000 67500 71878 71878 228750 228750 0.8 183000 183000 183000 704309 704309 1 1 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 15%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 46%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Target Price per share</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$5.00</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$10.00</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$20.00</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Number of shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">50,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">40,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">27,500</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> 75000 75000 265894 P3Y P10Y 116277 1.10 1.10 0.5 0.5 0.05 289689 -71878 217811 1.24 P4Y73D 652989 840000 626495 840000 -10197000 false --06-30 Q2 2016 2015-12-31 10-Q 0000875729 22262936 Yes Smaller Reporting Company BION ENVIRONMENTAL TECHNOLOGIES INC No No bnet 1479267 1353168 13125 2657125 2506731 101747327 100889127 178397 18300 18300 4603 74320 4000 89640 4000 69000 69000 62371 4000 64209 4000 173921 15783 175759 15783 11949 25431 11949 25431 8396364 7757653 4513870 3911370 7562213 5583740 14500 13500 2062417 2355241 232909 378022 1385125 1385125 2500000 50000000 339286 186148 178451 14971 -160835 -171177 1.05 1.05 1 1.05 1.10 0.75 0.75 3 2.25 3.10 1.50 1 1.50 100000 14000 957806 592916 8400000 6759500 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"><div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">10.</div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">COMMITMENTS AND CONTINGENCIES:</div></div></div></td> </tr> </table> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Employment and consulting agreements: </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Smith has held the positions of Director, President and General Counsel of Company and its subsidiaries under various agreements and terms since March 2003. During September 2014, Smith agreed to continue his employment agreement through April 15, 2015 and also agreed to continue to defer his temporarily reduced salary of $14,000 per month until such date. On February 10, 2015, the Company executed an Extension Agreement with Smith pursuant to which Smith extended his employment with the Company to December 31, 2015 (with the Company having an option to extend his employment an additional six months). As part of the Extension Agreement, the balance of Smith&#x2019;s existing convertible note payable as of December 31, 2014, adjusted for conversions subsequent to that date, was replaced with a new convertible note with an initial principal amount of $760,520 with terms that i) materially reduce the interest rate by 50% (from 8% to 4%), ii) increases the conversion price by 11% (from $0.45 to $0.50), iii) sets the conversion price at a fixed price so there can be no further reductions, iv) reduces the number of warrants received on conversion by 75% (from 1 warrant per unit to 1/4 per unit) and v) extends the maturity date to December 31, 2017. Additionally, pursuant to the Extension Agreement, Smith: i) will continue to defer his cash compensation ($18,000 per month) until the Board of Directors re-instates cash payments to all employees and consultants who are deferring their compensation, ii) cancelled 150,000 contingent stock bonuses previously granted to him by the Company, iii) has been granted 150,000 new options which vested immediately and iv) outstanding options and warrants owned by Smith (and his donees) have been extended and had the exercise prices reduced to $1.50 (if the exercise price exceeded $1.50). In October 2015, the Company executed an Extension Agreement (&#x201c;FY2016 Extension Agreement&#x201d;) with Smith pursuant to which Smith extended his employment with the Company to June 30, 2016 (with Company having an option to extend his employment an additional six months). As part of the FY2016 Extension Agreement, Smith: i) will continue to defer his cash compensation ($19,000 per month) until the Board of Directors re-instates cash payments, ii) has been granted 100,000 new options which vested immediately, and iii) has been granted 75,000 shares of common stock as an extension bonus which are immediately vested and were issued on January 5, 2016. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Since March 31, 2005, the Company has had various agreements with Brightcap and/or Bassani, through which the services of Bassani are provided. The Board appointed Bassani as the Company's CEO effective May 13, 2011. During the fiscal years 2012 and 2013, Bassani entered into extension agreements whereby he was awarded fully vested stock grants totaling 600,000 shares, 500,000 shares of which are to be issued January 15, 2016 and 100,000 shares are to be issued January 15, 2017. The stock grants were expensed in the years they were awarded as they are fully vested. On February 10, 2015, the Company executed an Extension Agreement with Bassani pursuant to which Bassani extended the term of his service to the Company to December 31, 2017, (with the Company having an option to extend the term an additional six months.) As part of the agreement, the Company&#x2019;s then existing loan payable, deferred compensation and convertible note payable to Bassani, were restructured into two promissory notes as follows: a) The sum of the cash loaned by Bassani to the Company of $279,000 together with $116,277 of unreimbursed expenses through December 31, 2014, were placed into a new promissory note with initial principal of $395,277 which was due and payable on December 31, 2015 and now has been replaced with a September 2015 Convertible Note (Note 8). In connection with these sums and the new promissory note, Bassani was issued warrants to purchase 592,916 shares of the Company&#x2019;s common stock at a price of $1.00 until December 31, 2020; and b) the remaining balances of the Company&#x2019;s accrued obligations to Bassani ($1,464,545) were replaced with a new convertible promissory note with terms that compared with the largest prior convertible note obligation to Bassani: i) materially reduce the interest rate by 50% (from 8% to 4%), ii) increase the conversion price by 11% (from $0.45 to $0.50), iii) sets the conversion price at a fixed price so there can be no further reductions, iv) reduces the number of warrants received on conversion by 75% (from 1 warrant per unit to 1/4 per unit) and v) extends the maturity date to December 31, 2017 (Note 8). Additionally, pursuant to the Extension Agreement, Bassani i) will continue to defer his cash compensation ($31,000 per month) until the Board of Directors re-instates cash payments to all employees and consultants who are deferring their compensation, ii) cancelled 250,000 contingent stock bonuses previously granted to him by the Company, iii) has been granted 450,000 new options which vested immediately and iv) outstanding options and warrants owned by Bassani (and his donees) have been extended and had the exercise prices reduced to $1.50 (if the exercise price exceeded $1.50).</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="WIDTH: 100%; TEXT-ALIGN: center"> &nbsp; </div> <div style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center"> &nbsp; </div> <hr style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noshade="noshade" /> <div style="WIDTH: 100%; TEXT-ALIGN: left"> &nbsp; </div> </div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">SIX MONTHS ENDED DECEMBER 31, 2015</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On February 10, 2015, the Company entered into an agreement with Schafer pursuant to which Schafer will continue to provide services to the Company through December 31, 2015. Additionally, pursuant to the agreement, i) the exercise period of outstanding options and warrants owned by Schafer have been extended, and ii) 25,000 contingent stock bonuses previously granted to Schafer have been cancelled by the Company. In January 2016, Schafer agreed to extend his agreement with the Company through December 31, 2016.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Contingent stock bonuses:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has declared contingent deferred stock bonuses to its key employees and consultants at various times throughout the years. The stock bonuses are contingent upon the Company&#x2019;s stock price exceeding a certain target price per share, and the grantees still being employed by or providing services to the Company at the time the target prices are reached. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company&#x2019;s outstanding contingent stock bonuses as of December 31, 2015 are as follows:</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 15%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 46%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Target Price per share</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$5.00</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$10.00</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$20.00</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Number of shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">50,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">40,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">27,500</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Execution/exercise bonuses:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As part of agreements the Company entered into with Bassani and Smith effective May 15, 2013, they were each granted the following: a) a 50% execution/exercise bonus which shall be applied upon the effective date of the notice of intent to exercise (for options and warrants) or issuance event, as applicable, of any currently outstanding and/or subsequently acquired&nbsp; options, warrants and/or&nbsp; contingent stock bonuses owned by each (and/or their donees) as follows: i) in the case of exercise by payment of cash, the bonus shall take the form of reduction of the exercise price; ii) in the case of cashless exercise, the bonus shall be applied to reduce the exercise price prior to the cashless exercise calculations; and iii) with regard to contingent stock bonuses, issuance shall be triggered upon the Company&#x2019;s common stock reaching a closing price equal to 50% of currently specified price; and b) the right to extend the exercise period of all or part of the applicable options and warrants for up to five years (one year at a time) by annual payments of $.05 per option or warrant to the Company on or before a date during the three months prior to expiration of the exercise period at least three business days before the end of the expiration period. Effective January 1, 2016 such annual payments to extend warrant exercise periods have been reduced to $.01 per option or warrant. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the year ended June 30, 2014, the Company extended execution/exercise bonuses with the same terms as described above to Schafer and to Jon Northrop, the Company&#x2019;s other board member.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of December 31, 2015, the execution/exercise bonus was applicable to 3,045,000 of the Company&#x2019;s outstanding options and 6,759,500 of the Company&#x2019;s outstanding warrants. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Litigation:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and has demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA-1 did not make the payment and does not have the resources to make the payment demanded by Pennvest. During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the &#x2018;technology guaranty&#x2019; standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1. No litigation has commenced related to this matter but such litigation is likely if negotiations do not produce a resolution (Note 1 and Note 7).</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company currently is not involved in any other material litigation.</div></div></div> 500000 100000 0 0 105000 100000000 100000000 22855964 22089650 22606852 19787068 19576619 22151655 21385341 21902543 19082759 18872310 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Principles of consolidation:</div></div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Bion Integrated Projects Group, Inc. (&#x201c;Projects Group&#x201d;), Bion Technologies, Inc., BionSoil, Inc., Bion Services, PA-1, and Bion PA 2 LLC; and its 58.9% owned subsidiary, Centerpoint Corporation (&#x201c;Centerpoint&#x201d;). All significant intercompany accounts and transactions have been eliminated in consolidation.</div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The accompanying consolidated financial statements have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). The consolidated financial statements reflect all adjustments (consisting of only normal recurring entries) that, in the opinion of management, are necessary to present fairly the financial position at December 31, 2015, and the results of operations and cash flows of the Company for the three and six months ended December 31, 2015 and 2014. Operating results for the three and six months ended December 31, 2015 are not necessarily indicative of the results that may be expected for the year ending June 30, 2016.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 7800000 7754000 1522967 790856 393380 405831 16382 82921 410901 16587 83957 3218648 2654708 760520 1464545 405831 16382 82921 8137117 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"><div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">7.</div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">LOAN PAYABLE:</div></div></div></td> </tr> </table> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of December 31, 2015, PA-1, the Company&#x2019;s wholly-owned subsidiary, owes $7,754,000 under the terms of the Pennvest Loan related to the construction of the Kreider 1 System. The terms of the Pennvest Loan provide for funding of up to $7,754,000 which is to be repaid by interest-only payments for three years, followed by an additional ten-year amortization of principal. The Pennvest Loan accrues interest at 2.547% for years 1 through 5 and 3.184% for years 6 through maturity. The Pennvest Loan requires minimum annual principal payments of approximately $574,000 in fiscal year 2013, $704,000 in fiscal year 2014, $723,000 in fiscal year 2015, $741,000 in fiscal year 2016, $760,000 in fiscal year 2017 and $4,252,000 thereafter. The Pennvest Loan is collateralized by the Kreider 1 System and by a pledge of all revenues generated from Kreider 1 including, but not limited to, revenues generated from nutrient reduction credit sales and by-product sales. In addition, in consideration for the excess credit risk associated with the project, Pennvest is entitled to participate in the profits from Kreider 1 calculated on a net cash flow basis, as defined. The Company has incurred interest expense related to the Pennvest Loan of $49,373 for both of the three months ended December 31, 2015 and 2014, respectively. The Company has incurred interest expense related to the Pennvest Loan of $98,747 for both of the six months ended December 31, 2015 and 2014, respectively. As of December 31, 2015, the accrued interest and late charges related to the Pennvest Loan total $693,332. Based on the limited development of the depth and breadth of the Pennsylvania nutrient reduction credit market to date, PA-1 has commenced negotiations with Pennvest related to forbearance and/or re-structuring the obligations under the Pennvest Loan. In the context of such negotiations, PA-1 has elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013. Additionally, the Company has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of December 31, 2015. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA-1 did not make the payment and does not have the resources to make the payment demanded by Pennvest. PA-1 has engaged in on/off discussions and negotiations with Pennvest concerning this matter but no such discussions/negotiations are currently active. Neither party has any formal proposal on the table as of the date of this report. It is not possible at this date to predict the outcome of such negotiations, but the Company believes it is possible that an agreement may yet be reached that will result in a viable loan modification. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA-1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days. </div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="WIDTH: 100%; TEXT-ALIGN: center"> &nbsp; </div> <div style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center"> &nbsp; </div> <hr style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noshade="noshade" /> <div style="WIDTH: 100%; TEXT-ALIGN: left"> &nbsp; </div> </div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">SIX MONTHS ENDED DECEMBER 31, 2015</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In connection with the Pennvest Loan financing documents, the Company provided a &#x2018;technology guaranty&#x2019; regarding nutrient reduction performance of Kreider 1 which was structured to expire when Kreider 1&#x2019;s nutrient reduction performance had been demonstrated. During August 2012 the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 System had surpassed the requisite performance criteria and that the Company&#x2019;s &#x2018;technology guaranty&#x2019; was met. As a result, the Pennvest Loan is solely an obligation of PA-1.</div></div></div> 0.60 0.45 0.50 0.45 0.50 395277 0.02547 0.03184 0.04 0.04 0.08 0.04 0.08 0.04 1170731 378852 54632 183316 312447 168000 984 72500 839288 76083 127159 151962 312043 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"><div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">6.</div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">DEFERRED COMPENSATION:</div></div></div></td> </tr> </table> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company owes deferred compensation to various employees, former employees and consultants totaling $1,170,731 as of December 31, 2015. Included in the deferred compensation balances as of December 31, 2015, are $378,852, $54,632 and $183,316 owed Bassani, Smith and Schafer, respectively, pursuant to extension agreements effective January 1, 2015, whereby unpaid compensation earned after January 1, 2015, accrues interest at 4% per annum and can be converted into shares of the Company&#x2019;s common stock at the election of the employee during the first five calendar days of any month. The conversion price shall be the average closing price of the Company&#x2019;s common stock for the last 10 trading days of the immediately preceding month. During the six months ended December 31, 2015, Smith converted $82,861 of deferred compensation into 99,159 shares of the Company&#x2019;s common stock at conversion prices between $0.76 and $0.96 per share. Also included are sums the Company owes various consultants, pursuant to various agreements, for deferred compensation of $312,447 as of December 31, 2015 with similar conversion terms as those described above for Bassani, Smith and Schafer, with the exception that the interest accrues at 3% per annum. The Company also owes a former employee and a current employee deferred compensation of $168,000 and $984, respectively, which is convertible into 226,168 and 1,131 shares, respectively, of the Company&#x2019;s common stock as of December 31, 2015 and, the Company owes a former employee $72,500, which is not convertible and is non-interest bearing.</div></div></div> 9000 2000 2000 1000 1000 1000 1000 279000 -0.03 -0.03 -0.07 -0.07 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Loss per share:</div></div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic loss per share amounts are calculated using the weighted average number of shares of common stock outstanding during the period. Diluted loss per share assumes the conversion, exercise or issuance of all potential common stock instruments, such as options or warrants, unless the effect is to reduce the loss per share. During the six months ended December 31, 2015 and 2014, the basic and diluted loss per share was the same, as the impact of potential dilutive common shares was anti-dilutive.</div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table represents the warrants, options and convertible securities excluded from the calculation of diluted loss per share:</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 20%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrants</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">8,396,364</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">7,757,653</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Options</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,513,870</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">3,911,370</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Convertible debt</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">7,562,213</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5,583,740</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Convertible preferred stock</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">14,500</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">13,500</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following is a reconciliation of the denominators of the basic loss per share computations for the three and six months ended December 31, 2015 and 2014: </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 18pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 18pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 18pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Six months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 18pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Six months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares issued &#x2013; beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">22,606,852</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">19,787,068</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">22,089,650</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">19,576,619</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares held by subsidiaries (Note 9)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares outstanding &#x2013; beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">21,902,543</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">19,082,759</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">21,385,341</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">18,872,310</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average shares for fully </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">vested stock bonuses (Note 9)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">652,989</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">840,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">626,495</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">840,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average shares issued </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">during the period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">29,469</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">42,700</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">425,203</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">178,957</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic weighted average shares &#x2013; </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">end of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">22,585,001</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">19,965,459</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">22,437,039</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">19,891,267</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 19826 0.589 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Fair value measurements:</div></div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. The Company uses a fair value hierarchy that has three levels of inputs, both observable and unobservable, with use of the lowest possible level of input to determine fair value. </div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 1 &#x2013; quoted prices (unadjusted) in active markets for identical assets or liabilities;</div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 2 &#x2013; observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and</div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 3 &#x2013; assets and liabilities whose significant value drivers are unobservable.</div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company&#x2019;s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment. </div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The fair value of cash, promissory note receivable and accounts payable approximates their carrying amounts due to their short-term maturities. The fair value of the loan payable approximates its carrying amount as it bears interest at rates commensurate with market rates. The fair value of the redeemable preferred stock approximates its carrying value due to the dividends accrued on the preferred stock which are reflected as part of the redemption value. The fair value of deferred compensation and convertible notes payable - affiliates are not practicable to estimate due to the related party nature of the underlying transactions.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 550095 333196 1058000 690537 1750000 2000000 0 1750000 27351 225779 490800 312000 -6153 -5341 -13125 -30000 26247 52495 5093 6311 86405 100356 200661 197303 49373 98747 49373 98747 1878 13649046 13098794 2062417 2355241 10430398 10444086 7754000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"><div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">4.</div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">PROMISSORY NOTE RECEIVABLE:</div></div></div></div></td> </tr> </table> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, the Company received an interest bearing, secured promissory note for $105,000. The promissory note bears interest at 4% per annum, is collateralized, and was payable on January 31, 2016. The promissory note receivable was issued as consideration for an unaffiliated investor&#x2019;s subscription agreement to exercise warrants into 100,000 restricted common shares of the Company&#x2019;s common stock at $1.05 per share. During January 2016, the Company received a $35,000 principal payment and entered into a new agreement with the borrowers which extended the maturity date of the remaining principal and interest until June 15, 2016. All the other terms of the original agreement remain unchanged. As of December 31, 2015, the Company has recorded the $35,000 as a promissory note receivable and the remaining unpaid principal and interest totaling $71,878, as a promissory note receivable for shares. The Company recorded interest income of $1,878 for the six months ended December 31, 2015.</div></div></div> 7754000 7754000 4252000 760000 741000 8137117 2923577 2923577 26400 25400 60811 63380 362514 123750 -4251 -519098 -294927 -795595 -663920 -1626829 -1368607 -1274 -1028 -2569 -2099 -796095 -664420 -1627829 -1369607 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Recent Accounting Pronouncements:</div></div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company&#x2019;s financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company&#x2019;s financial statements properly reflect the change. </div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In May 2014, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2014-09 &#x201c;Revenue from Contracts from Customers,&#x201d; which supersedes the revenue recognition requirements in &#x201c;Revenue Recognition (Topic 605),&#x201d; and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017 and early adoption is not permitted. The Company is currently evaluating the new standard and assessing the potential impact on its operations and financial statements. </div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In August 2014, the FASB issued ASU No. 2014-15, &#x201c;Presentation of Financial Statements &#x2013; Going Concern: Disclosures of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern.&#x201d; The new standard requires management to perform interim and annual assessments of an entity&#x2019;s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity&#x2019;s ability to continue as a going concern. The guidance is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early application is permitted. The Company believes that the adoption of ASU No. 2014-15 will not have a material impact on its financial statements.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> -86405 -100356 -200661 -197303 35000 35000 472230 395277 15956 80764 710464 564592 1428737 1173403 -710464 -564592 -1428737 -1173403 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"><div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">1.</div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ORGANIZATION, NATURE OF BUSINESS, GOING CONCERN AND MANAGEMENT&#x2019;S PLANS:</div></div></div></td> </tr> </table> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Organization and nature of business:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Bion Environmental Technologies, Inc. (&#x201c;Bion&#x201d; or &#x201c;We&#x201d; or the &quot;Company&quot;) was incorporated in 1987 in the State of Colorado and has developed and continues to develop patented and proprietary technology and business models that provide comprehensive environmental solutions to a significant source of pollution in United States agriculture, large scale livestock facilities known as Confined Animal Feeding Operations (&quot;CAFO's&quot;). Bion's technologies (and applications related thereto) produce substantial reductions of nutrient releases (primarily nitrogen and phosphorus) to both water and air (including ammonia, which is subsequently re-deposited to the ground) from livestock waste streams based upon our operations and research to date (and third party peer review thereof). We are continually involved in research and development to upgrade and improve our technology and technology applications, including integration with third party technology. Bion provides comprehensive and cost-effective treatment of livestock waste onsite (and/or at nearby locations), while it is still concentrated and before it contaminates air, soil, groundwater aquifers and/or downstream waters, and, in certain configurations, recovers nutrients for potential use as fertilizer and feed additives.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the 2014 and 2015 fiscal years, the Company increased its research and development activities with focus on augmenting the basic &#x2018;separate and aggregate&#x2019; approach of its technology platform to provide additional flexibility and to increase recovery of nutrient by-products (in organic and non-organic forms) and renewable energy production (either/both biogas and/or renewable electricity), thereby increasing potential related revenue streams and reducing dependence of its future projects on nutrient reduction credits (which still remain a very important part of project revenue streams). This research and development effort also involves ongoing review of potential &#x201c;add-ons&#x201d; and applications to our technology platform for use in different regulatory and/or climate environments. These research and development activities continued through the balance of the 2015 fiscal year, and we believe such activities will continue at least through the 2016 fiscal year, subject to availability of adequate financing for the Company&#x2019;s operations, of which there is no assurance.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Bion is actively pursuing business opportunities in three broad areas 1) installation of Bion systems to retrofit and environmentally remediate existing CAFO&#x2019;s to reduce nutrient (primarily nitrogen and phosphorus) releases, gaseous emissions (ammonia, greenhouse gases, volatile organic compounds, etc.), and pathogens, hormones and other compounds in order to clean the air and water in the surrounding areas (as described below) to ensure compliance with existing (and future) regulations and to permit herd expansion; 2) development of Integrated Projects opportunities within the United States and internationally; and 3) licensing and/or joint venturing of Bion&#x2019;s technology and applications outside North America. The opportunities described at 1) and 2) above (and below) each require substantial political and regulatory (federal, state and local) efforts on the part of the Company and a substantial part of Bion&#x2019;s efforts are focused on such political and regulatory matters. The most intense focus is currently on the requirements for the clean-up of the Chesapeake Bay faced by the Commonwealth of Pennsylvania and the potential use of Bion&#x2019;s technology and technology platform on CAFOs as an alternative to what the Company believes is far more expensive nutrient removal downstream in storm water projects.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Management believes that Bion's technology platform (including utilization of various third party technologies to supplement the Company&#x2019;s proprietary technologies), in addition to utilization for remediation of the waste streams of existing CAFOs, can enable the integration of large-scale CAFO's and their end-product users, renewable energy production from the CAFO waste stream, on site utilization of the renewable energy generated and biofuel/ethanol production in an environmentally and economically sustainable manner while reducing the aggregate capital expense and operating costs for the entire integrated complex (&quot;Integrated Projects&quot; or &quot;Projects&quot;). In the context of Integrated Projects, Bion's waste treatment process, in addition to mitigating polluting releases, enables generation of renewable energy from cellulosic portions of the CAFO waste stream, which renewable energy can be utilized by integrated facilities including ethanol plants, CAFO end-product processors (including cheese, ice cream and/or bottling plants in the case of dairy CAFO&#x2019;s and/or slaughter and/or processing facilities in the context of beef CAFO&#x2019;s) and/or other users as a fossil fuel replacement. The nutrients (primarily nitrogen and phosphorus) can be harvested from the solids and liquid streams recovered from the livestock waste stream and can be utilized as either high value fertilizer and/or the basis for high protein animal feed and the nutrient rich effluent can potentially be utilized in integrated hydroponic agriculture and/or field applied as fertilizer. Bion believes that its Integrated Projects will produce high quality, traceable animal protein which can address consumer food safety/security concerns at a lower cost than current industry practices while also maintaining a far lower net environmental footprint per unit of protein produced due to water recycling (possible due to the removal of nutrients, etc. from the water by Bion&#x2019;s technology applications), production of renewable energy from the waste stream (reducing the use of fossil fuels), and multiple levels of economies of scale, co-location and integration savings in transportation and other logistics. Some projects may involve only partial integration which will limit the benefits described herein.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On September 27, 2008, the Company executed an agreement with Kreider Farms (and its affiliated entities) (collectively &quot;Kreider&quot;) to design, construct and operate (through its wholly-owned subsidiaries, Bion Services Group, Inc. (&#x201c;Bion Services&#x201d;) and Bion PA-1 LLC (&#x201c;PA-1&#x201d;) a Bion system to treat the waste of 1,200 milking dairy cows (milkers, dry cows and heifers) at the Kreider Dairy, located in Manheim, Pennsylvania. In addition, the agreement (as amended and supplemented) provides for a second phase which will treat the wastes from the rest of Kreider&#x2019;s herd and includes renewable energy production from the cellulosic solid wastes from the Phase 1 system (referred to as &#x201c;Kreider 1&#x201d;) together with the waste stream from Kreider&#x2019;s poultry facilities for use at the facilities and/or for market sales. The Kreider projects are owned and operated by Bion through subsidiaries, in which Kreider has the option to acquire a noncontrolling interest. S</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ubstantial capital (equity and/or debt) has been and will continue to be expended on these projects. Additional funds will be required for continuing operations of Kreider 1 until sufficient revenues can be generated, of which there is no assurance. The Company anticipates that the Kreider 1 project will generate revenue primarily from the sale of nutrient reduction (and/or other) environmental credits while the Kreider Phase 2 poultry waste treatment system (&#x2018;Kreider 2&#x2019;)(not yet constructed) and other future projects will supplement its revenue from nutrient reductions with proceeds from multiple byproduct streams including i) feed additives and/or fertilizer (organic and non-organic) and ii) renewable energy (and related credits), which sales are projected to generate, in aggregate, revenue streams that, in certain circumstances, may approach 50% of total revenues. To date the market for long-term nutrient reduction credits in Pennsylvania has been very slow to develop and the Company&#x2019;s activities have been negatively affected by the lack of such development. A portion of Bion&#x2019;s research and development activities is currently taking place at the Kreider 1 facility.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company&#x2019;s subsidiary PA-1 financed Kreider 1 through a $7.8 million loan (&#x201c;Pennvest Loan&#x201d;) from Pennsylvania Infrastructure Investment Authority (&#x201c;Pennvest&#x201d;) secured by Kreider 1 (and its revenue streams, if any) plus advances from the Company. The economics (potential revenues and profitability) of Kreider 1 are based largely on the long-term sale of nutrient reduction credits (nitrogen and/or phosphorus) to meet the requirements of the Chesapeake Bay environmental clean-up. The Pennsylvania Department of Environmental Protection (&#x201c;PADEP&#x201d;) issued final permits for Kreider 1 (including the credit verification plan) on August 1, 2012 on which date the Company deemed that Kreider 1 was &#x2018;placed in service&#x2019;. However, liquidity in the Pennsylvania nutrient credit market has been slow to develop significant breadth and depth and has prevented Bion from monetizing the nutrient reduction credits created by PA-1&#x2019;s Kreider 1 project and Bion&#x2019;s other proposed projects. These challenges and difficulties raise significant questions as to when PA-1 will be able to generate such revenues from Kreider 1. PA-1 has elected not to make interest or principal payments on the Pennvest Loan since January 2013 and, therefore, the Company has classified the Pennvest Loan as a current liability as of December 31, 2015. The Company recorded a $1,750,000 impairment of the Kreider 1 assets for the year ended June 30, 2015 (following a $2,000,000 impairment during the year ended June 30, 2014).</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA-1 did not make the payment and does not have the resources to make the payment demanded by Pennvest. PA-1 has engaged in on/off discussions and negotiations with Pennvest concerning this matter but no such discussions/negotiations are currently active. Neither party has any formal proposal on the table as of the date of this report. It is not possible at this date to predict the outcome of such negotiations, but the Company believes it is possible that an agreement may yet be reached that will result in a viable loan modification. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA-1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days. </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the &#x2018;technology guaranty&#x2019; standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Development work and technology evaluation, including amended credit certification and discussions with potential joint venture partners, continues related to the details of Kreider 2, which primarily relates to treatment of the wastes from Kreider&#x2019;s poultry operations. Assuming there are positive developments related to the market for nutrient reductions in Pennsylvania, the Company intends to pursue development, design and construction of the Kreider 2 poultry waste/renewable energy project with a goal of achieving operational status during calendar year 2017. However, as discussed above, this project faces challenges related to the current limits of the existing nutrient reduction market and funding of technology-based, verifiable agricultural nutrient reductions which are anticipated to constitute the largest share of its revenues. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A significant portion of Bion&#x2019;s activities concern efforts with private and public stakeholders (at local and state level) in Pennsylvania (and other Chesapeake Bay and Midwest and Great Lakes states) and at the federal level (the Environmental Protection Agency (&#x201c;EPA&#x201d;) and the Department of Agriculture (&#x201c;USDA&#x201d;) (and other executive departments) and Congress) to establish appropriate public policies which will create regulations and funding mechanisms that foster installation of the low cost environmental solutions that Bion (and others) can provide through clean-up of agricultural waste streams. The Company anticipates that such efforts will continue in Pennsylvania throughout the next 12 months and in various additional states thereafter. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Going concern and management&#x2019;s plans:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has not generated significant revenues and has incurred net losses (including significant non-cash expenses) of approximately $5,640,000 and $5,762,000 during the years ended June 30, 2015 and 2014, respectively, and a net loss of approximately $1,629,000 during the six months ended December 31, 2015. At December 31, 2015, the Company has a working capital deficit and a stockholders&#x2019; deficit of approximately $10,197,000 and $11,647,000, respectively. These factors raise substantial doubt about the Company's ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability or classification of assets or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern. The following paragraphs describe management&#x2019;s plans with regard to these conditions. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company continues to explore sources of additional financing to satisfy its current operating requirements as it is not currently generating any significant revenues. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the years ended June 30, 2015 and 2014, the Company received total proceeds of $1,000,940 and $944,400, respectively, from the sale of its equity securities. Proceeds during the 2015 and 2014 fiscal years have been lower than in earlier years which reduction has negatively impacted the Company&#x2019;s business development efforts. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, the Company entered into subscription agreements to exercise certain warrants with expiry dates on or before December 31, 2015, into restricted shares of the Company&#x2019;s common stock at a reduced exercise price of $1.05, for the period from June 30, 2015 through July 15, 2015. Pursuant to the offering, 265,894 warrants were exercised and 265,894 shares of the Company&#x2019;s restricted common stock were issued during the six months ended December 31, 2015, resulting in cash proceeds of $174,189 and receipt of a $105,000 interest bearing, collateralized promissory note receivable for shares. In January 2016, the Company received $35,000 of the promissory note receivable for shares. </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, the Company sold units of the Company&#x2019;s restricted securities for $0.80 per unit, with each unit consisting of one share of the Company&#x2019;s restricted common stock and one warrant to purchase one half of a share of the Company&#x2019;s restricted common stock for $1.10 per share until June 30, 2017. During the six months ended December 31, 2015, the Company had sold a total of 228,750 units for gross proceeds of $183,000, and net proceeds of $164,700 after commissions of $18,300. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During fiscal years 2015 and 2014 and through the six months ended December 31, 2015, the Company experienced greater difficulty in raising equity funding than in the prior years. As a result, the Company faced, and continues to face, significant cash flow management challenges due to working capital constraints. To partially mitigate these working capital constraints, the Company&#x2019;s core senior management and several key employees and consultants have been deferring (and continue to defer) all or part of their cash compensation and/or are accepting compensation in the form of securities of the Company (Notes 6 and 8) and members of the Company&#x2019;s senior management have made loans to the Company. Additionally, the Company made reductions in its personnel during the year ended June 30, 2014. The constraint on available resources has had, and continues to have, negative effects on the pace and scope of the Company&#x2019;s efforts to develop its business. The Company has had to delay payment of trade obligations and has had to economize in many ways that have potentially negative consequences. If the Company does not have greater success in its efforts to raise needed funds during the balance of the 2016 fiscal year (and subsequent periods), management will need to consider deeper cuts (including additional personnel cuts) and curtailment of operations (including possibly Kreider 1 operations) and/or research and development activities.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company will need to obtain additional capital to fund its operations and technology development, to satisfy existing creditors, to develop Integrated Projects and CAFO waste remediation systems (including the Kreider 2 facility) and to continue to operate the Kreider 1 facility. The Company anticipates that it will seek to raise from $2,500,000 to $50,000,000 or more debt and/or equity through joint ventures and/or sale of its equity securities (common, preferred and/or hybrid) and/or debt (including convertible) securities, and/or through use of &#x2018;rights&#x2019; and/or warrants (new and/or existing) during the next twelve months. However, as discussed above, there is no assurance, especially in light of the difficulties the Company has experienced in recent periods and the extremely unsettled capital markets that presently exist (especially for small companies), that the Company will be able to obtain the funds that it needs to stay in business, complete its technology development or to successfully develop its business and projects. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">There is no realistic likelihood that funds required during the next twelve months or in the periods immediately thereafter for the Company&#x2019;s basic operations and/or proposed projects will be generated from operations. Therefore, the Company will need to raise sufficient funds from external sources such as debt or equity financings or other potential sources. The lack of sufficient additional capital resulting from the inability to generate cash flow from operations and/or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Further, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significantly dilutive effect on the Company's existing shareholders. All of these factors have been exacerbated by the extremely limited and unsettled credit and capital markets presently existing for small companies like Bion.</div></div></div> 200940 189573 7108 7108 171717 105000 105000 18300 18300 18300 4251 0.025 500 500 1000 1000 29000 28000 0.01 0.01 0.01 0.01 0.01 0.01 0.01 2 50000 50000 10000 10000 60000 60000 200 200 0 0 0 0 200 200 0 0 0 0 200 12350 18503 35000 26250 1000940 944400 164700 174189 174189 10500 184689 -5640000 -5762000 -1629398 -1370706 -796869 -664948 -1626829 -2569 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"><div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">3.</div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">PROPERTY AND EQUIPMENT:</div></div></div></td> </tr> </table> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Property and equipment consists of the following:</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">June 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Machinery and equipment</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2,923,577</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2,923,577</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Buildings and structures</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,385,125</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,385,125</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Computers and office equipment</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">177,931</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">175,248</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,486,633</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,483,950</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Less accumulated depreciation</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">(2,657,125</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">(2,506,731</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,829,508</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,977,219</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Management reviewed property and equipment for impairment as of June 30, 2015 and determined that the carrying amount of property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits. Kreider 1 was measured at estimated fair value on a non-recurring basis using level 3 inputs, which resulted in an impairment of $1,750,000 of the property and equipment for the year ended June 30, 2015. As of December 31, 2015, management believes that no additional impairment exists.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Depreciation expense was $76,083 and $127,159 for the three months ended December 31, 2015 and 2014, respectively, and $151,962 and $312,043 for the six months ended December 31, 2015 and 2014, respectively.</div></div></div> 4486633 4483950 1829508 1977219 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Property and equipment:</div></div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Property and equipment are stated at cost and are depreciated, when placed into service, using the straight-line method over the estimated useful lives of the related assets, generally three to twenty years. The Company capitalizes all direct costs and all indirect incrementally identifiable costs related to the design and construction of its Integrated Projects. The Company reviews its property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized based on the amount by which the carrying value of the assets or asset group exceeds its estimated fair value, and is recognized as a loss from operations.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">June 30,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Machinery and equipment</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2,923,577</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2,923,577</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Buildings and structures</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,385,125</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,385,125</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Computers and office equipment</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">177,931</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">175,248</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,486,633</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,483,950</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Less accumulated depreciation</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">(2,657,125</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">(2,506,731</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,829,508</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,977,219</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> P3Y P20Y 0.04 0.04 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">5.</div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">NOTES PAYABLE - AFFILIATES:</div></div></div></td> </tr> </table> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the year ended June 30, 2015, the Company entered into promissory notes (&#x201c;FY2015 Promissory Notes&#x201d;), with effective dates of January 1, 2015, for initial principal amounts of $395,277, $15,956 and $80,764, with Dominic Bassani (&#x201c;Bassani&#x201d;), the Company&#x2019;s Chief Executive Officer (&#x201c;CEO&#x201d;), Edward Schafer (&#x201c;Schafer&#x201d;), the Company&#x2019;s Vice Chairman, and a major shareholder, (&#x201c;Shareholder&#x201d;), respectively. The FY2015 Promissory Notes accrued interest at 4% per annum and were payable on December 31, 2015. Effective September 8, 2015, the Company entered into new convertible promissory notes (&#x201c;September 2015 Convertible Notes&#x201d;) with Bassani, Schafer and Shareholder which replaced the FY2015 Promissory Notes. The initial principal balances of the September 2015 Convertible Notes were $405,831, $16,382 and $82,921, respectively. The new convertible promissory notes bear interest at 4% per annum, have maturity dates of December 31, 2017 and may be converted (at the sole election of the noteholders) into restricted common shares of the Company at a conversion price of $0.60 per share (Note 8).</div></div></div> 574000 704000 723000 84286 104237 218775 170823 -113322889 -111696060 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Revenue Recognition:</div></div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Revenues are generated from the sale of nutrient reduction credits. The Company recognizes revenue from the sale of nutrient credits when there is persuasive evidence that an arrangement exists, when title has passed, the price is fixed or determinable, and collection is reasonably assured.</div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company expects that technology license fees will be generated from the licensing of Bion&#x2019;s integrated system. The Company anticipates that it will charge its customers a non-refundable up-front technology license fee, which will be recognized over the estimated life of the customer relationship. In addition, any on-going technology license fees will be recognized as earned based upon the performance requirements of the agreement. Annual waste treatment fees will be recognized upon receipt. Revenues, if any, from the Company&#x2019;s interest in Integrated Projects will be recognized when the entity in which the Integrated Project has been developed recognizes such revenue.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 20%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrants</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">8,396,364</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">7,757,653</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Options</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,513,870</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">3,911,370</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Convertible debt</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">7,562,213</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5,583,740</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Convertible preferred stock</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">14,500</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">13,500</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 18pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 18pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 18pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Six months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 18pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Six months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares issued &#x2013; beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">22,606,852</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">19,787,068</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">22,089,650</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">19,576,619</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares held by subsidiaries (Note 9)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares outstanding &#x2013; beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">21,902,543</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">19,082,759</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">21,385,341</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">18,872,310</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average shares for fully </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">vested stock bonuses (Note 9)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">652,989</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">840,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">626,495</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">840,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average shares issued </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">during the period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">29,469</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">42,700</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">425,203</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">178,957</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic weighted average shares &#x2013; </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">end of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">22,585,001</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">19,965,459</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">22,437,039</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">19,891,267</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Six months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Six months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">General and administrative:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value of stock bonus expensed </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">69,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">69,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value from modification of </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">option terms</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">42,550</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">11,783</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">42,550</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">11,783</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value of stock options expensed </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">62,371</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">64,209</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">173,921</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">15,783</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">175,759</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">15,783</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Research and development:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value of stock options expensed</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">11,949</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">25,431</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">11,949 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">25,431</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 15%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" colspan="2"> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: center; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Options</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Grant-Date Fair</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Nonvested at July 1, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">100,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.76</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">100,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.59</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vested</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">(100,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">(0.59</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Nonvested at December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">100,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.76</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" colspan="2"> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: center; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Options</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted-</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercise</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Price</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted-</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Remaining</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contractual</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Life</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Aggregate</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Intrinsic</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at July 1, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4,413,870</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.88</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4.1</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; PADDING-LEFT: 9pt; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">100,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.92</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; PADDING-LEFT: 9pt; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; PADDING-LEFT: 9pt; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; PADDING-LEFT: 9pt; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expired</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,513,870</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.86</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">3.9</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">36,050</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable at December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4,413,870</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.89</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3.7</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">22,050</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31, </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Range,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31, </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31, </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Range,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31, </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">74%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">74%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">80%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">80%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.75%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.75%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.51%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.51%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected term (years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">2</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">2</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> 233094 31043 0.74 0.74 0.8 0.8 0.0175 0.0175 0.0051 0.0051 22000000 4413870 1.89 397500 150000 250000 25000 100000 0 150000 100000 600000 450000 0.59 36050 3045000 50000 40000 27500 4413870 4513870 1.88 1.86 42550 42550 11783 42550 11783 0.92 0.69 1.15 5 10 20 P10Y P5Y P5Y P2Y P2Y 22050 P3Y255D 100000 100000 0.76 0.76 P4Y36D P3Y328D 0 59000 100000 0.59 0.80 0.80 22089650 22855964 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"><div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2.</div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">SIGNIFICANT ACCOUNTING POLICIES</div></div></div></td> </tr> </table> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Principles of consolidation:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Bion Integrated Projects Group, Inc. (&#x201c;Projects Group&#x201d;), Bion Technologies, Inc., BionSoil, Inc., Bion Services, PA-1, and Bion PA 2 LLC; and its 58.9% owned subsidiary, Centerpoint Corporation (&#x201c;Centerpoint&#x201d;). All significant intercompany accounts and transactions have been eliminated in consolidation.</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The accompanying consolidated financial statements have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). The consolidated financial statements reflect all adjustments (consisting of only normal recurring entries) that, in the opinion of management, are necessary to present fairly the financial position at December 31, 2015, and the results of operations and cash flows of the Company for the three and six months ended December 31, 2015 and 2014. Operating results for the three and six months ended December 31, 2015 are not necessarily indicative of the results that may be expected for the year ending June 30, 2016.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Property and equipment:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Property and equipment are stated at cost and are depreciated, when placed into service, using the straight-line method over the estimated useful lives of the related assets, generally three to twenty years. The Company capitalizes all direct costs and all indirect incrementally identifiable costs related to the design and construction of its Integrated Projects. The Company reviews its property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized based on the amount by which the carrying value of the assets or asset group exceeds its estimated fair value, and is recognized as a loss from operations.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Fair value measurements:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. The Company uses a fair value hierarchy that has three levels of inputs, both observable and unobservable, with use of the lowest possible level of input to determine fair value. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 1 &#x2013; quoted prices (unadjusted) in active markets for identical assets or liabilities;</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 2 &#x2013; observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 3 &#x2013; assets and liabilities whose significant value drivers are unobservable.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company&#x2019;s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The fair value of cash, promissory note receivable and accounts payable approximates their carrying amounts due to their short-term maturities. The fair value of the loan payable approximates its carrying amount as it bears interest at rates commensurate with market rates. The fair value of the redeemable preferred stock approximates its carrying value due to the dividends accrued on the preferred stock which are reflected as part of the redemption value. The fair value of deferred compensation and convertible notes payable - affiliates are not practicable to estimate due to the related party nature of the underlying transactions.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Revenue Recognition:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Revenues are generated from the sale of nutrient reduction credits. The Company recognizes revenue from the sale of nutrient credits when there is persuasive evidence that an arrangement exists, when title has passed, the price is fixed or determinable, and collection is reasonably assured.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company expects that technology license fees will be generated from the licensing of Bion&#x2019;s integrated system. The Company anticipates that it will charge its customers a non-refundable up-front technology license fee, which will be recognized over the estimated life of the customer relationship. In addition, any on-going technology license fees will be recognized as earned based upon the performance requirements of the agreement. Annual waste treatment fees will be recognized upon receipt. Revenues, if any, from the Company&#x2019;s interest in Integrated Projects will be recognized when the entity in which the Integrated Project has been developed recognizes such revenue.</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Loss per share:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic loss per share amounts are calculated using the weighted average number of shares of common stock outstanding during the period. Diluted loss per share assumes the conversion, exercise or issuance of all potential common stock instruments, such as options or warrants, unless the effect is to reduce the loss per share. During the six months ended December 31, 2015 and 2014, the basic and diluted loss per share was the same, as the impact of potential dilutive common shares was anti-dilutive.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table represents the warrants, options and convertible securities excluded from the calculation of diluted loss per share:</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 20%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrants</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">8,396,364</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">7,757,653</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Options</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,513,870</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">3,911,370</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Convertible debt</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">7,562,213</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5,583,740</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Convertible preferred stock</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">14,500</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">13,500</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following is a reconciliation of the denominators of the basic loss per share computations for the three and six months ended December 31, 2015 and 2014: </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 18pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 18pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 18pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Six months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 18pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Six months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares issued &#x2013; beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">22,606,852</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">19,787,068</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">22,089,650</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">19,576,619</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares held by subsidiaries (Note 9)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">(704,309</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares outstanding &#x2013; beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">21,902,543</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">19,082,759</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">21,385,341</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">18,872,310</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average shares for fully </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">vested stock bonuses (Note 9)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">652,989</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">840,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">626,495</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">840,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average shares issued </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">during the period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">29,469</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">42,700</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">425,203</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">178,957</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic weighted average shares &#x2013; </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">end of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">22,585,001</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">19,965,459</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">22,437,039</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">19,891,267</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Recent Accounting Pronouncements:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company&#x2019;s financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company&#x2019;s financial statements properly reflect the change. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In May 2014, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2014-09 &#x201c;Revenue from Contracts from Customers,&#x201d; which supersedes the revenue recognition requirements in &#x201c;Revenue Recognition (Topic 605),&#x201d; and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017 and early adoption is not permitted. The Company is currently evaluating the new standard and assessing the potential impact on its operations and financial statements. </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In August 2014, the FASB issued ASU No. 2014-15, &#x201c;Presentation of Financial Statements &#x2013; Going Concern: Disclosures of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern.&#x201d; The new standard requires management to perform interim and annual assessments of an entity&#x2019;s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity&#x2019;s ability to continue as a going concern. The guidance is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early application is permitted. The Company believes that the adoption of ASU No. 2014-15 will not have a material impact on its financial statements.</div></div></div> 208874 36296 75000 5031 75000 36296 228750 12500 31250 171717 171717 100904 69000 4500 100904 100904 13125 89640 89640 -11647440 -10806933 -11586629 -10743553 100889127 -111696060 63380 101747327 -71878 -113322889 60811 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"><div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">9.</div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">STOCKHOLDERS' EQUITY:</div></div></div></td> </tr> </table> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Series B Preferred stock:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At July 1, 2014, the Company had 200 shares of Series B redeemable convertible Preferred stock outstanding with a par value of $0.01 per share, convertible at the option of the holder at $2.00 per share, with dividends accrued and payable at 2.5% per quarter. The Series B Preferred stock is mandatorily redeemable at $2.00 per share by the Company three years after issuance and accordingly was classified outside of shareholders&#x2019; equity. The 200 shares have reached their maturity date, but due to the cash constraints of the Company have not been redeemed. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the years ended June 30, 2015 and 2014, the Company declared dividends of $2,000 and $2,000 respectively. During the six months ended December 31, 2015, the Company declared dividends of $1,000. At December 31, 2015, accrued dividends payable are $9,000.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Common stock:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Holders of common stock are entitled to one vote per share on all matters to be voted on by common stockholders. In the event of liquidation, dissolution or winding up of the Company, the holders of common stock are entitled to share in all assets remaining after liabilities have been paid in full or set aside and the rights of any outstanding preferred stock have been satisfied. Common stock has no preemptive, redemption or conversion rights. The rights of holders of common stock are subject to, and may be adversely affected by, the rights of the holders of any outstanding series of preferred stock or any series of preferred stock the Company may designate in the future. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Centerpoint holds 704,309 shares of the Company&#x2019;s common stock. These shares of the Company&#x2019;s common stock held by Centerpoint are for the benefit of its shareholders without any beneficial interest. The Company accounts for these shares similar to treasury stock.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, the Company issued 36,296 shares of the Company&#x2019;s common stock at prices ranging from $0.69 to $1.15 per share for services valued at $100,904, in the aggregate, to consultants and employees, including $69,000 expensed for 75,000 fully vested bonus shares to Smith that were granted but not issued. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, the Company issued 12,500 shares of the Company&#x2019;s restricted common stock upon receipt of its subscription receivable of $13,125 for the exercise of 12,500 warrants.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, the Company entered into subscription agreements to exercise certain warrants with expiry dates on or before December 31, 2015, into restricted shares of the Company&#x2019;s common stock at a reduced exercise price of $1.05, for the period from June 30, 2015 through July 15, 2015. Pursuant to the offering, 265,894 warrants were exercised and 265,894 shares of the Company&#x2019;s restricted common stock were issued resulting in cash proceeds of $174,189 and receipt of a $105,000 interest bearing, collateralized promissory note. During January 2016, the Company received a $35,000 principal payment and entered into a new agreement with the borrowers which extended the maturity date of the remaining principal and interest until June 15, 2016. All the other terms of the original agreement remain unchanged. As of December 31, 2015, the Company has recorded the $35,000 as a promissory note receivable and the remaining unpaid principal and interest totaling $71,878, as a promissory note receivable for shares. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, the Company entered into subscription agreements to sell units for $0.80 per unit, with each unit consisting of one share of the Company&#x2019;s restricted common stock and one warrant to purchase one half of a share of the Company&#x2019;s restricted common stock for $1.10 per share until June 30, 2017 and pursuant thereto, the Company issued 228,750 units for total proceeds of $183,000. During the six months ended December 31, 2015, cash commissions of $18,300 were paid to brokers related to the unit offering. The Company allocated the proceeds from the shares and the warrants based upon their relative fair values, using the share price on the day each of the subscription agreements were entered into and the fair value of the warrants, which was determined to be $0.05 per warrant. As a result, $4,603 was allocated to the warrants and $178,397 was allocated to the shares, and both were recorded as additional paid in capital. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, a warrant holder elected to exercise 14,000 warrants at an exercise price of $0.75 and 14,000 shares of the Company&#x2019;s common stock were issued resulting in cash proceeds of $10,500. </div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="WIDTH: 100%; TEXT-ALIGN: center"> &nbsp; </div> <div style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center"> &nbsp; </div> <hr style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noshade="noshade" /> <div style="WIDTH: 100%; TEXT-ALIGN: left"> &nbsp; </div> </div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">SIX MONTHS ENDED DECEMBER 31, 2015</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, Smith and various consultants elected to convert $82,861 and $88,856 of deferred compensation, respectively, into 99,159 and 109,715 shares, respectively, of the Company&#x2019;s common stock at conversion rates ranging from $0.76 to $1.15 per share. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Warrants:</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of December 31, 2015, the Company had approximately 8.4 million warrants outstanding, with exercise prices from $0.75 to $3.00 and expiring on various dates through December 31, 2020. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The weighted-average exercise price for the outstanding warrants is $1.24, and the weighted-average remaining contractual life as of December 31, 2015 is 4.2 years.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, warrants to purchase 957,806 shares of common stock of the Company at prices between $2.25 and $3.10 per share expired.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, the Company entered into subscription agreements to exercise certain warrants with expiry dates on or before December 31, 2015, into restricted shares of the Company&#x2019;s common stock at a reduced exercise price of $1.05, for the period from July 1, 2015 through July 15, 2015. As a result of the offering, 265,894 warrants were exercised and 265,894 shares of the Company&#x2019;s restricted common stock were issued resulting in cash proceeds of $174,189 and receipt of a collateralized promissory note receivable for $105,000, for the six months ended December 31, 2015.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, a warrant holder elected to exercise 14,000 warrants at an exercise price of $0.75 and 14,000 shares of the Company&#x2019;s common stock were issued resulting in cash proceeds of $10,500. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Stock options: </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company&#x2019;s 2006 Consolidated Incentive Plan, as amended (the &#x201c;2006 Plan&#x201d;), provides for the issuance of options (and/or other securities) to purchase up to 22,000,000 shares of the Company&#x2019;s common stock. Terms of exercise and expiration of options/securities granted under the 2006 Plan may be established at the discretion of the Board of Directors, but no option may be exercisable for more than ten years.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the six months ended December 31, 2015, the Company approved the modification of existing stock options held by a board member which extended certain expiration dates and resulted in incremental non-cash compensation expense of $42,550.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company recorded compensation expense related to employee stock options of $74,320 and $4,000 for the three months ended December 31, 2015 and 2014, respectively, and $89,640 and $4,000 for the six months ended December 31, 2015 and 2014, respectively. The Company granted 100,000 and zero options during the six months ended December 31, 2015 and 2014, respectively. During the six months ended December 31, 2014, 397,500 options expired.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The fair value of the options granted during the six months ended December 31, 2015 and 2014 were estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31, </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Range,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31, </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31, </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Range,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31, </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">74%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">74%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">80%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">80%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.75%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.75%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.51%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.51%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected term (years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">2</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">2</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="WIDTH: 100%; TEXT-ALIGN: center"> &nbsp; </div> <div style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center"> &nbsp; </div> <hr style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noshade="noshade" /> <div style="WIDTH: 100%; TEXT-ALIGN: left"> &nbsp; </div> </div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">SIX MONTHS ENDED DECEMBER 31, 2015</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A summary of option activity under the 2006 Plan for the six months ended December 31, 2015 is as follows:</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" colspan="2"> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: center; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Options</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted-</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercise</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Price</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted-</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Remaining</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contractual</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Life</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Aggregate</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Intrinsic</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at July 1, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4,413,870</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.88</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4.1</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; PADDING-LEFT: 9pt; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">100,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.92</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; PADDING-LEFT: 9pt; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; PADDING-LEFT: 9pt; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; PADDING-LEFT: 9pt; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expired</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,513,870</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.86</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">3.9</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">36,050</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable at December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">4,413,870</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.89</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3.7</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">22,050</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table presents information relating to nonvested stock options as of December 31, 2015:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 15%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" colspan="2"> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: center; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Options</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Grant-Date Fair</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Nonvested at July 1, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">100,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.76</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">100,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.59</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vested</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">(100,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">(0.59</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Nonvested at December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">100,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.76</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The total fair value of stock options that vested during the six months ended December 31, 2015 and 2014 was $59,000 and nil, respectively. As of December 31, 2015, the Company had $19,826 of unrecognized compensation cost related to stock options.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stock-based employee compensation charges in operating expenses in the Company&#x2019;s financial statements for the three and six months ended December 31, 2015 and 2014 are as follows: </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Six months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Six months</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">31,</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">General and administrative:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value of stock bonus expensed </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">69,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">69,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value from modification of </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">option terms</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">42,550</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">11,783</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">42,550</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">11,783</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value of stock options expensed </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">62,371</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">64,209</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">4,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">173,921</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">15,783</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">175,759</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">15,783</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Research and development:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value of stock options expensed</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">11,949</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">25,431</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">11,949 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">25,431</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"><div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">11.</div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">SUBSEQUENT EVENTS:</div></div></div></div></div></td> </tr> </table> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has evaluated events that occurred subsequent to December 31, 2015 for recognition and disclosure in the financial statements and notes to the financial statements.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">From January 1, 2016 through February 4, 2016, the Company has issued 5,031 shares of the Company&#x2019;s common shares to an employee and a consultant valued at approximately $4,500.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">From January 1, 2016 through February 4, 2016, the Company has issued 75,000 shares of the Company&#x2019;s common shares to Smith per the terms of his extension agreement. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">From January 1, 2016 through February 4, 2016, the Company has sold 31,250 units of the Company&#x2019;s restricted securities for $0.80 each, with each unit consisting of one share of the Company&#x2019;s restricted common stock and one warrant to purchase one half of a share of the Company&#x2019;s restricted common stock for $1.10 per share until June 30, 2017. The proceeds from the sale of the units totaled $25,000.</div></div></div> 704309 22585001 19965459 22437039 19891267 29469 42700 425203 178957 22585001 19965459 22437039 19891267 iso4217:USD xbrli:pure xbrli:shares iso4217:USD thunderdome:item iso4217:USD xbrli:shares 0000875729 bnet:ExtensionAgreementOneMember us-gaap:ChiefExecutiveOfficerMember 2012-01-01 2013-12-31 0000875729 bnet:PennvestLoanMember 2012-07-01 2013-06-30 0000875729 2013-07-01 2014-06-30 0000875729 bnet:PennvestLoanMember 2013-07-01 2014-06-30 0000875729 bnet:PropertyPlantAndEquipmentOfPA1Member 2013-07-01 2014-06-30 0000875729 us-gaap:SeriesBPreferredStockMember 2013-07-01 2014-06-30 0000875729 us-gaap:SeriesBPreferredStockMember 2014-07-01 2014-07-02 0000875729 2014-07-01 2014-12-31 0000875729 us-gaap:ConvertibleDebtSecuritiesMember 2014-07-01 2014-12-31 0000875729 bnet:ConvertiblePreferredStockAntidilutiveSecuritiesMember 2014-07-01 2014-12-31 0000875729 us-gaap:EmployeeStockOptionMember 2014-07-01 2014-12-31 0000875729 us-gaap:WarrantMember 2014-07-01 2014-12-31 0000875729 us-gaap:EmployeeStockOptionMember 2014-07-01 2014-12-31 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2014-07-01 2014-12-31 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:ResearchAndDevelopmentExpenseMember 2014-07-01 2014-12-31 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:WeightedAverageMember 2014-07-01 2014-12-31 0000875729 bnet:StockBonusMember us-gaap:GeneralAndAdministrativeExpenseMember 2014-07-01 2014-12-31 0000875729 bnet:PennvestLoanMember 2014-07-01 2014-12-31 0000875729 us-gaap:GeneralAndAdministrativeExpenseMember 2014-07-01 2014-12-31 0000875729 us-gaap:ResearchAndDevelopmentExpenseMember 2014-07-01 2014-12-31 0000875729 us-gaap:SeriesBPreferredStockMember 2014-07-01 2014-12-31 0000875729 2014-07-01 2015-06-30 0000875729 bnet:PennvestLoanMember 2014-07-01 2015-06-30 0000875729 bnet:PropertyPlantAndEquipmentOfPA1Member 2014-07-01 2015-06-30 0000875729 bnet:PromissoryNotes2015Member 2014-07-01 2015-06-30 0000875729 us-gaap:SeriesBPreferredStockMember 2014-07-01 2015-06-30 0000875729 us-gaap:EmployeeStockOptionMember 2014-07-01 2015-12-31 0000875729 bnet:PennvestLoanMember 2014-09-25 2014-09-25 0000875729 2014-10-01 2014-12-31 0000875729 us-gaap:EmployeeStockOptionMember 2014-10-01 2014-12-31 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2014-10-01 2014-12-31 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:ResearchAndDevelopmentExpenseMember 2014-10-01 2014-12-31 0000875729 bnet:StockBonusMember us-gaap:GeneralAndAdministrativeExpenseMember 2014-10-01 2014-12-31 0000875729 bnet:PennvestLoanMember 2014-10-01 2014-12-31 0000875729 us-gaap:GeneralAndAdministrativeExpenseMember 2014-10-01 2014-12-31 0000875729 us-gaap:ResearchAndDevelopmentExpenseMember 2014-10-01 2014-12-31 0000875729 2015-07-01 2015-12-13 0000875729 2015-07-01 2015-12-31 0000875729 bnet:SubscriptionsReceivableMember 2015-07-01 2015-12-31 0000875729 bnet:SubscriptionsReceivableMember us-gaap:RestrictedStockMember 2015-07-01 2015-12-31 0000875729 us-gaap:ConvertibleDebtSecuritiesMember 2015-07-01 2015-12-31 0000875729 bnet:ConvertiblePreferredStockAntidilutiveSecuritiesMember 2015-07-01 2015-12-31 0000875729 us-gaap:EmployeeStockOptionMember 2015-07-01 2015-12-31 0000875729 us-gaap:WarrantMember 2015-07-01 2015-12-31 0000875729 us-gaap:EmployeeStockOptionMember 2015-07-01 2015-12-31 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2015-07-01 2015-12-31 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:ResearchAndDevelopmentExpenseMember 2015-07-01 2015-12-31 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2015-07-01 2015-12-31 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:WeightedAverageMember 2015-07-01 2015-12-31 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:BoardOfDirectorsChairmanMember 2015-07-01 2015-12-31 0000875729 bnet:ExerciseBonusMember bnet:CeoAndPresidentMember 2015-07-01 2015-12-31 0000875729 bnet:StockBonusMember us-gaap:GeneralAndAdministrativeExpenseMember 2015-07-01 2015-12-31 0000875729 bnet:StockBonusMember bnet:ExtensionAgreementTwoMember us-gaap:ChiefExecutiveOfficerMember 2015-07-01 2015-12-31 0000875729 bnet:StockBonusMember us-gaap:MaximumMember us-gaap:ChiefExecutiveOfficerMember 2015-07-01 2015-12-31 0000875729 bnet:StockBonusMember us-gaap:ChiefExecutiveOfficerMember 2015-07-01 2015-12-31 0000875729 bnet:StockBonusMember us-gaap:PresidentMember 2015-07-01 2015-12-31 0000875729 bnet:CertainWarrantsWithExpiryDatesOnOrBeforeDecember312015Member 2015-07-01 2015-12-31 0000875729 bnet:CertainWarrantsWithExpiryDatesOnOrBeforeDecember312015Member bnet:NoteReceivableAsConsiderationForWarrantsExerciseMember 2015-07-01 2015-12-31 0000875729 bnet:CertainWarrantsWithExpiryDatesOnOrBeforeDecember312015Member bnet:ForThePeriodFromJune302015ThroughJuly152015Member bnet:SubscriptionAgreementMember 2015-07-01 2015-12-31 0000875729 bnet:January2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2015-07-01 2015-12-31 0000875729 bnet:PennvestLoanMember 2015-07-01 2015-12-31 0000875729 bnet:PennvestLoanMember bnet:AmortizationOfPrincipalNumberOfYearsMember 2015-07-01 2015-12-31 0000875729 bnet:PennvestLoanMember bnet:InterestOnlyPaymentsNumberOfYearsMember 2015-07-01 2015-12-31 0000875729 bnet:PennvestLoanMember bnet:YearsOneThroughFiveMember 2015-07-01 2015-12-31 0000875729 bnet:PennvestLoanMember bnet:YearsSixThroughMaturityMember 2015-07-01 2015-12-31 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2015-07-01 2015-12-31 0000875729 us-gaap:GeneralAndAdministrativeExpenseMember 2015-07-01 2015-12-31 0000875729 us-gaap:ResearchAndDevelopmentExpenseMember 2015-07-01 2015-12-31 0000875729 bnet:NoteReceivableAsConsiderationForWarrantsExerciseMember 2015-07-01 2015-12-31 0000875729 bnet:ExtensionAgreementOneMember us-gaap:PresidentMember 2015-07-01 2015-12-31 0000875729 us-gaap:MaximumMember 2015-07-01 2015-12-31 0000875729 us-gaap:MaximumMember bnet:PresidentAndVariousConsultantsMember 2015-07-01 2015-12-31 0000875729 us-gaap:MinimumMember 2015-07-01 2015-12-31 0000875729 us-gaap:MinimumMember bnet:PresidentAndVariousConsultantsMember 2015-07-01 2015-12-31 0000875729 us-gaap:SeriesBPreferredStockMember 2015-07-01 2015-12-31 0000875729 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2015-07-01 2015-12-31 0000875729 us-gaap:AdditionalPaidInCapitalMember 2015-07-01 2015-12-31 0000875729 us-gaap:CommonStockMember 2015-07-01 2015-12-31 0000875729 us-gaap:NoncontrollingInterestMember 2015-07-01 2015-12-31 0000875729 bnet:PromissoryNoteReceivableForSharesMember 2015-07-01 2015-12-31 0000875729 us-gaap:RetainedEarningsMember 2015-07-01 2015-12-31 0000875729 bnet:RestrictedSecuritiesUnitsMember 2015-07-01 2015-12-31 0000875729 bnet:SubscriptionAgreementMember 2015-07-01 2015-12-31 0000875729 bnet:SubscriptionAgreementMember bnet:CertainBrokersMember 2015-07-01 2015-12-31 0000875729 us-gaap:ChiefExecutiveOfficerMember 2015-07-01 2015-12-31 0000875729 us-gaap:ChiefFinancialOfficerMember 2015-07-01 2015-12-31 0000875729 bnet:ConsultantsMember 2015-07-01 2015-12-31 0000875729 bnet:EmployeesAndConsultantsMember 2015-07-01 2015-12-31 0000875729 bnet:FormerEmployee1Member 2015-07-01 2015-12-31 0000875729 bnet:IndividualEmployeeMember 2015-07-01 2015-12-31 0000875729 us-gaap:PresidentMember 2015-07-01 2015-12-31 0000875729 bnet:WarrantHolderOneMember 2015-07-01 2015-12-31 0000875729 bnet:September2015ConvertibleNotesMember 2015-09-08 2015-09-08 0000875729 2015-10-01 2015-12-31 0000875729 us-gaap:EmployeeStockOptionMember 2015-10-01 2015-12-31 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2015-10-01 2015-12-31 0000875729 us-gaap:EmployeeStockOptionMember us-gaap:ResearchAndDevelopmentExpenseMember 2015-10-01 2015-12-31 0000875729 bnet:ExtensionBonusMember bnet:Fy2016ExtensionAgreementMember us-gaap:PresidentMember 2015-10-01 2015-12-31 0000875729 bnet:StockBonusMember us-gaap:GeneralAndAdministrativeExpenseMember 2015-10-01 2015-12-31 0000875729 bnet:January2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2015-10-01 2015-12-31 0000875729 bnet:PennvestLoanMember 2015-10-01 2015-12-31 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2015-10-01 2015-12-31 0000875729 us-gaap:GeneralAndAdministrativeExpenseMember 2015-10-01 2015-12-31 0000875729 us-gaap:ResearchAndDevelopmentExpenseMember 2015-10-01 2015-12-31 0000875729 bnet:Fy2016ExtensionAgreementMember us-gaap:PresidentMember 2015-10-01 2015-12-31 0000875729 bnet:ExerciseBonusMember us-gaap:SubsequentEventMember bnet:CeoAndPresidentMember 2016-01-01 2016-01-01 0000875729 bnet:NoteReceivableAsConsiderationForWarrantsExerciseMember us-gaap:SubsequentEventMember 2016-01-01 2016-01-31 0000875729 bnet:Fy2016ExtensionAgreementMember us-gaap:SubsequentEventMember us-gaap:PresidentMember 2016-01-01 2016-02-04 0000875729 us-gaap:SubsequentEventMember bnet:RestrictedSecuritiesUnitsMember 2016-01-01 2016-02-04 0000875729 us-gaap:SubsequentEventMember bnet:EmployeesAndConsultantsMember 2016-01-01 2016-02-04 0000875729 bnet:ExtensionBonusMember bnet:Fy2016ExtensionAgreementMember us-gaap:SubsequentEventMember us-gaap:PresidentMember 2016-01-05 2016-01-05 0000875729 bnet:StockBonusMember us-gaap:ChiefExecutiveOfficerMember 2013-05-13 0000875729 2013-12-31 0000875729 bnet:ExtensionAgreementOneMember us-gaap:ChiefExecutiveOfficerMember 2013-12-31 0000875729 2014-06-30 0000875729 us-gaap:SeriesBPreferredStockMember 2014-07-02 0000875729 bnet:PA1Member 2014-09-25 0000875729 2014-09-30 0000875729 2014-12-31 0000875729 bnet:MrBassaniMember us-gaap:ConvertibleDebtMember 2014-12-31 0000875729 bnet:MrBassaniMember us-gaap:ConvertibleDebtMember us-gaap:ChiefExecutiveOfficerMember 2014-12-31 0000875729 bnet:NewSmithNoteMember us-gaap:ConvertibleDebtMember us-gaap:PresidentMember 2014-12-31 0000875729 us-gaap:ChiefExecutiveOfficerMember 2014-12-31 0000875729 2015-06-30 0000875729 bnet:PromissoryNotes2015Member us-gaap:ChiefExecutiveOfficerMember 2015-06-30 0000875729 bnet:PromissoryNotes2015Member bnet:ExecutiveViceChairmanMember 2015-06-30 0000875729 bnet:PromissoryNotes2015Member us-gaap:InvestorMember 2015-06-30 0000875729 us-gaap:SeriesAPreferredStockMember 2015-06-30 0000875729 us-gaap:SeriesBPreferredStockMember 2015-06-30 0000875729 us-gaap:SeriesCPreferredStockMember 2015-06-30 0000875729 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2015-06-30 0000875729 us-gaap:AdditionalPaidInCapitalMember 2015-06-30 0000875729 us-gaap:CommonStockMember 2015-06-30 0000875729 us-gaap:NoncontrollingInterestMember 2015-06-30 0000875729 bnet:PromissoryNoteReceivableForSharesMember 2015-06-30 0000875729 us-gaap:RetainedEarningsMember 2015-06-30 0000875729 bnet:CertainWarrantsWithExpiryDatesOnOrBeforeDecember312015Member 2015-07-15 0000875729 bnet:September2015ConvertibleNotesMember 2015-09-08 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ChiefExecutiveOfficerMember 2015-09-08 0000875729 bnet:September2015ConvertibleNotesMember bnet:ExecutiveViceChairmanMember 2015-09-08 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:InvestorMember 2015-09-08 0000875729 2015-09-30 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2015-09-30 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ChiefExecutiveOfficerMember 2015-09-30 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ChiefFinancialOfficerMember 2015-09-30 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ExecutiveVicePresidentMember 2015-09-30 0000875729 2015-12-31 0000875729 us-gaap:EmployeeStockOptionMember 2015-12-31 0000875729 bnet:ExerciseBonusMember 2015-12-31 0000875729 bnet:ExpiredMember 2015-12-31 0000875729 bnet:ExpiredMember us-gaap:MaximumMember 2015-12-31 0000875729 bnet:ExpiredMember us-gaap:MinimumMember 2015-12-31 0000875729 bnet:StockBonusMember bnet:StockBonusPayableUponStockPriceOf1000PerShareMember 2015-12-31 0000875729 bnet:StockBonusMember bnet:StockBonusPayableUponStockPriceOf2000PerShareMember 2015-12-31 0000875729 bnet:StockBonusMember bnet:StockBonusPayableUponStockPriceOf500PerShareMember 2015-12-31 0000875729 bnet:StockBonusMember us-gaap:ChiefExecutiveOfficerMember 2015-12-31 0000875729 bnet:CertainWarrantsWithExpiryDatesOnOrBeforeDecember312015Member 2015-12-31 0000875729 bnet:CertainWarrantsWithExpiryDatesOnOrBeforeDecember312015Member bnet:ForThePeriodFromJune302015ThroughJuly152015Member bnet:SubscriptionAgreementMember 2015-12-31 0000875729 bnet:CashNoteMember us-gaap:ChiefExecutiveOfficerMember 2015-12-31 0000875729 bnet:January2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2015-12-31 0000875729 bnet:January2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ChiefExecutiveOfficerMember 2015-12-31 0000875729 bnet:January2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ChiefFinancialOfficerMember 2015-12-31 0000875729 bnet:January2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ExecutiveVicePresidentMember 2015-12-31 0000875729 bnet:MrBassaniMember 2015-12-31 0000875729 bnet:MrBassaniMember us-gaap:ConvertibleDebtMember 2015-12-31 0000875729 bnet:MrBassaniMember us-gaap:ConvertibleDebtMember us-gaap:ChiefExecutiveOfficerMember 2015-12-31 0000875729 bnet:NewSmithNoteMember us-gaap:ConvertibleDebtMember us-gaap:PresidentMember 2015-12-31 0000875729 bnet:NewSmithNoteMember us-gaap:PresidentMember 2015-12-31 0000875729 bnet:PennvestLoanMember 2015-12-31 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2015-12-31 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ChiefExecutiveOfficerMember 2015-12-31 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ChiefFinancialOfficerMember 2015-12-31 0000875729 bnet:September2015ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:ExecutiveVicePresidentMember 2015-12-31 0000875729 bnet:CenterpointMember 2015-12-31 0000875729 bnet:NoteReceivableAsConsiderationForWarrantsExerciseMember 2015-12-31 0000875729 us-gaap:MaximumMember 2015-12-31 0000875729 us-gaap:MaximumMember us-gaap:ChiefFinancialOfficerMember 2015-12-31 0000875729 us-gaap:MaximumMember bnet:EmployeesAndConsultantsMember 2015-12-31 0000875729 us-gaap:MinimumMember 2015-12-31 0000875729 us-gaap:MinimumMember us-gaap:ChiefFinancialOfficerMember 2015-12-31 0000875729 us-gaap:MinimumMember bnet:EmployeesAndConsultantsMember 2015-12-31 0000875729 us-gaap:SeriesAPreferredStockMember 2015-12-31 0000875729 us-gaap:SeriesBPreferredStockMember 2015-12-31 0000875729 us-gaap:SeriesCPreferredStockMember 2015-12-31 0000875729 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2015-12-31 0000875729 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0000875729 us-gaap:CommonStockMember 2015-12-31 0000875729 us-gaap:NoncontrollingInterestMember 2015-12-31 0000875729 bnet:PromissoryNoteReceivableForSharesMember 2015-12-31 0000875729 us-gaap:RetainedEarningsMember 2015-12-31 0000875729 bnet:RestrictedSecuritiesUnitsMember 2015-12-31 0000875729 bnet:SubscriptionAgreementMember 2015-12-31 0000875729 us-gaap:ChiefExecutiveOfficerMember 2015-12-31 0000875729 us-gaap:ChiefFinancialOfficerMember 2015-12-31 0000875729 bnet:ConsultantsMember 2015-12-31 0000875729 bnet:ExecutiveViceChairmanMember 2015-12-31 0000875729 bnet:FormerEmployee1Member 2015-12-31 0000875729 bnet:FormerEmployeeMember 2015-12-31 0000875729 bnet:IndividualEmployeeMember 2015-12-31 0000875729 us-gaap:PresidentMember 2015-12-31 0000875729 bnet:WarrantHolderOneMember 2015-12-31 0000875729 2016-02-01 0000875729 us-gaap:SubsequentEventMember 2016-02-04 0000875729 us-gaap:SubsequentEventMember bnet:RestrictedSecuritiesUnitsMember 2016-02-04 EX-101.SCH 7 bnet-20151231.xsd 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Changes in Equity (Deficit) (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Organization, Nature of Business, Going Concern and Management's Plans link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Property and Equipment link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Promissory Note Receivable link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Notes Payable - Affiliates link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Deferred Compensation link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Loan Payable link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Convertible Notes Payable - Affiliates link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 10 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 11 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 2 - Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 3 - Property and Equipment (Tables) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 9 - Stockholders' Equity (Tables) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 10 - Commitments and Contingencies (Tables) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 1 - Organization, Nature of Business, Going Concern and Management's Plans (Details Textual) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 2 - Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 024 - Statement - Note 2 - Antidilutive Securities (Details) link:calculationLink link:definitionLink link:presentationLink 025 - Statement - Note 2 - Earnings Per Share, Basic and Diluted (Details) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 3 - Property and Equipment (Details Textual) link:calculationLink link:definitionLink link:presentationLink 027 - Statement - Note 3 - Property and Equipment (Details) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 4 - Promissory Note Receivable (Details Textual) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 5 - Notes Payable - Affiliates (Details Textual) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 6 - Deferred Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 7 - Loan Payable (Details Textual) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 8 - Convertible Notes Payable - Affiliates (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 9 - Stockholders' Equity (Details Textual) link:calculationLink link:definitionLink link:presentationLink 034 - Statement - Note 9 - Black-Scholes Valuation Assumptions for Options (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Statement - Note 9 - Stock Options Activity (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Statement - Note 9 - Nonvested Share Activity (Details) link:calculationLink link:definitionLink link:presentationLink 037 - Statement - Note 9 - Allocation of Recognized Period Costs (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 10 - Commitments and Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 039 - Statement - Note 10 - Summary of Outstanding Contingent Stock Bonuses (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 11 - Subsequent Events (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 bnet-20151231_cal.xml EX-101.DEF 9 bnet-20151231_def.xml EX-101.LAB 10 bnet-20151231_lab.xml Document And Entity Information Other Significant Noncash Transaction [Axis] Employee Stock Option [Member] Note To Financial Statement Details Textual Convertible Debt Securities [Member] Restricted Stock [Member] statementsignificantaccountingpoliciespolicies Other Significant Noncash Transaction, Name [Domain] statementnote2significantaccountingpoliciestables Warrant [Member] statementnote3propertyandequipmenttables us-gaap_IncreaseDecreaseInDeferredCompensation Increase in deferred compensation and convertible notes Antidilutive Securities [Axis] statementnote9stockholdersequitytables statementnote10commitmentsandcontingenciestables statementnote2antidilutivesecuritiesdetails Antidilutive Securities, Name [Domain] statementnote2earningspersharebasicanddiluteddetails statementnote3propertyandequipmentdetails statementnote9blackscholesvaluationassumptionsforoptionsdetails statementnote9stockoptionsactivitydetails us-gaap_AllocatedShareBasedCompensationExpense Allocated Share-based Compensation Expense statementnote9nonvestedshareactivitydetails statementnote9allocationofrecognizedperiodcostsdetails statementnote10summaryofoutstandingcontingentstockbonusesdetails Notes To Financial Statements Supplemental disclosure of cash flow information: Notes To Financial Statements [Abstract] us-gaap_NetIncomeLoss Net loss attributable to Bion Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase in accounts payable and accrued expenses Issuance of common stock to satisfy deferred compensation us-gaap_PreferredStockDividendsIncomeStatementImpact Dividends on preferred stock us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1 Other Significant Noncash Transaction, Value of Consideration Received us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic Net loss applicable to Bion's common stockholders bnet_DebtInstrumentConvertibleConversionPriceInceasePercentage Debt Instrument, Convertible Conversion Price, Incease, Percentage Represents the percentage increase of the convertible conversion price. bnet_MonthlyOfficersCashCompensation Monthly Officers' Cash Compensation Represents information about monthly officers' cash compensation. New Smith Note [Member] Represents the New Smith Note. bnet_DebtInstrumentInterestRateReductionPercentage Debt Instrument, Interest Rate Reduction, Percentage Represents the percentage reduction of interest rate for a debt instrument. CASH FLOWS FROM INVESTING ACTIVITIES us-gaap_ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities us-gaap_WeightedAverageNumberOfSharesIssuedBasic Weighted average shares issued during the period (in shares) Weighted-average number of common shares outstanding: us-gaap_InterestExpenseDebt Interest Expense, Debt Cash Cash at beginning of period Cash at end of period Research and development (including stock-based compensation (Note 9)) Interest expense, net Interest Expense Fair Value Measurement, Policy [Policy Text Block] us-gaap_TableTextBlock Notes Tables Earnings Per Share, Policy [Policy Text Block] Series B preferred stock dividends accrued us-gaap_TreasuryStockNumberOfSharesHeld Treasury Stock, Number of Shares Held Chief Executive Officer [Member] Chief Financial Officer [Member] Preferred stock, outstanding (in shares) Preferred Stock, Shares Outstanding us-gaap_SharesIssuedPricePerShare Shares Issued, Price Per Share Common stock, outstanding (in shares) Shares outstanding – beginning of period (in shares) Operating expenses: Stockholders' Equity Note Disclosure [Text Block] us-gaap_SharesOutstanding Balances (in shares) Balances (in shares) us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchase of property and equipment us-gaap_ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding us-gaap_Assets Total assets Class of Warrant or Right [Domain] Class of Warrant or Right [Axis] Current liabilities: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights Property and equipment, net (Note 3) Net us-gaap_PropertyPlantAndEquipmentGross Total us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Less accumulated depreciation us-gaap_MachineryAndEquipmentGross Machinery and equipment us-gaap_BuildingsAndImprovementsGross Buildings and structures Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $29,000 and $28,000, respecitvely Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Debt Instrument, Name [Domain] Debt Instrument [Axis] Issuance of common stock for services Stock Issued During Period, Value, Issued for Services Issuance of common stock for services (in shares) Stock Issued During Period, Shares, Issued for Services us-gaap_StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues us-gaap_StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Property, Plant and Equipment [Table Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period us-gaap_OtherNoncashExpense Accrued interest on deferred compensation and other us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and deficit Non-cash investing and financing transactions: Accumulated deficit us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year Conversion of debt (in shares) Conversion of debt us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-term Debt, Maturities, Repayments of Principal in Year Three us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-term Debt, Maturities, Repayments of Principal in Year Two Vesting of options for services us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Commissions on sale of units us-gaap_DividendsPreferredStock Dividend on Series B preferred stock Dividends, Preferred Stock us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued us-gaap_AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other Common stock, no par value, 100,000,000 shares authorized, 22,855,964 and 22,089,650 shares issued, respectively; 22,151,655 and 21,385,341 shares outstanding, respectively Common stock, issued (in shares) Shares issued – beginning of period (in shares) Common stock, authorized (in shares) Common stock, par value (in dollars per share) us-gaap_CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance us-gaap_IncreaseDecreaseInReceivables Decrease in subscription receivable bnet_UnreimbursedExpenses Unreimbursed Expenses Represents unreimbursed expense. Cash Note [Member] Exercise of warrants for promissory note receivable for shares Preferred stock, liquidation preference (in dollars per share) Series A Preferred stock, $0.01 par value, 10,000 shares authorized, no shares issued and outstanding New Accounting Pronouncements, Policy [Policy Text Block] bnet_NumberOfWarrantsPerUnitReductionPercentage Number of Warrants Per Unit Reduction Percentage Represents the percentage reduction of warrants per unit. bnet_ExtensionOfExercisePeriodAnnualPaymentPerOptionOrWarrant Extension of Exercise Period Annual Payment per Option or Warrant Represents the annual payment per option or warrant to be paid to the Company by certain individuals should they choose to exercise the right to extend the exercise period of all or part of the applicable options and warrants. bnet_Extensionofexerciseperiod ExtensionOfExercisePeriod Extension of exercise period for applicable options and warrants. bnet_Contingentstockbonuspercentagethresholdforissuance ContingentStockBonusPercentageThresholdForIssuance Contingent Stock Bonus, Percentage Threshold for Issuance. us-gaap_IncreaseDecreaseInPrepaidExpense Decrease in prepaid expenses Consolidation, Policy [Policy Text Block] us-gaap_CapitalRequiredForCapitalAdequacy Capital Required for Capital Adequacy us-gaap_NonoperatingIncomeExpense Total other expense Contingent Consideration by Type [Axis] us-gaap_OperatingIncomeLoss Loss from operations Contingent Consideration Type [Domain] us-gaap_InvestmentIncomeInterest Investment Income, Interest Property, Plant and Equipment Disclosure [Text Block] Subscription Agreement [Member] This item represents transactions occurring related to a subscription agreement. us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Subscriptions Receivable [Member] This item represents the subscriptions of shares that have not yet been fulfilled. bnet_WorkingCapital Working Capital This item represents the capital available for operations for the Company. Amendment Flag Proceeds from exercise of warrants Proceeds from Warrant Exercises Centerpoint [Member] This item represents the separate legal entity of Centerpoint. us-gaap_LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value Research and Development Expense [Member] Income Statement Location [Domain] Plan Name [Domain] Income Statement Location [Axis] Plan Name [Axis] Weighted Average [Member] us-gaap_ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity Minimum [Member] Maximum [Member] Range [Axis] Range [Domain] Document Fiscal Year Focus us-gaap_ProceedsFromSaleOfInterestInCorporateUnit Proceeds from Sale of Interest in Corporate Unit Document Fiscal Period Focus Proceeds from sale of common stock Document Period End Date Current Fiscal Year End Date us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Award Type [Axis] Entity Current Reporting Status Entity Voluntary Filers us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties Entity Filer Category Document Type Equity Award [Domain] us-gaap_ConvertibleNotesPayable Convertible Notes Payable Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] General and Administrative Expense [Member] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Entity Well-known Seasoned Issuer Convertible Preferred Stock Antidilutive Securities [Member] This item represents the convertible preferred stock securities that have been excluded from the computation of earnings per share. Notes payable - affiliates, net of discount (Note 5) Granted (in dollars per share) Promissory note receivable (Note 4) Notes, Loans and Financing Receivable, Net, Current Subscription receivable (Note 9) Statement [Table] Receivable [Domain] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Outstanding (in dollars per share) Outstanding (in dollars per share) Receivable Type [Axis] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Nonvested at July 1, 2015 (in shares) Nonvested at December 31, 2015 (in shares) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Vested (in shares) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Nonvested at July 1, 2015 (in dollars per share) Nonvested at December 31, 2015 (in dollars per share) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Vested (in dollars per share) Convertible Debt [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Outstanding Outstanding us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Granted (in dollars per share) us-gaap_RelatedPartyTransactionRate Related Party Transaction, Rate us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 Outstanding Current assets: us-gaap_ConstructionLoan Construction Loan us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Exercisable (in shares) Related Party Transaction [Domain] us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Net decrease in cash us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Exercisable us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Related Party Transaction [Axis] Investor [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Exercisable (in dollars per share) Income Statement [Abstract] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 Exercisable us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by financing activities us-gaap_PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs Commissions on sale of units us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Loans, Notes, Trade and Other Receivables Disclosure [Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Outstanding (in shares) Outstanding (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Total Bion's stockholders' deficit Stockholders' Equity Attributable to Parent us-gaap_EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage bnet_ConversionPricePerUnit Conversion Price Per Unit Represents the conversion price on a per Unit basis of convertible debt instruments. January 2015 Convertible Notes [Member] Represents information the of the 2015 January Notes. bnet_ConvertiblePreferredStockRedemptionPeriod Convertible Preferred Stock Redemption Period Redemption period of convertible preferred stock. Risk-free interest rate bnet_CommonStockVotingRightsVotesPerShare Common Stock Voting Rights Votes Per Share Voting rights per share of common stock. Preferred stock, issued (in shares) bnet_DeferredCompensationConvertedToCommonStockShares Deferred Compensation Converted to Common Stock Shares Represents the number of shares of the Company's common stock into which deferred compensation was converted during the period. Preferred stock, authorized (in shares) bnet_DeferredCompensationConvertedToCommonStockConversionRate Deferred Compensation Converted to Common Stock Conversion Rate Represents the per-share rate at which deferred compensation was converted to the Company's common stock during the period. bnet_WeightedAverageExercisePriceForOutstandingWarrants Weighted Average Exercise Price for Outstanding Warrants Represents weighted average exercise price for outstanding warrants. bnet_WeightedAverageRemainingContractualLifeForOutstandingWarrants Weighted Average Remaining Contractual Life for Outstanding Warrants Represents weighted average remaining contractual life for outstanding warrants. Employees and Consultants [Member] Represents information pertaining to employees and consultants of the Company. Volatility Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share President and Various Consultants [Member] Represents information pertaining to the Company's president and various consultants. Expired [Member] Represents expired warrants in a given period. For the Period from June 30, 2015 through July 15, 2015 [Member] Represents information that pertains to the period from June 30, 2015 through July 15, 2015. Stock Bonus [Member] This item represent bonuses given in stock. Expected term (years) us-gaap_DebtDefaultLongtermDebtAmount Debt Instrument, Debt Default, Amount Executive Vice President [Member] Prepaid expenses us-gaap_PreferredStockRedemptionPricePerShare Preferred Stock, Redemption Price Per Share bnet_NumberOfWarrantsPerUnit Number of Warrants Per Unit The number of warrants per unit. Relationship to Entity [Domain] bnet_NumberOfSharePerUnit Number of Share Per Unit Number of the Company's shares per unit. Title of Individual [Axis] Dividend yield bnet_DeferredCompensationConsecutiveTradingDays Deferred Compensation Consecutive Trading Days Number of specified trading days during the end of a month for which the share price of common stock during that period will be applied to deferred compensation if converted. bnet_DeferredCompensationConvertedToCommonStockAmount Deferred Compensation Converted to Common Stock Amount Represents the amount of deferred compensation converted to the Company's common stock during the period. Executive Vice Chairman [Member] Represents the Executive Vice Chairman. bnet_DeferredCompensationConversionDays Deferred Compensation Conversion Days Number of specified trading days during the end of a month for which the share price of common stock during that period will be applied to deferred compensation if converted. President [Member] Consultants [Member] Consultants of the Company. bnet_DeferredCompensationSharesIssuedUponConversion Deferred Compensation Shares Issued upon Conversion Number of shares issued upon the conversion of deferred compensation. us-gaap_PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage bnet_DeferredCompensationConversionPrice Deferred Compensation Conversion Price The price per share of the deferred compensation conversion feature. Former Employee [Member] Represents former employee. Noncontrolling interest Former Employee 1 [Member] Represents a former employee. Individual Employee [Member] Represents individual employee. bnet_TermLoanPaymentTerm Term Loan Payment Term Duration of the required periodic payments of interest, principal, or both. bnet_DebtInstrumentAccruedInterestAndLateCharges Debt Instrument Accrued Interest and Late Charges Represents the amount of late charges and accrued, but unpaid interest on the debt instrument for the period. PA-1 [Member] Depicts the subsidiary PA-1. us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Balances Balances Total deficit Property, Plant and Equipment of PA1 [Member] Represents the Property, Plant and Equipment of PA1. bnet_StockIssuedDuringPeriodSharesWarrantsExercised Stock Issued During Period, Shares, Warrants Exercised Number of new stock issued during the period from the exercise of warrants. bnet_ClassOfWarrantOrRightExercisedDuringPeriod Class of Warrant or Right Exercised During Period The number of warrants or rights exercised during period. Note Receivable as Consideration for Warrants Exercise [Member] Represents the note receivable as consideration for warrants exercise. Certain Warrants with Expiry Dates on or before December 31, 2015 [Member] Represents information pertaining to certain warrants with expiry dates on or before December 31, 2015. Additional paid-in capital bnet_FinancingReceivableNoteInterestRate Financing Receivable Note Interest Rate Fixed interest rate related to the financing receivable note. September 2015 Convertible Notes [Member] Represents information about the September 2015 convertible notes. Promissory Notes 2015 [Member] A written promise to repay a related party for notes issued in 2015. Legal Entity [Axis] Entity Registrant Name Extension Agreement One [Member] This item represents the first extension agreement. Entity Central Index Key Entity [Domain] Warrants exercised for common stock (in shares) Common Stock Shares Issued upon Exercise of Warrants Represents warrants exercised for common stock shares. Commitments and Contingencies Disclosure [Text Block] Litigation Case [Axis] Warrants exercised for common stock Represents the equity impact of the warrants exercised for common stock. Entity Common Stock, Shares Outstanding (in shares) us-gaap_Liabilities Total liabilities Litigation Case [Domain] Long-term Debt, Type [Domain] Long-term Debt, Type [Axis] bnet_MonthlyOfficersCompensation Monthly Officer's Compensation This item represents the amount of compensation paid monthly to Officers of the Company. Trading Symbol Scenario [Axis] Scenario, Unspecified [Domain] us-gaap_AssetsCurrent Total current assets Extension Agreement Two [Member] This item represents the second extension agreement. Proceeds from sale of units This item represents the cash inflow related to the sale of units. bnet_StockIssuedDuringPeriodSharesVestedButNotIssuedForservices Stock Issued During Period Shares Vested But Not Issued ForServices Number of shares vested but not issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. us-gaap_LiabilitiesCurrent Total current liabilities Certain Brokers [Member] bnet_WarrantFairValuePricePerShare Warrant Fair Value Price Per Share Price per share of warrant, based upon fair value. bnet_SaleOfUnitsPricePerUnitIssued Sale Of Units Price Per Unit Issued Price per unit of units sold in subscription agreements. Adjustments to reconcile net loss to net cash used in operating activities: Convertible notes payable - affiliates, net of current portion (Note 8) Convertible Notes Payable, Noncurrent bnet_WarrantComponentOfCorporateUnitExercisePricePerShareOfRestrictedCommonStock Warrant Component of Corporate Unit, Exercise Price Per Share of Restricted Common Stock With regard to corporate units that include one or more warrants as part of the corporate unit, this element represents the warrant's exercise price per share of restricted common stock. bnet_WarrantComponentOfEquityUnitNumberOfSharesOfRestrictedCommonStockCalledByEachWarrant Warrant Component of Equity Unit, Number of Shares of Restricted Common Stock Called by Each Warrant With regard to equity units which include one or more warrants as part of the corporate unit, this element represents the number of shares of restricted common stock that may be purchased by each warrant. bnet_NumberOfWarrantsInEachUnit Number of Warrants in Each Unit Represents the number of warrants included in each corporate unit. bnet_SharesOfRestrictedCommonStockInEachUnit Shares of Restricted Common Stock in Each Unit Represents the number of shares of restricted common stock included in each corporate unit. us-gaap_NetIncomeLossAttributableToNoncontrollingInterest Net loss attributable to the noncontrolling interest Depreciation Depreciation Extension Bonus [Member] Property, Plant and Equipment, Policy [Policy Text Block] FY2016 Extension Agreement [Member] Property, Plant and Equipment, Type [Axis] bnet_GrossProceedsFromSaleOfInterestInCorporateUnit Gross Proceeds from Sale of Interest in Corporate Unit Represents the cash inflow, before the deduction of commissions, resulting from the sale of an interest in a corporate unit during the period. us-gaap_ProceedsFromCollectionOfNotesReceivable Proceeds from Collection of Notes Receivable Property, Plant and Equipment, Type [Domain] Restricted Securities Units [Member] Represents information pertaining to units of the Company's restricted securities. Subsequent Event Type [Domain] Sale of units Sale of Units, Value Represents the equity impact of units issued during the period. Subsequent Event Type [Axis] Amortization of Principal Number of Years [Member] This item represents the number of years used for amortization of principal. Statement of Financial Position [Abstract] Sale of units (in shares) Sale of Units, Number Of Units Issued Number of units issued pursuant to a subscription agreement. Interest Only Payments Number of Years [Member] This item represents the number of years that interest only payments will be paid. Subsequent Events [Text Block] Modification of options Represents the modification of options. Pennvest Loan [Member] This item represents the Pennvest Loan. us-gaap_ShareBasedCompensation Stock-based compensation Years One Through Five [Member] This item represents events that will occur during years one through five. us-gaap_DueToRelatedPartiesCurrent Due to Related Parties, Current Years Six Through Maturity [Member] This item represents events that occur during years six through loan maturity. Subsequent Event [Member] us-gaap_PropertyPlantAndEquipmentUsefulLife Property, Plant and Equipment, Useful Life Net loss Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Statement of Cash Flows [Abstract] CEO and President [Member] This item represents transactions between the Company and the CEO and President. Convertible Debt [Text Block] The entire disclosure for convertible debt. Statement of Stockholders' Equity [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES us-gaap_ConvertibleNotesPayableCurrent Convertible Notes Payable, Current us-gaap_DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage Mr. Bassani [Member] This item represents transactions between the Company and Mr. Bassani. Loan payable (Note 7) Basic and diluted (in shares) Exercise Bonus [Member] This item represents the exercise bonus. bnet_ExecutionBonusAsPercentageOfExercisedOptionsAndWarrants Execution Bonus as Percentage of Exercised Options and Warrants This item represents the percentage of exercised options and warrants that have been granted as execution/exercise bonuses. us-gaap_DebtInstrumentFaceAmount Debt Instrument, Face Amount Deferred compensation (Note 6) Deferred Compensation Liability, Current Deficit: Cash paid for interest us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive securities (in shares) us-gaap_DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price Promissory Note Receivable for Shares [Member] The remaining unpaid principal and interest of the promissory note receivable for shares issued as consideration for an unaffiliated investor's subscription agreement to exercise warrants into restricted shares of common stock. us-gaap_SharePrice Share Price bnet_PromissoryNoteReceivableForShares Promissory note receivable for shares (Notes 4 and 9) Promissory Note Receivable for Shares The remaining unpaid principal and interest of the promissory note receivable for shares issued as consideration for an unaffiliated investor's subscription agreement to exercise warrants into restricted shares of common stock. Net loss applicable to Bion's common stockholders per basic and diluted common share (in dollars per share) CASH FLOWS FROM FINANCING ACTIVITIES us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash used by investing activities us-gaap_WeightedAverageNumberOfSharesOutstandingBasic Basic weighted average shares – end of period (in shares) Accounts payable and accrued expenses us-gaap_DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period us-gaap_PaymentsForCommissions Payments for Commissions Revenue Recognition, Policy [Policy Text Block] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Class of Stock [Axis] Class of Stock [Domain] Significant Accounting Policies [Text Block] Shares Outstanding under Contingent Stock Bonuses Plan by Target Price Per Share [Table Text Block] Tabular disclosure of Outstanding Contingent Stock Bonuses. Accounting Policies [Abstract] bnet_InterestRateOnDeferredCompensation Interest Rate on Deferred Compensation This item represents the interest rate that is accrued on deferred compensation. bnet_AccruedInterestOnDeferredCompensationAndOtherExpenses Accrued Interest on Deferred Compensation and Other Expenses This item represents the interest accrued on deferred compensation. Deposits and other receivables bnet_ComputersAndOfficeEquipmentGross Computers and office equipment This item represents the gross amount computers and office equipment held by the Company. bnet_SharesHeldBySubsidiaries Shares held by subsidiaries (Note 9) (in shares) Number of shares held by subsidiaries. bnet_WeightedAverageSharesForFullyVestedStockBonuses Weighted average shares for fully vested stock bonuses (Note 9) (in shares) This item represents the weighted average shares outstanding for fully vested stock bonuses. Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Related Party Transactions Disclosure [Text Block] us-gaap_OperatingExpenses Total operating expenses General and administrative (including stock-based compensation (Note 9)) Statement [Line Items] Related Party [Axis] Sale of Stock [Axis] Schedule of Nonvested Share Activity [Table Text Block] Related Party [Domain] Sale of Stock [Domain] Debt Disclosure [Text Block] Other expense: us-gaap_RepaymentsOfLongTermDebt Repayments of Long-term Debt us-gaap_DividendsPayableCurrentAndNoncurrent Dividends Payable us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity Equity Component [Domain] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Series C Preferred Stock [Member] Series A Preferred Stock [Member] Series B Preferred Stock [Member] Additional Paid-in Capital [Member] us-gaap_PolicyTextBlockAbstract Accounting Policies Board of Directors Chairman [Member] Retained Earnings [Member] Stock Bonus Payable Upon Stock Price of $5.00 per Share [Member] Stock Bonus Payable Upon Stock Price of $10.00 per Share [Member] Stock Bonus Payable Upon Stock Price of $20.00 per Share [Member] Noncontrolling Interest [Member] Warrant Holder One [Member] EX-101.PRE 11 bnet-20151231_pre.xml XML 12 R1.htm IDEA: XBRL DOCUMENT v3.3.1.900
Document And Entity Information - shares
6 Months Ended
Dec. 31, 2015
Feb. 01, 2016
Entity Registrant Name BION ENVIRONMENTAL TECHNOLOGIES INC  
Entity Central Index Key 0000875729  
Trading Symbol bnet  
Current Fiscal Year End Date --06-30  
Entity Filer Category Smaller Reporting Company  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well-known Seasoned Issuer No  
Entity Common Stock, Shares Outstanding (in shares)   22,262,936
Document Type 10-Q  
Document Period End Date Dec. 31, 2015  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q2  
Amendment Flag false  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Dec. 31, 2015
Jun. 30, 2015
Series B Preferred Stock [Member]    
Current liabilities:    
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $29,000 and $28,000, respecitvely $ 26,400 $ 25,400
Series A Preferred Stock [Member]    
Deficit:    
Series A Preferred stock, $0.01 par value, 10,000 shares authorized, no shares issued and outstanding
Series C Preferred Stock [Member]    
Deficit:    
Series A Preferred stock, $0.01 par value, 10,000 shares authorized, no shares issued and outstanding
Cash $ 178,451 $ 339,286
Promissory note receivable (Note 4) 35,000
Prepaid expenses $ 12,350 $ 18,503
Subscription receivable (Note 9) 13,125
Deposits and other receivables $ 7,108 7,108
Total current assets 232,909 378,022
Property and equipment, net (Note 3) 1,829,508 1,977,219
Total assets 2,062,417 2,355,241
Accounts payable and accrued expenses $ 1,479,267 1,353,168
Notes payable - affiliates, net of discount (Note 5) 472,230
Deferred compensation (Note 6) $ 1,170,731 839,288
Loan payable (Note 7) 7,754,000 7,754,000
Total current liabilities 10,430,398 10,444,086
Convertible notes payable - affiliates, net of current portion (Note 8) 3,218,648 2,654,708
Total liabilities $ 13,649,046 $ 13,098,794
Common stock, no par value, 100,000,000 shares authorized, 22,855,964 and 22,089,650 shares issued, respectively; 22,151,655 and 21,385,341 shares outstanding, respectively
Promissory note receivable for shares (Notes 4 and 9) $ (71,878)
Additional paid-in capital 101,747,327 $ 100,889,127
Accumulated deficit (113,322,889) (111,696,060)
Total Bion's stockholders' deficit (11,647,440) (10,806,933)
Noncontrolling interest 60,811 63,380
Total deficit (11,586,629) (10,743,553)
Total liabilities and deficit $ 2,062,417 $ 2,355,241
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares
Dec. 31, 2015
Jun. 30, 2015
Series B Preferred Stock [Member]    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, authorized (in shares) 50,000 50,000
Preferred stock, issued (in shares) 200 200
Preferred stock, outstanding (in shares) 200 200
Preferred stock, liquidation preference (in dollars per share) $ 29,000 $ 28,000
Series A Preferred Stock [Member]    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, authorized (in shares) 10,000 10,000
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Series C Preferred Stock [Member]    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, authorized (in shares) 60,000 60,000
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, authorized (in shares) 100,000,000 100,000,000
Common stock, issued (in shares) 22,855,964 22,089,650
Common stock, outstanding (in shares) 22,151,655 21,385,341
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Operating expenses:        
General and administrative (including stock-based compensation (Note 9)) $ 550,095 $ 333,196 $ 1,058,000 $ 690,537
Depreciation 76,083 127,159 151,962 312,043
Research and development (including stock-based compensation (Note 9)) 84,286 104,237 218,775 170,823
Total operating expenses 710,464 564,592 1,428,737 1,173,403
Loss from operations (710,464) (564,592) (1,428,737) (1,173,403)
Other expense:        
Interest expense, net 86,405 100,356 200,661 197,303
Total other expense 86,405 100,356 200,661 197,303
Net loss (796,869) (664,948) (1,629,398) (1,370,706)
Net loss attributable to the noncontrolling interest 1,274 1,028 2,569 2,099
Net loss attributable to Bion (795,595) (663,920) (1,626,829) (1,368,607)
Dividends on preferred stock (500) (500) (1,000) (1,000)
Net loss applicable to Bion's common stockholders $ (796,095) $ (664,420) $ (1,627,829) $ (1,369,607)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in dollars per share) $ (0.03) $ (0.03) $ (0.07) $ (0.07)
Weighted-average number of common shares outstanding:        
Basic and diluted (in shares) 22,585,001 19,965,459 22,437,039 19,891,267
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Changes in Equity (Deficit) (Unaudited) - 6 months ended Dec. 31, 2015 - USD ($)
Preferred Stock [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Promissory Note Receivable for Shares [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balances (in shares) at Jun. 30, 2015 22,089,650          
Balances at Jun. 30, 2015     $ 100,889,127 $ (111,696,060) $ 63,380 $ (10,743,553)
Issuance of common stock for services (in shares) 36,296         36,296
Issuance of common stock for services     100,904 $ 100,904
Vesting of options for services     89,640 89,640
Modification of options     42,550 42,550
Sale of units (in shares) 228,750          
Sale of units     183,000 183,000
Commissions on sale of units     (18,300) (18,300)
Warrants exercised for common stock (in shares) 292,394          
Warrants exercised for common stock     289,689 $ (71,878) 217,811
Dividend on Series B preferred stock     (1,000) (1,000)
Conversion of debt (in shares) 208,874          
Conversion of debt     $ 171,717 171,717
Net loss     $ (1,626,829) $ (2,569) (1,629,398)
Balances (in shares) at Dec. 31, 2015 22,855,964          
Balances at Dec. 31, 2015     $ 101,747,327 $ (71,878) $ (113,322,889) $ 60,811 $ (11,586,629)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Series B Preferred Stock [Member]    
Non-cash investing and financing transactions:    
Series B preferred stock dividends accrued $ 1,000 $ 1,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest (1,629,398) (1,370,706)
Depreciation 151,962 312,043
Accrued interest on deferred compensation and other 200,940 189,573
Stock-based compensation 233,094 31,043
Decrease in prepaid expenses 6,153 5,341
Increase in accounts payable and accrued expenses 27,351 225,779
Increase in deferred compensation and convertible notes 490,800 312,000
Net cash used in operating activities (519,098) $ (294,927)
Purchase of property and equipment (4,251)
Net cash used by investing activities (4,251)
Decrease in subscription receivable $ 13,125 $ 30,000
Proceeds from sale of common stock 26,250
Proceeds from sale of units $ 183,000 $ 67,500
Commissions on sale of units (18,300)
Proceeds from exercise of warrants 184,689
Net cash provided by financing activities 362,514 $ 123,750
Net decrease in cash (160,835) (171,177)
Cash at beginning of period 339,286 186,148
Cash at end of period $ 178,451 $ 14,971
Cash paid for interest
Issuance of common stock to satisfy deferred compensation $ 171,717
Exercise of warrants for promissory note receivable for shares $ 105,000
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 1 - Organization, Nature of Business, Going Concern and Management's Plans
6 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
1.
ORGANIZATION, NATURE OF BUSINESS, GOING CONCERN AND MANAGEMENT’S PLANS:
 
Organization and nature of business:
 
Bion Environmental Technologies, Inc. (“Bion” or “We” or the "Company") was incorporated in 1987 in the State of Colorado and has developed and continues to develop patented and proprietary technology and business models that provide comprehensive environmental solutions to a significant source of pollution in United States agriculture, large scale livestock facilities known as Confined Animal Feeding Operations ("CAFO's"). Bion's technologies (and applications related thereto) produce substantial reductions of nutrient releases (primarily nitrogen and phosphorus) to both water and air (including ammonia, which is subsequently re-deposited to the ground) from livestock waste streams based upon our operations and research to date (and third party peer review thereof). We are continually involved in research and development to upgrade and improve our technology and technology applications, including integration with third party technology. Bion provides comprehensive and cost-effective treatment of livestock waste onsite (and/or at nearby locations), while it is still concentrated and before it contaminates air, soil, groundwater aquifers and/or downstream waters, and, in certain configurations, recovers nutrients for potential use as fertilizer and feed additives.
 
During the 2014 and 2015 fiscal years, the Company increased its research and development activities with focus on augmenting the basic ‘separate and aggregate’ approach of its technology platform to provide additional flexibility and to increase recovery of nutrient by-products (in organic and non-organic forms) and renewable energy production (either/both biogas and/or renewable electricity), thereby increasing potential related revenue streams and reducing dependence of its future projects on nutrient reduction credits (which still remain a very important part of project revenue streams). This research and development effort also involves ongoing review of potential “add-ons” and applications to our technology platform for use in different regulatory and/or climate environments. These research and development activities continued through the balance of the 2015 fiscal year, and we believe such activities will continue at least through the 2016 fiscal year, subject to availability of adequate financing for the Company’s operations, of which there is no assurance.
 
Bion is actively pursuing business opportunities in three broad areas 1) installation of Bion systems to retrofit and environmentally remediate existing CAFO’s to reduce nutrient (primarily nitrogen and phosphorus) releases, gaseous emissions (ammonia, greenhouse gases, volatile organic compounds, etc.), and pathogens, hormones and other compounds in order to clean the air and water in the surrounding areas (as described below) to ensure compliance with existing (and future) regulations and to permit herd expansion; 2) development of Integrated Projects opportunities within the United States and internationally; and 3) licensing and/or joint venturing of Bion’s technology and applications outside North America. The opportunities described at 1) and 2) above (and below) each require substantial political and regulatory (federal, state and local) efforts on the part of the Company and a substantial part of Bion’s efforts are focused on such political and regulatory matters. The most intense focus is currently on the requirements for the clean-up of the Chesapeake Bay faced by the Commonwealth of Pennsylvania and the potential use of Bion’s technology and technology platform on CAFOs as an alternative to what the Company believes is far more expensive nutrient removal downstream in storm water projects.
 
Management believes that Bion's technology platform (including utilization of various third party technologies to supplement the Company’s proprietary technologies), in addition to utilization for remediation of the waste streams of existing CAFOs, can enable the integration of large-scale CAFO's and their end-product users, renewable energy production from the CAFO waste stream, on site utilization of the renewable energy generated and biofuel/ethanol production in an environmentally and economically sustainable manner while reducing the aggregate capital expense and operating costs for the entire integrated complex ("Integrated Projects" or "Projects"). In the context of Integrated Projects, Bion's waste treatment process, in addition to mitigating polluting releases, enables generation of renewable energy from cellulosic portions of the CAFO waste stream, which renewable energy can be utilized by integrated facilities including ethanol plants, CAFO end-product processors (including cheese, ice cream and/or bottling plants in the case of dairy CAFO’s and/or slaughter and/or processing facilities in the context of beef CAFO’s) and/or other users as a fossil fuel replacement. The nutrients (primarily nitrogen and phosphorus) can be harvested from the solids and liquid streams recovered from the livestock waste stream and can be utilized as either high value fertilizer and/or the basis for high protein animal feed and the nutrient rich effluent can potentially be utilized in integrated hydroponic agriculture and/or field applied as fertilizer. Bion believes that its Integrated Projects will produce high quality, traceable animal protein which can address consumer food safety/security concerns at a lower cost than current industry practices while also maintaining a far lower net environmental footprint per unit of protein produced due to water recycling (possible due to the removal of nutrients, etc. from the water by Bion’s technology applications), production of renewable energy from the waste stream (reducing the use of fossil fuels), and multiple levels of economies of scale, co-location and integration savings in transportation and other logistics. Some projects may involve only partial integration which will limit the benefits described herein.
 
On September 27, 2008, the Company executed an agreement with Kreider Farms (and its affiliated entities) (collectively "Kreider") to design, construct and operate (through its wholly-owned subsidiaries, Bion Services Group, Inc. (“Bion Services”) and Bion PA-1 LLC (“PA-1”) a Bion system to treat the waste of 1,200 milking dairy cows (milkers, dry cows and heifers) at the Kreider Dairy, located in Manheim, Pennsylvania. In addition, the agreement (as amended and supplemented) provides for a second phase which will treat the wastes from the rest of Kreider’s herd and includes renewable energy production from the cellulosic solid wastes from the Phase 1 system (referred to as “Kreider 1”) together with the waste stream from Kreider’s poultry facilities for use at the facilities and/or for market sales. The Kreider projects are owned and operated by Bion through subsidiaries, in which Kreider has the option to acquire a noncontrolling interest. S
ubstantial capital (equity and/or debt) has been and will continue to be expended on these projects. Additional funds will be required for continuing operations of Kreider 1 until sufficient revenues can be generated, of which there is no assurance. The Company anticipates that the Kreider 1 project will generate revenue primarily from the sale of nutrient reduction (and/or other) environmental credits while the Kreider Phase 2 poultry waste treatment system (‘Kreider 2’)(not yet constructed) and other future projects will supplement its revenue from nutrient reductions with proceeds from multiple byproduct streams including i) feed additives and/or fertilizer (organic and non-organic) and ii) renewable energy (and related credits), which sales are projected to generate, in aggregate, revenue streams that, in certain circumstances, may approach 50% of total revenues. To date the market for long-term nutrient reduction credits in Pennsylvania has been very slow to develop and the Company’s activities have been negatively affected by the lack of such development. A portion of Bion’s research and development activities is currently taking place at the Kreider 1 facility.
 
The Company’s subsidiary PA-1 financed Kreider 1 through a $7.8 million loan (“Pennvest Loan”) from Pennsylvania Infrastructure Investment Authority (“Pennvest”) secured by Kreider 1 (and its revenue streams, if any) plus advances from the Company. The economics (potential revenues and profitability) of Kreider 1 are based largely on the long-term sale of nutrient reduction credits (nitrogen and/or phosphorus) to meet the requirements of the Chesapeake Bay environmental clean-up. The Pennsylvania Department of Environmental Protection (“PADEP”) issued final permits for Kreider 1 (including the credit verification plan) on August 1, 2012 on which date the Company deemed that Kreider 1 was ‘placed in service’. However, liquidity in the Pennsylvania nutrient credit market has been slow to develop significant breadth and depth and has prevented Bion from monetizing the nutrient reduction credits created by PA-1’s Kreider 1 project and Bion’s other proposed projects. These challenges and difficulties raise significant questions as to when PA-1 will be able to generate such revenues from Kreider 1. PA-1 has elected not to make interest or principal payments on the Pennvest Loan since January 2013 and, therefore, the Company has classified the Pennvest Loan as a current liability as of December 31, 2015. The Company recorded a $1,750,000 impairment of the Kreider 1 assets for the year ended June 30, 2015 (following a $2,000,000 impairment during the year ended June 30, 2014).
 
On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA-1 did not make the payment and does not have the resources to make the payment demanded by Pennvest. PA-1 has engaged in on/off discussions and negotiations with Pennvest concerning this matter but no such discussions/negotiations are currently active. Neither party has any formal proposal on the table as of the date of this report. It is not possible at this date to predict the outcome of such negotiations, but the Company believes it is possible that an agreement may yet be reached that will result in a viable loan modification. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA-1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days.
 
During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the ‘technology guaranty’ standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1.
 
Development work and technology evaluation, including amended credit certification and discussions with potential joint venture partners, continues related to the details of Kreider 2, which primarily relates to treatment of the wastes from Kreider’s poultry operations. Assuming there are positive developments related to the market for nutrient reductions in Pennsylvania, the Company intends to pursue development, design and construction of the Kreider 2 poultry waste/renewable energy project with a goal of achieving operational status during calendar year 2017. However, as discussed above, this project faces challenges related to the current limits of the existing nutrient reduction market and funding of technology-based, verifiable agricultural nutrient reductions which are anticipated to constitute the largest share of its revenues.
 
A significant portion of Bion’s activities concern efforts with private and public stakeholders (at local and state level) in Pennsylvania (and other Chesapeake Bay and Midwest and Great Lakes states) and at the federal level (the Environmental Protection Agency (“EPA”) and the Department of Agriculture (“USDA”) (and other executive departments) and Congress) to establish appropriate public policies which will create regulations and funding mechanisms that foster installation of the low cost environmental solutions that Bion (and others) can provide through clean-up of agricultural waste streams. The Company anticipates that such efforts will continue in Pennsylvania throughout the next 12 months and in various additional states thereafter.
 
Going concern and management’s plans:
 
The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has not generated significant revenues and has incurred net losses (including significant non-cash expenses) of approximately $5,640,000 and $5,762,000 during the years ended June 30, 2015 and 2014, respectively, and a net loss of approximately $1,629,000 during the six months ended December 31, 2015. At December 31, 2015, the Company has a working capital deficit and a stockholders’ deficit of approximately $10,197,000 and $11,647,000, respectively. These factors raise substantial doubt about the Company's ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability or classification of assets or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern. The following paragraphs describe management’s plans with regard to these conditions.
 
The Company continues to explore sources of additional financing to satisfy its current operating requirements as it is not currently generating any significant revenues.
 
During the years ended June 30, 2015 and 2014, the Company received total proceeds of $1,000,940 and $944,400, respectively, from the sale of its equity securities. Proceeds during the 2015 and 2014 fiscal years have been lower than in earlier years which reduction has negatively impacted the Company’s business development efforts.
 
During the six months ended December 31, 2015, the Company entered into subscription agreements to exercise certain warrants with expiry dates on or before December 31, 2015, into restricted shares of the Company’s common stock at a reduced exercise price of $1.05, for the period from June 30, 2015 through July 15, 2015. Pursuant to the offering, 265,894 warrants were exercised and 265,894 shares of the Company’s restricted common stock were issued during the six months ended December 31, 2015, resulting in cash proceeds of $174,189 and receipt of a $105,000 interest bearing, collateralized promissory note receivable for shares. In January 2016, the Company received $35,000 of the promissory note receivable for shares.
 
During the six months ended December 31, 2015, the Company sold units of the Company’s restricted securities for $0.80 per unit, with each unit consisting of one share of the Company’s restricted common stock and one warrant to purchase one half of a share of the Company’s restricted common stock for $1.10 per share until June 30, 2017. During the six months ended December 31, 2015, the Company had sold a total of 228,750 units for gross proceeds of $183,000, and net proceeds of $164,700 after commissions of $18,300.
 
During fiscal years 2015 and 2014 and through the six months ended December 31, 2015, the Company experienced greater difficulty in raising equity funding than in the prior years. As a result, the Company faced, and continues to face, significant cash flow management challenges due to working capital constraints. To partially mitigate these working capital constraints, the Company’s core senior management and several key employees and consultants have been deferring (and continue to defer) all or part of their cash compensation and/or are accepting compensation in the form of securities of the Company (Notes 6 and 8) and members of the Company’s senior management have made loans to the Company. Additionally, the Company made reductions in its personnel during the year ended June 30, 2014. The constraint on available resources has had, and continues to have, negative effects on the pace and scope of the Company’s efforts to develop its business. The Company has had to delay payment of trade obligations and has had to economize in many ways that have potentially negative consequences. If the Company does not have greater success in its efforts to raise needed funds during the balance of the 2016 fiscal year (and subsequent periods), management will need to consider deeper cuts (including additional personnel cuts) and curtailment of operations (including possibly Kreider 1 operations) and/or research and development activities.
 
The Company will need to obtain additional capital to fund its operations and technology development, to satisfy existing creditors, to develop Integrated Projects and CAFO waste remediation systems (including the Kreider 2 facility) and to continue to operate the Kreider 1 facility. The Company anticipates that it will seek to raise from $2,500,000 to $50,000,000 or more debt and/or equity through joint ventures and/or sale of its equity securities (common, preferred and/or hybrid) and/or debt (including convertible) securities, and/or through use of ‘rights’ and/or warrants (new and/or existing) during the next twelve months. However, as discussed above, there is no assurance, especially in light of the difficulties the Company has experienced in recent periods and the extremely unsettled capital markets that presently exist (especially for small companies), that the Company will be able to obtain the funds that it needs to stay in business, complete its technology development or to successfully develop its business and projects.
 
There is no realistic likelihood that funds required during the next twelve months or in the periods immediately thereafter for the Company’s basic operations and/or proposed projects will be generated from operations. Therefore, the Company will need to raise sufficient funds from external sources such as debt or equity financings or other potential sources. The lack of sufficient additional capital resulting from the inability to generate cash flow from operations and/or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Further, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significantly dilutive effect on the Company's existing shareholders. All of these factors have been exacerbated by the extremely limited and unsettled credit and capital markets presently existing for small companies like Bion.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 2 - Significant Accounting Policies
6 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
Significant Accounting Policies [Text Block]
2.
SIGNIFICANT ACCOUNTING POLICIES
 
Principles of consolidation:
 
The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Bion Integrated Projects Group, Inc. (“Projects Group”), Bion Technologies, Inc., BionSoil, Inc., Bion Services, PA-1, and Bion PA 2 LLC; and its 58.9% owned subsidiary, Centerpoint Corporation (“Centerpoint”). All significant intercompany accounts and transactions have been eliminated in consolidation.
 
The accompanying consolidated financial statements have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The consolidated financial statements reflect all adjustments (consisting of only normal recurring entries) that, in the opinion of management, are necessary to present fairly the financial position at December 31, 2015, and the results of operations and cash flows of the Company for the three and six months ended December 31, 2015 and 2014. Operating results for the three and six months ended December 31, 2015 are not necessarily indicative of the results that may be expected for the year ending June 30, 2016.
 
Property and equipment:
 
Property and equipment are stated at cost and are depreciated, when placed into service, using the straight-line method over the estimated useful lives of the related assets, generally three to twenty years. The Company capitalizes all direct costs and all indirect incrementally identifiable costs related to the design and construction of its Integrated Projects. The Company reviews its property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized based on the amount by which the carrying value of the assets or asset group exceeds its estimated fair value, and is recognized as a loss from operations.
 
Fair value measurements:
 
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. The Company uses a fair value hierarchy that has three levels of inputs, both observable and unobservable, with use of the lowest possible level of input to determine fair value.
 
Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities;
 
Level 2 – observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and
 
Level 3 – assets and liabilities whose significant value drivers are unobservable.
 
Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment.
 
The fair value of cash, promissory note receivable and accounts payable approximates their carrying amounts due to their short-term maturities. The fair value of the loan payable approximates its carrying amount as it bears interest at rates commensurate with market rates. The fair value of the redeemable preferred stock approximates its carrying value due to the dividends accrued on the preferred stock which are reflected as part of the redemption value. The fair value of deferred compensation and convertible notes payable - affiliates are not practicable to estimate due to the related party nature of the underlying transactions.
 
Revenue Recognition:
 
Revenues are generated from the sale of nutrient reduction credits. The Company recognizes revenue from the sale of nutrient credits when there is persuasive evidence that an arrangement exists, when title has passed, the price is fixed or determinable, and collection is reasonably assured.
 
The Company expects that technology license fees will be generated from the licensing of Bion’s integrated system. The Company anticipates that it will charge its customers a non-refundable up-front technology license fee, which will be recognized over the estimated life of the customer relationship. In addition, any on-going technology license fees will be recognized as earned based upon the performance requirements of the agreement. Annual waste treatment fees will be recognized upon receipt. Revenues, if any, from the Company’s interest in Integrated Projects will be recognized when the entity in which the Integrated Project has been developed recognizes such revenue.
 
Loss per share:
 
Basic loss per share amounts are calculated using the weighted average number of shares of common stock outstanding during the period. Diluted loss per share assumes the conversion, exercise or issuance of all potential common stock instruments, such as options or warrants, unless the effect is to reduce the loss per share. During the six months ended December 31, 2015 and 2014, the basic and diluted loss per share was the same, as the impact of potential dilutive common shares was anti-dilutive.
 
The following table represents the warrants, options and convertible securities excluded from the calculation of diluted loss per share:
 
 
   
December 31,
2015
   
December 31,
2014
 
Warrants
    8,396,364       7,757,653  
Options
    4,513,870       3,911,370  
Convertible debt
    7,562,213       5,583,740  
Convertible preferred stock
    14,500       13,500  
 
The following is a reconciliation of the denominators of the basic loss per share computations for the three and six months ended December 31, 2015 and 2014:
 
   
Three months
ended
December 31,
2015
   
Three months
ended
December 31,
2014
   
Six months
ended
December 31,
2015
   
Six months
ended
December 31,
2014
 
Shares issued – beginning of period
    22,606,852       19,787,068       22,089,650       19,576,619  
Shares held by subsidiaries (Note 9)
    (704,309 )     (704,309 )     (704,309 )     (704,309 )
Shares outstanding – beginning of period
    21,902,543       19,082,759       21,385,341       18,872,310  
Weighted average shares for fully
vested stock bonuses (Note 9)
    652,989       840,000       626,495       840,000  
Weighted average shares issued
during the period
    29,469       42,700       425,203       178,957  
Basic weighted average shares –
end of period
    22,585,001       19,965,459       22,437,039       19,891,267  
 
 
Recent Accounting Pronouncements:
 
The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company’s financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company’s financial statements properly reflect the change.
 
In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09 “Revenue from Contracts from Customers,” which supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605),” and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017 and early adoption is not permitted. The Company is currently evaluating the new standard and assessing the potential impact on its operations and financial statements.
 
In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements – Going Concern: Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The guidance is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early application is permitted. The Company believes that the adoption of ASU No. 2014-15 will not have a material impact on its financial statements.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 3 - Property and Equipment
6 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
Property, Plant and Equipment Disclosure [Text Block]
3.
PROPERTY AND EQUIPMENT:
 
Property and equipment consists of the following:
 
   
December 31,
2015
   
June 30,
2015
 
Machinery and equipment
  $ 2,923,577     $ 2,923,577  
Buildings and structures
    1,385,125       1,385,125  
Computers and office equipment
    177,931       175,248  
      4,486,633       4,483,950  
Less accumulated depreciation
    (2,657,125 )     (2,506,731 )
    $ 1,829,508     $ 1,977,219  
 
Management reviewed property and equipment for impairment as of June 30, 2015 and determined that the carrying amount of property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits. Kreider 1 was measured at estimated fair value on a non-recurring basis using level 3 inputs, which resulted in an impairment of $1,750,000 of the property and equipment for the year ended June 30, 2015. As of December 31, 2015, management believes that no additional impairment exists.
 
Depreciation expense was $76,083 and $127,159 for the three months ended December 31, 2015 and 2014, respectively, and $151,962 and $312,043 for the six months ended December 31, 2015 and 2014, respectively.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 4 - Promissory Note Receivable
6 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]
4.
PROMISSORY NOTE RECEIVABLE:
 
During the six months ended December 31, 2015, the Company received an interest bearing, secured promissory note for $105,000. The promissory note bears interest at 4% per annum, is collateralized, and was payable on January 31, 2016. The promissory note receivable was issued as consideration for an unaffiliated investor’s subscription agreement to exercise warrants into 100,000 restricted common shares of the Company’s common stock at $1.05 per share. During January 2016, the Company received a $35,000 principal payment and entered into a new agreement with the borrowers which extended the maturity date of the remaining principal and interest until June 15, 2016. All the other terms of the original agreement remain unchanged. As of December 31, 2015, the Company has recorded the $35,000 as a promissory note receivable and the remaining unpaid principal and interest totaling $71,878, as a promissory note receivable for shares. The Company recorded interest income of $1,878 for the six months ended December 31, 2015.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 5 - Notes Payable - Affiliates
6 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]
5.
NOTES PAYABLE - AFFILIATES:
 
During the year ended June 30, 2015, the Company entered into promissory notes (“FY2015 Promissory Notes”), with effective dates of January 1, 2015, for initial principal amounts of $395,277, $15,956 and $80,764, with Dominic Bassani (“Bassani”), the Company’s Chief Executive Officer (“CEO”), Edward Schafer (“Schafer”), the Company’s Vice Chairman, and a major shareholder, (“Shareholder”), respectively. The FY2015 Promissory Notes accrued interest at 4% per annum and were payable on December 31, 2015. Effective September 8, 2015, the Company entered into new convertible promissory notes (“September 2015 Convertible Notes”) with Bassani, Schafer and Shareholder which replaced the FY2015 Promissory Notes. The initial principal balances of the September 2015 Convertible Notes were $405,831, $16,382 and $82,921, respectively. The new convertible promissory notes bear interest at 4% per annum, have maturity dates of December 31, 2017 and may be converted (at the sole election of the noteholders) into restricted common shares of the Company at a conversion price of $0.60 per share (Note 8).
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 6 - Deferred Compensation
6 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
6.
DEFERRED COMPENSATION:
 
The Company owes deferred compensation to various employees, former employees and consultants totaling $1,170,731 as of December 31, 2015. Included in the deferred compensation balances as of December 31, 2015, are $378,852, $54,632 and $183,316 owed Bassani, Smith and Schafer, respectively, pursuant to extension agreements effective January 1, 2015, whereby unpaid compensation earned after January 1, 2015, accrues interest at 4% per annum and can be converted into shares of the Company’s common stock at the election of the employee during the first five calendar days of any month. The conversion price shall be the average closing price of the Company’s common stock for the last 10 trading days of the immediately preceding month. During the six months ended December 31, 2015, Smith converted $82,861 of deferred compensation into 99,159 shares of the Company’s common stock at conversion prices between $0.76 and $0.96 per share. Also included are sums the Company owes various consultants, pursuant to various agreements, for deferred compensation of $312,447 as of December 31, 2015 with similar conversion terms as those described above for Bassani, Smith and Schafer, with the exception that the interest accrues at 3% per annum. The Company also owes a former employee and a current employee deferred compensation of $168,000 and $984, respectively, which is convertible into 226,168 and 1,131 shares, respectively, of the Company’s common stock as of December 31, 2015 and, the Company owes a former employee $72,500, which is not convertible and is non-interest bearing.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 7 - Loan Payable
6 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
Debt Disclosure [Text Block]
7.
LOAN PAYABLE:
 
As of December 31, 2015, PA-1, the Company’s wholly-owned subsidiary, owes $7,754,000 under the terms of the Pennvest Loan related to the construction of the Kreider 1 System. The terms of the Pennvest Loan provide for funding of up to $7,754,000 which is to be repaid by interest-only payments for three years, followed by an additional ten-year amortization of principal. The Pennvest Loan accrues interest at 2.547% for years 1 through 5 and 3.184% for years 6 through maturity. The Pennvest Loan requires minimum annual principal payments of approximately $574,000 in fiscal year 2013, $704,000 in fiscal year 2014, $723,000 in fiscal year 2015, $741,000 in fiscal year 2016, $760,000 in fiscal year 2017 and $4,252,000 thereafter. The Pennvest Loan is collateralized by the Kreider 1 System and by a pledge of all revenues generated from Kreider 1 including, but not limited to, revenues generated from nutrient reduction credit sales and by-product sales. In addition, in consideration for the excess credit risk associated with the project, Pennvest is entitled to participate in the profits from Kreider 1 calculated on a net cash flow basis, as defined. The Company has incurred interest expense related to the Pennvest Loan of $49,373 for both of the three months ended December 31, 2015 and 2014, respectively. The Company has incurred interest expense related to the Pennvest Loan of $98,747 for both of the six months ended December 31, 2015 and 2014, respectively. As of December 31, 2015, the accrued interest and late charges related to the Pennvest Loan total $693,332. Based on the limited development of the depth and breadth of the Pennsylvania nutrient reduction credit market to date, PA-1 has commenced negotiations with Pennvest related to forbearance and/or re-structuring the obligations under the Pennvest Loan. In the context of such negotiations, PA-1 has elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013. Additionally, the Company has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of December 31, 2015.
 
On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA-1 did not make the payment and does not have the resources to make the payment demanded by Pennvest. PA-1 has engaged in on/off discussions and negotiations with Pennvest concerning this matter but no such discussions/negotiations are currently active. Neither party has any formal proposal on the table as of the date of this report. It is not possible at this date to predict the outcome of such negotiations, but the Company believes it is possible that an agreement may yet be reached that will result in a viable loan modification. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA-1 and Bion will continue to evaluate various options with regard to Kreider 1 over the next 30-180 days.
 
 
 

 
 
BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
SIX MONTHS ENDED DECEMBER 31, 2015
 
In connection with the Pennvest Loan financing documents, the Company provided a ‘technology guaranty’ regarding nutrient reduction performance of Kreider 1 which was structured to expire when Kreider 1’s nutrient reduction performance had been demonstrated. During August 2012 the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 System had surpassed the requisite performance criteria and that the Company’s ‘technology guaranty’ was met. As a result, the Pennvest Loan is solely an obligation of PA-1.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 8 - Convertible Notes Payable - Affiliates
6 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
Convertible Debt [Text Block]
8.
CONVERTIBLE NOTES PAYABLE - AFFILIATES:
 
January 2015 Convertible Notes
 
The January 2015 Convertible Notes accrue interest at 4% per annum and are due and payable on December 31, 2017. The January 2015 Convertible Notes (including accrued interest, plus all future deferred compensation), are convertible, at the sole election of the noteholder, into Units consisting of one share of the Company’s common stock and one quarter warrant to purchase a share of the Company’s common stock, at a price of $0.50 per Unit until December 31, 2020. The warrant contained in the Unit shall be exercisable at $1.00 per share until December 31, 2020. The original conversion price of $0.50 per Unit approximated the fair value of the Units at the date of the agreements; therefore no beneficial conversion feature exists. Management evaluated the terms and conditions of the embedded conversion features based on the guidance of ASC 815-15 “Embedded Derivatives” to determine if there was an embedded derivative requiring bifurcation. An embedded derivative instrument (such as a conversion option embedded in the deferred compensation) must be bifurcated from its host instruments and accounted for separately as a derivative instrument only if the “risks and rewards” of the embedded derivative instrument are not “clearly and closely related” to the risks and rewards of the host instrument in which it is embedded. Management concluded that the embedded conversion feature of the deferred compensation was not required to be bifurcated because the conversion feature is clearly and closely related to the host instrument, and because of the Company’s limited trading volume that indicates the feature is not readily convertible to cash in accordance with ASC 815-10, “Derivatives and Hedging”.
 
As of December 31, 2015, the January 2015 Convertible Note balances, including accrued interest, owed Bassani, Smith and Schafer were $1,522,967, $790,856 and $393,380, respectively. During the three and six months ended December 31, 2015, the Company recorded interest expense of $26,247 and $52,495, respectively, related to the January 2015 Convertible Notes.
 
September 2015 Convertible Notes
 
During the six months ended December 31, 2015, the Company entered into September 2015 Convertible Notes with Bassani, Schafer and Shareholder which replaced the previously issued FY2015 Promissory Notes. The initial principal balances of the September 2015 Convertible Notes were $405,831, $16,382 and $82,921, respectively. The September 2015 Convertible Notes bear interest at 4% per annum, have maturity dates of December 31, 2017 and may be converted at the sole election of the noteholders into restricted common shares of the Company at a conversion price of $0.60 per share. As the conversion price of $0.60 approximated the fair value of the common shares at the date of the September 2015 Convertible Notes, no beneficial conversion feature exists. The balances of the September 2015 Convertible Notes as of December 31, 2015 are $410,901, $16,587 and $83,957, respectively. The Company recorded interest expense related to the 2015 Convertible Notes of $5,093 and $6,311 for the three and six months ended December 31, 2015, respectively.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 9 - Stockholders' Equity
6 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
9.
STOCKHOLDERS' EQUITY:
 
Series B Preferred stock:
 
At July 1, 2014, the Company had 200 shares of Series B redeemable convertible Preferred stock outstanding with a par value of $0.01 per share, convertible at the option of the holder at $2.00 per share, with dividends accrued and payable at 2.5% per quarter. The Series B Preferred stock is mandatorily redeemable at $2.00 per share by the Company three years after issuance and accordingly was classified outside of shareholders’ equity. The 200 shares have reached their maturity date, but due to the cash constraints of the Company have not been redeemed.
 
During the years ended June 30, 2015 and 2014, the Company declared dividends of $2,000 and $2,000 respectively. During the six months ended December 31, 2015, the Company declared dividends of $1,000. At December 31, 2015, accrued dividends payable are $9,000.
 
Common stock:
 
Holders of common stock are entitled to one vote per share on all matters to be voted on by common stockholders. In the event of liquidation, dissolution or winding up of the Company, the holders of common stock are entitled to share in all assets remaining after liabilities have been paid in full or set aside and the rights of any outstanding preferred stock have been satisfied. Common stock has no preemptive, redemption or conversion rights. The rights of holders of common stock are subject to, and may be adversely affected by, the rights of the holders of any outstanding series of preferred stock or any series of preferred stock the Company may designate in the future.
 
Centerpoint holds 704,309 shares of the Company’s common stock. These shares of the Company’s common stock held by Centerpoint are for the benefit of its shareholders without any beneficial interest. The Company accounts for these shares similar to treasury stock.
 
During the six months ended December 31, 2015, the Company issued 36,296 shares of the Company’s common stock at prices ranging from $0.69 to $1.15 per share for services valued at $100,904, in the aggregate, to consultants and employees, including $69,000 expensed for 75,000 fully vested bonus shares to Smith that were granted but not issued.
 
During the six months ended December 31, 2015, the Company issued 12,500 shares of the Company’s restricted common stock upon receipt of its subscription receivable of $13,125 for the exercise of 12,500 warrants.
 
During the six months ended December 31, 2015, the Company entered into subscription agreements to exercise certain warrants with expiry dates on or before December 31, 2015, into restricted shares of the Company’s common stock at a reduced exercise price of $1.05, for the period from June 30, 2015 through July 15, 2015. Pursuant to the offering, 265,894 warrants were exercised and 265,894 shares of the Company’s restricted common stock were issued resulting in cash proceeds of $174,189 and receipt of a $105,000 interest bearing, collateralized promissory note. During January 2016, the Company received a $35,000 principal payment and entered into a new agreement with the borrowers which extended the maturity date of the remaining principal and interest until June 15, 2016. All the other terms of the original agreement remain unchanged. As of December 31, 2015, the Company has recorded the $35,000 as a promissory note receivable and the remaining unpaid principal and interest totaling $71,878, as a promissory note receivable for shares.
 
During the six months ended December 31, 2015, the Company entered into subscription agreements to sell units for $0.80 per unit, with each unit consisting of one share of the Company’s restricted common stock and one warrant to purchase one half of a share of the Company’s restricted common stock for $1.10 per share until June 30, 2017 and pursuant thereto, the Company issued 228,750 units for total proceeds of $183,000. During the six months ended December 31, 2015, cash commissions of $18,300 were paid to brokers related to the unit offering. The Company allocated the proceeds from the shares and the warrants based upon their relative fair values, using the share price on the day each of the subscription agreements were entered into and the fair value of the warrants, which was determined to be $0.05 per warrant. As a result, $4,603 was allocated to the warrants and $178,397 was allocated to the shares, and both were recorded as additional paid in capital.
 
During the six months ended December 31, 2015, a warrant holder elected to exercise 14,000 warrants at an exercise price of $0.75 and 14,000 shares of the Company’s common stock were issued resulting in cash proceeds of $10,500.
 
 
 

 
 
BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
SIX MONTHS ENDED DECEMBER 31, 2015
 
During the six months ended December 31, 2015, Smith and various consultants elected to convert $82,861 and $88,856 of deferred compensation, respectively, into 99,159 and 109,715 shares, respectively, of the Company’s common stock at conversion rates ranging from $0.76 to $1.15 per share.
 
Warrants:
 
As of December 31, 2015, the Company had approximately 8.4 million warrants outstanding, with exercise prices from $0.75 to $3.00 and expiring on various dates through December 31, 2020.
 
The weighted-average exercise price for the outstanding warrants is $1.24, and the weighted-average remaining contractual life as of December 31, 2015 is 4.2 years.
 
During the six months ended December 31, 2015, warrants to purchase 957,806 shares of common stock of the Company at prices between $2.25 and $3.10 per share expired.
 
During the six months ended December 31, 2015, the Company entered into subscription agreements to exercise certain warrants with expiry dates on or before December 31, 2015, into restricted shares of the Company’s common stock at a reduced exercise price of $1.05, for the period from July 1, 2015 through July 15, 2015. As a result of the offering, 265,894 warrants were exercised and 265,894 shares of the Company’s restricted common stock were issued resulting in cash proceeds of $174,189 and receipt of a collateralized promissory note receivable for $105,000, for the six months ended December 31, 2015.
 
During the six months ended December 31, 2015, a warrant holder elected to exercise 14,000 warrants at an exercise price of $0.75 and 14,000 shares of the Company’s common stock were issued resulting in cash proceeds of $10,500.
 
Stock options:
 
The Company’s 2006 Consolidated Incentive Plan, as amended (the “2006 Plan”), provides for the issuance of options (and/or other securities) to purchase up to 22,000,000 shares of the Company’s common stock. Terms of exercise and expiration of options/securities granted under the 2006 Plan may be established at the discretion of the Board of Directors, but no option may be exercisable for more than ten years.
 
During the six months ended December 31, 2015, the Company approved the modification of existing stock options held by a board member which extended certain expiration dates and resulted in incremental non-cash compensation expense of $42,550.
 
The Company recorded compensation expense related to employee stock options of $74,320 and $4,000 for the three months ended December 31, 2015 and 2014, respectively, and $89,640 and $4,000 for the six months ended December 31, 2015 and 2014, respectively. The Company granted 100,000 and zero options during the six months ended December 31, 2015 and 2014, respectively. During the six months ended December 31, 2014, 397,500 options expired.
 
The fair value of the options granted during the six months ended December 31, 2015 and 2014 were estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:
 
   
Weighted
Average,
December
31,
2015
   
Range,
December
31,
2015
   
Weighted
Average,
December
31,
2014
   
Range,
December
31,
2014
 
Volatility
    74%       74%       80%       80%  
Dividend yield
    -       -       -       -  
Risk-free interest rate
    1.75%       1.75%       0.51%       0.51%  
Expected term (years)
    5       5       2       2  
 
 
 

 
 
BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
SIX MONTHS ENDED DECEMBER 31, 2015
 
A summary of option activity under the 2006 Plan for the six months ended December 31, 2015 is as follows:
 
 
   
Options
   
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life
   
Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2015
    4,413,870     $ 1.88       4.1       -  
Granted
    100,000       0.92                  
Exercised
    -       -                  
Forfeited
    -       -                  
Expired
    -       -                  
Outstanding at December 31, 2015
    4,513,870     $ 1.86       3.9     $ 36,050  
Exercisable at December 31, 2015
    4,413,870     $ 1.89       3.7     $ 22,050  
 
The following table presents information relating to nonvested stock options as of December 31, 2015:
 
   
Options
   
Weighted Average
Grant-Date Fair
Value
 
Nonvested at July 1, 2015
    100,000     $ 0.76  
Granted
    100,000       0.59  
Vested
    (100,000 )     (0.59 )
Nonvested at December 31, 2015
    100,000     $ 0.76  
 
The total fair value of stock options that vested during the six months ended December 31, 2015 and 2014 was $59,000 and nil, respectively. As of December 31, 2015, the Company had $19,826 of unrecognized compensation cost related to stock options.
 
Stock-based employee compensation charges in operating expenses in the Company’s financial statements for the three and six months ended December 31, 2015 and 2014 are as follows:
 
   
Three
months
ended
December
31,
2015
   
Three
months
ended
December
31,
2014
   
Six months
ended
December
31,
2015
   
Six months
ended
December
31,
2014
 
General and administrative:
                               
Fair value of stock bonus expensed
  $ 69,000     $ -     $ 69,000     $ -  
Change in fair value from modification of
option terms
    42,550       11,783       42,550       11,783  
Fair value of stock options expensed
    62,371       4,000       64,209       4,000  
Total
  $ 173,921     $ 15,783     $ 175,759     $ 15,783  
                                 
Research and development:
                               
Fair value of stock options expensed
  $ 11,949     $ -     $ 25,431     $ -  
Total
  $ 11,949     $ -     $ 25,431     $ -  
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 10 - Commitments and Contingencies
6 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]
10.
COMMITMENTS AND CONTINGENCIES:
 
Employment and consulting agreements:
 
Smith has held the positions of Director, President and General Counsel of Company and its subsidiaries under various agreements and terms since March 2003. During September 2014, Smith agreed to continue his employment agreement through April 15, 2015 and also agreed to continue to defer his temporarily reduced salary of $14,000 per month until such date. On February 10, 2015, the Company executed an Extension Agreement with Smith pursuant to which Smith extended his employment with the Company to December 31, 2015 (with the Company having an option to extend his employment an additional six months). As part of the Extension Agreement, the balance of Smith’s existing convertible note payable as of December 31, 2014, adjusted for conversions subsequent to that date, was replaced with a new convertible note with an initial principal amount of $760,520 with terms that i) materially reduce the interest rate by 50% (from 8% to 4%), ii) increases the conversion price by 11% (from $0.45 to $0.50), iii) sets the conversion price at a fixed price so there can be no further reductions, iv) reduces the number of warrants received on conversion by 75% (from 1 warrant per unit to 1/4 per unit) and v) extends the maturity date to December 31, 2017. Additionally, pursuant to the Extension Agreement, Smith: i) will continue to defer his cash compensation ($18,000 per month) until the Board of Directors re-instates cash payments to all employees and consultants who are deferring their compensation, ii) cancelled 150,000 contingent stock bonuses previously granted to him by the Company, iii) has been granted 150,000 new options which vested immediately and iv) outstanding options and warrants owned by Smith (and his donees) have been extended and had the exercise prices reduced to $1.50 (if the exercise price exceeded $1.50). In October 2015, the Company executed an Extension Agreement (“FY2016 Extension Agreement”) with Smith pursuant to which Smith extended his employment with the Company to June 30, 2016 (with Company having an option to extend his employment an additional six months). As part of the FY2016 Extension Agreement, Smith: i) will continue to defer his cash compensation ($19,000 per month) until the Board of Directors re-instates cash payments, ii) has been granted 100,000 new options which vested immediately, and iii) has been granted 75,000 shares of common stock as an extension bonus which are immediately vested and were issued on January 5, 2016.
 
Since March 31, 2005, the Company has had various agreements with Brightcap and/or Bassani, through which the services of Bassani are provided. The Board appointed Bassani as the Company's CEO effective May 13, 2011. During the fiscal years 2012 and 2013, Bassani entered into extension agreements whereby he was awarded fully vested stock grants totaling 600,000 shares, 500,000 shares of which are to be issued January 15, 2016 and 100,000 shares are to be issued January 15, 2017. The stock grants were expensed in the years they were awarded as they are fully vested. On February 10, 2015, the Company executed an Extension Agreement with Bassani pursuant to which Bassani extended the term of his service to the Company to December 31, 2017, (with the Company having an option to extend the term an additional six months.) As part of the agreement, the Company’s then existing loan payable, deferred compensation and convertible note payable to Bassani, were restructured into two promissory notes as follows: a) The sum of the cash loaned by Bassani to the Company of $279,000 together with $116,277 of unreimbursed expenses through December 31, 2014, were placed into a new promissory note with initial principal of $395,277 which was due and payable on December 31, 2015 and now has been replaced with a September 2015 Convertible Note (Note 8). In connection with these sums and the new promissory note, Bassani was issued warrants to purchase 592,916 shares of the Company’s common stock at a price of $1.00 until December 31, 2020; and b) the remaining balances of the Company’s accrued obligations to Bassani ($1,464,545) were replaced with a new convertible promissory note with terms that compared with the largest prior convertible note obligation to Bassani: i) materially reduce the interest rate by 50% (from 8% to 4%), ii) increase the conversion price by 11% (from $0.45 to $0.50), iii) sets the conversion price at a fixed price so there can be no further reductions, iv) reduces the number of warrants received on conversion by 75% (from 1 warrant per unit to 1/4 per unit) and v) extends the maturity date to December 31, 2017 (Note 8). Additionally, pursuant to the Extension Agreement, Bassani i) will continue to defer his cash compensation ($31,000 per month) until the Board of Directors re-instates cash payments to all employees and consultants who are deferring their compensation, ii) cancelled 250,000 contingent stock bonuses previously granted to him by the Company, iii) has been granted 450,000 new options which vested immediately and iv) outstanding options and warrants owned by Bassani (and his donees) have been extended and had the exercise prices reduced to $1.50 (if the exercise price exceeded $1.50).
 
 
 

 
 
BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
SIX MONTHS ENDED DECEMBER 31, 2015
 
On February 10, 2015, the Company entered into an agreement with Schafer pursuant to which Schafer will continue to provide services to the Company through December 31, 2015. Additionally, pursuant to the agreement, i) the exercise period of outstanding options and warrants owned by Schafer have been extended, and ii) 25,000 contingent stock bonuses previously granted to Schafer have been cancelled by the Company. In January 2016, Schafer agreed to extend his agreement with the Company through December 31, 2016.
 
Contingent stock bonuses:
 
The Company has declared contingent deferred stock bonuses to its key employees and consultants at various times throughout the years. The stock bonuses are contingent upon the Company’s stock price exceeding a certain target price per share, and the grantees still being employed by or providing services to the Company at the time the target prices are reached.
 
The Company’s outstanding contingent stock bonuses as of December 31, 2015 are as follows:
 
Target Price per share
    $5.00       $10.00       $20.00  
Number of shares
    50,000       40,000       27,500  
 
Execution/exercise bonuses:
 
As part of agreements the Company entered into with Bassani and Smith effective May 15, 2013, they were each granted the following: a) a 50% execution/exercise bonus which shall be applied upon the effective date of the notice of intent to exercise (for options and warrants) or issuance event, as applicable, of any currently outstanding and/or subsequently acquired  options, warrants and/or  contingent stock bonuses owned by each (and/or their donees) as follows: i) in the case of exercise by payment of cash, the bonus shall take the form of reduction of the exercise price; ii) in the case of cashless exercise, the bonus shall be applied to reduce the exercise price prior to the cashless exercise calculations; and iii) with regard to contingent stock bonuses, issuance shall be triggered upon the Company’s common stock reaching a closing price equal to 50% of currently specified price; and b) the right to extend the exercise period of all or part of the applicable options and warrants for up to five years (one year at a time) by annual payments of $.05 per option or warrant to the Company on or before a date during the three months prior to expiration of the exercise period at least three business days before the end of the expiration period. Effective January 1, 2016 such annual payments to extend warrant exercise periods have been reduced to $.01 per option or warrant.
 
During the year ended June 30, 2014, the Company extended execution/exercise bonuses with the same terms as described above to Schafer and to Jon Northrop, the Company’s other board member.
 
As of December 31, 2015, the execution/exercise bonus was applicable to 3,045,000 of the Company’s outstanding options and 6,759,500 of the Company’s outstanding warrants.
 
Litigation:
 
On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and has demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. PA-1 did not make the payment and does not have the resources to make the payment demanded by Pennvest. During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the ‘technology guaranty’ standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1. No litigation has commenced related to this matter but such litigation is likely if negotiations do not produce a resolution (Note 1 and Note 7).
 
The Company currently is not involved in any other material litigation.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 11 - Subsequent Events
6 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
Subsequent Events [Text Block]
11.
SUBSEQUENT EVENTS:
 
The Company has evaluated events that occurred subsequent to December 31, 2015 for recognition and disclosure in the financial statements and notes to the financial statements.
 
From January 1, 2016 through February 4, 2016, the Company has issued 5,031 shares of the Company’s common shares to an employee and a consultant valued at approximately $4,500.
 
From January 1, 2016 through February 4, 2016, the Company has issued 75,000 shares of the Company’s common shares to Smith per the terms of his extension agreement.
 
From January 1, 2016 through February 4, 2016, the Company has sold 31,250 units of the Company’s restricted securities for $0.80 each, with each unit consisting of one share of the Company’s restricted common stock and one warrant to purchase one half of a share of the Company’s restricted common stock for $1.10 per share until June 30, 2017. The proceeds from the sale of the units totaled $25,000.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.3.1.900
Significant Accounting Policies (Policies)
6 Months Ended
Dec. 31, 2015
Accounting Policies [Abstract]  
Consolidation, Policy [Policy Text Block]
Principles of consolidation:
 
The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Bion Integrated Projects Group, Inc. (“Projects Group”), Bion Technologies, Inc., BionSoil, Inc., Bion Services, PA-1, and Bion PA 2 LLC; and its 58.9% owned subsidiary, Centerpoint Corporation (“Centerpoint”). All significant intercompany accounts and transactions have been eliminated in consolidation.
 
The accompanying consolidated financial statements have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The consolidated financial statements reflect all adjustments (consisting of only normal recurring entries) that, in the opinion of management, are necessary to present fairly the financial position at December 31, 2015, and the results of operations and cash flows of the Company for the three and six months ended December 31, 2015 and 2014. Operating results for the three and six months ended December 31, 2015 are not necessarily indicative of the results that may be expected for the year ending June 30, 2016.
Property, Plant and Equipment, Policy [Policy Text Block]
Property and equipment:
 
Property and equipment are stated at cost and are depreciated, when placed into service, using the straight-line method over the estimated useful lives of the related assets, generally three to twenty years. The Company capitalizes all direct costs and all indirect incrementally identifiable costs related to the design and construction of its Integrated Projects. The Company reviews its property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized based on the amount by which the carrying value of the assets or asset group exceeds its estimated fair value, and is recognized as a loss from operations.
Fair Value Measurement, Policy [Policy Text Block]
Fair value measurements:
 
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. The Company uses a fair value hierarchy that has three levels of inputs, both observable and unobservable, with use of the lowest possible level of input to determine fair value.
 
Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities;
 
Level 2 – observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and
 
Level 3 – assets and liabilities whose significant value drivers are unobservable.
 
Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment.
 
The fair value of cash, promissory note receivable and accounts payable approximates their carrying amounts due to their short-term maturities. The fair value of the loan payable approximates its carrying amount as it bears interest at rates commensurate with market rates. The fair value of the redeemable preferred stock approximates its carrying value due to the dividends accrued on the preferred stock which are reflected as part of the redemption value. The fair value of deferred compensation and convertible notes payable - affiliates are not practicable to estimate due to the related party nature of the underlying transactions.
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition:
 
Revenues are generated from the sale of nutrient reduction credits. The Company recognizes revenue from the sale of nutrient credits when there is persuasive evidence that an arrangement exists, when title has passed, the price is fixed or determinable, and collection is reasonably assured.
 
The Company expects that technology license fees will be generated from the licensing of Bion’s integrated system. The Company anticipates that it will charge its customers a non-refundable up-front technology license fee, which will be recognized over the estimated life of the customer relationship. In addition, any on-going technology license fees will be recognized as earned based upon the performance requirements of the agreement. Annual waste treatment fees will be recognized upon receipt. Revenues, if any, from the Company’s interest in Integrated Projects will be recognized when the entity in which the Integrated Project has been developed recognizes such revenue.
Earnings Per Share, Policy [Policy Text Block]
Loss per share:
 
Basic loss per share amounts are calculated using the weighted average number of shares of common stock outstanding during the period. Diluted loss per share assumes the conversion, exercise or issuance of all potential common stock instruments, such as options or warrants, unless the effect is to reduce the loss per share. During the six months ended December 31, 2015 and 2014, the basic and diluted loss per share was the same, as the impact of potential dilutive common shares was anti-dilutive.
 
The following table represents the warrants, options and convertible securities excluded from the calculation of diluted loss per share:
 
 
   
December 31,
2015
   
December 31,
2014
 
Warrants
    8,396,364       7,757,653  
Options
    4,513,870       3,911,370  
Convertible debt
    7,562,213       5,583,740  
Convertible preferred stock
    14,500       13,500  
 
The following is a reconciliation of the denominators of the basic loss per share computations for the three and six months ended December 31, 2015 and 2014:
 
   
Three months
ended
December 31,
2015
   
Three months
ended
December 31,
2014
   
Six months
ended
December 31,
2015
   
Six months
ended
December 31,
2014
 
Shares issued – beginning of period
    22,606,852       19,787,068       22,089,650       19,576,619  
Shares held by subsidiaries (Note 9)
    (704,309 )     (704,309 )     (704,309 )     (704,309 )
Shares outstanding – beginning of period
    21,902,543       19,082,759       21,385,341       18,872,310  
Weighted average shares for fully
vested stock bonuses (Note 9)
    652,989       840,000       626,495       840,000  
Weighted average shares issued
during the period
    29,469       42,700       425,203       178,957  
Basic weighted average shares –
end of period
    22,585,001       19,965,459       22,437,039       19,891,267  
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements:
 
The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company’s financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company’s financial statements properly reflect the change.
 
In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09 “Revenue from Contracts from Customers,” which supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605),” and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017 and early adoption is not permitted. The Company is currently evaluating the new standard and assessing the potential impact on its operations and financial statements.
 
In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements – Going Concern: Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The guidance is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early application is permitted. The Company believes that the adoption of ASU No. 2014-15 will not have a material impact on its financial statements.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 2 - Significant Accounting Policies (Tables)
6 Months Ended
Dec. 31, 2015
Notes Tables  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   
December 31,
2015
   
December 31,
2014
 
Warrants
    8,396,364       7,757,653  
Options
    4,513,870       3,911,370  
Convertible debt
    7,562,213       5,583,740  
Convertible preferred stock
    14,500       13,500  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   
Three months
ended
December 31,
2015
   
Three months
ended
December 31,
2014
   
Six months
ended
December 31,
2015
   
Six months
ended
December 31,
2014
 
Shares issued – beginning of period
    22,606,852       19,787,068       22,089,650       19,576,619  
Shares held by subsidiaries (Note 9)
    (704,309 )     (704,309 )     (704,309 )     (704,309 )
Shares outstanding – beginning of period
    21,902,543       19,082,759       21,385,341       18,872,310  
Weighted average shares for fully
vested stock bonuses (Note 9)
    652,989       840,000       626,495       840,000  
Weighted average shares issued
during the period
    29,469       42,700       425,203       178,957  
Basic weighted average shares –
end of period
    22,585,001       19,965,459       22,437,039       19,891,267  
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 3 - Property and Equipment (Tables)
6 Months Ended
Dec. 31, 2015
Notes Tables  
Property, Plant and Equipment [Table Text Block]
   
December 31,
2015
   
June 30,
2015
 
Machinery and equipment
  $ 2,923,577     $ 2,923,577  
Buildings and structures
    1,385,125       1,385,125  
Computers and office equipment
    177,931       175,248  
      4,486,633       4,483,950  
Less accumulated depreciation
    (2,657,125 )     (2,506,731 )
    $ 1,829,508     $ 1,977,219  
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 9 - Stockholders' Equity (Tables)
6 Months Ended
Dec. 31, 2015
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
Weighted
Average,
December
31,
2015
   
Range,
December
31,
2015
   
Weighted
Average,
December
31,
2014
   
Range,
December
31,
2014
 
Volatility
    74%       74%       80%       80%  
Dividend yield
    -       -       -       -  
Risk-free interest rate
    1.75%       1.75%       0.51%       0.51%  
Expected term (years)
    5       5       2       2  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
   
Options
   
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life
   
Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2015
    4,413,870     $ 1.88       4.1       -  
Granted
    100,000       0.92                  
Exercised
    -       -                  
Forfeited
    -       -                  
Expired
    -       -                  
Outstanding at December 31, 2015
    4,513,870     $ 1.86       3.9     $ 36,050  
Exercisable at December 31, 2015
    4,413,870     $ 1.89       3.7     $ 22,050  
Schedule of Nonvested Share Activity [Table Text Block]
   
Options
   
Weighted Average
Grant-Date Fair
Value
 
Nonvested at July 1, 2015
    100,000     $ 0.76  
Granted
    100,000       0.59  
Vested
    (100,000 )     (0.59 )
Nonvested at December 31, 2015
    100,000     $ 0.76  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
   
Three
months
ended
December
31,
2015
   
Three
months
ended
December
31,
2014
   
Six months
ended
December
31,
2015
   
Six months
ended
December
31,
2014
 
General and administrative:
                               
Fair value of stock bonus expensed
  $ 69,000     $ -     $ 69,000     $ -  
Change in fair value from modification of
option terms
    42,550       11,783       42,550       11,783  
Fair value of stock options expensed
    62,371       4,000       64,209       4,000  
Total
  $ 173,921     $ 15,783     $ 175,759     $ 15,783  
                                 
Research and development:
                               
Fair value of stock options expensed
  $ 11,949     $ -     $ 25,431     $ -  
Total
  $ 11,949     $ -     $ 25,431     $ -  
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 10 - Commitments and Contingencies (Tables)
6 Months Ended
Dec. 31, 2015
Notes Tables  
Shares Outstanding under Contingent Stock Bonuses Plan by Target Price Per Share [Table Text Block]
Target Price per share
    $5.00       $10.00       $20.00  
Number of shares
    50,000       40,000       27,500  
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 1 - Organization, Nature of Business, Going Concern and Management's Plans (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 04, 2016
Jan. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Jun. 30, 2015
Jun. 30, 2014
Jul. 15, 2015
Sep. 25, 2014
Property, Plant and Equipment of PA1 [Member]                    
Impairment of Long-Lived Assets Held-for-use             $ 1,750,000 $ 2,000,000    
PA-1 [Member]                    
Debt Instrument, Debt Default, Amount                   $ 8,137,117
Certain Warrants with Expiry Dates on or before December 31, 2015 [Member] | Note Receivable as Consideration for Warrants Exercise [Member]                    
Other Significant Noncash Transaction, Value of Consideration Received         $ 105,000          
Certain Warrants with Expiry Dates on or before December 31, 2015 [Member]                    
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 1.05   $ 1.05       $ 1.05  
Class of Warrant or Right Exercised During Period         265,894          
Stock Issued During Period, Shares, Warrants Exercised         265,894          
Proceeds from Warrant Exercises         $ 174,189          
Note Receivable as Consideration for Warrants Exercise [Member] | Subsequent Event [Member]                    
Proceeds from Collection of Notes Receivable   $ 35,000                
Note Receivable as Consideration for Warrants Exercise [Member]                    
Other Significant Noncash Transaction, Value of Consideration Received         $ 105,000          
Subsequent Event [Member] | Restricted Securities Units [Member]                    
Shares Issued, Price Per Share $ 0.80                  
Number of Warrants in Each Unit 1                  
Stock Issued During Period, Shares, New Issues 31,250                  
Gross Proceeds from Sale of Interest in Corporate Unit $ 25,000                  
Subsequent Event [Member]                    
Shares of Restricted Common Stock in Each Unit 1                  
Warrant Component of Equity Unit, Number of Shares of Restricted Common Stock Called by Each Warrant 0.5                  
Warrant Component of Corporate Unit, Exercise Price Per Share of Restricted Common Stock $ 1.10                  
Restricted Securities Units [Member]                    
Shares Issued, Price Per Share     $ 0.80   $ 0.80          
Shares of Restricted Common Stock in Each Unit     1   1          
Number of Warrants in Each Unit     1   1          
Warrant Component of Equity Unit, Number of Shares of Restricted Common Stock Called by Each Warrant     0.5   0.5          
Warrant Component of Corporate Unit, Exercise Price Per Share of Restricted Common Stock     $ 1.10   $ 1.10          
Stock Issued During Period, Shares, New Issues         228,750          
Gross Proceeds from Sale of Interest in Corporate Unit         $ 183,000          
Proceeds from Sale of Interest in Corporate Unit         164,700          
Payments of Stock Issuance Costs         $ 18,300          
Minimum [Member]                    
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 0.75   $ 0.75          
Capital Required for Capital Adequacy     $ 2,500,000   $ 2,500,000          
Maximum [Member]                    
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 3   $ 3          
Capital Required for Capital Adequacy     $ 50,000,000   $ 50,000,000          
Construction Loan     7,800,000   7,800,000          
Impairment of Long-Lived Assets Held-for-use         0   1,750,000      
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest     (796,869) $ (664,948) (1,629,398) $ (1,370,706) (5,640,000) (5,762,000)    
Working Capital     (10,197,000)   (10,197,000)          
Stockholders' Equity Attributable to Parent     $ (11,647,440)   (11,647,440)   (10,806,933)      
Proceeds from Issuance or Sale of Equity             $ 1,000,940 $ 944,400    
Proceeds from Warrant Exercises         184,689        
Payments of Stock Issuance Costs         $ 18,300        
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 2 - Significant Accounting Policies (Details Textual)
6 Months Ended
Dec. 31, 2015
Centerpoint [Member]  
Equity Method Investment, Ownership Percentage 58.90%
Minimum [Member]  
Property, Plant and Equipment, Useful Life 3 years
Maximum [Member]  
Property, Plant and Equipment, Useful Life 20 years
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 2 - Antidilutive Securities (Details) - shares
6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Warrant [Member]    
Antidilutive securities (in shares) 8,396,364 7,757,653
Employee Stock Option [Member]    
Antidilutive securities (in shares) 4,513,870 3,911,370
Convertible Debt Securities [Member]    
Antidilutive securities (in shares) 7,562,213 5,583,740
Convertible Preferred Stock Antidilutive Securities [Member]    
Antidilutive securities (in shares) 14,500 13,500
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 2 - Earnings Per Share, Basic and Diluted (Details) - shares
3 Months Ended 6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Shares issued – beginning of period (in shares) 22,855,964   22,855,964  
Shares held by subsidiaries (Note 9) (in shares) (704,309) (704,309) (704,309) (704,309)
Shares outstanding – beginning of period (in shares) 22,151,655   22,151,655  
Weighted average shares for fully vested stock bonuses (Note 9) (in shares) 652,989 840,000 626,495 840,000
Weighted average shares issued during the period (in shares) 29,469 42,700 425,203 178,957
Basic weighted average shares – end of period (in shares) 22,585,001 19,965,459 22,437,039 19,891,267
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 3 - Property and Equipment (Details Textual) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Jun. 30, 2015
Impairment of Long-Lived Assets Held-for-use     $ 0   $ 1,750,000
Depreciation $ 76,083 $ 127,159 $ 151,962 $ 312,043  
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 3 - Property and Equipment (Details) - USD ($)
Dec. 31, 2015
Jun. 30, 2015
Machinery and equipment $ 2,923,577 $ 2,923,577
Buildings and structures 1,385,125 1,385,125
Computers and office equipment 177,931 175,248
Total 4,486,633 4,483,950
Less accumulated depreciation (2,657,125) (2,506,731)
Net $ 1,829,508 $ 1,977,219
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 4 - Promissory Note Receivable (Details Textual) - USD ($)
1 Months Ended 6 Months Ended
Jan. 31, 2016
Dec. 31, 2015
Jul. 15, 2015
Jun. 30, 2015
Note Receivable as Consideration for Warrants Exercise [Member] | Certain Warrants with Expiry Dates on or before December 31, 2015 [Member]        
Other Significant Noncash Transaction, Value of Consideration Received   $ 105,000    
Note Receivable as Consideration for Warrants Exercise [Member] | Subsequent Event [Member]        
Proceeds from Collection of Notes Receivable $ 35,000      
Note Receivable as Consideration for Warrants Exercise [Member]        
Other Significant Noncash Transaction, Value of Consideration Received   105,000    
Notes, Loans and Financing Receivable, Net, Current   35,000    
Promissory Note Receivable for Shares   $ 71,878    
Certain Warrants with Expiry Dates on or before December 31, 2015 [Member]        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   100,000    
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 1.05 $ 1.05  
Financing Receivable Note Interest Rate   4.00%    
Notes, Loans and Financing Receivable, Net, Current   $ 35,000  
Promissory Note Receivable for Shares   71,878  
Investment Income, Interest   $ 1,878    
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 5 - Notes Payable - Affiliates (Details Textual) - USD ($)
12 Months Ended
Sep. 08, 2015
Jun. 30, 2015
Promissory Notes 2015 [Member] | Chief Executive Officer [Member]    
Notes Payable, Related Parties   $ 395,277
Promissory Notes 2015 [Member] | Executive Vice Chairman [Member]    
Notes Payable, Related Parties   15,956
Promissory Notes 2015 [Member] | Investor [Member]    
Notes Payable, Related Parties   $ 80,764
Promissory Notes 2015 [Member]    
Related Party Transaction, Rate   4.00%
September 2015 Convertible Notes [Member] | Chief Executive Officer [Member]    
Convertible Notes Payable, Current $ 405,831  
September 2015 Convertible Notes [Member] | Executive Vice Chairman [Member]    
Convertible Notes Payable, Current 16,382  
September 2015 Convertible Notes [Member] | Investor [Member]    
Convertible Notes Payable, Current $ 82,921  
September 2015 Convertible Notes [Member]    
Related Party Transaction, Rate 4.00%  
Debt Instrument, Convertible, Conversion Price $ 0.60  
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 6 - Deferred Compensation (Details Textual) - USD ($)
6 Months Ended
Dec. 31, 2015
Jun. 30, 2015
Chief Executive Officer [Member]    
Deferred Compensation Liability, Current $ 378,852  
Chief Financial Officer [Member] | Minimum [Member]    
Deferred Compensation Conversion Price $ 0.76  
Chief Financial Officer [Member] | Maximum [Member]    
Deferred Compensation Conversion Price $ 0.96  
Chief Financial Officer [Member]    
Deferred Compensation Liability, Current $ 54,632  
Deferred Compensation Converted to Common Stock Amount $ 82,861  
Deferred Compensation Shares Issued upon Conversion 99,159  
Executive Vice Chairman [Member]    
Deferred Compensation Liability, Current $ 183,316  
Consultants [Member]    
Deferred Compensation Liability, Current $ 312,447  
Interest Rate on Deferred Compensation 3.00%  
Deferred Compensation Converted to Common Stock Amount $ 88,856  
Former Employee 1 [Member]    
Deferred Compensation Liability, Current $ 168,000  
Deferred Compensation Shares Issued upon Conversion 226,168  
Individual Employee [Member]    
Deferred Compensation Liability, Current $ 984  
Deferred Compensation Shares Issued upon Conversion 1,131  
Former Employee [Member]    
Deferred Compensation Liability, Current $ 72,500  
Deferred Compensation Liability, Current $ 1,170,731 $ 839,288
Interest Rate on Deferred Compensation 4.00%  
Deferred Compensation Conversion Days 5 days  
Deferred Compensation Consecutive Trading Days 10 days  
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 7 - Loan Payable (Details Textual) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2013
Sep. 25, 2014
Pennvest Loan [Member] | Amortization of Principal Number of Years [Member]                
Term Loan Payment Term     3 years          
Pennvest Loan [Member] | Interest Only Payments Number of Years [Member]                
Term Loan Payment Term     10 years          
Pennvest Loan [Member] | Years One Through Five [Member]                
Debt Instrument, Interest Rate During Period     2.547%          
Pennvest Loan [Member] | Years Six Through Maturity [Member]                
Debt Instrument, Interest Rate During Period     3.184%          
Pennvest Loan [Member]                
Interest Expense, Debt $ 49,373 $ 49,373 $ 98,747 $ 98,747        
Construction Loan 7,754,000   7,754,000          
Line of Credit Facility, Maximum Borrowing Capacity 7,754,000   7,754,000          
Repayments of Long-term Debt         $ 723,000 $ 704,000 $ 574,000  
Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year 741,000   741,000          
Long-term Debt, Maturities, Repayments of Principal in Year Two 760,000   760,000          
Long-term Debt, Maturities, Repayments of Principal in Year Three 4,252,000   4,252,000          
Debt Instrument Accrued Interest and Late Charges 693,332   693,332          
PA-1 [Member]                
Debt Instrument, Debt Default, Amount               $ 8,137,117
Construction Loan $ 7,800,000   $ 7,800,000          
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 8 - Convertible Notes Payable - Affiliates (Details Textual)
3 Months Ended 6 Months Ended
Dec. 31, 2015
USD ($)
$ / shares
Dec. 31, 2014
USD ($)
Dec. 31, 2015
USD ($)
$ / shares
Dec. 31, 2014
USD ($)
Sep. 30, 2015
USD ($)
$ / shares
Jun. 30, 2015
USD ($)
January 2015 Convertible Notes [Member] | Convertible Debt [Member] | Chief Executive Officer [Member]            
Convertible Notes Payable, Noncurrent $ 1,522,967   $ 1,522,967      
January 2015 Convertible Notes [Member] | Convertible Debt [Member] | Chief Financial Officer [Member]            
Convertible Notes Payable, Noncurrent 790,856   790,856      
January 2015 Convertible Notes [Member] | Convertible Debt [Member] | Executive Vice President [Member]            
Convertible Notes Payable, Noncurrent $ 393,380   $ 393,380      
January 2015 Convertible Notes [Member] | Convertible Debt [Member]            
Debt Instrument, Interest Rate, Stated Percentage 4.00%   4.00%      
Number of Share Per Unit 1   1      
Number of Warrants Per Unit 1   1      
Conversion Price Per Unit | $ / shares $ 0.50   $ 0.50      
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 1   $ 1      
Interest Expense $ 26,247   $ 52,495      
September 2015 Convertible Notes [Member] | Convertible Debt [Member] | Chief Executive Officer [Member]            
Convertible Notes Payable, Noncurrent 410,901   410,901   $ 405,831  
September 2015 Convertible Notes [Member] | Convertible Debt [Member] | Chief Financial Officer [Member]            
Convertible Notes Payable, Noncurrent 16,587   16,587   16,382  
September 2015 Convertible Notes [Member] | Convertible Debt [Member] | Executive Vice President [Member]            
Convertible Notes Payable, Noncurrent $ 83,957   $ 83,957   $ 82,921  
September 2015 Convertible Notes [Member] | Convertible Debt [Member]            
Debt Instrument, Interest Rate, Stated Percentage 4.00%   4.00%      
Conversion Price Per Unit | $ / shares         $ 0.60  
Interest Expense $ 5,093   $ 6,311      
Chief Executive Officer [Member]            
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 1.50   $ 1.50      
Convertible Notes Payable, Noncurrent $ 3,218,648   $ 3,218,648     $ 2,654,708
Interest Expense $ 86,405 $ 100,356 $ 200,661 $ 197,303    
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 9 - Stockholders' Equity (Details Textual)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 18 Months Ended
Jul. 02, 2014
$ / shares
shares
Feb. 04, 2016
USD ($)
shares
Jan. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
$ / shares
$ / item
shares
Dec. 31, 2014
USD ($)
Dec. 31, 2015
USD ($)
$ / shares
$ / item
shares
Dec. 31, 2014
USD ($)
shares
Jun. 30, 2015
USD ($)
$ / shares
shares
Jun. 30, 2014
USD ($)
Dec. 31, 2015
USD ($)
$ / shares
$ / item
shares
Jul. 15, 2015
$ / shares
Series B Preferred Stock [Member]                      
Preferred Stock, Shares Outstanding | shares 200     200   200   200   200  
Preferred Stock, Par or Stated Value Per Share | $ / shares $ 0.01     $ 0.01   $ 0.01   $ 0.01   $ 0.01  
Preferred Stock, Redemption Price Per Share | $ / shares $ 2                    
Preferred Stock, Dividend Rate, Percentage 2.50%                    
Convertible Preferred Stock Redemption Period 3 years                    
Dividends, Preferred Stock               $ 2,000 $ 2,000    
Minimum [Member] | Employees and Consultants [Member]                      
Share Price | $ / shares       0.69   0.69       0.69  
Minimum [Member] | President and Various Consultants [Member]                      
Deferred Compensation Converted to Common Stock Conversion Rate | $ / shares           0.76          
Minimum [Member] | Expired [Member]                      
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares       2.25   2.25       2.25  
Minimum [Member]                      
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares       0.75   0.75       0.75  
Maximum [Member] | Employees and Consultants [Member]                      
Share Price | $ / shares       1.15   1.15       1.15  
Maximum [Member] | President and Various Consultants [Member]                      
Deferred Compensation Converted to Common Stock Conversion Rate | $ / shares           1.15          
Maximum [Member] | Expired [Member]                      
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares       3.10   $ 3.10       3.10  
Maximum [Member] | Employee Stock Option [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period           10 years          
Maximum [Member]                      
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares       3   $ 3       3  
Employees and Consultants [Member] | Subsequent Event [Member]                      
Stock Issued During Period, Shares, Issued for Services | shares   5,031                  
Stock Issued During Period, Value, Issued for Services   $ 4,500                  
Employees and Consultants [Member]                      
Stock Issued During Period, Value, Issued for Services           $ 100,904          
President [Member]                      
Stock Issued During Period, Value, Issued for Services           $ 69,000          
Stock Issued During Period Shares Vested But Not Issued ForServices | shares           75,000          
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares       1.50   $ 1.50       1.50  
Deferred Compensation Converted to Common Stock Amount           $ 82,861          
Deferred Compensation Converted to Common Stock Shares | shares           99,159          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares           150,000          
Certain Brokers [Member] | Subscription Agreement [Member]                      
Payments for Commissions           $ 18,300          
Warrant Holder One [Member]                      
Class of Warrant or Right Exercised During Period | shares           14,000          
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares       $ 0.75   $ 0.75       $ 0.75  
Proceeds from Warrant Exercises           $ 10,500          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares       14,000   14,000       14,000  
Consultants [Member]                      
Deferred Compensation Converted to Common Stock Amount           $ 88,856          
Deferred Compensation Converted to Common Stock Shares | shares           109,715          
Board of Directors Chairman [Member] | Employee Stock Option [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost           $ 42,550          
Subscriptions Receivable [Member] | Restricted Stock [Member]                      
Stock Issued During Period, Shares, New Issues | shares           12,500          
Stock Issued During Period, Value, New Issues           $ 13,125          
Subscriptions Receivable [Member]                      
Class of Warrant or Right Exercised During Period | shares           12,500          
Expired [Member]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares       957,806   957,806       957,806  
Employee Stock Option [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares       22,000,000   22,000,000       22,000,000  
Allocated Share-based Compensation Expense       $ 74,320 $ 4,000 $ 89,640       $ 4,000  
Certain Warrants with Expiry Dates on or before December 31, 2015 [Member] | For the Period from June 30, 2015 through July 15, 2015 [Member] | Subscription Agreement [Member]                      
Class of Warrant or Right Exercised During Period | shares           265,894          
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares       $ 1.05   $ 1.05       $ 1.05  
Common Stock Shares Issued upon Exercise of Warrants | shares           265,894          
Proceeds from Warrant Exercises           $ 174,189          
Certain Warrants with Expiry Dates on or before December 31, 2015 [Member] | Note Receivable as Consideration for Warrants Exercise [Member]                      
Other Significant Noncash Transaction, Value of Consideration Received           $ 105,000          
Certain Warrants with Expiry Dates on or before December 31, 2015 [Member]                      
Class of Warrant or Right Exercised During Period | shares           265,894          
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares       $ 1.05   $ 1.05       $ 1.05 $ 1.05
Proceeds from Warrant Exercises           $ 174,189          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares       100,000   100,000       100,000  
Subscription Agreement [Member]                      
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares       $ 1.10   $ 1.10       $ 1.10  
Sale Of Units Price Per Unit Issued | $ / item       0.8   0.8       0.8  
Number of Share Per Unit       1   1       1  
Number of Warrants Per Unit       1   1       1  
Sale of Units, Number Of Units Issued | shares           228,750          
Sale of Units, Value           $ 183,000          
Warrant Fair Value Price Per Share | $ / shares       $ 0.05   $ 0.05       $ 0.05  
Adjustments to Additional Paid in Capital, Warrant Issued           $ 4,603          
Adjustments to Additional Paid in Capital, Other           178,397          
Note Receivable as Consideration for Warrants Exercise [Member] | Subsequent Event [Member]                      
Proceeds from Collection of Notes Receivable     $ 35,000                
Note Receivable as Consideration for Warrants Exercise [Member]                      
Other Significant Noncash Transaction, Value of Consideration Received           105,000          
Notes, Loans and Financing Receivable, Net, Current       $ 35,000   35,000       $ 35,000  
Promissory Note Receivable for Shares       71,878   71,878       71,878  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value           59,000 $ 0        
Dividends, Preferred Stock           1,000          
Dividends Payable       $ 9,000   $ 9,000       $ 9,000  
Common Stock Voting Rights Votes Per Share           1          
Treasury Stock, Number of Shares Held | shares       704,309   704,309       704,309  
Stock Issued During Period, Shares, Issued for Services | shares           36,296          
Stock Issued During Period, Value, Issued for Services           $ 100,904          
Proceeds from Warrant Exercises           184,689        
Notes, Loans and Financing Receivable, Net, Current       $ 35,000   35,000     $ 35,000  
Promissory Note Receivable for Shares       $ 71,878   71,878     $ 71,878  
Sale of Units, Value           $ 183,000          
Class of Warrant or Right, Outstanding | shares       8,400,000   8,400,000       8,400,000  
Weighted Average Exercise Price for Outstanding Warrants | $ / shares           $ 1.24          
Weighted Average Remaining Contractual Life for Outstanding Warrants           4 years 73 days          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares           100,000 0        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares             397,500        
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options       $ 19,826   $ 19,826       $ 19,826  
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 9 - Black-Scholes Valuation Assumptions for Options (Details) - Employee Stock Option [Member]
6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Weighted Average [Member]    
Volatility 74.00% 80.00%
Dividend yield
Risk-free interest rate 1.75% 0.51%
Expected term (years) 5 years 2 years
Volatility 74.00% 80.00%
Dividend yield
Risk-free interest rate 1.75% 0.51%
Expected term (years) 5 years 2 years
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 9 - Stock Options Activity (Details)
5 Months Ended 6 Months Ended
Dec. 13, 2015
USD ($)
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Outstanding (in shares) | shares 4,413,870 4,413,870
Outstanding (in dollars per share) | $ / shares $ 1.88 $ 1.88
Outstanding 4 years 36 days 3 years 328 days
Outstanding | $
Granted (in shares) | shares   100,000
Granted (in dollars per share) | $ / shares   $ 0.92
Outstanding (in shares) | shares   4,513,870
Outstanding (in dollars per share) | $ / shares   $ 1.86
Outstanding | $   $ 36,050
Exercisable (in shares) | shares   4,413,870
Exercisable (in dollars per share) | $ / shares   $ 1.89
Exercisable   3 years 255 days
Exercisable | $   $ 22,050
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 9 - Nonvested Share Activity (Details)
6 Months Ended
Dec. 31, 2015
$ / shares
shares
Nonvested at July 1, 2015 (in shares) | shares 100,000
Nonvested at July 1, 2015 (in dollars per share) | $ / shares $ 0.76
Granted (in shares) | shares 100,000
Granted (in dollars per share) | $ / shares $ 0.59
Vested (in shares) | shares (100,000)
Vested (in dollars per share) | $ / shares $ (0.59)
Nonvested at December 31, 2015 (in shares) | shares 100,000
Nonvested at December 31, 2015 (in dollars per share) | $ / shares $ 0.76
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 9 - Allocation of Recognized Period Costs (Details) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
General and Administrative Expense [Member] | Stock Bonus [Member]        
Allocated Share-based Compensation Expense $ 69,000 $ 69,000
General and Administrative Expense [Member] | Employee Stock Option [Member]        
Allocated Share-based Compensation Expense 62,371 $ 4,000 64,209 $ 4,000
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost 42,550 11,783 42,550 11,783
General and Administrative Expense [Member]        
Allocated Share-based Compensation Expense 173,921 $ 15,783 175,759 $ 15,783
Research and Development Expense [Member] | Employee Stock Option [Member]        
Allocated Share-based Compensation Expense 11,949 25,431
Research and Development Expense [Member]        
Allocated Share-based Compensation Expense 11,949 25,431
Employee Stock Option [Member]        
Allocated Share-based Compensation Expense $ 74,320 $ 4,000 $ 89,640  
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 10 - Commitments and Contingencies (Details Textual)
1 Months Ended 3 Months Ended 6 Months Ended 24 Months Ended
Jan. 05, 2016
shares
Jan. 01, 2016
$ / shares
Sep. 25, 2014
USD ($)
Feb. 04, 2016
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2014
USD ($)
$ / shares
shares
Dec. 31, 2013
shares
Jun. 30, 2015
shares
May. 13, 2013
FY2016 Extension Agreement [Member] | President [Member] | Extension Bonus [Member] | Subsequent Event [Member]                    
Stock Issued During Period, Shares, Issued for Services 75,000                  
FY2016 Extension Agreement [Member] | President [Member] | Extension Bonus [Member]                    
Stock Issued During Period Shares Vested But Not Issued ForServices         75,000          
FY2016 Extension Agreement [Member] | President [Member] | Subsequent Event [Member]                    
Stock Issued During Period, Shares, Issued for Services       75,000            
FY2016 Extension Agreement [Member] | President [Member]                    
Monthly Officers' Cash Compensation | $         $ 19,000          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         100,000          
Extension Agreement One [Member] | President [Member]                    
Monthly Officer's Compensation | $           $ 14,000        
Extension Agreement One [Member] | Chief Executive Officer [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross               600,000    
Common Stock, Capital Shares Reserved for Future Issuance               500,000    
Extension Agreement Two [Member] | Chief Executive Officer [Member] | Stock Bonus [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period           250,000        
President [Member] | Stock Bonus [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period           150,000        
President [Member] | New Smith Note [Member] | Convertible Debt [Member]                    
Number of Warrants Per Unit         0.25 0.25 1      
Debt Instrument, Interest Rate Reduction, Percentage         50.00% 50.00%        
Debt Instrument, Interest Rate, Stated Percentage         4.00% 4.00% 8.00%      
Debt Instrument, Convertible Conversion Price, Incease, Percentage         11.00% 11.00%        
Debt Instrument, Convertible, Conversion Price | $ / shares         $ 0.50 $ 0.50 $ 0.45      
Accrued Interest on Deferred Compensation and Other Expenses | $         $ 75 $ 75        
President [Member] | New Smith Note [Member]                    
Convertible Notes Payable | $         $ 760,520 $ 760,520        
President [Member]                    
Stock Issued During Period Shares Vested But Not Issued ForServices           75,000        
Monthly Officers' Cash Compensation | $           $ 18,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross           150,000        
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares         $ 1.50 $ 1.50        
Chief Executive Officer [Member] | Stock Bonus [Member] | Maximum [Member]                    
ExtensionOfExercisePeriod           5 years        
Chief Executive Officer [Member] | Stock Bonus [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period           25,000        
Execution Bonus as Percentage of Exercised Options and Warrants                   50.00%
ContingentStockBonusPercentageThresholdForIssuance         50.00% 50.00%        
Chief Executive Officer [Member] | Mr. Bassani [Member] | Convertible Debt [Member]                    
Number of Warrants Per Unit         0.25 0.25 1      
Chief Executive Officer [Member] | Cash Note [Member]                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares         $ 1 $ 1        
Debt Instrument, Face Amount | $         $ 395,277 $ 395,277        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights         592,916 592,916        
Chief Executive Officer [Member]                    
Monthly Officers' Cash Compensation | $           $ 31,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross           450,000        
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares         $ 1.50 $ 1.50        
Due to Related Parties, Current | $             $ 279,000      
Unreimbursed Expenses | $             $ 116,277      
CEO and President [Member] | Exercise Bonus [Member] | Subsequent Event [Member]                    
Extension of Exercise Period Annual Payment per Option or Warrant | $ / shares   $ 0.01                
CEO and President [Member] | Exercise Bonus [Member]                    
Extension of Exercise Period Annual Payment per Option or Warrant | $ / shares           $ 0.05        
Exercise Bonus [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number         3,045,000 3,045,000        
Class of Warrant or Right, Outstanding         6,759,500 6,759,500        
Mr. Bassani [Member] | Convertible Debt [Member]                    
Debt Instrument, Interest Rate Reduction, Percentage         50.00% 50.00%        
Debt Instrument, Interest Rate, Stated Percentage         4.00% 4.00% 8.00%      
Debt Instrument, Convertible Conversion Price, Incease, Percentage         11.00% 11.00%        
Debt Instrument, Convertible, Conversion Price | $ / shares         $ 0.50 $ 0.50 $ 0.45      
Number of Warrants Per Unit Reduction Percentage         75.00% 75.00%        
Mr. Bassani [Member]                    
Convertible Notes Payable | $         $ 1,464,545 $ 1,464,545        
Maximum [Member]                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares         $ 3 $ 3        
Pennvest Loan [Member]                    
Loss Contingency, Damages Sought, Value | $     $ 8,137,117              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross           100,000 0      
Stock Issued During Period, Shares, Issued for Services           36,296        
Common Stock, Capital Shares Reserved for Future Issuance               100,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number         4,513,870 4,513,870     4,413,870  
Class of Warrant or Right, Outstanding         8,400,000 8,400,000        
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 10 - Summary of Outstanding Contingent Stock Bonuses (Details)
Dec. 31, 2015
$ / shares
shares
Stock Bonus Payable Upon Stock Price of $5.00 per Share [Member] | Stock Bonus [Member]  
Share Price | $ / shares $ 5
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 50,000
Stock Bonus Payable Upon Stock Price of $10.00 per Share [Member] | Stock Bonus [Member]  
Share Price | $ / shares $ 10
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 40,000
Stock Bonus Payable Upon Stock Price of $20.00 per Share [Member] | Stock Bonus [Member]  
Share Price | $ / shares $ 20
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 27,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 4,513,870
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 11 - Subsequent Events (Details Textual) - USD ($)
1 Months Ended 6 Months Ended
Feb. 04, 2016
Dec. 31, 2015
Subsequent Event [Member] | Employees and Consultants [Member]    
Stock Issued During Period, Shares, Issued for Services 5,031  
Stock Issued During Period, Value, Issued for Services $ 4,500  
Subsequent Event [Member] | President [Member] | FY2016 Extension Agreement [Member]    
Stock Issued During Period, Shares, Issued for Services 75,000  
Subsequent Event [Member] | Restricted Securities Units [Member]    
Stock Issued During Period, Shares, New Issues 31,250  
Shares Issued, Price Per Share $ 0.80  
Number of Warrants in Each Unit 1  
Gross Proceeds from Sale of Interest in Corporate Unit $ 25,000  
Subsequent Event [Member]    
Shares of Restricted Common Stock in Each Unit 1  
Warrant Component of Equity Unit, Number of Shares of Restricted Common Stock Called by Each Warrant 0.5  
Warrant Component of Corporate Unit, Exercise Price Per Share of Restricted Common Stock $ 1.10  
Employees and Consultants [Member]    
Stock Issued During Period, Value, Issued for Services   $ 100,904
President [Member]    
Stock Issued During Period, Value, Issued for Services   $ 69,000
Restricted Securities Units [Member]    
Stock Issued During Period, Shares, New Issues   228,750
Shares Issued, Price Per Share   $ 0.80
Shares of Restricted Common Stock in Each Unit   1
Number of Warrants in Each Unit   1
Warrant Component of Equity Unit, Number of Shares of Restricted Common Stock Called by Each Warrant   0.5
Warrant Component of Corporate Unit, Exercise Price Per Share of Restricted Common Stock   $ 1.10
Gross Proceeds from Sale of Interest in Corporate Unit   $ 183,000
Stock Issued During Period, Shares, Issued for Services   36,296
Stock Issued During Period, Value, Issued for Services   $ 100,904
EXCEL 53 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( .M=1$CSW$M9R0$ $H: 3 6T-O;G1E;G1?5'EP97-= M+GAM;,V9RT[#,!!%?Z7*%C6N[?(494/9 A+\@$FFC=4XMFRWE+_'3@%!51"O M2G>31^]X[DW&.9N>WS\Y"H.U:;LP*9H8W1ECH6K(J%!:1UU29M8;%=.MGS.G MJH6:$Q.CT1&K;!>IB\.8>Q07YS;"/7X4C?)4WT6?YKO[VWA? ML+\<>:[]]6=#[\7 ^M,>(?&C' (DAP3),0;)<0B2XP@DQS%(CA.0'*<@.?@( M)0@*43D*4CD*4SD*5#D*53D*5CD*5SD*6#D*604*604*604*604*604*604* M604*604*604*604*624*624*624*624*624*624*624*624*624*624*6<[% *P( L !?.0Q(OW[CMB MPD.MQ-*O>X^NO ZIK XTHO8<4M?'5$Q^#*G*_=ITJK$"2+8CCVG!D4*>-BP> M-9?20D0[8$NP+,L5R*V.V:SGVL7.U49V[M,41Y26M#;3"&>6X9MY6&3I//B) M]!=C;IK>TI;MR5/0!_ZS#0//>997'L=V+YRO+0O]C^AY%.!)T:'B1?4C9@,2 M[2F]@OIZ (4QOCLEFI2"(S>C@KN_V/P"4$L#!!0 ( .M=1$@;CBH[JP$ M (@9 : >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/%V<>$5==>.V[0L$'8UH+F2FM+Y]4Q?%7N:C"^';)"0#9_X0^!&291/R MQ9,_E_'8-J$Z=F'T7I^;L!CNK[(JQF[A7-A6OB[#0]OY9EC=MWU=QN&R/[BN MW)[*@W>:YQ/7W\[)ULN?LT>;W2KK-SO)1B]E?_!QE;VU_2E4WL?@KB=YX MEB^=_\_V[7Y_W/K'=OM:^R;^4>&^-LA<.DC304H)LG2048**=%!!"1JG@\:4 MH$DZ:$()FJ:#II2@63IH1@F:IX/FE"#)@8PY)PEAS=%: -?"\5H V,(16P#9 MPC%; -K"45L V\)Q6P#RM%;@=Y*>M=&+]LBM'+T5Z*TBM'+T5Z*TAM'+T-Z&TAC"4=O WH;1V\#>AM';P-Z&T=O WH;1V\#>AM';P-Z&T?O NA=#G[^Z=(^_739?T!4$L#!!0 ( .M=1$AZ#Y3C*@, *$+ 0 9&]C M4')O<',O87!P+GAM;+U637/:,!#]*QHNS2&IP=!\,,0S!)AI9]*$J=/TK,@+ M:) E1Y(](;^^*QD()-B-.90+DKQ/JWW[=J6!-.W^5*L,M.5@R$LJI.GCXG5K M86W6#P+#%I!2\Q5-)'Z=*9U2BU,]#]1LQAF,%7LELNE^9T]J#&UL(O:_U#NOJ :$G2ZM_MV MT=M\7V&(1M'&1=L*O;?QM*=BLEWL#3;B<3RG7)AH4 MME\ LTJOTU388[.4*.:2;AX?\'RF19ZH 3>\;A54N!5@[F=3 MJNU_HL+'M"&BUVGM1+_9@@QE0B;2HAS)#UFZPN3M4K(=C90T2O $Q960&RJH M9$!B3R$Y&>5'8+K_QL06_]Q)#5$SDXE M?_5LG9([:G,-1%5C0L3$?"XY)I ZWAE3.?(NY]68+F+6K6U%J$O4<\XS=\AJ M3*_$I-P8I5?$K_T"!KRHQGQ#C!L8,J4K^B0 YT-4FN#5F'.T&<,,-'82XOH3 M2%,M'0^Y0,BMHG+CI=KR$BTQ.X5KO^XX;X>KQEPY@JUBRX42";:@+YXMNZI) M8]N[25-NR\0[BM&MK0F[XW(?YT\&GG-7/I/"(0_:'\XVF:+D&%XJS:72N6HN ME;#=G#%RTIRS,&Q>+N'A\J_E(.S58X9HDW"16UY@GRDO6EZC-(>94"TQ,R@P MT,3?C:?8JH[@^N((S&7S4@YK=%!5RMT:'526,OE\+9.3,5C*A:G!5%5UMT8' M51KMUNC 86X$95YQKC,?X"<<)9 MH^HQ0R%4^4IT5PUF5*'.7YO77+=&!QX3YVE*43GNXLRML8CC-?WY<&]SF?WP M0MI]ZKQ[V 3[#_+H+U!+ P04 " #K741(Q#S^ECX! !I P $0 &1O M8U!R;W!S+V-O&ULS9/!3L,P#(9?!?7>I=VF@:*N!T"F)2%DEQZ$&A] MAU>RQ[N=KPBF)(,*:C 86#[*65*^F*VQC2G8H"^+Z+@2 1=6Z94&==L.9;]3 ML3."K\-1#JIO3W__]$ 9EG25^Z#[JJ9I1LV$ZN+ .7M;/#[3V:3:!!1&0E0% MS;%U,$].G5\G=_?+AZ0<9_DLS<9I-EWF.9]>\^SF_3#9F;_!<-T-\6\=GPS2 M=E%C!1?NEC2*EDN?!%(0I-<.M347X0CS34RPL/OX!(F7@SHA7;8MM(WU*I1T MOX;H\'+BRM;6M\?4C^CL595?4$L#!!0 ( .M=1$B97)PC$ 8 )PG 3 M >&PO=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S M:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N M+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X M%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53" MQ,!J9S]6:\?1TDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@ MX_%X.+;+THMP' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMH MG J-6T_3:W?=TXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2 M%;7E0-,@ %AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9R MG9 %#@ WQ-%,4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S M>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,B MUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C? MC8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SCFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1 MVC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE M"0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ MZK:4OK4F.$KTL@'37[]EUVY".E,%.70[@:0KX#;;J= MW#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B M(>ZAAIC/PT.'>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)5 M8#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6Q MP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>; MG*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4< M!A87,N10[I*0!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E M$A2*L P%(1=RX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TSU#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+? M.7#;.MX#7N83+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4 MJUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5 MBZPYC0IO0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%0 M2P,$% @ ZUU$2)O=N]1- @ 5@H T !X;"]S='EL97,N>&ULS59M M:]LP$/XK0AVCA1';*4WI:AM&(3#8RJ#YL&]%MF5'H!=/EK.DOWXGR2])(&N7 MMBSYHM.CN^<>2>>W.[CYV[A B//\;5(<#2[PL'+22?A85Y8VZ.>':#NW(&I MC]P+O+:!0;?Y-"Z5',]@BCV0QLT36A$._I%USQ57&ADX9,C@$$D$]1YWA+-, M,PN61#"^\?#4 NY>.C_!I-(NM\^PGV<2CIETE24X['XO3Y>-[&ZPVV.<[VX/ M@#2NB3%4RSE,4&C:BM=&:,$& 4CE9*$6\H^HC. -J>YP[TND?>Q=QQB M9%7T)AQ$9XYEX XUV&;SW-NTQ_&B=3DD@&A2UWSSA;-*"NK%>FBNNMES]-$! M^C0F/2M:*LV>P-\60@X U1BMJ#8LWT9^:U(OZ-IT%1RLRT,*C]WRJ6L:\T/1 M_<\#<;6/]_3\78*#[EN143UW?W?_+NSR^OV4O6D]'WU/;W!(MFF=Z/W9IG>R MTMZQMEY9]3>O5!9TC6&K^^STG@%%6P[P%FLQY;C M5@W)X)&WDP7("EJ2EIL?;*6,6TSP:'^S\J/9X+48*!(\VM]IP5IQXQ2,+\GT M#U!+ P04 " #K741(]3@KL#4$ !8#@ #P 'AL+W=O#O[XK MF1SKNVQ;GF(Y]F?]^':U^N3G3]8]KJU]9-]JT_BY6V2[$-KY:.3+G:JE_]6V MJH'_-M;5,D#3;4=VL]&ENK1E5ZLFC/AX/!TY9630MO$[W?KLE>;_#\VW3LG* M[Y0*M>EAM=1-]OF3GV^T40_*>0 SV;8WLE:+[)O)F)$^7%4ZJ&J1%="T3VIP MPW7M1:=-;$S&DVP488>AWCE6VDKUL/N=]G^__I&Q2FUD9\(]=/;PW466\X+S M:<^(CSUH]>0Q,-Y@L@QZK^[E>I&-,R:[8'_3)BAW*8/ZW=FNUT$"@00"B?\ K0+\Q(%Z9C?LME4.@0H$*MX%6NXDGJ,) DW>!Y)^AT!3 M!)K^#+JQ0;&UT&\>(0#,$FA&@H@?5VGOKGEFZ]T65 M2N^QD&-LY)A 30 5+SR[D\\28@/:YY#=C,:H@=Q'[$ZH*;QZJ3;*.5B^I:TA MT?F?H@3;G1_1.Y%.@?2GET:N$9@[#7^1&Q>Q_'J5-UK4.O=30 .AD&,XW-SDFU MH]NK;NW5URXFIZM]!&(,]CH_(O9QG]D=A%^IU0"%S7/L.:<\IZ:=%QB% M/>>4YQ%U#J]6VG1Q'V85A%+9=4+9'U+DQMNP-@!(*!+60*5XP"MLN*-NIU">P[0+;+BC;$VK5 MU;6$L(F%9A=\ )S&-4*!;2\HVX_O@5%4C,*V%_EKW?]6ZL-I1S>JB@TFH" #B" & 'AL+W=O:MK2:47&!UMFW M7^"@TTX8]48%O^_\ #D>\I[Q-U%2*KWWIF[%QB^E[)Z#0!Q+VA#QQ#K:JC=G MQALB59-? M%Q2D[&U-0!#L,T:$C5^D5N^EYXD;.KK*N6OG!/7)N&\'\[6K-^ MXR-_Z'BM+J74'4&1!Z/O5#6T%15K/4[/&W^+GOWKP!\;> M=./G:>.'>@RTID>I0Q!UN]$]K6L=29'_VJ ?3&V\?QZB?S?35<,_$$'WK/Y3 MG62I1AOZWHF>R;66KZS_0>T<$AWPR&IAKM[Q*B1K!HOO->0=[E5K[CV\2;"U MN0W8&O!HB-))0V0-T6A L9DIC,S,ZQN1I,@YZSW1$?VUT;.21 ML<<3:B5B#/YE 6$DZCT"A MDV&Z582ISSUHEE"0FV)3=_7UUMU;#<8XQ>MH"0N[69#%:&I_60U>L,&0.]<1 MI#*>VF*#9L$>0^Z$1Y#/.)I(^4$3+OH^[I1'D-'8^>^*+<=J%OR]D#OO$:0U M3J?6S&JR3Y3@KJ0TE%],J17>D5U;"15E[!W+^=84O>!#7N0=N=!?A%^J5G@' M)E5A,_7GS)BD"A\^J44MU8%C;-3T+/5CIE<;2C T).N&$\5XK"G^ U!+ P04 M " #K741(W:UI"BSVT)Z5F(Z-E2Q74N+MOZ^D M(1T[&=&\V);\#/ERQ'DUTO+]72V;U[XZ'-WW-NM> MZ[IL_UN[JCD_+O@BG/AQ>-GWXXE\M9__:#OI_-.<_G%^#&@=\;JIN^LR> M7[N^J4/((JO+7_A].$[?9_S',A]&!X /@$L E]$ X0/$AX IC';*5.KY=L*[#)_&\>Y06!"UAZ9)S:> M*"Y(/LQ/BH!;$7CR&TSQ@MV/%[?Q&N,%QO/[\9*<7V+\AR4>)\1@$A !+1F; MIS:>4M?4K!9%:E&H1=R/UV0N-,;+^_&&G-]@O*(N-R)KC^AY9/,)F55A2146 MX\W]^(+,0I&H8;*Q6/[,\PEBC MIBBBRY7[>BVHF917Y!G%/A;,;7H@/3V"%H/%+R-EN?8,AT%.+#L>LXHEE!^G MO82C!T@>VSB2W#C7"=QXA@L.*D$,;28 M)U5,$S+ -$AN8IH\*)0"F7!_Y 6M"?U4DALV["-DN#0%Z*@F#PHEN$[834 [ M-*"S2A,I-* =^D;.91R E X$:)<&=%894VT6P-:+&W#09.W828%$T6LXMY)*5G*#0UHSP;T M6OK6&52%)I%;35_E("JTBDJ:%+,$VKH!#5?%K-LS7&A9L%AQ;BXD*ZPI$MHB MH"TBVBK3ND!]DOAAN#?F$$]2DMZM FS:@SZJ8 M:7N&,VZD$4!:9+A< 676%AP2VF"@C1O0:U7$ ->>^<*Y$# 83NRV^\YR76BF M4Q[9:/L6:+LJV:834LCZ1;/"[N@S#)=I#P^"=K(!7JOBI3XVC.:61ZS M\8 )85/R1+NX0.-5,1?WS) G9;6&V 6\H,S(H2E(R1/MY$+X'$3JSS.1-L7O M]P"2;4I^]5[C5+ZXO\KVY7#LLJ>F[YMZ>I.Q:YK>#0.QK\,R]Z[<7@XJM^O' MGV9K%=NTF3H(*.,-.T[W]C.VD*3TVY"* \YWCSW!R9,HS'U[%@3$9 MO'=M+];A0/ Z%8'=6V$XSB-.MKT M857JL:>A*OE)MDW/GH9 G+J.#O\>6F2@1V8\4FB.S'ADMI =S\90M:7R1<\F!UUR4_')?'P!QA?S%5\LJ7@ M%VFB-L#;FH(S]>]9;P>4\3M 3=' M9+I:DBW( #EN:>?JL97Q-]@OB]H!;)+(],O?=C^*CXD\%56?27CO$C)$BNX:V+3[C+/+7BT#,:(H)1X MZJR^D"C)2;*:_M>CFXWJD>[9+SKLFUX$+URJ/:_>FNXXETQEBN]4QH-Z%[E> MM&PGQ]-LG,KLSLV%Y,?+R\;UC:?Z#U!+ P04 " #K741($?84)/P# "$ M$0 & 'AL+W=OD%K<4M*W//V0ZE()KK\P(O?,/W\_'4]0WI M:IF.=OMS::KV7%=)8P[/BR_X:8MUCPS$WV=S;3]\3_K@7^KZ9__PY_YY@?H8 M3&%V7>\BMQ]O9F.*HO=D>_[EG+[WV1M^_.Z]?QWDVO!?\M9LZN+'>=^=;+1H MD>S-(7\MNN_U]0_C-/#>X:XNVN%_LGMMN[KT)HNDS'_#Y[D:/J_PBT+.+&Q MG $9#<9^P@;4&=!W Q8U8,Z S>V!.P/^J8<4M ^9R_(N7RV;^IJTE[R?3_C) MXDWOQ'I.;+I:.Q*#SV88B]7R;27Q,GWK_=P@9$#6#B'32 ;(NY/4]A\,@BQ" M/9#!/-+!!@A)(S'<=;+]CY/),.EMF )R1<&>W;=GM_84[!G8\]L0JP&1D E M.$=(1[ -8)12K,4TE@&&$5<(H6EN"YS0B%-Y7QP/BN,@+A@.V*T]@A2=IC9 M82(QU]-8YC!N,T"FL2U@%!/$9HR["$H3$+>,2 -$,:(B"=@(-QZ,T(BS##"" ME0S/%2?->9-(D1G29%":!&DJ(LTA-FK!(MH XX)Q'1F/##!L$R5C.=@Z#DO* MT QU*JA.0>B1:;0&Y.&N/,?=U>>X^P(].%>A#FY)&N8=NF^/43!%0[/U@",Y M\HQ@*#(?-P[#"%$>6069X_JZ142ZW7I_6M(Y"<(X+!#.)A49M+5G[@G$,P7B MF0+Q_Q-(P@+A6(OMJ6O'/$@ME(@LAXT'A6":17:%S(-8$$UUA-R.))5((C%# M)PWKI&Z/C>FD_O"(K65/(1)5"!3AL81M/86TGJ$L7!=@.']59.ZM'6-'D/-P M:>#%,3^"5)/@H>_UL7$$A2)1C9ZD=O:@&14"#I<(F+ME%M/)W48;+EB\R#E4 MYBD\4?UX>2%L6ENX1L"N @AN^:ZX>-8;A@P' PJ^#*44XG, _H$04W)>54SL*R#YA$-W_!O54YO3.LIK5_ M*B?<88OAS%9S5KH.9P_.:QV9CFO'$,(5G]#H5X%VYX<6G$6+Y=$GLYLPC:YU M[U-I3,3G>9)^N&*6ICD.E_LVV=6O50>WIK%U?('PA?17U$_M:_RTP8'VK'_A M,%QIW]VOEI?\:/[*F^.Y:I.7NK,7X^'^>JCKSMB@T:,-_F3R_?A0F$/7?Y6] M*GA) ]=??'O/,87+ZM_ 5!+ P04 " #K741(+NW;T/<# #\$@ & M 'AL+W=OOQ^R;WNYIOS7K-%/5?%OOF^/IMIH%>SU M(?LHVI_59:=! ^\2OE5%T_\/WCZ:MBJ'D%509G_L:W[J7R_V$Q5!&!Y (8". M 5QY Q@$L#& 4F] # 'Q&,"$-X!# !\#8ND-$! @ODKR!T@(D%\E,6^ @@ U M!I ^(+3MZ)OYG+799EU7EZ Y9]T2)_<&K[LD)G-@.MB8Q='GK/OEL5E_;A*R M#C^[/!.$]L@C(-2-/ '"W,@S(+$;>0&$NY$M(,*-I(!(-[(#1(U(:.8+G30Z MG31F)XW:^ 0;PB*/%F$WA9YZA-M)LPBED4H$C^9K86@MK,]"H@@;2=JY'QFE M$D+1F;'97IBG;)ML:Y$[0HA(1"0\XZ86%8PI#[4;$D8R9IRS^8F(T8F(022Z ME*$K\7Q7!H3>+K)K:H=1SGHY6B^'>JE[F.>!B9((?7"@:QR5=8ULYY$41R:M M0NMQZA:H;@$YF$>W9V6)>]CR2XLBDVU@Y3M4252U!=>Q1;9F8=5SR,ICDQ48^4X52M4M0+5Z)8.SZ2:?R85[)1*+BDE04M)H!3/.,_ *!;= M;J>3#B3S'9A'4AR9= "MQZF;1*CP_G:G7'J4 W37C^61#IQ7^P(F=3 3]7A- M;OD$ET] OO*L08"\BQ 8FE"6+-C\"&X="(5R$E\WP!J8'4>AG(1N6.Y.$B4] M\K8$=R/3CLP[EMU0%Y&*D 53@#L6 G:$H*9@F(+1%?C7(VY8INKGF=3!3-5C M);G%XRZ%@$TA/IM"%O@48(Q[5'+)]"(%O=O3@PD#]O(=X<3 3WPS,'1%4*.IYK-.!I%QX=HG=5<*$ M+3G,$-R:$/ FQ#,+CV3>,#P!8[ZG.3=>:4%!N&L@8!L(:I:&13EX"R)CR6X/ M-=-M4CFWR6F'U'"T8_YJ0E>J]:<_OM#^J&J6FU21=_,+!]UMA\O"GUHN[>RFW[[XXR]:*OS\%O3 M^(/7YG]02P,$% @ ZUU$2"S/X?W- P [! !@ !X;"]W;W)K[US1Q M$G0 9X$T9]]^#1[3IIVX5J4"SC_CS_;P.\[FJH:?XTG**?C5M?WX%)ZFZ?P8 M1>/N)+MZ_*;.LM>?'-30U9-^'([1>!YDO5^"NC:".,ZBKF[Z<+M9VKX/VXVZ M3&W3R^]#,%ZZKA[^*V6KKD\A"VW#C^9XFN:&:+N)UKA]T\E^;%0?#/+P%#ZS MQPK$+%D4?S?R.KZ[#V;X%Z5^S@]_[I_">&:0K=Q-3 MOO4Y![Z_M]E_7X:K\5_J45:J_:?93R=-&X?!7A[J2SO]4-<_)(XAG1/N5#LN M_X/=99Q49T/"H*M_F6O3+]>K^40(#*,# -@#5C[H0,X!O"W@&09J2%;QO5; M/=7;S:"NP7BNY]5FCUH^S$ETYD /9M3SM.0\R.()&$6=[,060D+&5%!@X>(^,,XL2C6'*2)L<)*APX1J-]KTC(U4(<3)47 MJ4_M%B1.87* HY_2:(!SS>/ *7!VO":'Q23.TCSS, >%@' M8S0.>@\XJJ)$$0B>.J@K*X-4B,*#"&@B0"+'T$L4)46>$;; M'^.(Y"B.$D4/^A6+Z7<>+<@*H4@*$!Y0"0V%I@JI"\J('A+XN'+O]0.T20.:-'=M&E:4)UE>.'!0YX5#FS0P6ZDN'(;=Z)>+]"E<+YL, MN/ I(:!=&M"EN6O?0)'^'A3GW&%3U2H4^BN>AR4"[=. /LU=6P>*."\@=[UI M-EF>L23W0*)=&M"EN6-)2BL2>4)OL';I4)<4PN>P0#LUH%-_7) ;*X)/%DS4 MM;]- VW38!V87 <[.2@2\Y\+)_/'H4T:T*2Y:]>PHCC]9(NW.)_,W.!$[PZ1 MG1R.R^%Z#';JTD_F@+>VK@?X9Y@/H1_:2WVP-\?PMS3;S;D^RK_JX=CT8_"B M)GW$74ZB!Z4FJ;'B;[JZ3[+>KP^M/$SSK9C+WAS&S<.DSO:WA?4'CNW_4$L# M!!0 ( .M=1$AYT@Z#HP$ +$# 8 >&PO=V]R:W-H965T&ULA5/;3N,P$/T5RQ^ T[2P;)5&HJP0^X"$>&"?W6226-B>K.TT\/?X MDH065>(EGIF<<^:,+\6(YLUV (Z\*ZGMCG;.]5O&;-6!XO8*>]#^3X-&<>=3 MTS+;&^!U)"G)\BR[88H+3#@I-#P;(@=E.+F8P\2QQU=T;GP(MK. MA0(K"[;P:J% 6X&:&&AV]&ZUW6\"(@)>!8SV)";!^P'Q+21_ZQW-@@604+F@ MP/URA'N0,@CYQO\GS:^6@7@:S^H/<5KO_L MW*/\)VK7>;,9)34T?)#N!<=' MF$:X#H(52AN_I!JL0S53*%'\/:U"QW5,?VZSB7:9D$^$_!N!I4;1YA_N>%D8 M'(GM>3B[U=;#31#QRL1[LW[LJ&GBX&5Q+%?KVX(=@] 9)A'W$V9!,*]^L45. M+]'S2,]_IJ_/Z3?)X7IR^/MG@V=*DNM_,NCV?R!2^+GK?PQ$TKM"4'=/YDXP$TB Y\^^SJFI+.OY\E MD="X$/[RL4E7*B4.^_F!+*^T_ 102P,$% @ ZUU$2,(.,>FE 0 L0, M !@ !X;"]W;W)K&<,V=\J68TKW8 <.1- M26T/='!NW#-FFP$4MWQ]FSJ M"BY 'W?[8QD0 M$?!+P&PO8A*\GQ!?0_*C/= L6 )C0L*W"]G> (I@Y!O_&?1?&\9B)?QJOXM M3NO=G[B%)Y2_1>L&;S:CI(6.3]*]X/P=EA'N@V"#TL8O:2;K4*T42A1_2ZO0 M<9W3GW*EW2;D"R'?")^S:#PUBC:_WV'FZ"B%OJW.]*_.*G8/0%281CPMF0S"O?K-%3F_1\TC//Z87U_2'Y+!(W8LO'PN4 MUP)%$BB7$8M;(R;,<<64_S5A%WNJP/3QZEC2X*1=VM*MNMW.QSR>R3N\KD;> MPT]N>J$M.:'S)QL/H$-TX-MG=_>4#/[];(F$SH7PDX]-NE(I<3BN#V1[I?4_ M4$L#!!0 ( .M=1$CG-IW=I@$ +$# 8 >&PO=V]R:W-H965T&ULA5/;;J,P$/T5RQ]0$T+2W8@@-:VJ[L-*51]VGQT8P*K-4-N$ M]N_K"]"DBM07/#.<<^:,+_F(^M6T ):\*]F9/6VM[7>,F;(%Q0..[IBLZ% M%]&TUA=8D;.%5PD%G1'8$0WUGMZM=H?,(P+@GX#1G,7$>S\BOOKD3[6GB;< M$DKK%;A;3G /4GHAU_AMTOQJZ8GG\:S^&*9U[H_5@+*J90HGB[W$575C'^&>33;3KA'0BI OA5Q*,QT;! MY@.WO,@UCL3TW)_=:N?@VHLX9>*\&3=VT-1A\"(_%:MLD[.3%[K 1.)APBP( MYM2OMDCI-7H:Z.G/]/4E?1L=KF/W]>^?!;)+@744R*81M]=&C)C#C+G]UH2= M[:D"W82K8TB)0V?CEB[5Y7;>I>%,ON!%WO,&_G+=B,Z0(UIWLN$ :D0+KGUR MLZ&D=>]G2234UH>W+M;Q2L7$8C\_D.65%I]02P,$% @ ZUU$2&0W&K6G M 0 L0, !D !X;"]W;W)K&ULA5/;3N,P$/T5 MRQ^ T_2R4*61*"L$#RLA'G:?W6226-B>8#L-_#V^I*%=5>(EGIF<<^:,+\6( MYLUV (Y\**GMCG;.]5O&;-6!XO8&>]#^3X-&<>=3TS+;&^!U)"G)\BS;,,6% MIF41:R^F+'!P4FAX,<0.2G'SN0>)XXXNZ*GP*MK.A0(K"S;S:J% 6X&:&&AV M]'ZQW:\"(@+^"ACM64R"]P/B6TB>ZQW-@@604+F@P/URA >0,@CYQN^3YG?+ M0#R/3^J/<5KO_L M/*#\)VK7>;,9)34T?)#N%<A[-;;#W.FB8.7A;'0(/HP+?/;M:4=/[]S(F$QH7PEX]-NE(I M<=B?'LC\2LLO4$L#!!0 ( .M=1$AHLN&BI@$ +$# 9 >&PO=V]R M:W-H965TW?UQ>@R2I27_#,<,Z9,[X4$^I7TP%8\JYD;_:TLW;8,6:J M#A0W-SA [_XTJ!6W+M4M,X,&7@>2DBQ+DENFN.AI683:LRX+'*T4/3QK8D:E MN/XX@,1I3U.Z%%Y$VUE?8&7!5EXM%/1&8$\T-'MZE^X.&X\(@+\")G,6$^_] MB/CJDZ=Z3Q-O 214UBMPMYS@'J3T0J[QVZSYU=(3S^-%_2%,Z]P?N8%[E/]$ M;3MG-J&DAH:/TK[@] CS"%LO6*$TX4NJT5A4"X42Q=_C*OJP3O'/-IUIUPG9 M3,A6PL\D&(^-@LW?W/*RT#@1,W!_=NG.P;47<3-N[*"IP^!E<2K3;5JP MDQ>ZP$3B8<:L".;4K[;(Z#5Z%NC9]_3\DGX;'>:Q>_[K>X'-I4 >!3;SB-FU M$2/FL&#R_YJPLSU5H-MP=0RI<.QMW-*UNM[.NRR\+ ;>PA^N6]$;4G4$L#!!0 ( M .M=1$C3":@-IP$ +$# 9 >&PO=V]R:W-H965TZ:EE42$Y*HD9:5_7SXDQ0X, MY"+NKF9F9_DH1C1OM@-PY%U);0^TZ(K.A5?1=BX46%FP MA5<+!=H*U,1 Y/W,(CRC^B=ITWFU%20\,'Z5YQ?(9IA&T0 MK%#:^"758!VJF4*)XN]I%3JN8_ISOYMHMPGY1,@7PK*C!MO#J6 M5#AHE[9TJ2ZW\R&/9_(!+XN>M_"+FU9H2T[H_,G& V@0'?CVV=V6DLZ_GR61 MT+@0WOO8I"N5$H?]_$"65UK^!U!+ P04 " #K741(O*\04Z8! "Q P M&0 'AL+W=O;,]@"/O M2FI[H+USPYXQ6_>@N+W# ;0_:=$H[KQK.F8' [R))"59GF7W3'&A:57&V(NI M2AR=%!I>#+&C4MS\/8+$Z4 W= F\BJYW(<"JDJV\1BC05J F!MH#?=KLC]N MB(!? B9[89-0^PGQ+3@_F@/-0@D@H79!@?OM#,\@91#RB?_,FA\I _'27M2_ MQ6Y]]2=NX1GE;]&XWA>;4=) RT?I7G'Z#G,+NR!8H[1Q)?5H':J%0HGB[VD7 M.NY3.BFRF7:;D,^$?"4\1@)+B6*97[GC56EP(G;@87:;O8>;(.*5B:_-^K:C MIHF-5^6YVNP>2G8.0E>81#S.F!7!O/K-%#F]1<\C/?^<7ES3[U.%1?/E< M8'LM4"2![=SBXZT6$^:X8/Y/PB[N5('IXM.QI,91NW2E:W1]G4]YG,D'O"H' MWL%/;CJA+3FA\Y.- V@1'?CTV=V.DM[_G]61T+I@/GC;I">5'(?#\D'67UK] M U!+ P04 " #K741([BD+A:8! "Q P &0 'AL+W=OP)$W);4]T-ZY8<^8K7M0W-[A -K_ M:=$H[GQJ.F8' [R))"59D64[IKC0M"IC[=E4)8Y."@W/AMA1*6[^'4'B=* Y M70HOHNM=*+"J9"NO$0JT%:B)@?9 '_/]<1L0$?!;P&0O8A*\GQ!?0_*S.= L M6 )M0L*W"]G> (I@Y!O_'?6?&\9B)?QHOX]3NO=G[B%)Y1_1.-Z;S:CI(&6 MC]*]X/0#YA'N@V"-TL8OJ4?K4"T42A1_2ZO0<9W2G^W#3+M-*&9"L1(>LF@\ M-8HVOW''J]+@1.S P]GE>P\W0<0K$^_-^K&CIHF#5^6YRG=9R7 M[&)/%9@N7AU+:ARU2UNZ5M?;^5C$,WF'5^7 ._C%32>T)2=T_F3C ;2(#GS[ M[.Z>DMZ_GS61T+H0?O&Q25@4+ M9Z8! "Q P &0 'AL+W=O;4]@"-O2FI[I+USPX$Q6_>@N'W ;0_:=$H[KQK.F8' [R))"59GF5[ MIKC0M"IC[-E4)8Y."@W/AMA1*6[^GD#B=*0;N@1>1->[$&!5R59>(Q1H*U 3 M ^V1/FX.IVU 1, O 9.]LDFH_8SX&IP?S9%FH0204+N@P/UV@2>0,@CYQ']F MS?>4@7AM+^K?8K>^^C.W\(3RMVA<[XO-*&F@Y:-T+SA]A[F%71"L4=JXDGJT M#M5"H43QM[0+'?RRF7:?D,^$?"5\C@26$L4ROW+'J]+@1.S P^PV!P\W M0<0K$U^;]6U'31,;K\I+M=D7);L$H1M,(IYFS(I@7OUNBIS>H^>1GG],+V[I M^U1AD;(77SX6V-X*%$E@.[>XO==BPIP6S.Z_).SJ3A68+CX=2VH *\C24F69]F.*2XT+8M8>S%E@8.30L.+(790 MBIN_1Y X'NB*SH57T78N%%A9L(57"P7:"M3$0'.@CZO]<1,0$?!;P&@O8A*\ MGQ#?0O*S/M L6 )E0L*W"]G> (I@Y!O_#YI?K8,Q,MX5G^.TWKW)V[A">4? M4;O.F\THJ:'A@W2O./Z :81M$*Q0VO@EU6 =JIE"B>(?:14ZKF/ZL]U,M-N$ M?"+D"^$AB\93HVCS.W>\+ R.Q/8\G-UJ[^$FB'AEXKU9/W;4-''PLCB7J]VN M8.<@=(5)Q..$61#,J]]LD=-;]#S2\Z_IZVOZ+CEMT):< MT/F3C0?0(#KP[;.[+26=?S]+(J%Q(;SWL4E7*B4.^_F!+*^T_ =02P,$% M @ ZUU$2$.XLV2F 0 L0, !D !X;"]W;W)K&ULA5/;;J,P$/T5RQ]0KW8>5JCZTSPX,8-5F6-N$[M_7%Z#) M*E)?\,QPSIDSOA03ZG?3 5CRH61O]K2S=M@Q9JH.%#!Y*2+$N2+5-<]+0L0NU9EP6.5HH>GC4QHU)<_SN Q&E/4[H47D3;65]@ M9<%67BT4]$9@3S0T>_J8[@X;CPB 5P&3.8N)]WY$?/?)[WI/$V\!)%36*W"W MG. )I/1"KO'?6?.KI2>>QXOZSS"M7]&UTF,?N^ZI M^'J M&%+AV-NXI6MUO9V/63B3+WA9#+R%/URWHC?DB-:=;#B !M&":Y_S M)A(:Z\,[%^MXI6)B<5@>R/I*RT]02P,$% @ ZUU$2)/S7-+I 0 J@4 M !D !X;"]W;W)K&ULC53;;J,P$/T5BP\HA(1+ M(H+4=%5U'U:J^K#[[,!P46W,VB9T_WY]@R85"GW!'OM<9F1FLI'Q=]$ 2/1! M22>.7B-E?_!]431 L7A@/73JIF*<8JE"7ONBYX!+0Z+$#X,@]BEN.R_/S-DK MSS,V2-)V\,J1&"C%_-\)"!N/WL:;#M[:NI'ZP,\S?^:5+85.M*Q#'*JC][@Y MG/8:80"_6QC%U1[IW,^,O>O@9WGT IT"$"BD5L!JN< 3$**%E/%?I_EIJ8G7 M^TG]V52KLC]C 4^,_&E+V:AD P^54.&!R#FPSW+H, MM^L"NUN!K178.8'=4HD6+)GLG<._A)\S7A_>OFHD" MK\W,$*A@0R=M+\VG\UAZ#$TS?L+SK,&PO=V]R:W-H965T<'CX9PS9QB;;$#] M9AH 2]Z5;,V!-M9V>\9,T8#BY@X[:-V;"K7BUFUUS4RG@9>!I"1+DV3+%!]%YAKV5HH4734RO%-?_CB!Q.- 5G1*OHFZL3[ \8S.O% I:([ E&JH# M?5KMCQN/"(#? @9S$1/O_83XYC<_RP--O 604%BOP-URAF>0T@NYPG]'S8^2 MGG@93^K?0[?._8D;>$;Y1Y2V<6832DJH>"_M*PX_8&PA."Q0FO D16\LJHE" MB>+O<15M6(?X9I>,M&5".A+23P06"P6;W[CE>:9Q(*;C?G:KO8-K+^*4B?-F M7-M!4X?&\^R!^%-@MM1@QQPGS>+O(9K'()@H\)E\4F3"?OR2[&)P"78?S:4B! M?6OCW.;L? 6>TC#X#WB>=;R&7US7HC7DA-8=GS#E"M&"*Y_<;2AIW"6=-Q(J MZ\,'%^MX;N/&8C?=POE7D/\'4$L#!!0 ( .M=1$@Y\M7CI@$ +$# 9 M >&PO=V]R:W-H965TDV(&!7,3=U3%7B MZ*30\&*('97BYM\!)$Y[NJ%+X55TO0L%5I5LY35"@;8"-3'0[NG39G&7BO5D_=M0T M&S%A#@NF^-2$G>VI M/%JV-)C:-V:4O7ZGH[G_)X)A_PJAQX M![^XZ82VY(C.GVP\@!;1@6^?W=Q2TOOWLR826A?">Q^;=*52XG!8'LCZ2JO_ M4$L#!!0 ( .M=1$B%=B9&PO=V]R:W-H965TI#^^S <%%MS-HF MM']?7X F%4KZ@L?VNMS>NPS7'OW37)=X/9<8.T%;L<2XZ42/68_87YA$BV: M1*/ YH+)A+F[;A(OFL3^3P;!!9,)\XOC2A9-DE$@O& R8=8_3,C)%>0@*]=I M"N6B;[6_@?/JW,SWH;O"W_ L[6@%_ZBLFE:A@]"F$=Q]+8708.R#FPBCVCPW M\X1!J6V8F%CZ#O03+;KI/9D?M>P+4$L#!!0 ( .M=1$A?A&WSHP$ +$# M 9 >&PO=V]R:W-H965TUC;A.[?KR] DRI27_#,<"XSOA0CFG?; 3CR MH:2V!]HYU^\9LU4'BML[[$'[/PT:Q9U/3?"FV@[%PJL+-C"JX4";05J8J YT,?5_K@) MB CX+6"T%S$)O9\0WT/RLS[0++0 $BH7%+A?SO $4@8A;_QWTORT#,3+>%9_ MCM/Z[D_'X M,(VR!8H;3Q2ZK!.E0SA1+%/](J M=%S'].%P9'8GH>S6^T]W 01KTQ\;]:/'35- M'+PLSF6>;0IV#D)7F$0\)LQJ03"O?M,BI[?H>;+XGKZ^IN]2A^OD_G#_O<#F M6F"=!#;3B-M;(R;,<<;LOIBPBSU58-IX=2RI<- N;>E276[G8Q[/Y!->%CUO MX1^]BD*Y42A_W\0)976OX' M4$L#!!0 ( .M=1$A#.T2C3P4 /H< 9 >&PO=V]R:W-H965T MYF767%>'?-_]Y:6JRZSM?M:O?G.H\VPS&)6%+Q@+_3+;[6?+Q7#M1[U<5&]M ML=OG/VJO>2O+K/[W-B^JX\V,S^R%G[O7;=M?\)<+?[3;[,I\W^RJO5?G+S>S M;WS^&+ >&8A?N_S8G'SW^N2?JNIW_V.]N9FQ/H>\R)_;WD76?;SG=WE1])ZZ MR/^ TX^8O>'I=^L]'8;;I?^4-?E=5?R]V[3;+ELV\S;Y2_96M#^KXRJ',02] MP^>J:(;_O>>WIJU*:S+SRNR/^=SMA\^C^4O$P PW$& @1H,Q#FX@P4!^&"C2 M0(&!ZRFJZHAWK2,A\"2 MC4"8#,2O63!-I4[4=XPBLN9XUJ!R0F*1 L@'H#"(8I=VY */!2TM%!5+_,]8 M>.]S:'Z!SB"4#D!<*QZY%"G'58)#:XO0Q0?>UQP:6^CI?.\ DHZESG$!X* M(G+Q@;!R_0+O&L%-*1$%4)#*( <5UK@32N@::5+ MXPN\&04THT0;W\Z,)0 I*/)M*"?)T BJXDC$/(,Q 8S$)'/2N'G)$0^ MN)@IT"G\_,+.DH&N=!Q&(:IZ9O'N+1B&*E:$Q]2"/!2QC(FSDX>1E)II1LS: MRI)!J.C%7(^D#H7C[.'RK*P\4[=$ %UQQF-]H:67Q/ M4?9PBUCS%" >J3!"3WCS+<)Y.H"=I>.?O'XH M\_IU>$76>,_5V[XU1ZOCU?$UW#?1O[[XLKG#]CU%9^O MS4NYCW26BT/VFO^5U:^[?>,]56U;E<.KD)>J:O-N>-V]]&'[[3+P/Y*-6;;@$,>N=, MZ"-NC>D/A.BR!4[U@^Q!V)U:*DZ-+55#=*^ 5I[$&4F39$LX[00N,#/#D9]-4E$2!="\"'!R,?\0@TMI1BQ3'Z&FPN$U??Z:O0\+UE/#QML F M*K ) ED2:S%@3C/FCB:SJ$DVI;Q#8!L5V$X)TO^DG#'KVR:[J,EN2GF'P#XJ ML+\CY8S9_&-"KLXG!]7X:ZA1*0=APO%<5I>;_I3Z\_T!+_*>-O"#JJ83&IVE ML;?$'^9:2@/6/GG(,&KM6[04#&KCICL[5^%ZAL+(?GYLEA>O^ M02P,$% M @ ZUU$2!U?^?0N @ P 8 !D !X;"]W;W)K&ULC57;CILP%/P5BP]8,,:81 0I256U#Y56^] ^.XD3T!I,;2=L_[Z^$#99 M.9>7V#[,S)D!Y;@=S2IHNJTM5>956*H^9-QUXE4,>VI?+?BG$Q+"(8G0MO MS:'6MA!793SQ=DW+.M6(#DBV7T1+.%_#Q$(_BY6T2) M]< XVVHK0FJ:55*,0#54_NUX=S I14QRL"$4>8].4WIWE15GJH4 MXS(^6:$K3.HP*X^!$R(VZL$6:12BI[[%[09KCR#H<0=TW<$7EV@,D3\6R((" MV2A KDUV#H-]#(\IT"Q'>78;M_8X0C#)\1.)<- 0'@T5CP7RH$#^1"*/R3!$ M!4GN)/(X-(,07>!N&B)!0V0T-'LL4 0%BB<2>0S!>9I"=">1QV%<()(]D6@6 M-#3SAO(G!& 25'#E1YE&$,QP#H67RX :F EMQ[+3_TT[5 M:2@O4SM8OM17=EB[@?,I4Y4]/;!?5!Z:3H&-T&9LN>FR%T(SXRQY,0YKX'K#]HT9_OB^G2JOX#4$L#!!0 ( .M=1$@>W,.?B0( /T( M 9 >&PO=V]R:W-H965T/]12CO2*UC0=\/_9:5'=N MD:NU%UKDY,2;NL,OU&&GMD7T;XD;O6]RQFG0. MQ8>E^QPL-JE$*,#O&E_8S=B1WK>$O,O)S_W2]:4%W. =EPI(',YXA9M&"HG" M?XSFM:0DWHX']>\JK7"_10RO2/-6[WDES/JNL\<'=&KX*[G\P"8"E(([TC#U M[^Q.C)-VH+A.BS[TL>[4\:+/)+&A31. (8"1,-:9)H2&$%X)D940&4+T: 5H M"/"N@J>SJYU;(XZ*G)*+PWHD;Z=@(>!4B@AE1VP7$U=":5)U+8K\7( XR+VS M%/J$ 0I3:DP"YB%K#;F*>,+ I O@3E4 VL5\@95&)*'%PYK-"LUEW-3J%T<328$ *819'\\#U#'#64C1I*3*60HLEC?F6^%'H9_.XU8.X M]8.XS31N-B"<# A-0,M6E@8# AC$$%JUP&Q30+ M;CWJD-[-R[W%]*C:*G-VY-1Q_;H:5\?._0QD<[A;+X/%*IA87XM.KQOS5;[( M>W3$OQ ]UAUSMH2+EJ0ZQX$0CH5G_TEXK\2WR#AI\('+82)#Z?:L)YSTP\?& M^,53_ -02P,$% @ ZUU$2,R.%!4> @ -P8 !D !X;"]W;W)K&ULC57;DJ(P$/V5%!\P).$V6DC5>*O=AZV:FH?=YZA1 MJ$D(FT29_?O-!5&G0/5!DN:K.*U5)6H@Z7X6O*'I.K8(!_A=T59=K8'U MOA'BTVY^[F8!M!8HHUMM%8BYG.B",F:%3.*_G>8EI25>K\_J:U>M<;\ABBX$ M^U/M=&G,P@#LZ)X$5^*G#ZFHLN$9STF-"8''2*@R$7V N,IUAX1!;=\?E09/589-V)/%%)=%M)Y'L> M>3Y*;W/4#I-YHQX#QQ%KCT!9 LWOL95XT$KLJ[WC9'Z&P-=H'+7P*(0SE$SN ME-7!$C1)\3ALY6$1PC".OI467KWEG,J#&T@*;,6QUK[A?;2?>6_8GI)O\3F: M+M! ?(FF*S_2+O)%WI #_47DH:H5V AMSJ8[0GLA-#6.X8LYQ*69XOV&T;VV MR\RLI1]L?J-%B^ ]02P,$% @ ZUU$2!0']^<3 @ 2@8 !D M !X;"]W;W)K&ULA97+;J,P&(5?!;&?&@S&(2)( M#54ULQBIZF)F[21.0 5,;2=TWGY\(TTJ0S?QA7..O]]@IQ@9?Q,UI3+XZ-I> M;,):RF$-@-C7M"/B@0VT5T^.C'=$JB$_ 3%P2@[&U+4 1E$&.M+T85F8N1=> M%NPLVZ:G+SP0YZXC_-^6MFS-N?TI]-M8I^1P2M6/NW.T3!)W-;X#. *^&.%TT),Z0?#$ 2V;J>B*2E 5G8R &HE]V MO%9RKD-40$N.NA. XUFZS3SBLHI/D. O!2P'L* M._D(K1]']VOT1H,MA=/D,$$8S^LJOVX6*/$")0XH]BV$+)#5Q,D*Q1#-ZRJ_ M;A8H]0*E#@@N %E-C'&>+'!7DPS!=/4]#O+B().1KQ9HK"1-5UF6) LX5UV2 MH^A[GLS+D[GM65AH:S4_8(;P\@N;A"C*\,U.SB)A+Q)V2.G"-VTU\0JJTKU[ MZ;YII\LQAO'70P9NCOU 3O0WX:>F%\&.276#F(-^9$Q2E1,]J IK=;%?!RT] M2MW%NG1[U]F!9,-T&PO=V]R:W-H965TY8$Q%;PW M=2L7X4&IXSR*Y.; &BHG_,A:_<^.BX8J/13[2!X%HUM+:NJ(()1&#:W:L"SL MW),H"WY2==6R)Q'(4]-0\7?):GY>A#CL)IZK_4&9B:@LHIZWK1K6RHJW@6"[ M1?B YX\X,Q"+^%6QL[QZ#TSP+YR_FL&/[2)$)@96LXTR$E0_WMB*U;51TLY_ MO.C%TQ"OWSOU;W:Y.OP7*MF*U[^KK3KH:%$8;-F.GFKUS,_?F5]#8@0WO);V M-]B2I(E1?1F MA#Y@B,4L/0;EMS$KA\$](M(1@&&0$+(@S@+C 0N/N8U8=RKQ; M@.%- :=#Q=E][Q0H3B":='PT\-Z!_>:1@R71Y<:!@$Z)KD[,AHF]O:O(8,-/ MK7('9C_;WX<>B#UQ+_"R.-(]^TG%OFIE\,*5/K?M\;KC7#$= )KH-1STC:T? MU&RGS&MF%N?N,&Z@^+&[DO7WPO(?4$L#!!0 ( .M=1$CX(SPS4@( *(( M 9 >&PO=V]R:W-H965TX1?Z(C'N23(V4]$G+(3H"/#*.#+NH)B*,H!SWJAK"I M]=PK:VIZ%J0;\"L+^+GO$?N[P81.ZQ"&\\1;=VJ%F@!-#:YUAZ[' ^_H$#!\ M7(?/<+6%I8)HQ*\.3_SF/E#F=Y2^J\&/PSJ,E =,\%XH"B0O%[S%A"@FJ?S' MDO[75(6W]S/[-[U<:7^'.-Y2\KL[B%:ZC<+@@(_H3,0;G;YCNX9,$>XIX?HW MV)^YH/U<$@8]^C#7;M#7R3PI"EOF+HAM07PM@.G#@L06))\*@'&FU_6"!&IJ M1J> CTC]VW EX4R12.9 +H;+?=*<3.]44U^:N$QJ<%%$=YA88S8S)OT:L[68 MZ@H!TH+31WSOPTP^QU8C6R9(G 2))U.AX$ MF9,@>V0T,T8-!F95EB_+Y$Z9W,J4RP2%DZ#PV%"#*:,B3Y=E2J=,:64\.J=R M$E2V\R)7=QK,UF)*N"P"(Z>*GE8R/A3033%G)/YZ1S<6E$99F?A(N=,$;9RJ MQ(/"G2>8/'*;6;<&!/.DC#V4W(F"-E*51P]!=Z9@YK.U!E1*E,_.NF,%;:XJ MCQ<5= <+%LL=NYE!7BWK3A:TT:J<"2ZMC@%%3Y]?-.#F-!G1"?]$[-0-/-A1 M(0\F?7X<*158DD1/LAU:^<%P'1!\%.JV4'UBCE S$'2I"%*;:=H>)E5]V)YIXB2H@#-PFN[?S]@7 MVDYWY;X$[)Q[SKVVC['+JQZ>QY-2)GCMVG[N-K8Y'*/Q/*AZ[X*Z-N)QG$5=W?1A5;J^AZ$J]<6T3:\>AF"\=%T]_+E7 MK;YN0A;.'8_-\62FCJ@JHR5NWW2J'QO=!X,Z;,([=KL5\01QB)^-NH[OWH,I M^2>MGZ?&]_TFC*<<5*MV9J*H[>-%;57;3DQ6^3>0OFE.@>_?9_:OKER;_E,] MJJUN?S5[<[+9QF&P5X?ZTII'??VFH(9T(MSI=G2_P>XR&MW-(6'0U:_^V?3N M>?7_I 6$X0$< O@2L.C@ 0("Q%M XBKUF;FZOM2FKLI!7X/Q7$^SS6XM?)A( M+'-@BQGM.#G.P8U45;Y4O,C+Z&4B^H#A#G/O,6Q!1)8=E> A%LZ]Q/\%MH H MUA7$1P7?>2<@7JX3)"A! @3%QR1[A\E]&1XC;:NDJ,J.:@0ZI0H@22D*2'-@I!F@:H4H"+6"5B,,KCNM8D' M4)ID@C @C.%*#))-/E/R(,EE1G ;X[@2!Z444TI!R8.*@J4$US'<=DR $F$& M&6X\1G$>@)@4@E&D<.^QV7PY@0)W'\LHV8)'&4\2BA1N039[4&+[I@"I&429 M0]RI3%+6I0=)N_51QA]W*P.[,L+FQW&[6;5 M"%*X83D8EE&^L+@3N: ,C <5,B'HX';E"654P*Y,4 K"S&H[LRC,%.7WKC3\9+[W(MN>/N M:/T&K\IS?50_ZN'8]&/PI(T]H+MS]$%KHZQ^?&,=<+(7IZ71JH.97O/)&OXJ MX1M&G^>;T7(]J_X"4$L#!!0 ( .M=1$A$%\"/4 , !T/ 9 >&PO M=V]R:W-H965T>9996[D\CB\DF>15[_JC3)Q5MAE)Y M^4QF6TH;I"5^)^):WKT;C?D/*3^;C^U^;MJ-!Y&*7=5(Q/7C2RQ%FC9*=>:_ M('K+V03>OW?JZ[:[M?V/N!1+F?Y)]M6I=FN;QEX0"& ]@%]'CR 00"[!3B# 0X$.%,S MN!#@3LW@08!W"_ & S@$\*D9? CPIP8$$! \!%AJ_MK97\55'(6%O!KE.6[V M!)G5>-&(U,I&/>5EO9I:S:)=3U'X%3'"0^NK$?K!T)99*(93/;)2"-$3:T50 M.^@9JS:).J4FYH(J 7V*I2(X&_ Y*O(R+K(&D4"/O )"!C)M* R]KV>VG8XS M/FKLYZ@Q-;\,DDP8=@<5<)0 M3&7BEDIAKIL/(F+)G$A"1D7\% !;X++CJ'C M23B:A(/ A&[ZJ( / LZ RXYQQY,$:)( !+QQ 6*C"FWSF,\>XA/R$#P/%!_J M3Y"@N 1LHL?-F+<0A_JE("=@C]OZ'EM.PU: !3YWN!Y[03%]]_#=2]3VI8Z# M97*A>PKBW'5LV]:#*PVH-X57! (E@0WD6@ TP10.ZDWA%81 "6%$/R=K@#AE M&D^*>^TX6^==<1O@7#[1.EZ["!0F1H?&4T'<(2/#B7)Z2WBE(U#J&+H1.DL* MXIX]8@GE]);PVDF@,++!K: @A[ITQ!,.ZDWAM99 L67ND"D%>0$;G.(5SNE/ M27CQIC8<&294'8K790IGM<>3R?W:WP+D$\;)I%QX :=TJ,)! 0>(^[9NJ4%M MUH#*E'5W/LY$<6QO5Z6QDY>\4J>?OK6_P3VW%[B']@69+0G2OB*S%ZQ]368; M=6^[I8W"7T?Y&'/T'4$L#!!0 ( .M=1$CDB]E6P@, "X2 9 M>&PO=V]R:W-H965TGU\26;:: 7,!Q^_8%M"*IL\BZ"2#_=O5)VGQ"+*^J^=&>I.R\ M7U59MX_^J>O.BR!H=R=9Y>V#.LNZ_^6@FBKO^L?F&+3G1N;[,:@J V L#JJ\ MJ/W5(!N0D?B_D-?VP[TWB']5ZL?P\._^T6>#!EG*73>DR/O+ MFWR293EDZGO^B4G?^QP"/]Z;[-MQN+W\U[R53ZK\7NR[4Z^6^=Y>'O)+V7U3 MUW\DCD$,"7>J;,>_WN[2=JHR(;Y7Y;_TM:C'ZU7_DC(,HP, V *"+DU(,2 M< H >T"$ 9%K#P(#A&L/,0;$KCTD&)#<]!#HV1W79I-W^6K9J*O7GO.A8OFB MQYLA29_9ZQ>D[==ZS-F,J[U:OJW",%X&;T.BOQ@8F;5F$IA'-AKA$Q'T D@5 MX%,] *I(YKMX,DQJD>&0Y]DAS]8PV3SS@DS$[@\Z_'O0H9[Z$!,XS%I$)H@P MP:X0(@BY-Y;D-SLX($*4B@H/!^@IA,$-M&)/2(-)-D+!7Q/+8A ML5DY"2DG03G1_00IF2!U6"%DLKXBF66!2&Q63D;*R5".N)^ ,S+#V#RD(/TB M1+_0$*1\'MH0T+P83HM!\XK(PL9RX;?6]+E4/B'S0H 68KP@M0F!^T)ND7DA MM*5PXRD9U4N*0C3$'L0\M"&@>3&T/7'T)V$IZS5"Y*Q@Y7]"YH70ML31EX2E MES5"$ -=3D:,Q@1$F<$.*2@K8DG-FLQ):>AB+.,6>ON'J>E; W' M1!JZ+ =MBARM3#AL$YPV,IZYC%Y#/!:IQ2 V;MAVPL+48=6 MD] ^Q0..PK0 MI@?<-G0L9H32,!.V8G;#M@:##%S>\&B/!/1(X?!O [2[@7$WV^:#D'WS(:!Y M,;2[@7G[LECM%B'VX/ * K1Y@8MY(218%MJ66U-QR%V&35L7:.N"+'5(05L7 M)+9] 33&T&8'+*YJ!@*;&78$7Q"$6$0)J^KZ M _9X#CXHU^GAU(>NN$V&38!_3E#/W3J;+[.3)^(5G\ 4$L# M!!0 ( .M=1$@_N0G&. @ LX 9 >&PO=V]R:W-H965T?:PWS^^FTYW M7Q[:]6)WWCVVF\._W'?;]6)_^'/[=;I[W+:+NV.B]6KJC$G3]6*Y.;NZ.'[V MV_;JHONV7RTW[6_;R>[;>KW8_N]]N^J>+L_L&7_P^_+KP[[_8'IU,3VENUNN MV\UNV6TFV_;^\NP_]MTG:V+/')$_ENW3[L7ODS[ZSUWW5__'[=WEF>F#:%?M MEWV?Q^+PXWM[W:Y6?5:'HO]+N3X7VB=\^3OG_O%8WT/\GQ>[]KI;_;F\VS\< MPC5GD[OV?O%MM?^]>[IIJ1+'"+]TJ]WQ_Y,OWW;[;LU)SB;KQ=_#S^7F^/-I M^)=B*!E.X"B!.R7P<@)/"?PI@$H0H)DB4(&E+R)0@ M:TLHE*!H*UTI07UN5CE!W^=#SQEM+>RILZVV'I:[VS[WMPO'@3H,K..P_+#8 M+ZXNMMW39/>XZ&>K?=?SVSZ?0^:3PV#<'<;Y,=OM<:1?77R_\C%=3+_W.;UB MAH3OF?KP+QGIBI*R;"4/.20X0RC4@;&1:\HIA]NO943N14$6+JTA:S1JM6NQ52V+-T(NG&CL*/B=-4=C EA2LRP/[S)+0(AR MIUX=*'?NY%JIL 9A0N#81I94$S1"L]@V-JDJG[BOY,JKL 9A0N!88)8-EC5Y M8#W9HIK/ V7/K5QY%=8@3 @B6;8.=:)9 M[QW6B1-U0MM=AL;7^[F$T$;V!T0(%BO$D4**JM&P0APII BA7A,4C5>-)3SG M')K81NR* 2JN),V<\M@ G@U0I*X8H%IMU*Q?'HO"LRC@CIZ+HLU!W^NJ M;L>J\*2*JCKD8PD$DD 5SFYS@FSQNOL$[(I KJ@:#P?L@$ .J(*'YP39H&O= M@%41O#2I^&[#BUMAOMS04 VBA*A';FWHQ('/)=R?@82L6S\"MDX@ZU0X@6D3 M0-#KO@!=IL(:B F!8_,$-H_F3!&P4D)6V(N@4DK4K%D!*R6P4B1[$61-S:HM M?,!*":P431X1*R6R4N#-(34-0<'%J.G)B)4262F:GHQ8*9&5(C4O0=;I9DS$ M2HFD%'S=PRTS0-9;U:5!Q!Z(PQ0/NG!'KD%Y@DNR)4C=,GA*QD3AJBYM\92, M6>$C@FK,Q<#QR=72<0WFA-CQ'(]T\QDU)_V(YVZD0X%Q4OTKK0_&&%G):K(9 M(X4K<6R.1%(PPIEQ1E .W@E7R1]/>4D7SG.B2DU!P!J4F5 [+*MD*1/-&2AA M627-_H<@EV*IJK*PK9)F T20/3?2!DA%-8@2HL;B2RP^X6G=G"!]"V%!IJC8 M;!%D<[!%<[!((\^+!D,ZJ\H#&S)EGJA2O/EYS::T:ZB&A7U"5%"W;!YLE6,4X+4XS1C0V4VE+0*$V3?6H.4 M7(,Y(79LO.S)'9J5/&/_9/$Q$X\C.H")]]<:J &0$#+66(Y4;7A352GD2*=3 MN$VN%+(":@ DA(QMF.D(%X3+M1E!L/EX@+V)-#\@0K C#^%I8QJ$$\:,(#'8 M-Y'F!T0(%GL[%QH,TG$HL]Q+5AW?,O9[YAVK=!XBZ'CYI"FK8+\7VL)9:5X6 M?M(N^EU%-8@2HL;F+K1GM-+U'$/)J%[AP-XNCDH23@]S@FPNNB-WP9XM]':2 MTWBV8,\6ON@27M+Y4$XRU@T=[,?"VSR-L H65DG2UHN;-_W$6DE2Z(D*-LB87,=UD!,"!R+K)#(K+11)2A6 ML2EO"%.] 8555_F1O[28$&25[UIA/576DW +.B-(KO9<136($J+&JJNL.NF( M2)!F):W8!7D<'1<@SDA=FS7R@\OI0'-4')5(_**[5KI MEE%\)$N0^A%RQ1:N;&&QY\G"):1_/\5[F=E-Y=-J:O.U./8RR)O M&1,NYQN8E5 Y;/,JVIPKI[/Y./:Z]^RF_TX9+HXN M$!P\.V0>GN3P6IST9%#)-9@;HI^^^-K/X^)K^^MB^W6YV4T^=_M]M[[LO^=S MWW7[]I"/.3\TQT.[N#O]L6KO]_VON6^GX:MJPQ_[[O&2OGIW^O[?U3]02P,$ M% @ ZUU$2 1$ &\X @ !0@ !D !X;"]W;W)K&ULC57;;N(P%/P5*Q_0W"&@$ E85=V'E:H^[#X;,"2J'6=M0[I_O[[% MT-:$O!#[9&;..(Q\RIZR=UXC), 'P2U?!;40W3(,^;Y&!/(GVJ%6OCE21J"0 M6W8*><<0/&@2P6$21;.0P*8-JE+77EE5TK/ 38M>&>!G0B#[MT&8]JL@#H;" M6W.JA2J$51DZWJ$AJ.4-;0%#QU6PCI?;6$,TXG>#>GZS!LK\CM)WM?EY6 61 M\H PV@LE >7C@K8(8Z4D._^UHM>>BGB['M2?]7&E_1WD:$OQG^8@:NDV"L ! M'>$9BS?:OR![AEP)[BGF^A?LSUQ0,E "0."'>3:M?O;F31%9FI^06$+B"*Z/ MGY!:0GHE9/JDQID^UP\H8%4RV@/>0?5OQTL)9TI$*@-Y&"Z_D]9D^DM5Y:7* MDK0,+TKH$R;1F(W!Q X12G5OBR3PT1--3^XWV!K$/'W<(?WCRHXP,H-&0.-"$E,2QWTP\(2<.-!84!_J:E/#F=B6( MG?34X6!/SZTP-Y^KNLFV3M3M_*6^41-/W]I7F:KLX G]@NS4M!SLJ)!WO[ZB MCY0*)'U%3WD :CF3W0:CHU#+N5PS,Z7,1M!N&+IN\E?_ 5!+ P04 " #K M741(/0_V#H " !D"0 &0 'AL+W=O:,E0LQY;^J6[MR2L6[K>?14H@;2%>Y0R]]<,&D@XX_DZM&. M('B604WM!;Z_]AI8M6Z>R;87DF?XQNJJ12_$H;>F@>3? =6XW[G -0VOU;5D MHL'+,V^(.U<-:FF%6X>@R\[=@VT!8H%(XG>%>OIP[PCS1XS?Q,//\\[UA0=4 MHQ,3*2"_W%&!ZEIDXLI_==(/31'X>&^R?Y?=Y?:/D*("UW^J,RNY6]]USN@" M;S5[Q?T/I/L@'9YP3>6_<[I1AAL3XCH-?%?7JI777KV)4AUF#PAT0# $A,ED M0*@#PD\!GG(F^_4-,IAG!/<.[:"8;;#E.!%)>&:'=X;R<9(YB1RI/+OG41AG MWETD>F("R1P,LQYG"L6 @?"X ZN-P+5)!%HBF9 P3#HO$CZ+J,9]J!-LGD5: MR<3*B&8B$*:)/\X5=F[44&0U%.DD5J%4&5(,6*7I.%18H%$KL=5*;/ICFP#% M' P3C#.%8<)Y(VNKD;5.$$T848R]'K6/+\BHC<1J(]$VXHD:4 SPQ6]>)[7J MI%IG/3&[BO%7FV!>96-5V&%% ]^J))MG:KK0$*_7!?,#@%T(V M% M"25:".@R\.,E70KL2GKAB9*)T1N@I<-G7Z* 65>FOG8-\>';+!"R+SW K#V; MB8_(0(L&S[ZN@-B4U=0T*2@(ODZ3]["I-8A&PO=V]R M:W-H965T=,ANXKO!@L%?&@NC#"9Z!4N.DR7^]Z0?3%%Z>G]V_V[BZ M_1V1\,SIG[Y1G>XVCE #!W*DZI5//\!GR(WAGE-IO]'^*!5GYY((,?+NCOU@ MCY.[4I2^+%R0^H)T+EC8.X$=R+;YC2A25X)/2([$/+QDK>7"F&AGI'N3.K;U M%#9X79WJ+$\K?#)&5QI7N'6:9%9@[1Y$I%&H//6(Q7V#Q;7!PO6X\ ;9=8^# MU>0.XC1);#[W.5F0DWE.'N(L'<=IXL>RN$_)@Y3<4;(@Q:?)OY2F"'(*SREN MI"E\FGQUGU(&*:6_9T&*3^,T#Y^-LPR"EAY4WHCC- ^?R[,*8E8>L[R19_6E MIY/$09#=-J35C4!>%/BYX8N7G8%H[4R3:,^/@W+O^KP[S\VGU Z+#WE=C:2% M7T2T_2#1CBL]@[V2$.CW9YP6%@S*GI;D7;M:YA>+C>73/_Q_U M?U!+ P04 " #K741(=]<-C]@" "M"P &0 'AL+W=OK%[G6I4ID L MB;7[[S=?4JN!YD9(?,^3<]YHX : /@$#"LXPY -@!]!N#) &P#L.\*B0U(;E:(3.W:N141I"QZ M=@[XD:C?$YA+>:\@DAQ(N[C<">&%)E5"@=!ZV\0.L[T&A)B;.DQ'H"OP>D3D ZY8D)7!I- M"E$&Q@NN+J3;>J]1*XO",,['46L':K2LS%E69GS-G3MDRS(:#)-D(N/*J #( M9A,6K;Q8:Q=KM+"9L["9W7 /0.X$Y!X;;C0@0SF* ,AQ/G%*6)G[F+#N6 U,, (3Y\0]:KPPZ"X, M6F\2#X3[ ;(QQODYPWR\ ;Y>7.'&B_,?3$ ;!>:>2#;-BI$^9V'6:'3O,1JE[F9GX) MYA5PS*]49ZI[GT]\61S)GOXF_;[N>/#"A.R@=*.S8TQ0F7'\(!T\R-YYT M)]1KIJPUW:09"':\-,=#AU[^!U!+ P04 " #K741(#V3)$2 & #!)0 M&0 'AL+W=OEWN1E7Q=#7^2US>.],A/?%S7;S5']Z/.O$/9?FK M^W"WO!IGG89B4SPV78J\?7DMKHO-ILO4COPO)'T?LPO\^#YEO^T/MY7_D-?% M=;GY9[UL5JW:;#Q:%D_YRZ;Y4;XM"CB&7N%CN:G[OZ/'E[HIMRED/-KFO^/K M>M>_OL7_^ S"\ ) ?(0(.D !0'J/4"3 1H"]'N ( ,,!!BN) L!]A"@'!G@ M(,!Q SP$>&Y @(# /89NSN/,9>R0PV2_S[;HYV(2KY+^&KO)FWPVKO7:8C1O;,E\2X8>8Z,7Z8 MN4E,&&:^ N.R8>86&$6,-6 M*15G2D(&P\B@T P*,GR:ZUW/F#C7D7$FRS+&.!H=1\,XCI'!H!D,9/##2F_- M'RFUZ#@6Q@F,# [-X,Z?TZ_NCY1Z=!P?Q_&<# '-$""#P)2Z>$XC(P)/J 639IQ>O0P&%Z(G+^PX@PQX+KT4!Q>@YMB'P:A10CIXPCCE TG#U MXA4I4DERS$/@-2D"1R]4)5>OQ,M20ED&5@Z\W&0L-Z51O5TOT]4V4-F%- 0V M/X/%HU\ )3BB!Q9.J.^ KO,*-"<(7>@5*#Z%"#6X!4@%IQ#MN)*:",G/9GVL MA@$M -*!8Y 2=QP)CA,T)3E!AI)\"A%J<$^2X$D!]20/:@Q<6^BEY4$- UH< M(,W2C'N;!&\+;GB)N07(H6I@&3IE""VX1TKPR. Y.7#OD^!](5#'$R%G,R,S MZIA0CM"$>ZF,-JD^K%5$@XQ[I,K.-YYS@+C]G,*M5*7.A>C'Y@ )SQP*-T"5 M&ARB8Y@#Q%YEU, ]!MB;06<#)!6 M')M5N$DH"P-Q5A>%%[?B-$#J0P/$&0KW .5!+GK;&Z%[E8R"=4QX8:L U'+ M#T#T^HU Q+TM;A$Z S6.FI),ID5,:(268.T^X*>ET4T8M=0GB+G4:]R4= M&$L=0/12AT#$CAGN2R;Y$NHI\20O &JO,-Z1&]R_C("QB/9O 9 0EE<4!K<= M [8C6'IQVS$*U \^!TOX,M9\!D-!6&TUMT@R A"K< M6BW3C-<;@IN?28BGKL M Q#["9[#S<0E"Z#Z!X!TVZGXSS\-.#Y^)O@M@?H8).3C[N.2^U"-!D!>G[E* MY@-@5#7Y\ ./??Y<_)U7S^M=/7HHFZ;<]K_H>"K+IF@3M8O >+0J\N7APZ9X M:KJWKALI_L(H?FC*??K!U.%76[/_ 5!+ P04 " #K741(&Y,_[.L! F M!@ &0 'AL+W=OO.D$9)3;9;RC-4@@=;.Q!E.XGB#.>WZ MJ"K=WJNL2G'1K.OA52)UX9S*OP=@8MQ'))HWWKISJ^T&KDI\\]4=AUYUHD<2 MFGWTA>P.Q$F4?Z0*7@3[W=6Z-=7&$:JAH1>FW\3X':8SY#;P))ARW^AT M45KPV1(A3C_\V/5N'/V3;3S9PH9D,B0W0^H,V(-O";+TYL&F_P@)'F$I!Z23)!D M.2 -!J0N("W2QRI[IRE\E5Z3+R.R("+S=I*%$+E'3)K8?)8Q>1"33ZU8T0U846009Q8I>>$VVKA?;(&8[]2);#G@.!CROZ(77)"N*)'$0XK:7 MNC&)DB)?TPY"PB2RAC2_C23=%I]9^.X*&.@9?E)Y[GJ%CD*;V\2]](T0&DQ0 M_&0"6W-IWQ8,&FVGA27Y:\POM!CF6_GVUU#] U!+ P04 " #K741("_AZ M( T# #@#0 &0 'AL+W=O<>VV? M*[N\B/%5'CE7P7O?#7(3'I4ZW4>1W!YYW\@[<>*#_F\ZR8FK?S3D?[1G )OWV?VSZ9I1+]'!(&??-NG^U@GA?[3TY<&!X +@"N 5<= M/("Y /970&0S,W5]:E13E:.X!/+43*M-[S5\G$@T#.=H9JHJWZH$ MDC)ZFX@^8,!@'BT&2/Y_3&TQ](J(= 9H&A!B$F E*%F0<)AU"?91P@X^,%=I MNDX0HP2Q(8BS]&..@\$DM@Z+20CSF(D$54D, \MC3"6S*A83)X2LJZ2H2NHF M(ULGR%""S&,R+";3:7KDF:,RN5US*-8)"I2@L 0,%O*T&$8A\33WZ-Z .Q2(1[8.E!9>>QIPC\+L40^; M VY F VXT+?J&01YYM.Y '<@S Y#&H'\FH&@)L4LO5F4#N05S, W,F0K_?[VH%HSOS,@3L9BO63 M0^U +(7"P_ ,-SSS,;P#H>TINCE0]WP\F(N&#+;B/"A[GKZ.7B\S#V .Y'_@ M57EJ#OQ;,Q[:008O0NECO3E][X507*>@]T<8'/5UZ_K1\;V:7K-I-NP%Q'XH M<9KO4]=+7?4;4$L#!!0 ( .M=1$B\8XB\86$ &>/ 0 4 >&PO9;_LW\F90OXPR>S/-B$57PS^+A3;DLXFA6/L9QM4C?]#J=T9M%E&3?_/8W9?+;WU2_ M/=D:'_4[+XMXG:5P$I_#=0UXT5G:[B%)\?A,O\Z+"-9[FBV64 M-5Y46Y5UF?=OJZA:-:[RI^;MR@@_YBF 7%3(RAJO7>8M'_XA3M/#SUG^E 6W M<53F63P++LIR%1=M:\T7"X"VVRJ??@Z#6P*YX&I5E564T77L)YE XD$#V!0( MWSTO&P?>[1S^1^L'UW&1Y+/6RU)0_/_\M__F@V,]C'WQ[^''QCG5WY1YO>_^ M1Z_^RPE\.N//T^BA_G0>I65CY:=Y5N9I,H--S8)W41IETQA.%8A &>PKN)!5 M?,JBU2R!%P\ V3_=G@7[>XTC_OTJ@Y/H^/'Y%L:!VWH77!?Q/(:Q9WR/P1\_ MQHO[N/C_VQ F3:+[)$TJ^/IMZZ W\2P&XG:?Q@ DV9<8(!G_-G.5##-[G:-. M-UC"%7R)TE4!EF^?NNU29'1O"V7T33^MV_@',JX^!)_\]N@96FGVX- M5#[6?[LN\@4L"B@?K+**X5"G<9.4 *DL$T 2.I7J$:BM^:HQ^EU> 3)/!9JCL@3T\FQJ"3#[ M3"/& %1+Q&2XA[B25?0;J^!Q_>.=3*' M032? ]X!<2AY(0#6,Z!,.+ L:N@Y&KG8*3 =F(5Q@]\>-=[^D$>9GI!?&K?L M<]JD!AYRIA$_V[P7-2*Q/;W(2]7KA9#@,CT<# MNB'X9V=R'(Z&-5(.GX'M_K#KOPWI _ZX;]R3#L#[KJ,X=*V=_N@$T@ MW:GA]ADT>)%-?#B9 6> (X1C0CP[!"8\C98)')L'+E>+54H,9\8$S'_<[V"X M[TH^T\<\G8%8\5W;%Y=Y-@4IL\C3%&6 )*N #I-,B.3>HMP8J$G)FL-FH B/Y9)\1,\=P,#=.C&I\9DP M@%T^R;>3R!K?M;#3[?;K8N&NI^5^O=U1N=]L/B?W_2T/R8$UE,QCY PE$K K MV X=%D#=-N)9?VME;%!_*%/!4A7S:,@=/\19C"H3<9K9(LE(,T.J@]N;IBO: M*6W^\#XJ_2SB^,#';($H)?16_=D-B!I1,7T49 4"EQ/C?-V,3 ORQI:;W*LL M@SD04/4NW$3CX$@ZD!$:9W8AI$J]0+RI93GV0 T*"!PMA=6T_1Y$554D]ZN* M"'N5!S 8T/NMR&;K&.\\%W*6?$EFH(< ?"H4UOC=/O!RF0)%M(8%RC^UD$48 MP*L'(/P'2$BF##!)NJH8*NA-1, MR<4?XN3A$;X]C$#BB![@,%4%;(@G,@H"!%[HMR<% C#*-@P10@1@H0./:7=KK1 M)JWO+LY;ZGOK2Y8P<2W"Q"D+$ZV?6$(,X?2-*\2(G:#MZYNXBA(T/9Q'10;W MU/YF3=#0V-OV/F%N\]9)7BCMRP;<"M8JS_JC32^B^202'=3& );F0"]+:E._ M:(#Z1S_"*>")P#?YDCG2NM<_YK,$X)/)L/FFH99%*2UCE:&NM6;-SHL^H /@ MH$7A9M:]^X>H0&,BX,?/<3%-D&7@/IQS6+..+3YO(YBX-&W,V$ X6<\IY?!F M\7VU@7#4WMX6(M>:9VV(7/OB.L(%ZGWP/LV?MA1@ /\.I_A- EMBB$/J.4\R M6 K^"TW!930E:&JW%=6.%ZBO8EJB(?L8S06@_@+8 S+]@Q#_*?+%M:B/)S7V MV$(L/!H1*>6*_2(@S+Q*M#8V-#;6(N%X)+PBAK>042PWF$1@?_K=Z"7&!'N M]OU,ZRJ[[^CIRERLGZ:^V<;PEJGL<^S M])N0/)QJ&L*F7^ZJB0?CZDQ"FUFW#*2$.T-8-.K5O'3^< M6=N?>@QUA-U '>[CAR3+A#TL22MN>Y4(X=J7"&B1J+:)JZW\"U 2 :^%R\)P?S;S+P^$)4-J&SJ)LP1#GQ527J,%-ZLT M>_:-&9PEY12$;US]'^_BGZO@70JG7!>!6@S#W:/@ZN:'D\N+_^_D[N+J$L[A MY.[3S7EP]3YX]^GVXO+\]A;.X>KB\H?@].KR]/SF,CBY/ L^GER>_'".GKR_ M_?5_W@;7'TXN;]\Z)TKKS_2AWLNAOB6E /3>+TF19[@!V,Q=/'W,\C1_2- H M"/3J*-C_VU__%[[YM[_^[P"N$O[UAUC^1HWI&_&D?7, $('R]C0OEGE!G V0 MH'L\&>-_\54Z*>)Q,$,1S7):&1 EI::*31U91)*M^/+D$0!Y!4N4-Y" >,B M_UJEELSD3&T/I/I9G,(0CX!#@LH$VT7\"."-*GCL;!TN?,5B&LP:!67RD)% M!IISF0/Q9,H)G(O>PCU]RA+-OX%//A3)=)7B,8Z!6".NV(>.;TY/W5]^5WQP<*46NLNXIV"?> MP_H>?U'$;$Y$SAA7^0$>P&P%6T"2#*I7A8 +R+YBL0!WEJV 5:.9 +Y%"@;# MPA$OHB)) :<3X-D/,8/2\C$OX7_%"B0B.*I[X+]P]4!YF Q L H38GIY>D7!N:BS;0"TZR6#P#2+ 7$7+A>NNGRNL(9%S>@.8 M#3B3P5:!\P$%XR4>T!T"/"<576.5I"F>U)3" A1FWL= [^D=/,1H 622D",I M0D"C) WE>@5@0/:8HQ%"IIT!4O -,T3!N<"3D+@I""P1_A?QY6%5J',#3I.C M+*\!6!A2CN0"P1RD%\2S.8I4:?(7 =-YC LFM1H.XB@X6Q4D+ /\H:V/70AH M 9BSW_D93@-FP^="\/#&B-?#?5=E.VP8@8%OTB8S68I_'/ M"9GQ!0QSO7QU@L\.%;A_/F2:(5IF3@R%+3,9J!SJWS@G:D:$=%G\1"P?K9ZX M)AZ [(IQ@ECVAHC%?9(_1/K.K<]2@-0";33/!R%CY;T^9CPF$A?TIQIW!RBRZIQ8+\\U(NV::Q9!>Q!C\ M XR!C@HP'%0,%$1IF2M:@^MZ((%'"!0Q M'K5U8,!PL8< _,B%&Z0?;K9&=C1H(%ZL1/M(YN1)P/4^H.\))3>YD&D*9+]R MV&.)NX@)5C9#N6+?2' !UQ\>!;Q3)8(*DCFX18@>/,%[<9K N, FT#M3*@%\BBD_O LKJ9'!WSK(-H]XKSP*TP(H\5V%('^AC3=8@8_P3:F ML"*6*E'@(-@ACB*B)MP)L1D20>A8]TG,1'WT'E4Z -PG$E]@VE7!DF&:$(02 ME=9G1Y(#TXT#A2Q:SD!B&Q<+N E8*>G]H(? T^^#WH&#'G")%\+68U0F%/UQ MP $GEO771,M,;"%9Q/0<_=WX8_\ &/D463Z;?1!]_P24HP(JE57,T@1^^/Y= M8<0A'&B51ZYQ"2MZ#$X6H&].(\+[VC+-*0(6=IGVPW:C>Q1Y]ED(H-.-D545 M:%\H7,D3I.B$_+U"KS4%VI_',W28 >96B@.B )(>")TDDHT'I,BNS9!I2^Y$ M\I8^ #4*2GG$B&.R,A*Q:5T54$.41?@L%B!4T65DI0R!*"]Q$X!$LC[9]D(+ M)/@C >WA:JD7#C0U6L;1YSAX%SVC>L#6!MD48,)3'*45\?OK.,O*Y_0+X%'$ ML(>GX$@Y:V[:QPY@I4@8RH!X,7 @ ; O9*I[0KW)/ETAS+3=>53 012Q6+KP M$XN/+O(O&%1@9+F$[ V%"'6:_1Y92KP9GA2VNIIC+=M2+E8DT6DR^07(&!(G MK[R<8ZJ?([ZXR'KCZS\J3L':@="C1+.\-X+DH+;92_2HVBS,)"S ML)!@'^7^VDDR!->&?"!GMA;TDWR^BM,W,=P7G)0](9Y6UN!+Q*N @><+Q#'X MH5R5*-'3%(LH@\%%P= "')%W)0"K\!EE7646H2V?J.P83$.L*,RIBED+A&!0 MICV$^!NT9GRC_P5"VP6C,0H<:,CQT^]0P2D?JE&PEFAU+,L&X "G2!YXO6)) M("%/<5>&AU*=M%Q&XR+H0J?4V M+7.%P3E]WRD:_T*>S(9(V7M>E#:J3A_C&'WYP*U0O@:B(.P*-(**G $\H&+@ M4S%5SX"]/QL!1CXJ4U">'L7D\(;MCS@I27'VJNN7>!_'1*G(I#P%LR"1;!V M&03J9SZ)BM0$9>VB38&4CS)_B(ZP:2R^&MJ?VBXC!^X$<+5 ,1T@IER!! 1' MD\.U1/.X>GY3QL#E47N8LAF:W'P1R"=/)*62,@)CJ!#*))L!@2N0%*-"@&Y! M)F^DZJ$RB=2/!#?BISP.QF&Z=DE80@5PAE0%@10 3=1-6KML%92Q%;-MXK M0,]3PJK])8(R;EI>8-+.+-I2^$4B-P#' P%!\(H4EN ([-&B_:WTJLX4@WV' MS(O\8B%>*=K! @ E6:(=%>5IYJ7,1F+Z!S%)X*?YH3)5:7E9,=0R^D(Q#$@/ MT!M*NKOK/PR0UP.#GH)42G^&>"-N2TB3,Q""RDG M_PZ#H![T/BH68OZER&L5SSLC_H!?OJW MO_YOUA?HU^N3PV[PX<,IO8?_X,>VNDL0BVS5@A^X\VZ(B0B+)/U,=A[B$5-R MF>-O)!'-U$_D8XC)S$@>?!Q('> 9?AFRC9,)%DBD\#)P3%O>)G% \?%0Q!)U M(ZA81@L.'L*YC(2)?GMMGD4B"\H)@BXR"&1O%M#4]E@:G&'_]UPMF3"1E$T& M)#,1[&G-=T[*ZZNSW=4P VD]*M#RI@^.KJH#C$?*(F;J&X32N MO6[0XU.DB!:+5C8IV;WU1#$&^!_PV,] %]'1*UJ86H?&4E3H&#@M$)XI^J7- M1"[D:MJOAD-?5$4*KY+8HBFKKU%;:""0B\#2.)60NA]SU)DR;,?WU0$-#Q(( MDQW7H(6.%%&G9JR35F1P,[J2%0,V)W,(#7"O54T55T,#DN)O?"(&?N!V5_!& M"B.^@WD,UF2Q:)ZK&%:5QM(:=EJ"FTN-9*4 MD8_$K^^QT.[;@MM!C6$J\RUS6WL1#-\]#8=UL5W!_=_^^I_JDQX [L%^EE?! M\TMB7-@Z80K:-9W_ZRD:R4B6NZB@YHS M0V..$?GV6\SWO(DD.6@2D'TV@K"978[T0"D2A(F$<[)GIA'J5EGO48I;V+#2 M(W2X3IVDF*X6B$13Q$MDN=K7,>Q\2XH-1?PJ4 7($\\>WJ_0!X3_-,\>#@$S M?6>L(0-F=,PI&B_)ME^")&9[GI4$;-L*+,/T8_0EYJ\SW"[SV8B\;L:: QK$ M9Q)6T-!D&08!K76NC6V^V<;.[IB=JNBS*%'3N,[ENHJL/CL(2Q-I@OC,[)BM MX;!P\[&BG5&P-SZ:(-=-<;DIYBD1YX:C1.4DP,PEX@L$O,X)7V3S(F+404RY MH \X>9K3"C! UQJ+AB&!F\_0K$9+.S6@ GB:PVD] \M-5W!!LR\L'[QK M/@)EB$ =SG(J"1V4$ .0W<1A<.!24 1\=D"3G<98_0STK2%>VKUDZXRDQ+J. M]44<5TU;HM]T6*. 8F?DO3H7<8;.1>T%=H,_KE&G$ )+$MG9^35=A*1Q(&RD M8O!FSFU=BR%()&K0'A&?3% K*O@'>%(GJP?0C *.C>P%6GS6^*PX"J:ODAL) M -I,]42BR'\2J)/,)B&U ,]'P>] BX)95=X,PI58 9QCT-?@]ZLLUM'KP?X<1,S\B2T#>SV=*FF-/3/1"BW## [J2N:0?P_-&9B(;**G MF+W!, ^'5L2>\^*PU0@@2(-\- 6M0H1MSP$3BBPB6AZA,<$$W'*P-PF[_7'8 M[8[)C,;W'QJP("J>DMWW$8EL2:0##88<87(UK7+:UX#W)> V2QC,",;84?3, MC!.7DL+=H5Q7:5&B[M;_32$25E8S989P_1@T3@9F_R.:<"K\0Q2J)6 M_)!7260)>/I\Q(C$UYB4XF0*[E<5)9J3G&!&>^.,1#%*FO6SN_DHN!2K'SL^ MZ'( 3JD>22HT FT^C%@$V93^6KBN+!E9QCKSFDG?G]232+GH' Q+%YH#B(TC?I.B 2*EAZXKB, M$N&10S,2VA5))@LKGP)T-!,((-<.'^G-K[DF$@5B=B37'+H1N\"*_!ZYF26# M^J3[FL@9,A1I4TA#&8S1;(MGK)Q:*H>$EH>"=4$BMR$O:#&6W?Q< 1DX[$XZ M<$W/)KA)^"XR79=0ZDAGO>U])?22$'# L\*=1X@3I 1%$KC4D#5%B5J(\ *< MVC(D2-0H3$2#S-= M0Q)8Q=/RINVI9X]V1J8K$_^JXS@9;&>8E94ZZGQ/J61&@>:/2FTZL[F1;?'Q M66:,S0 T$Y#Z%L)F"@Z,I$A-]/9:J-!8Y:Z8X,;4591T@I0%@V>E/A17PW_CLXZ)+0*EM^ A9V,XT!8@28[M! .#J?2/XKEH;4:P9<8+ MN#2VA$Z,,>'[1L$ R)")I=J0G3QE[9<5CL[(XR0C"W[TKYCC_0HI\U1*DRG M\"L-MYP#$XHHSE1?NU]@=UY3!$%41-X99=.A)=*A)]5*Y'32?@#).$M48NR, MBG[BB)<^-=>-&J/8?A6A(>:0Y(N* UFN &FG>!N?8Y6[NH]Q8+D*V>"8$7(3 M'#1T_'UCKJGI3I1-D,R>%+G_@6RQ'^!QR4-*?*,R47*("L^#1O*X78TZ 4EY MRIKM^?6)MG[C-ZXB=F)YQ/#M3[=G_+JU;'8(,/:I;V5IIZ!WHN.*(YI*9.X) M9H\L.:8!CT6.#X--K(XIY)'S.E;D"L@D MP3QVW/OVMYG*2%1I<&0](5C\F2)+@4?M#Q2!U%//0CMA]WAL#J@+*Q^,[9)9O&>EZ@-CJ3#D0M1ZRR,QRU?W%3(C M5_[&B"+1=YFPKP<;S'>D[^3)!IB=Y01G3\2AZG@ <= MGEMHO=TD1(OZ+-ISM.#T2Q(%&N_:-6N(#J *(9I""2B>.A9="EK(E'%CXU$8 M]1SC]!^*:/EH7+Q>3*\+[>S:04]@(K*6C9E.^A/@4(I:AE)3*7+9.(),EJ_) MY"-;DL@1)C[*,2)&2NO"2S*:I(H[HF#29R]!<#(EMD%0^YPY*Y!$B8IU4G9V M8&VX+L'V\4#@_7@P" =U8 ^;SB'FR@YBV]AU]'H@-]1GS,,;)XYJ>YT$(#')FXAM3TF#>V M[62:4J@,QY[/S'I -I'2@-VC#@RN;&.<[,JW[0*6D@Y^OX(3[PX5>;Y&92'* MM(*?8WH#%?KJC8;AY'A@;3FFN%5E^B* D'?:]V)MV-D6ZZQL'M^)HX1"CMB5 MK!..+7P8#\+NY%ABD0%OEF)T -8P9'N@,I7= W327C'4 \-V(HZ_VBHIEV(; M+)/JJ 5E]_H\JQS.EF._ KB!P\RDS,7Z"S%X3U/O=8XF'1TK%0J(HR>18J>0 M=R6F,@? EM9>MKUTDERS6(&4**N279]AK%\ZY[O:>6C:0/>HVS%U=L1?;Z/! M^%4'^QC-^' CH<.POEYO@C9L.6]#<(SB"LK MM"M=882^#?N=CEZW0WU=PLP*DLGJV9DH_HS4(R8GY@-I-H7Q?) W"&4D"F5E MOJ'T'$7T&;R37,@^&D)JUB4U%07LA\H<89@V_AXZ[)/P>X[JD9$/;#. BMZK M28]LY,!00?9X2^@9D#Z))(Y%EECS8>@AS"A0Q%E"H35Z.:1"HQT#OO\QOI8&(H491[3L"2O("X(8+R5I'@1M;X')O&A)+A5/T0YD M$XF#(HD]-7WDVKH0GP @RSS+XG0;Q\V15@OY BE5E)/74MMA@=('H+('_'#] MH99, LX MC)GIFQ0*:<@'?I.1.G+EO\3=Z'$F*8>B12%7DZC9^T\P8$I(]H8 M6XTZ*5^(&_XOI(TO2(F-GD5DIUNP0XOUAO!L*(-\2NS+O7W7QZ,(0+F:8GRX MNA!KAZPP94#&XID$5EF7U,Q:=#(,&>I-1KL(+A@H8\$3*>8X@S*AD9%R%L=( MXZ>KRM&D+>G>@ V^Q( ,0(\V8'7"5HR7-8;X4NRP"?.BCGK?(L;$O6IG'_D] M29+6:25T4%K.2>A$TIGNAX#4Q&Q#I]"(. 4<@(K3)/\MWC\WV1S#1,J,)9.FW# MU"(ZL 8,31(!+TK"M__VU_\D-S(9-^05+7CO9_&3WI/<\H&-;&1RJYYBC+1F MCK_1M.X)2@P#KB@NU1N"E/S:RLUIAT#4K3>VY)!PQ2*#TMIP"XM$"(/!5T"& MJBI%&4Y GXWQNN@(E8Q)!::#?6M=)"-C4X* S2J<9E;5<^[J@1>"=,0'B50I M2,M(#$,TJBA<71/K4!*?JKA>,<#Q9A:<&T=$\@UQF\ZMB3A:0SI\^6C=6;J\T5%%R2(\E! M;GR,/E=C_*R5+)7--6-*'!JHC&TZDI;W*J6F*)TRU98;3F@O&<4,6FL3#FU> M GJTBU ^9E)C@@CUA![R:_1*;2S!)#MMZM/!.T8FK6U>([?:H1K:O[$GLJ?! M44W=Z"VQ28@=$JY/>!>9]ZCR1(T[T$!.- _Q\ AC(P :T,LSPU(?2J1!B<85 M3-[##(](+9@R2#RS31U4>,&SBEU2L=.HGEF*0.--4*)AEZC52>/PS MR'3%?60%G!HJ1:Y$,718%(O]U9P_YA*O&MU2E1%JY(KPG%PY1]ZZ7KW@,+BU M-""IOL_5 =D'U:C9M_[U%]34ZAT%MQ<_7%Z\OS@]N;P+3DY/KSY=WF$)K>NK M#Q>GV._FFF./4M8CC&4;-K:M@T99N2NQDZ^RALTB4%&KF_)H?/)-/:7&?8!N M0OFX6;V+']Q2X1WS;YV/PV$HH9V2 Q?WX& M=B+TD5#)38X^L R*Q2J-57D9XR:52[XUDA:^/*7#5A0X4U]) D)DC/R+WW1NJ":0ON7)'^'C'KU($]:26Y^[2=-*6CII^I\I.N'X#E:"L5PL)?-,*C M6J.#6M*%ZR&]6&VI9).-_Q:HRJ:)P\7#1O4DH+AO$@6FIO"XD]6B("@V4OX4 M-*-G#B*C_C%H,L[X8 F@$ ;O+>=H&@,ES>SYR\"#26$OFC4F>1J>%! M,M"Y7&9N3@^7RS4^5EX%UFI; E2SE9=T2PT<2!M41Q=B%J6] '*>IIYF ""D MZ0\!]"*LOD-T[:W] "-,8ZZ+*"EY["KBN$]KP\J?"&".9%(='UD<$X8,Y"AS MS'NW0KRY1 55$T+(-4P'A@7PC75<%5E<4:\G!L7W9JV:XV"-T5C"V$F-1PS% M+)0*Z"S&C/"(+LBM,(XBLLXR>$S@I(KIX[.R@I6"6";].E27#5]E3%OPHPXJHM,-%+)DH0OA+A3W9<)3\=RT'\OH_=H=&L[O$U1B<@X M+\L(:VL@Z13D@S0J_%,T%^8;PJRS.1X7:7 &='1]Q3)X%DEE)E#Z!?)C1<9K'#!M4;$32(#4ETH2L$B3'?HBB$B"ZK91!P+,4>7 MU#.82H*3![>EO@R#@DY[K+UMDYG$LJ!PJK"5V&(8N^!W':W)2%0ZQR,LTS\= MQLM3GB+3@D@*>-/\Y:93EB 9,S"J52#QA>M\QL3[&R7534A4J1U'#LLLK:H6 M"?I+\Z+B_+L%UCNV;-CN>OBLK#YKSE040%/CS1PQ0&1'0%=.EQVPH*TY^Q7GZ_?3V"N*:81Z-2OW;TU,8T4;VB63!SM2NIX8H8 MTQ3E;ZY\A\+UWEYSFE9*711EVU22A5NHA 4\3FDQ-:SQV2HCYEUO<7 4W$AB MZ U+(ZS)W^B QJ)A]K/CB=KS\YKI7R3JU#*[O6.9C/0X,T9K=.^L(JY$35T8YY=<=FC^Z3)7(.:FE/B%@'* M'I-EK2@(KA^6P_&"FP[,%92!J&1:9J>2UF( I]PM! M?!K .\4*E (M5-\H9 MM$U)4TA,D487G4 =-E*F]=41T4O\1BK// K L("'%=L$EFY1/ M026'6>XVT/>S%'TV= %L;D[L"K#, ^UE[AA55 OR;/80JQW"DVAR9;2(0Z76 M<="D6^%86\G=MF%/E-%8)8?J>3T\03F/-0AU5F5Y2<%31RN$$X[/;#R;@3 M],/C;C?LPU]V#U?R'HW#X:@7]KK]8!@.)_UP/'!?JG-^N*)AIQ/ P/@?]] 2 M#F[""&=BT%8V!["DG,2_W$3.W/OP#"6!5246OE?9\-#DCI]M>'V+EP;![>9I M-[XR4(W2),83=2Q/[Q9L/COJC,+)L!=TC\/Q9!QV1A.[=2W\.AR/PE'W6(WX MB 7O[I\=)X#NOQCLCSN#L-\Y#K;X\[;15J]]G=WPN-,+AX,^KJ@SZ0$ 'MN] MV.]V@C_4B:/@(5XP^XBEHB$#V7V>D35#;V$T[(7'D^-@(HD>H]XH M'!P/];_;QF^&TZK%'X>#T7$PZ%&12\<].'V^L?XZ^2X&_9&8VJ>5W-*@: !?T^5[-FCM8-+/9JR MP=6-59]SOBF,V+;(DY1=42X#Y>H[CW%CVJ9@EDACW,7JV.)GI M[6-=^*W.5GZ78QH'.G3>G]R^LPND>%__M.0.)/#^R>TG>OTR/Z+I#@%]X><; M6X$XQ3U'>%?\3R7NAECM7ZHOK5!UB&0P/1LEW#]%8J:<\088Y;T0Q&HNV64B;G09?;ZU.6D11/F6"\^QCI5RV"'M7 MX=43VI^8 )=3)X'+&?@(@?RN?DX:XBUK%E?VIV!C=NE M;)=6IZ %$P;(2V@7XG =KC;-U.DFY H2V%_@I>@>5T(=9]81)G,KVXS,H.RO MVIPMN/.^&%8?L&=YQC8)%XWD!!7.B&_4CQPC/YZ9,+!088ZI1RN6%1_BN!6$ M28=6&(7/%&Q/2#0]>Y>][6>5&]%5)CN\I]^75=YOI' MP?7-U?7YS=U/U#[N_#\^75QC][A6Q[-$&QA[ME(=?%J/FZSU$0LJ9'%1'W(O M ,FP!]K(>.S\_6Z5I#,*A>-T?BD75P8LGW9[0^NO4U(ZI'D4)GRA"W;C6=VUR_4L,2^F)(DF=H(VM+]&D1K+02-9KL1P,&0' MQ$GV1DCHZ+W5@L88-TJ<.*RH(@(GV.:PO7$2J@"8[CD.9N 4O&< M*8>J2O#$P Z.-(JR6DDOJ]:7R81KNV [ J2>(DMI1;XR8T[J@$NR,)#1!'Q: M"V,3,=:PL>!7]4G D]H#W;,SZ4LN>0^@&G0=5U/?VMC33+G?ZPX!"48]_D>_ M"VHO*)AJ^)TL24YNNY>,#IB,MC0WKW^"]7_@9BDE* SN=(N^*_(JF^]>V;QS M0&3UX\7M[=7-3\'EU=UY<'-^>G[QX\F[#^=O7Y.MIV,'5RDS@J:Q_YY[(8"J^*63./8?S0A(^D6 M.;.1SIIM5#AD:F'G;XL&[U9Z)Y-;7A28E:X2T#$ 6PKJQMI52JD0M#M*D($$.N.#89AXP+Y('*OYIEB?]\%89*U:S-?3,/ANT M\>O2B?A G1!)DAL\Q.[>5AF%^+1LD5);\;6],3#K\23<.(.=MUQW]=%R+1>( MJG.W1V/O0.K\-&T(-(VS%J^UQ_1$>TSKG]P(6[\FK^B='3'[*B(&/ DIUVUP M??(3TBUW@2S:@_$3DOT;.2PYIYL1MK3Q( M>8*Y1CP-7]SZ.N&.7P8:%CH0>Z]_#$(@"&G(J4#RX]30O4DG'(\&,M$9FKJ3 M*9H1RRA+N'S)]0P;P%)YO), M_O8/^B,*L:>/R->C3-6S641_4J#)&0$A#V1^X,$:=6&"EO/5D0)MY)])?4Q5 MZ32M]U3%.=>W8PJ-3C:" M*YJ>.N\("&5;D4MV"[-S2,\,W)+87ZE''QUN%H ML4ZB8JOV@^%3:\*2I(%: =_K%\=GMS< !CS!T]H#%M&?B'PT086GZ[NNC0># M3'L-SY;$98LC>$DRVYPD9%GF@W/9%_T"RR1RR5[+%X3S2SK*0:,&R#J>RI4_ MC-/3JOG1.1K9=0[8<3 Y\)/($5"C,^76.EW3H]XB@?G<>3-0A/,TIX *@A&N MCX=TERTLNY--8)UGY^_/;V[.SX+3JX_7YY>WU,'==0I@9%9+[ P%.9Q92+A*ID"WH65<@[$P+$FW*6@$;PP(:E/])>@2+*.#L M1:(JV++4^)(I8+L +(D*F8LB'%"_M>A(!K0:(JG[M/U;\Z2@ZJ9?8E->$BNW MLFWQF44*G3;B(E*)121PE63/$J<7(H"(?R9YO76E2GI)L:%NMT-I^]Q7YUEO MTT[#1!V3F]3+PG94;Q@DS*DB19R,NNW!973LQ\>DM&Y_^O6C*G5L-U">L<@ MG:/CD2W#,9M MN,?,3L4E6YMC29WB*=#Q8+5GI8ZL..DZ;-1Z!AJ#I.^-,C49[!!T@=_[%I;4 MPK?P[.ATHCKU$DE&E24S2-!Z&MW1Q%2_.YXT[ [,U$E+-0R3 *77&X7P-7T) ME!&H(L-,?82-(-1R#Y&4G'"8V"" M5-%8U(0&[\/HD%?I ..CX,/5R:52 =ZV:W6<.5@_07]^(YXV'M(>!KP,Z%[) MLB*N:LEU6(P"]2WQAY%3!-, M=(=,O*I#Z0;W;#?Y14N:N/[84![3-Y%3*0.8W"&I4*"C "B8OJM:XC2=.ZQB M^AZ6U3L:#L;?TMQ<2\FT:V&K6O^H.QG8+XST"TI0],UE7&(@#"^(';+;QM.I MH5G;9[76(CE)+_E4[4 MKO*P=8!6V[AJR43KT;U8I6.:$Z@J^;.NV4W1_[)4XQ5)B22PS#FQT+ )\1U8 M?222TO&WZY0I.S,JIT:(M4.P8C+94A_;E;+(4L^%/S@5K%EX2%>EU3BAC-XU MRN'>+_*7P7'8'[.1FO.HYJ^UA7_5Y1U/PC'( O7EO=R6OMX\US0(8 :1U7UC M_8JYCMS>Z!@T@'[O".4-DX>@X+K6/H&U$-4^1S75L4AVLUE/ ^@ERZ+B7F"A M:7=Q=1F<7_YX<7-UB:$K)Q^"N_/3WUU>?;CZX>+\-@PN+D^/ M*+KE]M.[VXNSBY,;K/3"OHV[J^#TZO+VZL/%V_>X6YCF#M\[.3\\_OCN_,6SV@L2H3(P[6CIR"8:G84U+ MYYUH3:,<$U+AX81VFE!N-RD4^AV5)I!F)A7%,5>6DG.L=KZ@NVT8'6LV2GJ. M:@&$,EFSN9!_AU^CMY!(W53!=E5P!IQ@ .@K95*Y:5-34&\P9DN'YS=X%.OG4N M/TN@\'DY4-[=\ H+ENO-K%3#9"5=7MK]3>.C;2:T2VG6A-I06H.FJ8IP\IJ? M#MC*;1EJPF [UXA41_]$191W*#3MK2[]9]@ELE!?E>DUE:7ML4)VOM@>ER%[ M7'")$@50.^:>Q(NH:9&*J6*71408MWR%ZK M96)@C&^F4_.QRTW9X1#&!/N]$591++D'Y1HKZ;E+F,><9ZR"JJRH/L7&9I;A M2MPR.KA6F?GOXQDU!FL,7+H%#W2H+,6@G@:3[A##3[%ED!KC+*8^2%B&!P.8 MG02,9,Y[DO0X,_%,?R36'(I^2^8 0R)%G/C?-AF&P;Y*,'0\>!(SJ[]=YU(Z MX.!D@!0UM3)EX&4]YA1-H3,:[3H ,5=1*K$\%QN6:!W^A9(ICH\"3PZ-%ZI: M%SK@Z=CJ-^,?266GPRC8@8BBB_&&T[R,=7.UF5P#L9[Z7&JBVN9,^BM+B&H= M#H"A&,VN!\VNUD"24:-]5O0GT?)JA2.L>[B/IQ%6AZE@]E_; M)@KZJ1Q X7:QV\#_@@?78LZ!B+C@8C*O""83J$ M2211:%SJ4":"A4.TPM_%,R ^#W"1&TPC:_F-]I@Z/0$;?&>#2U3"!;KAL-<+ MCT<8IS(^[H03%:C21[O*I-'YQW*[[9)LV0A6JT4W*1L5$N'>*.P-Q'HZ[&'Z M7MV+4H.&]=SY:'/DQ-=JA[(Y1..EL2/8Y1EU&*0X',GXCQE-LG'87S2:9,M@ MDE\FEH10ND;5:N]N(5"X2_$(%IM..-Q>R, +VQDN6CV4!"Y ^(X[ B[#B2 Q M93Z,UQFNVPE"#=5;%H4G/ P[QQ)L#J#:[;XH*7R;8/!CK#)K-57[CO)DJN=& M:5G/.TS 7^4M/0:"=G=U^N^_N_IP=GYS^QVET]S]]!8+K&*FVCN@"4XJ_EML M),>]BY3]TK69HNV^8T&_'L@J%F0SP-KX3A*X=#<%^(]Q+Z$"S_I"MQ[&/DNF*:#2*.OE/*"#C83;#J@/-_U4"?W15#259DB$EIV+Q(5 MZ2\YFX64SIR1!8 -U,J[_R47)^3]LS.@KL M7AW*F\19T^3/*RE '*)E6[4X MI1(L">,?]RZUCB>T$&KSVGFY"2]7"ON9Z'<&;[O(GU73&",5T%>SXN8[)171 M2V96%#UU:5#Q93;1J-<.,:-RAXX$0=*^#/$FX8=4.PS+'UIUQ'(G5HGG95PR M:UAW(J4V=8>VH"&5X%$UH?! \FJ$M;W53KN^U9))$,5=U*AH02^WOV##/*Z( M2\]:'F\V,!TY9;)Q*66@ZG9L%\BF^GMN&?:FBHK8T^(I*O[+P@A!,.K?-JDS M!;#)FZ&%%B4&U&*]5+$^&=DL446H2?MQX*S/:BNO("PB:?=!'SD>[1 $*)%_ M6$U-MT1 ?"8HGVZ1UTKM4?L#5*>@%CFC(U:V)D2KDU=;O3P@#9YI/'2T4?% MY%)6CXGA-3KAWHC;SHHLQ;:-,:>^.,54J(R*VB#J,0MV+:"#"-6 ![3*X7L2 M-:*RP5]_MET*5WM!$T2[GIB&+#M5RTJR(6[0IZ1:$W>BBF#-U1I4%M>OW3'_ M:;IC_MW;7?Z:J/>OD*CW=Z /5%G<-,;\5^@ORBJEVD1Z.HFJ[#2N\7Y?Y)\1[VH6"KH01>SJL>J@YFO;CUZMJ>$J1A\! M9DT?W2*=B2H)^L6V'Y5.KX5'+FA%I%P<)2 P$L"HH+X6V&-:[)">K,U69D==KWNV]03CJ]-F39,XG=T^ U="NO4>*"3'PV@[1V/6I>6+ M+?GW+HRN@Q+./T@0RXL2=_!X/.DO]L&+44EG]K#I<4(>C;8LG[ICP4[ZH1OI M'(=C6/,+DSF<@*"E MB"H>XH!C:98UI&7UC\1F0P(I\9=,W\-,G&8L_K6Y]*4VXJ%*$ZLA@)(O'1NB MKJ=0XLE@>**FB?7A#,>?2A$[3!F@0LIMEFH8=7#44ZUB=@1'O3:;0:)U>]*Q M542W?F_#H5#/#>L=]8;B=G/Y) =.O4[5^A?12;1]NU4EL?B.EEW_"VDEZU6/ MNK"J=!AS7%L4BOA7882WC)<<#^KD3-/PO0X@\ZG=+.TBPV*L*')A=316%Q9\ M+/L2_T$?X5,NC" QB*8VL5UK6T6B[DO.$VLU],=>[X>W<+,!'3-53MBZKX#RNP+";5#<9$U?E%*L175S&>CVE_:0*&M MFA&(D[@-[N9>U[(5J;3.E DD8Z\IZF7U%:/CL$8M +A\-.BX_4^Y6E MA>AD4'=#."Z0EGZOHQ+3R [XU>IQ8='I@7?L5R00V0>@P%(56,)O_A(7N=[A M;!<(:9UR%SB#CT$C(?.A6H3FV'=>G4F]IC;SLC4+<]+EYU18'Y%B,O889? = MMO ]O)T"A8Y5#/PA$EU.II_%J;$FF1+M5GF]MZ9J]@E+7:%G:3=HZ/$]V/SQ MH.WC0?!CCIHNY>B,!]_2_R8=_M^9N.Z"YP11]5#^[R8I/Q_.$9BUM8:,%3P6 M'Y'> ?$2BNC@>X>;5BT!U*4=JEO#HD/,0JZ)7S=?N-&2^*DEB7] 2?Q$^2ZP M P? .Q9-_Y&PXLH2^Z/*E>(&X4#:$NS!O4TF(+5WX8)_J)&!SM%Q3Z^.X>!] M7LQC"OC#?YTS1M+?M?F:YV%Z(="DHZ!_= Q_]D=A9]A1TZC( -_GSIJ/X7,J M-]JCS^\>FZTC=..()*,< G%>I)*/D".W<&K>ZY82?O6F>8?ZANCD#L_P'JCM M(5_!I1Z_?@'JA/<"TE.;!P]:\H_\Z;[Z\2#8I]\/W'&;)U4;'(^&K7@NS73W M3"XI&?6EE!,K4PZ/-0?)L$WQ#EFKMLJ]A^7Z>V1>6&56$QJ'0U/;5(L].SL2 M450* FG.[0X@V;"8(Z>;S0K?+Y5[<&,Y^E>UR BXH8RA$_]H'3-^X(ZP''$S MPP("G-+S)79:?&J 8H^G=HSN!>(JW0,:X?SCE$NX8V"#&88TSKH<*82972,L MP 7=;CB>]&O_\JW'DAYX1:->V!]W Q:D1H.PUSF6?]QQWG/0'?U1W&'MKZ)]N@+9@\S_)(M6Y=_Y#:2QB#Y=\/#B68^D-PT&_2__0BVAY[@V< MZW8H!6FQ2"H3><^5TQ_BS->=?>W+KPNCZV)\S]7'CQ=WS(>1AP.WQD;MYY?8 MI?UM<$[HJ!UR8GJLI(:?-)P"V=-\ M!8=-K1.UOI+-M$-;MVEA1M\L\<.V,8(ZSLC^2#<.TD!?"[-.5.= &U5Q#&4[ MY;3)QT35 ^-MFWJG8E(Y ,9BU)&,+X9!X7IL5V["J\C T\9 MI2+4[(G&CX8OPG1Q$'$.;X2.U:LL>!_?%UQ1RU_ZDMU]7.00O(.N@O]]"I_<9KC]$7 A>=OZ+JC35F<(NU&-)\0.S( M[I?HV9IJAI4J^P+MAGB!UF[KC1)-P)N7VZ'-57KL$NLPAFP&2^J](L[]J)+@ MPR?RWTK8ND2"UNL+TMS\+&NMH,G*ZJ@3#D%;Y5,E .>$C0-=%U\#$UM8'($? M=/A$&2'+ VCAU8.4BR'K -GW:[ZM.]SM& K>&8'48# MP AE7+5\3#9,[HDHU=)R]F:JTFY9'LQ7!5E\3'8S#/OE0#;# YNV<-IRIF,' M2*S0\\)R4:OAY7:U24ZYBW'MW3<#_>\#]J8<""26GE !#WB/Z\4=EK4 #R]< M$B"^Q2MKI&<;VM"TA>RCQ]4A" ="$?QV)2R<04UMJ3$JF?VL,A88R]A>TO#I M,9>.]N@@$I$2V[XZ?B*\\RFB5XJ1DETIQSY5_*BJ-:2R\C64I@\+>4P6M>AA M@2;=A5#;.&0"Q!Z=MDZ$2J1?NS8>L0NX3]N'8C>>,_X?JI %*V!J1TG15(D@ MSV(T.IJX2TT(N4C%S V:4@%N0L?9@04"SKYDP]5LN[KB/[UU0(&MNO;$SF1< MU_ =^1Z;$JU?C]+;80HCH?*_)(5OW]UK$.KXZR 4HT(38#O; ZQT6/&.(^&) M+9XT23?5!\-BO&DR;&.%4CY556'Q$.2F@+P.;KJUY"8F=QU/9!*B@4?\XIPN M"@">1DM5R42G!R32/TM&>L#M5^5D:D%'5 C8=\IU$2XJGC6?F3:^WO21I/$[*Q/_GJ@Z MHD;S\Q>MSO" MLN_*)I0L[E<%V7:4P:8E8 (E;HXO8_'9"ONL>WIIHJ;HG)NB\W9 UN8B%ZS& M9?F3(<=U*7Y#6J"IH]U2HZ:4FK8JCL.S+4.&K'X=WG"+X7$O/.[N$I$?N3$$ MG;8:$=]S_-A!+9BTGB1I3Z4RB>PZ;08TD?&&@]$@' Z&!PI,URM(WMNVU!_$ M$$IWTIB8$ZI:!J=_&OW_U' MUJ=ZO[0^-?AE]2F-[?^W-*I_"#_E%J*0&UA<3VA0!1$\2ILJ6E&'>E59V>[P MZDA!+=QVN G_+$$F.:C= <>=HXU;-M $"*4-':#]_ 5(T!S9X)6+',2< MWRT M\]65Q,,WAKF*54)EK,B+QWNABP+6S< L::)><)98*]P>_V'-RON0[/"C1E"; M#:NM(+:NNH/C_^-YK]W=!GM#%*[VNAWZ3X_^DIU&> MO=%HIN'&4C'LB-4VNN+H4U1;9>%V=2(=F17#?F@I>Y0?H3'KT6D["II"1()0 MW+)0U2=;%2FC]K"Q2=NH=96RRI*(8(IB5ZVQW#Y:WGUTY0"A10<44H(XQR1* M[W94J23YV!0YM0% K!3&DD]%4*5FD\P8.OD7;UBT](.-)G-TA"JJD?F^8H4V M^)#LJ/2MV(E0O-?E[#=4CBHFHJDJL]0K.9];Q2-S'[_\7J159T8< M.L7BX^K=YCS6-5(XLQ:1:^R8!6^KY((SKBXYCH?ZO;%]UPQ@/1D(+!$%RB0H[/UHI4C6/+1N#A MC!%7 7!, QHX_;P2@9U#7:DK#9MB]G6O:M((D/ =<',#[@U@=0384XE&JI:( M4\?04=_MZ/6(\7%6+VPE$0?Z;MVP6=^V885IC/UL>(![C,%#0*">-C(;?9?- MS!!Z4![$[F_F-A :L3>TOG%S$VJSM67911IL^5+59&F<5J/ZAZ?XQZ!NXA+A MMHTZJMI79/^,%K%I(%-O'6-)-,0Z\^#WL+K+O$!FOFQ:E3ATVH[1W1# TT[ M'0**,_?#SF!H]]UMXZ!'S@_:BOP0/5,/1JGZ/W3X+#)BHC&U:K\I3X1E/29*8 MUY8-1B/?VM+!@&E!JL&QUM? 275U"ZX3;;(^3+#HXN>8*V0ZQ<%G.9=#IW8A M,2]8%;)AXPCG[G'SH0,W!MSP*"G0F&1?\O1++(VSGX4<*,.6M2)_+:\N1I3> MFGB&$F\$9XNZ]_E_? )].CC_$;7JIDYDJKW&7T3,!=#*I]+4 MPPV]:,KI?KK+GAFMRX:'%! MQ[6>4^08;GK77KU.0*,9@D)/Y\:OSU"S4GY,D0&4%O\Y"PSH/N'UM/LHU=/Q ML9'3$JUK;)%ID([;!/ +8S]A'R=AU@P7(!L\,"^[YDY.9? #0#6(L'#R='QMT&S89Q= MPNI4&##Q)>RO;)[AZK@D2FE! DE TWJM*I(@[';9E@40RQ)GBL4[M\2PBH/0 M<&*SV7!E5C$V[!RG?$147VN%K8OJ-LYBI?IW@1JJ-%1UR;>&.N ;YS]S+1<. MX*7:&-PS^?R4CV,[L"KB.::( M2"R^$OMU#[$&EKPJ\OXHN-(Q_VKREPTH-<;5D6 @KI2^1EU3%P?B*4CJT-F9 MDB&EYE4Z(14ZLF.C&H02D!I67P%F85X2R_)8"'7)5[0+0>.!.(%5C? V\/_. M1?RJ2))/* .#A 9R2V$K6>HO%W)#$MOA+G97IY@*ELX$+>LPQ=+W(,\_HH5# M=8HQ.7B@Y,Y7*'%^,=*!$IBYDF(HG?725%4-I1@%6/"S;9O6LBY7)TG^$G/_ MB!EYYV@W4K0^3>D*Z6J!VH9NM[A$"NDAV?5T MU"])_%32RTO_+2"\)/!V4K 3 0X[QG,3R18-BD12*(EEFA2@RZ R-*4?N"B[ MT:RF(#<0'301PM3/"^M,(J!R$5,2?C'="?9-S0:L^4$&!E:5KS"O-PZL=!VG M-8(,#XJCB=C2$^LVTBH>D'&);X#/Q0"'21X1=T]I+X#T-EH>"26& MLC00RLK;^DAU#N-=,LC8X[5;HUTM0"SF8D0&^ZH*V)(*RC=UC$S73:L5;/E3O=[U($PZ.-& ME)]]@0^!(:!'B$=T89A='G9FSV,"1P]2Z3/O]9&VCYB:8O),R7;ZY0IQF5LD MWB/%T#7(5IGY081HJR,!=F8MK49@-*8>TFVQ8=9T%'R@][K!W_[Z/X(_KZAJ MK#A\]E>9BM(_X'X$1,QYK\PHF!)@Z)^!5ZN"Z_H]&M[;#VU3UWC 77Y81 MUM9 E=&D_J9WBN;"?$.8=3;'PZ.M#:BVR*W.A+?Q+%*S%3.;#ZG?AIGHB;I5 MR]9(RS ;1@,H/;9E.H:*&0Y2U+]@<9)/I4_'U[+<;8:U(0=X?N,>J/"THE." M'62(RN^E50XW. 'NC[W6R(O !C*JSI6Z,WA'K:M;,HN5"7X4?/(,(KT^G T: M02SXTVKVP.Z<0A%$$G O0'W#5G?HCY$.93+@JF2B(ICNT!5#1)#HSYD%(N8D M6,F%R+S&5)+P/+@ME949%(3CA/6W;3*3Z$VJJF96%6\C*0A^U]&:7!I51I/ M4/'.B^J0XD4E#BI1_2B:=1#L\$]W*NIC56/V$;4XO">/D-T\@FMJL8$2CB]2 MX7("NO2X;056D?=ZI>7V]0CBF@+KS4KTN6)'[I@FNEE4(&:NMH/,JF ME+^Y M\NT#95'K#5$\J.PZR1C<53"T1*VDE.A'H'F: M$G!;.+KK5+4W(=H4E3D^?29B7=2[5K,")[S2\D+ X5/MF'E,[CEV+7O.D]\3 MS1PM*L0>$J,AL*^C5NPR4PVY5=J>=!MEKQ"C%4@NP *0!5)1', ,@"L"R=7R M$.;/VM:K2T[*JBUAVJ.:43DX%> M\.!N7(\ MD*A,JQ3:.6\WB!1*KMW6E1ULACH+^7>?HA*U'[C:BG6IEBGM.MA'&C-"]+I0 M.*2^1)NS:Q*:^&USGGD4N'.W@&?36 Q_:XYA(C EZYR\1QK-R%LDN-8@&><1 M]?0M@VNXI5N.HMJ:8OB]+Q]0M]+&X;<8'91,6>,R)F/%U"@:S'2)-_Q=%1\, M5/'!K![:U*C\9[E[K0 #Y>H_2U)*#*DO!"6N1FYJ:!4M+YQJ8B@$+7.,'N*& M/]8"K#YW8: :Z^F*4-KEC]5C,PI:,9%*2%G\ MA_ DFB=&"X1*#45M?DK\TNR7OD?"Z[I?N#5AE1RJYT?>\BM%K NPT!7K\[!= M^C9KM9PFH.ISWSR-9%:D#S%K[];>>@ZG6=%"50 -L.CM*.R/!L$X' _'X6C8 MUR5>3+6:?GC<[89]^,O.S9AAM]9Q.!SUPEZW'PS#X:0?C@?N2W5)I4M>,\PB MP_^XAY:PAQE;!I) 847# -/+25S-"TW7[GUXAI++JA+3Z:N,H_]X=4AN&?C$ M8X@Z(36QSX1Y2J!0KQ>..J-P,NP%W>-P/!F'G=&$B@1A$36L%'(<#L>C<-0] M5B.JV.]V3+4A11P%#_&"/>F!*BI(;V$T[(7'D^-@(G&AH]X(6__I M?[>-+T?=H*Y![S@#0,!W@4O7#0A]OK'^.OD^-NV!N-F\5/XB?'30AR#?P]C84L[R(- M8Q7*]K'<< ()DR=[,,J7)5F[X &U$C!C+)TQ7#,4:W8J*HH4[Z/@#R@+<$-1 MN]PWB;MK!Y>^.65#(#%^&*#'H$5215;;AT+J!H9](OTIJ]7LN;%.,F-3;(25 MJ24^*PD?;XU[8+%92<@DU$M&+I(MJBRP+OQ61PMQU@YEPY_#VD[X7#!71 :%$2ZT\;O$EH#2?+'2X)UI $F7@DO<, M=><>7IISJ01I=MUPW]V9A(1*B-42<:RJZEHE)IKI:"P)6U(D&(F BFM3" ;T M1U-H?1U*H,L(/VLN57\ $N")B>!3J (8H*$?3D]#-FZ/@@M(QM/RBD&M6X.= M2/1_R*6 (2!W]M:J,$44Y5,F.,]>\7ON7!6>P")*2FY)@>%<)-3G M*Y!<^80-=NVP+X95W>>\@48JC%IP1KS9?N08^?&,^ 1]$2K,83ZID*<%<>[C M-(F_6-S&8%P^KX,OZ^(Z]#4RH8TNZGAQQ1ORV,.(QTT!3'>H'#7#E[C;*C]L M!$5AVM&*K64G,)[6RZQ DG-'8SHUB@!^U-3[@S_25#NK^_^E%*QUY^@SA;S3 MFK,R'[STE'Y5GGY5GO[QE2?<8A]HEA/JHX.(6DG5VM"CKTA8W&9X'RG7*B[J MH3![ ;9,!X0?CYV_WZV2=$883J8/5;^D#!A,L&6A^8OI)9G+Z7CGDL4EIC6,J&_CV&N'B#83@VR6^_*)GF$85(/]UK2.4ZP"D\H M71NN5';BCRQR8H4$XZ)^\N*8<.\Z,VV'S')P G>A9749*6M%5@1P C8]DY8EGC:6_MX_?Q_5'0D92P^L/?1]F1KLS2>+C"AY+.W7R8'NDJ MWPVHB)='.C5Y-[F;TDR[P1\_$B%I.#@N3+0VO/DASQX./U#\Y@E'5OX.I*!# M4(H. =8:$V,6<=O 9ZBG7VAG.(IA]\@4*"\:J#89?!OI5V+"^H/3!^^<^^"= M;=$'3R\G^.^7NN&PG=_N5VW!@9 R9Q(3(T#G*#XD%8E^_,.Z5^J=D8H&TX2QZ3\ 1F MO T8)JIUP?JO\V8H2G[8O(W&*-=.,J%:BWJ]L>I7P@! 43T3N?6\W96=FG@Q M$OCP(LTZOO(R-V5/V_NY,2F=EIGP$V5AMH['9)WO+JRSF,9F-#O0*P8 /\?4 M5ISF)7"!_EQZHW'!/Q08ZN">_:U$$%Y805W>:;32%4T4S^>S+!\S_2Y M,6CT\_I![5POK K1N*&\^$SR#4_DQ8^Z7>>D@L.^7U4JF/@Z0K?@^O/59P.; M4F?-P[W<:U&7N9KLS:3WMAV0;.DCY_E=D K)(L/5$R@[&"V*$(F!&"#SU;_& MQ.+.MSNF07[BS$$T6-2_[+,#M_YSK^/_71]5FP-&'1&*HRP>MV%HV_DX(UO! M-L.M6:(%M=" M8_\M'@5/:ZTUSH3ZVVO]!LUXM\;WM/\![U]E(=7%S%V/\U6"]"^GZ9!T'1)O MY;-]K\LUF16C$ F4_Y0#:#S\HNV0<&.W7C*S1L.RY#A#_XS MEG=\FV!EZ;% MHQLXL_IG@Z-.DQD:EHK%.W*,[E:#>*]Y"&# &LNUSFR-=[+U8!L-8-:GZA]4TX5T+B\BC@"SSI1L97L]=L'!7>_2/^$'E07<>J,\ MCXGSJ\\#A[U)__)/O>FHMIEXDXZV88A=%BH5/QQ5W6_M](_B&%LXV\R<0$/0 MWQ$U3JWBW:TF89O!I./\[S/"TS\T^K(&CMT1GF]Z$;6;[>]6Q_U MQ>!T%CTWV,*0BL=N/52ISA_H+\GYOC&['>^@7&\1,)=J12I>NP-JVPZ%?H.9 M.)4H+60 8 0J]!=3A5*7\3!2RT^4^-UVL'<8U* 637(%_K+U C2 76'-*6W$ MV7;V;HLJWCH?#W>5Q>BHY&-;$VX7(=8:N7M'P\&X:8U8OS)T^ZJ5?53] M3-I6US_J3@9;SM"*V>?L^&2G3$/SP/0.-!)2WG7P/IH*X5=4]%U>%)R<=AHM MX6G3@'03VV6BR:M$@3#>Z9RGH3H!JCWGCG-M:M]R ,J,P>4]!^CC87Z%P='L MB$,%=T_Y5QT.@P0VP!H:V:BD@;XI*GB"8'?*I7V]-&1"[N86$6R#\-Y/ODZL]:$"]-,^Q><=C=B''(VR6R-?;CF42'3HL^7X/%:M;U:%TCUB["Q M=L!^I3]V[=AUPOXJW>\KHLS7G7=[^/]:\^Z, 5]E8B^-;P_QW431*;*DTV,: M;6#(#TE.=(N0WQ9";8>ZM!#J]8T)8H<@:!Y,8=^PZ&M 8ZL84-ZJ[=7<:1X=$,\5M)[4@ M_#95P'6.(GN%7G%:38TYV^ZW#5M]S;2 R.NTK=I&\Q4.08>U[H@\DQG2@)/] M*$VQMIET5UN"Q7U(']EQH2I"NFTY=5/)BP[2,\C+#\BWHI=O8CN7:%NX<7!B ME9;")G/MN1/GIM&,'[@W'^LNX4?;A-'(4_)HJ&3L-LJT;KP?N:RJ9[C=]^@A M/YMX;.O*%.65"/5W*XS1J]2K[_-BXZYW14:9L/407P]&.M_C!QU*I:Z!8Y_: MYE;^MG=%_CDN&D U+1)& =,6N_5*E%Y+X3"Z&'EK(,/O2$(A@\O.P8EMT83M MV_R*3KC623S]6ANFUO\;-(9BOS]:\?E4GE]5I:X#<=/=9P."'9_8%C!(VWH- M!3*!?*\A/.WA@!LWU#2@K^_;UFJ^S4!>AM]M3*Y=A'L3ZSF#\#'3#-> M -B$&F)(!**.PY9%OV(@"IK_);FBL'J+*YK3:=4FE.%N+?#]F%.LHW"&']G@ MUQ;S?%=0->%GI3,UQP+;]JAI3'HFIS/M@GJ M8PZDQ>2X[_6'?4VX,-*W)3*UGN .Z88FQY&F+$-WJ2AO/L>5E8=82]QM->Z\ M2Z/IY\/;Z6..+6+\J=9TT/*W'<"VF^#1N-JV%TV>=/W)V!MH-.GX?G53JANN M(G]F=P6ZUWJ+F_\9&32OXLA4;ZN_/\C1%M-59@ =K*8?U>1L!Z(^\!*"O'O';3%5__^73M9U7;^B/6K!G]IR7!NO6?/16 MP'; ;;W-\Z[_>\3!5[OH6\UJO[CC)AC3XG3?M'V+G1CCAZV@',R5%N 1G'N[2]VV<7IMC?PD?48BR/GC4[;D13 MO?^)6H.>ZR:B3772,7([QFKUC0O]?P?K[M]A%[^ =?8KKGKK W[I' T@0GD/ M>)1XJ,OO0!=]2 8GK?;8YF_S8L<5*O1^B M 99;+1,C^OJ!/>@:7DDRPYK<3Z^^.?$JH6NB\1L1YF1%CZ-RK;>[V]UUGF;4 M_WI[73T6L"T4F_@^EZ<0N:'T8=XN-]E$L;;H0L]$+\21+>+T-8)>S96-RP_N M7PE-90#-]*+2 @C*G];>*F44P+MHLW^9&CXT.8UIQL, T1*C>P"AVRC4%OOZ M6!QATFP997]&MM(@U8BI]N6QFN(8%$$KFD>9"BG:CLB8Z@B7!E&UL4$L! A0#% @ MZUU$2$AU!>[% *P( L ( !^@$ %]R96QS+RYR96QS M4$L! A0#% @ ZUU$2!N.*CNK 0 B!D !H ( !Z ( M 'AL+U]R96QS+W=O&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 M ( .M=1$B;W;O430( %8* - " =$/ !X;"]S='EL M97,N>&UL4$L! A0#% @ ZUU$2/4X*[ U! 6 X \ M ( !21( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ZUU$2*SO M"._* @ _0P !@ ( !FQT 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0#% @ ZUU$2"S/X?W- P [! !@ M ( !^B@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! M A0#% @ ZUU$2.&UL4$L! A0#% @ ZUU$2&BRX:*F 0 L0, !D ( ! M:S0 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ ZUU$2.XI"X6F 0 L0, !D ( ! SH 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ZUU$2$.XLV2F M 0 L0, !D ( !FS\ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ZUU$2#GRU>.F 0 L0, !D M ( !@44 'AL+W=O1P >&PO=V]R M:W-H965T&UL M4$L! A0#% @ ZUU$2$,[1*-/!0 ^AP !D ( !/$L M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MZUU$2![&PO=V]R:W-H965T&UL4$L! A0#% @ ZUU$2!1!E62< @ M(PH !D ( !B%P 'AL+W=O&PO=V]R:W-H965T1A !X;"]W;W)K&UL4$L! A0#% @ ZUU$2$07P(]0 P '0\ !D M ( !'V4 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ ZUU$2 1$ &\X @ !0@ !D ( !#G4 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ZUU$ M2'?7#8_8 @ K0L !D ( !=7P 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ZUU$2 OX>B - P X T M !D ( !_8< 'AL+W=O&PO XML 54 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 55 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 57 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.1.900 html 204 238 1 false 72 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.biontech.com/20151231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.biontech.com/20151231/role/statement-consolidated-balance-sheets-current-period-unaudited Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.biontech.com/20151231/role/statement-consolidated-balance-sheets-current-period-unaudited-parentheticals Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://www.biontech.com/20151231/role/statement-consolidated-statements-of-operations-unaudited Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Changes in Equity (Deficit) (Unaudited) Sheet http://www.biontech.com/20151231/role/statement-consolidated-statements-of-changes-in-equity-deficit-unaudited Consolidated Statements of Changes in Equity (Deficit) (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.biontech.com/20151231/role/statement-consolidated-statements-of-cash-flows-unaudited Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Organization, Nature of Business, Going Concern and Management's Plans Sheet http://www.biontech.com/20151231/role/statement-note-1-organization-nature-of-business-going-concern-and-managements-plans Note 1 - Organization, Nature of Business, Going Concern and Management's Plans Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Significant Accounting Policies Sheet http://www.biontech.com/20151231/role/statement-note-2-significant-accounting-policies Note 2 - Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Property and Equipment Sheet http://www.biontech.com/20151231/role/statement-note-3-property-and-equipment Note 3 - Property and Equipment Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Promissory Note Receivable Sheet http://www.biontech.com/20151231/role/statement-note-4-promissory-note-receivable Note 4 - Promissory Note Receivable Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Notes Payable - Affiliates Notes http://www.biontech.com/20151231/role/statement-note-5-notes-payable-affiliates Note 5 - Notes Payable - Affiliates Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Deferred Compensation Sheet http://www.biontech.com/20151231/role/statement-note-6-deferred-compensation Note 6 - Deferred Compensation Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Loan Payable Sheet http://www.biontech.com/20151231/role/statement-note-7-loan-payable Note 7 - Loan Payable Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Convertible Notes Payable - Affiliates Notes http://www.biontech.com/20151231/role/statement-note-8-convertible-notes-payable-affiliates Note 8 - Convertible Notes Payable - Affiliates Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Stockholders' Equity Sheet http://www.biontech.com/20151231/role/statement-note-9-stockholders-equity Note 9 - Stockholders' Equity Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Commitments and Contingencies Sheet http://www.biontech.com/20151231/role/statement-note-10-commitments-and-contingencies Note 10 - Commitments and Contingencies Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Subsequent Events Sheet http://www.biontech.com/20151231/role/statement-note-11-subsequent-events Note 11 - Subsequent Events Notes 17 false false R18.htm 017 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.biontech.com/20151231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.biontech.com/20151231/role/statement-note-2-significant-accounting-policies 18 false false R19.htm 018 - Disclosure - Note 2 - Significant Accounting Policies (Tables) Sheet http://www.biontech.com/20151231/role/statement-note-2-significant-accounting-policies-tables Note 2 - Significant Accounting Policies (Tables) Tables http://www.biontech.com/20151231/role/statement-note-2-significant-accounting-policies 19 false false R20.htm 019 - Disclosure - Note 3 - Property and Equipment (Tables) Sheet http://www.biontech.com/20151231/role/statement-note-3-property-and-equipment-tables Note 3 - Property and Equipment (Tables) Tables http://www.biontech.com/20151231/role/statement-note-3-property-and-equipment 20 false false R21.htm 020 - Disclosure - Note 9 - Stockholders' Equity (Tables) Sheet http://www.biontech.com/20151231/role/statement-note-9-stockholders-equity-tables Note 9 - Stockholders' Equity (Tables) Tables http://www.biontech.com/20151231/role/statement-note-9-stockholders-equity 21 false false R22.htm 021 - Disclosure - Note 10 - Commitments and Contingencies (Tables) Sheet http://www.biontech.com/20151231/role/statement-note-10-commitments-and-contingencies-tables Note 10 - Commitments and Contingencies (Tables) Tables http://www.biontech.com/20151231/role/statement-note-10-commitments-and-contingencies 22 false false R23.htm 022 - Disclosure - Note 1 - Organization, Nature of Business, Going Concern and Management's Plans (Details Textual) Sheet http://www.biontech.com/20151231/role/statement-note-1-organization-nature-of-business-going-concern-and-managements-plans-details-textual Note 1 - Organization, Nature of Business, Going Concern and Management's Plans (Details Textual) Details http://www.biontech.com/20151231/role/statement-note-1-organization-nature-of-business-going-concern-and-managements-plans 23 false false R24.htm 023 - Disclosure - Note 2 - Significant Accounting Policies (Details Textual) Sheet http://www.biontech.com/20151231/role/statement-note-2-significant-accounting-policies-details-textual Note 2 - Significant Accounting Policies (Details Textual) Details http://www.biontech.com/20151231/role/statement-note-2-significant-accounting-policies-tables 24 false false R25.htm 024 - Statement - Note 2 - Antidilutive Securities (Details) Sheet http://www.biontech.com/20151231/role/statement-note-2-antidilutive-securities-details Note 2 - Antidilutive Securities (Details) Details 25 false false R26.htm 025 - Statement - Note 2 - Earnings Per Share, Basic and Diluted (Details) Sheet http://www.biontech.com/20151231/role/statement-note-2-earnings-per-share-basic-and-diluted-details Note 2 - Earnings Per Share, Basic and Diluted (Details) Details 26 false false R27.htm 026 - Disclosure - Note 3 - Property and Equipment (Details Textual) Sheet http://www.biontech.com/20151231/role/statement-note-3-property-and-equipment-details-textual Note 3 - Property and Equipment (Details Textual) Details http://www.biontech.com/20151231/role/statement-note-3-property-and-equipment-tables 27 false false R28.htm 027 - Statement - Note 3 - Property and Equipment (Details) Sheet http://www.biontech.com/20151231/role/statement-note-3-property-and-equipment-details Note 3 - Property and Equipment (Details) Details http://www.biontech.com/20151231/role/statement-note-3-property-and-equipment-tables 28 false false R29.htm 028 - Disclosure - Note 4 - Promissory Note Receivable (Details Textual) Sheet http://www.biontech.com/20151231/role/statement-note-4-promissory-note-receivable-details-textual Note 4 - Promissory Note Receivable (Details Textual) Details http://www.biontech.com/20151231/role/statement-note-4-promissory-note-receivable 29 false false R30.htm 029 - Disclosure - Note 5 - Notes Payable - Affiliates (Details Textual) Notes http://www.biontech.com/20151231/role/statement-note-5-notes-payable-affiliates-details-textual Note 5 - Notes Payable - Affiliates (Details Textual) Details http://www.biontech.com/20151231/role/statement-note-5-notes-payable-affiliates 30 false false R31.htm 030 - Disclosure - Note 6 - Deferred Compensation (Details Textual) Sheet http://www.biontech.com/20151231/role/statement-note-6-deferred-compensation-details-textual Note 6 - Deferred Compensation (Details Textual) Details http://www.biontech.com/20151231/role/statement-note-6-deferred-compensation 31 false false R32.htm 031 - Disclosure - Note 7 - Loan Payable (Details Textual) Sheet http://www.biontech.com/20151231/role/statement-note-7-loan-payable-details-textual Note 7 - Loan Payable (Details Textual) Details http://www.biontech.com/20151231/role/statement-note-7-loan-payable 32 false false R33.htm 032 - Disclosure - Note 8 - Convertible Notes Payable - Affiliates (Details Textual) Notes http://www.biontech.com/20151231/role/statement-note-8-convertible-notes-payable-affiliates-details-textual Note 8 - Convertible Notes Payable - Affiliates (Details Textual) Details http://www.biontech.com/20151231/role/statement-note-8-convertible-notes-payable-affiliates 33 false false R34.htm 033 - Disclosure - Note 9 - Stockholders' Equity (Details Textual) Sheet http://www.biontech.com/20151231/role/statement-note-9-stockholders-equity-details-textual Note 9 - Stockholders' Equity (Details Textual) Details http://www.biontech.com/20151231/role/statement-note-9-stockholders-equity-tables 34 false false R35.htm 034 - Statement - Note 9 - Black-Scholes Valuation Assumptions for Options (Details) Sheet http://www.biontech.com/20151231/role/statement-note-9-blackscholes-valuation-assumptions-for-options-details Note 9 - Black-Scholes Valuation Assumptions for Options (Details) Details 35 false false R36.htm 035 - Statement - Note 9 - Stock Options Activity (Details) Sheet http://www.biontech.com/20151231/role/statement-note-9-stock-options-activity-details Note 9 - Stock Options Activity (Details) Details 36 false false R37.htm 036 - Statement - Note 9 - Nonvested Share Activity (Details) Sheet http://www.biontech.com/20151231/role/statement-note-9-nonvested-share-activity-details Note 9 - Nonvested Share Activity (Details) Details 37 false false R38.htm 037 - Statement - Note 9 - Allocation of Recognized Period Costs (Details) Sheet http://www.biontech.com/20151231/role/statement-note-9-allocation-of-recognized-period-costs-details Note 9 - Allocation of Recognized Period Costs (Details) Details 38 false false R39.htm 038 - Disclosure - Note 10 - Commitments and Contingencies (Details Textual) Sheet http://www.biontech.com/20151231/role/statement-note-10-commitments-and-contingencies-details-textual Note 10 - Commitments and Contingencies (Details Textual) Details http://www.biontech.com/20151231/role/statement-note-10-commitments-and-contingencies-tables 39 false false R40.htm 039 - Statement - Note 10 - Summary of Outstanding Contingent Stock Bonuses (Details) Sheet http://www.biontech.com/20151231/role/statement-note-10-summary-of-outstanding-contingent-stock-bonuses-details Note 10 - Summary of Outstanding Contingent Stock Bonuses (Details) Details 40 false false R41.htm 040 - Disclosure - Note 11 - Subsequent Events (Details Textual) Sheet http://www.biontech.com/20151231/role/statement-note-11-subsequent-events-details-textual Note 11 - Subsequent Events (Details Textual) Details http://www.biontech.com/20151231/role/statement-note-11-subsequent-events 41 false false All Reports Book All Reports bnet-20151231.xml bnet-20151231.xsd bnet-20151231_cal.xml bnet-20151231_def.xml bnet-20151231_lab.xml bnet-20151231_pre.xml true true ZIP 59 0000948830-16-000099-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000948830-16-000099-xbrl.zip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end